assays_chembl_id,assays_doc_id,assays_assay_category,assays_assay_id,assays_assay_cell_type,assays_assay_tax_id,assays_assay_test_type,assays_tid,assays_assay_strain,assays_assay_type,assays_assay_organism,assays_bao_format,assays_description,assays_cell_id,assays_src_assay_id,assays_relationship_type,assays_confidence_score,assays_curated_by,assays_assay_tissue,assays_src_id,assays_variant_id,assays_tissue_id,assays_assay_subcellular_fraction
CHEMBL618647,9866,,7524,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618648,9866,,7525,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618649,9866,,7526,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618650,9866,,7527,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618651,9866,,7528,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL876497,9866,,7529,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618652,9866,,7530,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL618653,9866,,7531,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL618654,9866,,7532,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL618655,6351,,7533,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL618656,1465,,7534,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for solubility in water,,,N,1,Intermediate,,1,,,
CHEMBL618657,5182,,7535,,,,22229,,P,,BAO_0000100,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,U,0,Intermediate,,1,,,
CHEMBL618658,17847,,7536,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Solubility was determined,,,N,1,Intermediate,,1,,,
CHEMBL618659,15339,,7537,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,solubility in water (ug/mL) at 37 degree C.,,,N,1,Intermediate,,1,,,
CHEMBL618660,5202,,7538,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,,N,1,Intermediate,,1,,,
CHEMBL618661,1088,,7539,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,,N,1,Intermediate,,1,,,
CHEMBL873807,3169,,7540,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats,,,N,1,Intermediate,,1,,,
CHEMBL618662,5353,,7541,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL618663,2864,,7542,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after 3 mg/kg iv administration,,,N,1,Intermediate,,1,,,
CHEMBL618664,2864,,7543,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after 3 mg/kg iv administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL618665,2864,,7544,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after 3 mg/kg iv administration in the rat,,,N,1,Intermediate,,1,,,
CHEMBL876498,6362,,7545,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in female Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618666,6249,,7546,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat,,,N,1,Intermediate,,1,,,
CHEMBL620440,3169,,7547,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL620441,3169,,7548,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rats with metabolic oxidation,,,N,1,Intermediate,,1,,,
CHEMBL620442,3169,,7549,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rats,,,N,1,Intermediate,,1,,,
CHEMBL620443,17260,,7550,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL620444,17260,,7551,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL620445,17260,,7552,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL620446,17260,,7553,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL620447,2879,,7554,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biological half-life measured in plasma of rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621129,2879,,7555,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biological half-life measured in plasma of rat; 22-25,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621130,2879,,7556,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biological half-life measured in plasma of rat; 9-16,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL873808,3184,,7557,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for its half life when administered intravenously in rat,,,N,1,Intermediate,,1,,,
CHEMBL876598,4891,,7558,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,,N,1,Intermediate,,1,,,
CHEMBL621131,429,,7559,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621132,5656,,7560,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life (T1/2) after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL621133,4413,,7561,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound after iv administration of 20 mg/kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL621312,3598,,7562,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL621313,17267,,7563,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621314,4727,,7564,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound was determined in rat blood,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621315,17651,,7565,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life at 1 mg/kg was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621316,17651,,7566,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life at 10 mg/kg was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621317,401,,7567,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats,,,N,1,Intermediate,,1,,,
CHEMBL621318,4942,,7568,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats in hours,,,N,1,Intermediate,,1,,,
CHEMBL621319,17735,,7569,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL621377,6056,,7570,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL621378,5213,,7571,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was determined,,,N,1,Intermediate,,1,,,
CHEMBL876599,6616,,7572,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL621379,5937,,7573,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621380,5819,,7574,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621381,5819,,7575,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat plasma; Not detected,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618515,6803,,7576,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats,,,N,1,Intermediate,,1,,,
CHEMBL618516,17804,,7577,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period of compound was determined after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL618517,17804,,7578,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL618518,5948,,7579,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat,,,N,1,Intermediate,,1,,,
CHEMBL618519,1916,,7580,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL618698,1916,,7581,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,N,1,Intermediate,,1,,,
CHEMBL618862,1916,,7582,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,,N,1,Intermediate,,1,,,
CHEMBL618863,4890,,7583,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618864,17764,,7584,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL618865,4727,,7585,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life time in rat the dose of 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL618866,17509,,7586,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life 24 hr after 10 mg/kg iv administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL618867,17509,,7587,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life 24 hr after 2 mg/kg iv administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL875828,6597,,7588,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life consistent with the observed metabolic steady state in rats,,,N,1,Intermediate,,1,,,
CHEMBL618868,17735,,7589,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL618869,6597,,7590,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life for oxidative metabolic stability was determined using male human,,,N,1,Intermediate,,1,,,
CHEMBL618870,17670,,7591,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,,N,1,Intermediate,,1,,,
CHEMBL618871,1696,,7592,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618872,1742,,7593,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL873816,17800,,7594,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL618873,12923,,7595,,,,22224,,A,,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,U,0,Autocuration,,1,,,
CHEMBL621602,11954,,7596,,,,22224,,A,,BAO_0000019,Area under curve after oral dose of 0.1 mg//kg,,,U,0,Autocuration,,1,,,
CHEMBL621603,11954,,7597,,,,22224,,A,,BAO_0000218,Area under curve after oral dose of 0.3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621604,11954,,7598,,,,22224,,A,,BAO_0000218,Area under curve after oral dose of 1 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621605,11954,,7599,,,,22224,,A,,BAO_0000218,Area under curve after oral dose of 10 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621606,11954,,7600,,,,22224,,A,,BAO_0000218,Area under curve after oral dose of 23.4 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621607,11954,,7601,,,,22224,,A,,BAO_0000218,Area under curve after oral dose of 3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621608,11954,,7602,,,,22224,,A,,BAO_0000218,Area under curve after oral dose of 3.87 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621609,5237,,7603,,,,22224,,A,,BAO_0000019,Area under curve was determined,,,U,0,Autocuration,,1,,,
CHEMBL621610,4026,,7604,,,,22224,,A,,BAO_0000218,Area under curve at a dose of 10 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621611,5237,,7605,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined; ND=No data,,,N,1,Intermediate,,1,,,
CHEMBL621612,14793,,7606,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,N,1,Intermediate,,1,,,
CHEMBL622308,14793,,7607,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,N,1,Intermediate,,1,,,
CHEMBL622309,14793,,7608,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,N,1,Intermediate,,1,,,
CHEMBL622310,14793,,7609,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,,N,1,Intermediate,,1,,,
CHEMBL622311,14793,,7610,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,N,1,Intermediate,,1,,,
CHEMBL622312,14793,,7611,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,,N,1,Intermediate,,1,,,
CHEMBL622931,14793,,7612,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,N,1,Intermediate,,1,,,
CHEMBL622932,14793,,7613,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,,N,1,Intermediate,,1,,,
CHEMBL622736,14793,,7614,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622737,14793,,7615,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622738,14793,,7616,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622739,14793,,7617,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622740,14793,,7618,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622741,14793,,7619,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622742,14793,,7620,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622743,14793,,7621,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622744,11637,,7622,,10090.0,,50594,,A,Mus musculus,BAO_0000218,AUC in mice,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624134,11149,,7623,,,,22224,,A,,BAO_0000019,Area under curve was measured from the graph obtained from concentration Vs time,,,U,0,Autocuration,,1,,,
CHEMBL624135,10016,,7624,,,,22224,,A,,BAO_0000019,Area under curve value of compound per hour after oral administration,,,U,0,Autocuration,,1,,,
CHEMBL624136,17796,,7625,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined after oral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL624137,17796,,7626,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined after oral administration in rats; No data,,,N,1,Intermediate,,1,,,
CHEMBL624320,17796,,7627,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined after oral administration in rats;No data,,,N,1,Intermediate,,1,,,
CHEMBL624321,12923,,7628,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,N,1,Intermediate,,1,,,
CHEMBL624322,15372,,7629,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL624323,15372,,7630,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after iv dose of 5.06 in rats,,,N,1,Intermediate,,1,,,
CHEMBL624324,15372,,7631,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL624325,15372,,7632,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL624326,15372,,7633,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL624327,15372,,7634,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL624328,15372,,7635,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL627848,14169,,7636,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was determined in Dogs after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL627849,14169,,7637,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in Rats after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL627850,14258,,7638,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in carotid blood of rat when administered intradermally,,,N,1,Intermediate,,1,,,
CHEMBL627851,14258,,7639,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in portal blood of rat when administered intradermally,,,N,1,Intermediate,,1,,,
CHEMBL627852,15011,,7640,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627853,15011,,7641,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627854,15011,,7642,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,N,1,Intermediate,,1,,,
CHEMBL627855,15011,,7643,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627856,15011,,7644,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,,N,1,Intermediate,,1,,,
CHEMBL875339,15011,,7645,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627857,15011,,7646,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,,N,1,Intermediate,,1,,,
CHEMBL627858,11195,,7647,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627859,10130,,7648,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627860,10130,,7649,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627019,10130,,7650,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627020,10130,,7651,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627021,10130,,7652,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627022,10130,,7653,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627023,10130,,7654,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,,N,1,Intermediate,,1,,,
CHEMBL627024,10130,,7655,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627025,10130,,7656,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627026,10130,,7657,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627027,10130,,7658,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627028,10130,,7659,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627029,10130,,7660,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627030,10130,,7661,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627031,10130,,7662,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627032,10130,,7663,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627033,10130,,7664,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627034,10130,,7665,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,,N,1,Intermediate,,1,,,
CHEMBL627035,10130,,7666,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627036,10130,,7667,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL875340,10130,,7668,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627037,10130,,7669,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627038,10130,,7670,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627039,10130,,7671,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627040,10130,,7672,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624663,10130,,7673,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625963,10130,,7674,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL876799,10130,,7675,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626133,10130,,7676,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626134,10130,,7677,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,,N,1,Intermediate,,1,,,
CHEMBL626135,6295,,7678,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626136,6296,,7679,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626137,6296,,7680,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,,N,1,Intermediate,,1,,,
CHEMBL626138,6295,,7681,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626139,6296,,7682,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626140,17260,,7683,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL626141,17260,,7684,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL626142,17686,,7685,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,C24h in rat p.o. at 20 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL627930,9866,,7686,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627931,9866,,7687,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627932,9866,,7688,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627933,9866,,7689,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627934,9866,,7690,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627935,9866,,7691,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627936,9866,,7692,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627937,9866,,7693,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627938,9866,,7694,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627939,9866,,7695,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627940,9866,,7696,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627941,9866,,7697,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL876800,9866,,7698,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627942,9866,,7699,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627943,9866,,7700,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627944,9866,,7701,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627945,9866,,7702,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628584,9866,,7703,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628585,9866,,7704,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628586,9866,,7705,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628587,9866,,7706,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628588,9866,,7707,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628589,9866,,7708,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625304,9866,,7709,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625305,9866,,7710,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625306,9866,,7711,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625307,9866,,7712,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625308,9866,,7713,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627740,9866,,7714,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627741,9866,,7715,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627742,9866,,7716,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627743,9866,,7717,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627744,9866,,7718,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627745,9866,,7719,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL627746,9866,,7720,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL627747,9866,,7721,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL876810,9866,,7722,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL627748,9866,,7723,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL627749,9866,,7724,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL627750,9866,,7725,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618728,9866,,7726,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618729,9866,,7727,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618730,9866,,7728,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618731,9866,,7729,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618732,9866,,7730,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618733,9866,,7731,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618734,9866,,7732,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618735,9866,,7733,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL876602,9866,,7734,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618736,9866,,7735,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618737,9866,,7736,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618738,9866,,7737,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618739,9866,,7738,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618740,9866,,7739,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618741,9866,,7740,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618742,9866,,7741,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618743,9866,,7742,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL618744,17752,,7743,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life from rat plasma at a single oral dose of 25 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618745,5610,,7744,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in male rat,,,N,1,Intermediate,,1,,,
CHEMBL620479,5939,,7745,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat after peroral administration at 10 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL620480,5939,,7746,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat after peroral administration at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL620481,17771,,7747,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat at a dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620482,1974,,7748,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL876603,4239,,7749,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL620483,6681,,7750,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period for the compound was determined in rats at 50 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL620484,17752,,7751,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period in rats after intravenous administration at 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620485,6046,,7752,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period in rat at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620486,6685,,7753,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL620487,6685,,7754,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,,N,1,Intermediate,,1,,,
CHEMBL620488,6685,,7755,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,,N,1,Intermediate,,1,,,
CHEMBL620489,4727,,7756,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life time in rat the dose of 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620490,1088,,7757,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,,N,1,Intermediate,,1,,,
CHEMBL620491,5610,,7758,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL876604,3032,,7759,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620492,5199,,7760,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral half life was determined,,,N,1,Intermediate,,1,,,
CHEMBL620493,14941,,7761,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,,N,1,Intermediate,,1,,,
CHEMBL620494,4408,,7762,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (t1/2) in rat,,,N,1,Intermediate,,1,,,
CHEMBL620495,2552,,7763,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma elimination half-life was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620496,5199,,7764,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620497,15662,,7765,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half life was observed after intravenous administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620498,1465,,7766,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620499,1446,,7767,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life following oral administration in Fisher rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620500,6824,,7768,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL873809,17533,,7769,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasmatic Half-life after intravenous administration to rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620501,5979,,7770,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,N,1,Intermediate,,1,,,
CHEMBL620502,4689,,7771,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Terminal half life after intravenous administration (1 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL620503,4689,,7772,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Terminal half life in Rat at a oral dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620504,2463,,7773,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,N,1,Intermediate,,1,,,
CHEMBL876605,4883,,7774,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL620505,4883,,7775,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL873811,15662,,7776,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,plasma half life was observed after intravenous administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624016,3598,,7777,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL624017,4576,,7778,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL624018,4576,,7779,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean residence time determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL624019,4576,,7780,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half life determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL624020,4910,,7781,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624201,4891,,7782,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for pharmacokinetic parameter maximum time period,,,N,1,Intermediate,,1,,,
CHEMBL872528,429,,7783,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624202,5974,,7784,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624203,5974,,7785,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624350,5974,,7786,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL621320,5974,,7787,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL621321,17582,,7788,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL621322,4026,,7789,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time (Tmax) required to reach Cmax in rats,,,N,1,Intermediate,,1,,,
CHEMBL621323,4890,,7790,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL621324,6571,,7791,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time of clearance of compound in rats after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL621325,4727,,7792,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time at the dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL875837,17651,,7793,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621326,17651,,7794,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621327,14465,,7795,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax in Guinea pig (PO dose),,,N,1,Intermediate,,1,,,
CHEMBL621328,14941,,7796,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,,N,1,Intermediate,,1,,,
CHEMBL621329,5960,,7797,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Tmax) in rat,,,N,1,Intermediate,,1,,,
CHEMBL621330,5022,,7798,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Tmax) was estimated,,,N,1,Intermediate,,1,,,
CHEMBL621331,4408,,7799,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Tmax) in rat,,,N,1,Intermediate,,1,,,
CHEMBL621332,5983,,7800,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,N,1,Intermediate,,1,,,
CHEMBL621333,4689,,7801,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T max in Rat at a oral dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621334,2792,,7802,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T max was determined at 10 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL621335,15011,,7803,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,,N,1,Intermediate,,1,,,
CHEMBL621336,14180,,7804,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,,N,1,Intermediate,,1,,,
CHEMBL621337,14180,,7805,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL621338,14599,,7806,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was measured after i.v. administration into Beagle dog.,,,N,1,Intermediate,,1,,,
CHEMBL875838,14599,,7807,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was measured after iv administration into Beagle dog,,,N,1,Intermediate,,1,,,
CHEMBL621339,14599,,7808,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was measured after po administration into Beagle dog,,,N,1,Intermediate,,1,,,
CHEMBL621340,14599,,7809,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve was measured after po administration into Beagle dog.,,,N,1,Intermediate,,1,,,
CHEMBL621341,15675,,7810,,,,22224,,A,,BAO_0000218,Area under curve was measured at peroral dose of 3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621342,12706,,7811,,,,22224,,A,,BAO_0000019,Area under curve was measured by using concentration Vs time,,,U,0,Autocuration,,1,,,
CHEMBL621343,12706,,7812,,,,22224,,A,,BAO_0000019,Area under curve was measured by using concentration Vs time; not tested,,,U,0,Autocuration,,1,,,
CHEMBL621344,9750,,7813,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL621345,9750,,7814,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve(AUC) was measured in mice after oral administration.,,,N,1,Intermediate,,1,,,
CHEMBL621346,14691,,7815,,,,22224,,A,,BAO_0000019,Area under curve(AUC) value of the compound,,,U,0,Autocuration,,1,,,
CHEMBL621347,14691,,7816,,,,22224,,A,,BAO_0000218,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,U,0,Autocuration,,1,,,
CHEMBL621348,14691,,7817,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,,N,1,Intermediate,,1,,,
CHEMBL621349,2939,,7818,,,,22224,,A,,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL621350,2939,,7819,,,,22224,,A,,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL875839,2939,,7820,,,,22224,,A,,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood; No data,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL620211,2939,,7821,,,,22224,,A,,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL620212,2939,,7822,,,,22224,,A,,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL620213,2939,,7823,,,,22224,,A,,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood; No data,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL620214,9552,,7824,,9544.0,,50797,,A,Macaca mulatta,BAO_0000218,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620215,9552,,7825,,9544.0,,50797,,A,Macaca mulatta,BAO_0000218,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620216,9552,,7826,,9544.0,,50797,,A,Macaca mulatta,BAO_0000218,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620888,9552,,7827,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620889,9552,,7828,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620890,9552,,7829,,,,22224,,A,,BAO_0000019,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL620891,11911,,7830,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under plasma time curve determined in male rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL620892,16618,,7831,,,,22224,,A,,BAO_0000019,Area under the MAP curve measured over 5 min.,,,U,0,Autocuration,,1,,,
CHEMBL621079,14387,,7832,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,,N,1,Intermediate,,1,,,
CHEMBL621080,14387,,7833,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,,N,1,Intermediate,,1,,,
CHEMBL621081,12836,,7834,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL621082,12836,,7835,,10026.0,,100712,,A,Cricetinae,BAO_0000218,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL621083,12836,,7836,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL621084,14339,,7837,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,,N,1,Intermediate,,1,,,
CHEMBL621085,14339,,7838,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,,N,1,Intermediate,,1,,,
CHEMBL621086,14339,,7839,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,,N,1,Intermediate,,1,,,
CHEMBL621087,10524,,7840,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622607,9994,,7841,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622608,11325,,7842,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Serum AUC in marmosets (IV dose),,,N,1,Intermediate,,1,,,
CHEMBL624481,12536,,7843,,,,22224,,A,,BAO_0000019,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,U,0,Autocuration,,1,,,
CHEMBL624482,12536,,7844,,,,22224,,A,,BAO_0000019,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,U,0,Autocuration,,1,,,
CHEMBL624483,12536,,7845,,,,22224,,A,,BAO_0000019,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,U,0,Autocuration,,1,,,
CHEMBL624484,12536,,7846,,,,22224,,A,,BAO_0000019,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,U,0,Autocuration,,1,,,
CHEMBL624485,12536,,7847,,,,22224,,A,,BAO_0000019,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,U,0,Autocuration,,1,,,
CHEMBL624486,15556,,7848,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve for fumarate salt was evaluated in F344 Rats.,,,N,1,Intermediate,,1,,,
CHEMBL624487,2809,,7849,,,,22224,,A,,BAO_0000019,Area under the curve for the compound was calculated.,,,U,0,Autocuration,,1,,,
CHEMBL624488,9511,,7850,,,,22224,,A,,BAO_0000019,Area under the curve in concentration/ time,,,U,0,Autocuration,,1,,,
CHEMBL624489,12818,,7851,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve administered intraintestinal in rats.,,,N,1,Intermediate,,1,,,
CHEMBL625184,12818,,7852,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve administered intravenously in rats.,,,N,1,Intermediate,,1,,,
CHEMBL625185,15118,,7853,,,,22224,,A,,BAO_0000019,Area under the curve during intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL875954,15118,,7854,,,,22224,,A,,BAO_0000019,Area under the curve during intravenous administration; Not determined,,,U,0,Autocuration,,1,,,
CHEMBL625186,15118,,7855,,,,22224,,A,,BAO_0000019,Area under the curve during systemic administration,,,U,0,Autocuration,,1,,,
CHEMBL625187,15118,,7856,,,,22224,,A,,BAO_0000019,Area under the curve during systemic administration; Not determined,,,U,0,Autocuration,,1,,,
CHEMBL625188,2632,,7857,,,,22224,,A,,BAO_0000019,Area under the curve was calculated for the compound.,,,U,0,Autocuration,,1,,,
CHEMBL625189,14346,,7858,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL625190,14346,,7859,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL621733,14346,,7860,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL621734,14346,,7861,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL621735,11149,,7862,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,,N,1,Intermediate,,1,,,
CHEMBL621736,17796,,7863,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Clearance of the drug was measured in the plasma of rat; No data,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621737,5247,,7864,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The pharmacokinetic parameter plasma clearance in vivo in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621738,4727,,7865,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance at the dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL622806,5654,,7866,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL623519,5654,,7867,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL623520,17260,,7868,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL623521,17065,,7869,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,N,1,Intermediate,,1,,,
CHEMBL623522,17671,,7870,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623523,6672,,7871,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate in rat,,,N,1,Intermediate,,1,,,
CHEMBL623690,6673,,7872,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate in rat,,,N,1,Intermediate,,1,,,
CHEMBL623691,5978,,7873,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL623692,5978,,7874,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL623693,5978,,7875,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL623694,5978,,7876,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL623695,4413,,7877,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance of compound after iv administration of 20 mg/kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL623696,2661,,7878,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL623697,2661,,7879,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL623698,5005,,7880,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,U,0,Intermediate,Plasma,1,,1969.0,
CHEMBL623699,5005,,7881,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,,U,0,Intermediate,Plasma,1,,1969.0,
CHEMBL623700,15765,,7882,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Mean (%CV) PK parameters for CL(mL/min/kg).,,,N,1,Intermediate,,1,,,
CHEMBL623701,3747,,7883,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,,N,1,Intermediate,,1,,,
CHEMBL623702,16366,,7884,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623703,4199,,7885,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,,N,1,Intermediate,,1,,,
CHEMBL623704,17267,,7886,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL623705,6535,,7887,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat after administration of 2 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL623706,6535,,7888,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat after administration of 2 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL623707,5041,,7889,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined,,,N,1,Intermediate,,1,,,
CHEMBL623708,5960,,7890,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL623709,5937,,7891,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623710,5871,,7892,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat by iv administration,,,N,1,Intermediate,,1,,,
CHEMBL623711,5874,,7893,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623712,6504,,7894,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat p.o.,,,N,1,Intermediate,,1,,,
CHEMBL623713,6803,,7895,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats,,,N,1,Intermediate,,1,,,
CHEMBL623714,5041,,7896,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined; ND denotes no data,,,N,1,Intermediate,,1,,,
CHEMBL623715,5041,,7897,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined; ND denotes not determined,,,N,1,Intermediate,,1,,,
CHEMBL623716,1916,,7898,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL622980,5199,,7899,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,N,1,Intermediate,,1,,,
CHEMBL622981,16367,,7900,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL622982,6362,,7901,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance of the compound in female Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL622983,15662,,7902,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was observed after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL622984,6215,,7903,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL622985,1466,,7904,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL623631,15662,,7905,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,plasma clearance was observed after intravenous administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623632,4723,,7906,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo CL/F determined,,,N,1,Intermediate,,1,,,
CHEMBL623633,2792,,7907,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623634,2792,,7908,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623635,5213,,7909,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for the lower blood clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL621195,4687,,7910,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for the low clearance in rat (in vivo),,,N,1,Intermediate,,1,,,
CHEMBL621196,3371,,7911,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (CLb)of the compound was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL875287,4690,,7912,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Rapid clearance after intravenous administration in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL621197,5702,,7913,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL621198,740,,7914,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621199,4853,,7915,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Low plasma clearance was calculated in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621200,5789,,7916,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Clp) in rat,,,N,1,Intermediate,,1,,,
CHEMBL621201,4527,,7917,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL621202,4527,,7918,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL621203,6518,,7919,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL621204,6518,,7920,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after IV dosing at 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL621205,9866,,7921,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621206,9866,,7922,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621207,9866,,7923,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621208,9866,,7924,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621209,9866,,7925,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL876484,9866,,7926,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621210,9866,,7927,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621211,9866,,7928,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621212,9866,,7929,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621213,9866,,7930,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621214,9866,,7931,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621215,9866,,7932,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621216,9866,,7933,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621217,9866,,7934,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621218,9866,,7935,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621219,9866,,7936,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621220,9866,,7937,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621221,9866,,7938,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621222,9866,,7939,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621223,9866,,7940,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL876485,9866,,7941,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621224,9866,,7942,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621225,9866,,7943,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621226,9866,,7944,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621227,9866,,7945,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621228,9866,,7946,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621229,9866,,7947,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621230,9866,,7948,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621231,9866,,7949,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621232,9866,,7950,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621233,9866,,7951,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621234,9866,,7952,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621235,9866,,7953,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621236,9866,,7954,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621237,9866,,7955,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL876486,9866,,7956,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622436,9866,,7957,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622437,9866,,7958,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622438,9866,,7959,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622439,9866,,7960,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622440,9866,,7961,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622441,9866,,7962,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622442,9866,,7963,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622443,9866,,7964,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622444,9866,,7965,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622445,9866,,7966,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622446,9866,,7967,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622447,9866,,7968,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622448,9866,,7969,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622449,9866,,7970,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622450,9866,,7971,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622451,9866,,7972,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622452,9866,,7973,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622453,9866,,7974,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622454,9866,,7975,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622455,9866,,7976,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL876024,9866,,7977,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622456,2792,,7978,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,T max was determined at 3 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL622457,15078,,7979,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622458,15078,,7980,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622459,15022,,7981,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL873343,15022,,7982,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL622460,15022,,7983,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL622461,4576,,7984,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Time for maximum plasma concentration determined in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622462,6681,,7985,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622463,16365,,7986,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL622464,16365,,7987,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL622465,16365,,7988,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622466,16365,,7989,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL622467,16365,,7990,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622468,6824,,7991,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Time of maximum plasma concentration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876025,6685,,7992,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622469,6685,,7993,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622470,6685,,7994,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622471,15662,,7995,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time required to reach maximum concentration (Cmax) after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL622472,1742,,7996,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Time required to reach maximum concentration in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622473,2774,,7997,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624282,5199,,7998,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624283,12873,,7999,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624284,12873,,8000,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624285,1916,,8001,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624286,16367,,8002,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach Cmax after oral administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL624287,16366,,8003,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,,N,1,Intermediate,,1,,,
CHEMBL624288,216,,8004,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,,N,1,Intermediate,,1,,,
CHEMBL624289,6410,,8005,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL873344,6410,,8006,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL619623,6215,,8007,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax after peroral administration (10 mg/kg) was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621399,3598,,8008,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL621400,4527,,8009,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL621401,17670,,8010,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,,N,1,Intermediate,,1,,,
CHEMBL621402,1465,,8011,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tmax was determined,,,N,1,Intermediate,,1,,,
CHEMBL621403,2552,,8012,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tmax was determined,,,N,1,Intermediate,,1,,,
CHEMBL621121,5656,,8013,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL872525,17764,,8014,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax after peroral administration in rats at 2.4 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL621122,5610,,8015,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tmax in male rat,,,N,1,Intermediate,,1,,,
CHEMBL621123,6046,,8016,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax in rat at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621124,5874,,8017,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax in rat by po administration at a dose of 40 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621125,17596,,8018,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tmax in rats,,,N,1,Intermediate,,1,,,
CHEMBL621126,17804,,8019,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax was measured in rats after peroral administration at 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621127,1908,,8020,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,,N,1,Intermediate,,1,,,
CHEMBL621128,2959,,8021,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax value after administration of 20 mg/Kg oral dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL618263,6757,,8022,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax value at a dose of 10 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL618264,6757,,8023,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax value at a dose of 100 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL618265,6757,,8024,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax value at a dose of 50 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL618266,4186,,8025,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618267,15662,,8026,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,time required to reach maximum concentration (Cmax) after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL618450,429,,8027,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL618451,429,,8028,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL618452,5546,,8029,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,N,1,Intermediate,,1,,,
CHEMBL618453,3173,,8030,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL618454,3173,,8031,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL618455,3173,,8032,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL618456,4257,,8033,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,,N,1,Intermediate,,1,,,
CHEMBL618457,6011,,8034,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound distribution in rat tissues was determined,,,N,1,Intermediate,,1,,,
CHEMBL618458,5472,,8035,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL618459,14346,,8036,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL876733,14346,,8037,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618460,14346,,8038,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL618461,14346,,8039,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618462,15469,,8040,,,,22224,,A,,BAO_0000019,Area under the curve was determined after oral administration (300 uM/Kg),,,U,0,Autocuration,,1,,,
CHEMBL618463,14346,,8041,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618464,14346,,8042,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618465,14346,,8043,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618466,14346,,8044,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618467,14346,,8045,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618468,15372,,8046,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL618469,12935,,8047,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618470,12935,,8048,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618471,14813,,8049,,,,22224,,A,,BAO_0000218,Plasma drug AUC in rat (PO dose),,,U,0,Autocuration,,1,,,
CHEMBL618472,15792,,8050,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,,N,1,Intermediate,,1,,,
CHEMBL618473,3579,,8051,,,,22224,,A,,BAO_0000218,Area under was determined at a dose of 30 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL621699,12487,,8052,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,,N,1,Intermediate,,1,,,
CHEMBL621700,12487,,8053,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,,N,1,Intermediate,,1,,,
CHEMBL621701,12487,,8054,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,,N,1,Intermediate,,1,,,
CHEMBL621702,12487,,8055,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,,N,1,Intermediate,,1,,,
CHEMBL621703,12487,,8056,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,,N,1,Intermediate,,1,,,
CHEMBL621704,12487,,8057,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,,N,1,Intermediate,,1,,,
CHEMBL624259,12902,,8058,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624260,12902,,8059,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624430,12902,,8060,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624431,12902,,8061,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624432,12902,,8062,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624433,12902,,8063,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624434,12902,,8064,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL624435,12902,,8065,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,,N,1,Intermediate,,1,,,
CHEMBL618570,12745,,8066,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,,N,1,Intermediate,,1,,,
CHEMBL618571,12745,,8067,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,N,1,Intermediate,,1,,,
CHEMBL618572,12745,,8068,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,,N,1,Intermediate,,1,,,
CHEMBL618573,12745,,8069,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,N,1,Intermediate,,1,,,
CHEMBL619267,12745,,8070,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,,N,1,Intermediate,,1,,,
CHEMBL619431,12745,,8071,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,N,1,Intermediate,,1,,,
CHEMBL619432,12745,,8072,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,,N,1,Intermediate,,1,,,
CHEMBL619433,12745,,8073,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,N,1,Intermediate,,1,,,
CHEMBL619434,13298,,8074,,,,22224,,A,,BAO_0000218,AUC in mice after oral dose (50 mg/kg),,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL619435,12226,,8075,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL619436,12634,,8076,,,,22224,,A,,BAO_0000019,AUC (0-4 hr) ug/ml/h,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL619437,14810,,8077,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,,N,1,Intermediate,,1,,,
CHEMBL619438,13889,,8078,,,,22224,,A,,BAO_0000218,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,U,0,Autocuration,,1,,,
CHEMBL619439,10018,,8079,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for Area under curve in mice,,,N,1,Intermediate,,1,,,
CHEMBL619440,8758,,8080,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,N,1,Intermediate,,1,,,
CHEMBL619441,8758,,8081,,,,22224,,F,,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,U,0,Autocuration,,1,,,
CHEMBL619442,8758,,8082,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,N,1,Intermediate,,1,,,
CHEMBL875156,2249,,8083,,,,22224,,A,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,U,0,Autocuration,,1,,,
CHEMBL619443,2249,,8084,,,,22224,,A,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,U,0,Autocuration,,1,,,
CHEMBL619444,2249,,8085,,,,22224,,A,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,U,0,Autocuration,,1,,,
CHEMBL623464,2249,,8086,,,,22224,,A,,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,U,0,Autocuration,,1,,,
CHEMBL623465,15115,,8087,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for area under curve when administered through oral route in mouse,,,N,1,Intermediate,,1,,,
CHEMBL623466,6518,,8088,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,,N,1,Intermediate,,1,,,
CHEMBL623467,6518,,8089,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,,N,1,Intermediate,,1,,,
CHEMBL623468,6249,,8090,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL622660,2463,,8091,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,N,1,Intermediate,,1,,,
CHEMBL622661,4969,,8092,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance rate in Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL622662,17720,,8093,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL622663,3457,,8094,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (total body clearance) in rat,,,N,1,Intermediate,,1,,,
CHEMBL622664,5983,,8095,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,,N,1,Intermediate,,1,,,
CHEMBL622665,6295,,8096,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622666,6296,,8097,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621615,17686,,8098,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cl in rat i.v. at 2 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL621616,17764,,8099,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance of compound after intravenous administration in rats at 24 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL621617,5503,,8100,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was determined,,,N,1,Intermediate,,1,,,
CHEMBL621618,4368,,8101,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance by intravenous administration of 3.4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL621619,6005,,8102,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621620,5031,,8103,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate after i.v. administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL621786,4890,,8104,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL621787,5182,,8105,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL621788,5979,,8106,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,,N,1,Intermediate,,1,,,
CHEMBL621789,5656,,8107,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance (Cl) after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL621790,17804,,8108,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621791,4839,,8109,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621792,5041,,8110,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,In vitro microsome metabolism clearance in rat was determined,,,N,1,Intermediate,,1,,,Microsomes
CHEMBL621793,5041,,8111,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,,N,1,Intermediate,,1,,,Microsomes
CHEMBL621794,5974,,8112,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL621795,5496,,8113,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo plasma clearance was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621796,5739,,8114,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL621797,5676,,8115,Hepatocyte,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,401.0,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621798,4239,,8116,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Plasma clearance) was measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL621799,5676,,8117,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (clearance) in rat i.v.,,,N,1,Intermediate,,1,,,
CHEMBL621800,1918,,8118,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma Clearance was evaluated in rats, iv",,,N,1,Intermediate,,1,,,
CHEMBL621801,17800,,8119,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance (in vivo) in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL621802,6056,,8120,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL618596,5496,,8121,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined,,,N,1,Intermediate,,1,,,
CHEMBL618597,5939,,8122,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL618598,5939,,8123,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL618599,17752,,8124,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats,,,N,1,Intermediate,,1,,,
CHEMBL618600,4576,,8125,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance rate determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL618601,6011,,8126,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL618602,5510,,8127,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined,,,N,1,Intermediate,,1,,,
CHEMBL618603,5948,,8128,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance value in rat,,,N,1,Intermediate,,1,,,
CHEMBL618604,6125,,8129,,10116.0,Ex vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618605,4839,,8130,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL618606,17686,,8131,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total body clearance in rat i.v. at 2 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL618607,6571,,8132,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance of compound in rats after intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL618608,3364,,8133,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance after iv administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL618609,13569,,8134,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618610,13569,,8135,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618611,13569,,8136,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618612,13569,,8137,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618613,13569,,8138,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL621076,13569,,8139,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL621077,13569,,8140,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL621078,17670,,8141,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,,N,1,Intermediate,,1,,,
CHEMBL621251,5970,,8142,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL621252,6495,,8143,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat after oral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621253,4590,,8144,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat.,,,N,1,Intermediate,,1,,,
CHEMBL621254,6193,,8145,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate following an oral dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL621255,2832,,8146,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,,N,1,Intermediate,,1,,,
CHEMBL621256,1052,,8147,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621257,9866,,8148,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621258,9866,,8149,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621259,9866,,8150,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621260,9866,,8151,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL876494,9866,,8152,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621261,9866,,8153,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621262,9866,,8154,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621263,9866,,8155,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621264,9866,,8156,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621265,9866,,8157,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621266,9866,,8158,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621267,9866,,8159,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621268,9866,,8160,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621269,9866,,8161,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621270,9866,,8162,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621271,9866,,8163,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621272,9866,,8164,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621273,9866,,8165,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621274,9866,,8166,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL876495,9866,,8167,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621275,9866,,8168,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621276,9866,,8169,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621277,9866,,8170,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621278,9866,,8171,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621279,9866,,8172,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621280,9866,,8173,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621281,9866,,8174,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621282,9866,,8175,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621283,9866,,8176,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621284,9866,,8177,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621285,9866,,8178,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621286,9866,,8179,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623220,9866,,8180,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623221,9866,,8181,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL876029,9866,,8182,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623222,9866,,8183,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL623223,9866,,8184,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL621445,9866,,8185,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL621446,13950,,8186,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621447,13950,,8187,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL619681,13950,,8188,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL619682,13950,,8189,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL619683,13950,,8190,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL619684,13950,,8191,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619685,13950,,8192,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619686,13950,,8193,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619687,13950,,8194,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619688,13950,,8195,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619689,13950,,8196,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL619690,13950,,8197,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL619691,13950,,8198,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL619692,6062,,8199,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL619693,3598,,8200,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL619694,1908,,8201,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vc value after IV dose at a dose of 5 mg/kg in rats.,,,N,1,Intermediate,,1,,,
CHEMBL619695,17596,,8202,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL619696,4891,,8203,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for pharmacokinetic parameter volume of distribution,,,N,1,Intermediate,,1,,,
CHEMBL619697,740,,8204,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL619698,16366,,8205,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution was determined; steady state(ss),,,N,1,Intermediate,,1,,,
CHEMBL619699,3364,,8206,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume of distribution after iv administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL619700,2552,,8207,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume of distribution dosing at 3 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL619701,406,,8208,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was evaluated for volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL619702,12500,,8209,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL620335,12500,,8210,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,,N,1,Intermediate,,1,,,
CHEMBL620336,5656,,8211,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution (VD) after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL620337,17671,,8212,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620520,1094,,8213,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL620521,5833,,8214,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL875825,5939,,8215,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat after peroral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620522,5939,,8216,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat after peroral administration at 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620523,6005,,8217,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620524,1696,,8218,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat.,,,N,1,Intermediate,,1,,,
CHEMBL620525,6672,,8219,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL620526,6673,,8220,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL620527,5871,,8221,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat by iv administration,,,N,1,Intermediate,,1,,,
CHEMBL620528,6803,,8222,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rats,,,N,1,Intermediate,,1,,,
CHEMBL620529,5199,,8223,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,N,1,Intermediate,,1,,,
CHEMBL620530,4727,,8224,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution at the dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL620531,16367,,8225,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume of distribution was determined,,,N,1,Intermediate,,1,,,
CHEMBL620532,5005,,8226,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,U,0,Intermediate,,1,,,
CHEMBL620533,5005,,8227,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,,U,0,Intermediate,,1,,,
CHEMBL620534,5005,,8228,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,,U,0,Intermediate,,1,,,
CHEMBL620535,15765,,8229,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Mean (%CV) PK parameters for Vdss(mL/kg).,,,N,1,Intermediate,,1,,,
CHEMBL875826,2792,,8230,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL620536,2792,,8231,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL620537,5334,,8232,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL618526,5334,,8233,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,,N,1,Intermediate,,1,,,
CHEMBL618527,5739,,8234,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL618528,5789,,8235,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Vdss) in rat,,,N,1,Intermediate,,1,,,
CHEMBL618529,4239,,8236,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (vdss) was measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL618530,4709,,8237,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL618531,6642,,8238,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL618532,5247,,8239,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The pharmacokinetic parameter volume of distribution in vivo in rats,,,N,1,Intermediate,,1,,,
CHEMBL618533,17720,,8240,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL618534,17686,,8241,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vdss in rat i.v. at 2 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL618535,4689,,8242,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution after intravenous administration (1 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL618536,5654,,8243,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL618537,5654,,8244,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL618538,4527,,8245,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution at a dose of 10 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL618539,4521,,8246,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL618540,6057,,8247,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution was calculated in rat,,,N,1,Intermediate,,1,,,
CHEMBL618541,5510,,8248,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution was determined,,,N,1,Intermediate,,1,,,
CHEMBL618542,2938,,8249,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution after intravenous administration was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL622544,6679,,8250,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,N,1,Intermediate,,1,,,
CHEMBL622545,6685,,8251,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,,N,1,Intermediate,,1,,,
CHEMBL622546,6685,,8252,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,N,1,Intermediate,,1,,,
CHEMBL622547,6685,,8253,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,,N,1,Intermediate,,1,,,
CHEMBL622548,5145,,8254,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in steady state was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL622549,6467,,8255,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL622550,6467,,8256,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,N,1,Intermediate,,1,,,
CHEMBL622551,15115,,8257,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for area under curve when administered through oral route to mouse,,,N,1,Intermediate,,1,,,
CHEMBL622552,8758,,8258,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,N,1,Intermediate,,1,,,
CHEMBL622553,8758,,8259,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,N,1,Intermediate,,1,,,
CHEMBL622554,8267,,8260,,,In vivo,22224,,F,,BAO_0000218,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,U,0,Autocuration,,1,,,
CHEMBL622555,8267,,8261,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL622556,14239,,8262,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,,N,1,Intermediate,,1,,,
CHEMBL622557,14239,,8263,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,,N,1,Intermediate,,1,,,
CHEMBL622558,10754,,8264,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622559,10754,,8265,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622560,10754,,8266,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,,N,1,Intermediate,,1,,,
CHEMBL622561,14681,,8267,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,N,1,Intermediate,,1,,,
CHEMBL622562,14681,,8268,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,,N,1,Intermediate,,1,,,
CHEMBL622563,14681,,8269,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,N,1,Intermediate,,1,,,
CHEMBL622564,13118,,8270,,,,22224,,A,,BAO_0000019,Concentration of compound in Central nervous system,,,U,0,Autocuration,,1,,,
CHEMBL622565,13118,,8271,,,,22224,,A,,BAO_0000019,Concentration of compound in Central nervous system; Not detectable,,,U,0,Autocuration,,1,,,
CHEMBL622566,13318,,8272,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Concentration of diester in the blood, following oral administration in mice",,,N,1,Intermediate,,1,,,
CHEMBL624515,13318,,8273,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Concentration of monoester in the blood, following oral administration in mice",,,N,1,Intermediate,,1,,,
CHEMBL624516,13318,,8274,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,,N,1,Intermediate,,1,,,
CHEMBL624517,15692,,8275,,,,22224,,A,,BAO_0000019,Evaluated for Pharmacokinetic property: Area under the curve,,,U,0,Autocuration,,1,,,
CHEMBL624518,14839,,8276,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,,N,1,Intermediate,,1,,,
CHEMBL624519,14839,,8277,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,,N,1,Intermediate,,1,,,
CHEMBL624520,14839,,8278,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL624521,14839,,8279,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL624522,14839,,8280,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL624523,14839,,8281,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL624409,14839,,8282,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL624410,14839,,8283,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL624411,14839,,8284,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623531,14839,,8285,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623532,14839,,8286,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623533,14839,,8287,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623534,14839,,8288,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623535,14839,,8289,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL623536,14839,,8290,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL623537,14839,,8291,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL623538,14839,,8292,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL623539,14839,,8293,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL623540,14839,,8294,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,,N,1,Intermediate,,1,,,
CHEMBL623541,14839,,8295,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,,N,1,Intermediate,,1,,,
CHEMBL623542,14839,,8296,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,,N,1,Intermediate,,1,,,
CHEMBL623543,14839,,8297,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623544,14839,,8298,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,,N,1,Intermediate,,1,,,
CHEMBL623545,14839,,8299,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,,N,1,Intermediate,,1,,,
CHEMBL623546,14839,,8300,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,,N,1,Intermediate,,1,,,
CHEMBL623547,5408,,8301,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623548,6827,,8302,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,High i.v. clearance in Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL623549,17538,,8303,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,In vitro clearance in rat liver microsomes,,,N,1,Intermediate,Liver,1,,2107.0,Microsomes
CHEMBL623550,6331,,8304,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Intrinsic clearance in rat liver microsomes was determined,,,N,1,Intermediate,Liver,1,,2107.0,Microsomes
CHEMBL875276,5948,,8305,Hepatocyte,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Intrinsic clearance in rat hepatocytes was determined,401.0,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621872,4026,,8306,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma Clearance was determined,,,N,1,Intermediate,,1,,,
CHEMBL621873,6647,,8307,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL621874,1696,,8308,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat.,,,N,1,Intermediate,,1,,,
CHEMBL621875,6597,,8309,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats,,,N,1,Intermediate,,1,,,
CHEMBL621876,347,,8310,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,,N,1,Intermediate,,1,,,
CHEMBL621877,16423,,8311,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,,N,1,Intermediate,,1,,,
CHEMBL621878,2879,,8312,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL621879,4883,,8313,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621880,5328,,8314,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621881,5160,,8315,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621882,17582,,8316,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL875283,17651,,8317,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total clearance at 1 mg/kg was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621883,17651,,8318,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total clearance at 10 mg/kg was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621884,6596,,8319,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL621885,4796,,8320,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance rate determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL621886,6850,,8321,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance of compound in rat was evaluated,,,N,1,Intermediate,,1,,,
CHEMBL621887,5932,,8322,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621888,3371,,8323,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (blood clearance) in rat,,,N,1,Intermediate,,1,,,
CHEMBL621889,2083,,8324,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL621890,4942,,8325,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats,,,N,1,Intermediate,,1,,,
CHEMBL621891,6838,,8326,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,,N,1,Intermediate,Liver,1,,2107.0,Microsomes
CHEMBL621892,5353,,8327,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL621893,6641,,8328,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rat,,,N,1,Intermediate,,1,,,
CHEMBL621894,6641,,8329,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,,N,1,Intermediate,,1,,,
CHEMBL621895,6641,,8330,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rat; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL875284,6444,,8331,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,,N,1,Intermediate,,1,,,
CHEMBL618699,6444,,8332,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,N,1,Intermediate,,1,,,
CHEMBL618700,6444,,8333,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,N,1,Intermediate,,1,,,
CHEMBL618701,6211,,8334,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL876600,12873,,8335,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618702,6570,,8336,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance of compound in rat after 1 mg/kg i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL618703,3341,,8337,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for Hepatic clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL618704,4891,,8338,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo clearance after 5 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL618705,1094,,8339,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma clearance in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618706,2938,,8340,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Hepatic clearance after intravenous administration was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL618707,17853,,8341,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Lower clearance in rat (i.v.) at 0.5 mpk,,,N,1,Intermediate,,1,,,
CHEMBL618708,6049,,8342,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter expressed as plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618709,5789,,8343,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Clp) in rat,,,N,1,Intermediate,,1,,,
CHEMBL618710,4514,,8344,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL618711,6448,,8345,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance (Clp) in rat,,,N,1,Intermediate,,1,,,
CHEMBL618712,6062,,8346,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL618713,5710,,8347,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,,N,1,Intermediate,,1,,,
CHEMBL618714,4709,,8348,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after intravenous administration of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL618715,4521,,8349,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL618716,1742,,8350,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL876601,6057,,8351,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL618717,6057,,8352,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was calculated in rat,,,N,1,Intermediate,,1,,,
CHEMBL618718,5145,,8353,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL618719,5833,,8354,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL618720,6453,,8355,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL618721,6640,,8356,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL621477,6305,,8357,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats,,,N,1,Intermediate,,1,,,
CHEMBL621478,6642,,8358,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL621479,5472,,8359,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL621480,5472,,8360,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was evaluated in rat; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL621481,5144,,8361,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance rate was determined for the compound in rat,,,N,1,Intermediate,,1,,,
CHEMBL621482,6685,,8362,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,,N,1,Intermediate,,1,,,
CHEMBL621483,6685,,8363,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,N,1,Intermediate,,1,,,
CHEMBL621484,6685,,8364,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,,N,1,Intermediate,,1,,,
CHEMBL621485,13950,,8365,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621486,13950,,8366,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL621487,13950,,8367,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621488,13950,,8368,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621489,13950,,8369,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621490,13950,,8370,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621491,13950,,8371,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL621492,13950,,8372,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621493,13950,,8373,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621494,13950,,8374,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621495,13950,,8375,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621496,13950,,8376,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621497,13950,,8377,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621498,13950,,8378,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621499,13950,,8379,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618634,13950,,8380,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618635,13950,,8381,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618636,13950,,8382,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL619737,13950,,8383,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL619738,13950,,8384,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624329,13950,,8385,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624330,13950,,8386,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624331,13950,,8387,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624332,13950,,8388,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624333,13950,,8389,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624334,13950,,8390,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624335,13950,,8391,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620016,13950,,8392,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL620169,13950,,8393,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL620170,13950,,8394,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL620171,13950,,8395,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL620172,13950,,8396,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL620173,13950,,8397,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL620174,13950,,8398,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL620175,13950,,8399,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL620176,13950,,8400,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL620177,13950,,8401,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL620178,13950,,8402,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL620179,13950,,8403,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL620180,13950,,8404,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,,1,,,
CHEMBL620181,6570,,8405,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL620182,6571,,8406,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution of compound in rats after intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL620183,6453,,8407,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL620184,6444,,8408,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,,N,1,Intermediate,,1,,,
CHEMBL620185,6444,,8409,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,N,1,Intermediate,,1,,,
CHEMBL620186,6444,,8410,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,N,1,Intermediate,,1,,,
CHEMBL620187,5353,,8411,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined in Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL620188,5334,,8412,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL620189,5334,,8413,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was reported in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL620190,6641,,8414,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volumes of distribution in rat after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL620191,6641,,8415,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volumes of distribution in rat after po administration,,,N,1,Intermediate,,1,,,
CHEMBL620192,6641,,8416,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volumes of distribution in rat after po administration; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL620193,5676,,8417,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Volume) in rat i.v.,,,N,1,Intermediate,,1,,,
CHEMBL620194,6410,,8418,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,,N,1,Intermediate,,1,,,
CHEMBL876730,17670,,8419,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,,N,1,Intermediate,,1,,,
CHEMBL620195,6495,,8420,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat after oral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620196,5408,,8421,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL620197,4883,,8422,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620198,6647,,8423,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL620199,6495,,8424,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rats,,,N,1,Intermediate,,1,,,
CHEMBL620200,2661,,8425,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL620201,2661,,8426,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL620202,5974,,8427,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL620203,5974,,8428,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL620204,5974,,8429,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,,N,1,Intermediate,,1,,,
CHEMBL620205,5974,,8430,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624664,5960,,8431,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Vss) in rat,,,N,1,Intermediate,,1,,,
CHEMBL624665,5676,,8432,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Volume) in rat i.v.,,,N,1,Intermediate,,1,,,
CHEMBL624666,5948,,8433,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Vss) in rat,,,N,1,Intermediate,,1,,,
CHEMBL624667,5979,,8434,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,N,1,Intermediate,,1,,,
CHEMBL624668,5978,,8435,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624669,5978,,8436,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624670,5978,,8437,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624671,5978,,8438,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624672,6448,,8439,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume distribution in rat,,,N,1,Intermediate,,1,,,
CHEMBL624673,12873,,8440,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624674,4576,,8441,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady state volume of distribution determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL624675,17582,,8442,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL621728,1466,,8443,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL621729,5182,,8444,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL621730,5182,,8445,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,,N,1,Intermediate,,1,,,
CHEMBL621731,6535,,8446,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat after administration of 2 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL621732,6535,,8447,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rat after administration of 2 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL621908,5041,,8448,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume in steady state distribution value was determined,,,N,1,Intermediate,,1,,,
CHEMBL875347,5041,,8449,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume in steady state distribution value was determined; ND denotes no data,,,N,1,Intermediate,,1,,,
CHEMBL621909,5041,,8450,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume in steady state distribution value was determined; ND denotes not determined,,,N,1,Intermediate,,1,,,
CHEMBL621910,17065,,8451,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,N,1,Intermediate,,1,,,
CHEMBL621911,6597,,8452,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution at steady state was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL621912,15662,,8453,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution at steady state was observed after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL621913,6485,,8454,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in steady state was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621914,17655,,8455,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in steady state was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621915,6616,,8456,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL621916,1916,,8457,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL621917,16438,,8458,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621918,16438,,8459,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621919,16438,,8460,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (oxidized form) in spleen tissue,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621920,16438,,8461,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621921,16438,,8462,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622401,16438,,8463,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL875348,16438,,8464,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622402,16438,,8465,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622403,16438,,8466,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622404,16438,,8467,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622405,16438,,8468,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622406,16438,,8469,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622407,16438,,8470,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622408,16438,,8471,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622409,16438,,8472,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622410,16438,,8473,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622411,16438,,8474,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627864,16438,,8475,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627865,16438,,8476,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627866,16438,,8477,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627751,16438,,8478,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627752,16438,,8479,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627753,16438,,8480,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627754,16438,,8481,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627755,12467,,8482,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,,N,1,Intermediate,,1,,,
CHEMBL627756,17208,,8483,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627757,17208,,8484,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627758,17208,,8485,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627759,17208,,8486,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627760,17208,,8487,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627761,17208,,8488,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL876811,17208,,8489,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627762,17208,,8490,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627763,17208,,8491,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627764,17208,,8492,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627765,17208,,8493,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627766,17208,,8494,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627767,17208,,8495,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627768,17208,,8496,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628422,17208,,8497,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628423,17208,,8498,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628424,5089,,8499,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL628425,5089,,8500,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL628426,4257,,8501,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,,N,1,Intermediate,,1,,,
CHEMBL628427,6679,,8502,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,N,1,Intermediate,,1,,,
CHEMBL626938,5546,,8503,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,N,1,Intermediate,,1,,,
CHEMBL626939,6141,,8504,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL626940,5334,,8505,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626941,5334,,8506,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626942,5334,,8507,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was reported in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL876812,4689,,8508,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after intravenous administration (1 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL626943,6848,,8509,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance of compound in rats was evaluated,,,N,1,Intermediate,,1,,,
CHEMBL626944,6848,,8510,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,,N,1,Intermediate,,1,,,
CHEMBL626945,6467,,8511,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL626946,6467,,8512,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,N,1,Intermediate,,1,,,
CHEMBL626856,4956,,8513,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance rate in Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL626857,5529,,8514,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL626858,406,,8515,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was evaluated for plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627018,17655,,8516,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625331,3293,,8517,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625332,4075,,8518,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL877590,2792,,8519,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,C max was determined at 10 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL625333,2792,,8520,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,C max was determined at 3 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL625334,17594,,8521,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL625335,17594,,8522,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after single intravenous bolus of 1 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL625336,4762,,8523,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax of compound at 5 mg/kg after po administration was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL625337,17509,,8524,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax 24 hr after 10 mg/kg oral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL625338,17509,,8525,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax 24 hr after 2 mg/kg oral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL625339,1466,,8526,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625340,6535,,8527,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat after administration of 2 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL625341,6535,,8528,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat after administration of 2 mg/kg iv,,,N,1,Intermediate,,1,,,
CHEMBL622687,3169,,8529,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622688,6515,,8530,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622689,11149,,8531,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL620295,11149,,8532,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL620296,17858,,8533,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after 10 mg/kg oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL620297,6518,,8534,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,,N,1,Intermediate,,1,,,
CHEMBL620298,6518,,8535,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after IV dosing at 1 mg/kg in rat; no data,,,N,1,Intermediate,,1,,,
CHEMBL620299,4426,,8536,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after oral administration at 20 mpk in rats,,,N,1,Intermediate,,1,,,
CHEMBL620300,4426,,8537,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after oral administration at 20 mpk in rats; Not performed.,,,N,1,Intermediate,,1,,,
CHEMBL620301,4426,,8538,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after oral administration at 20 mpk in rats d; Not performed.,,,N,1,Intermediate,,1,,,
CHEMBL620302,5656,,8539,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL620303,6518,,8540,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after oral administration at a dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL620304,6518,,8541,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after oral administration at a dose of 4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL620305,6113,,8542,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rats after 20 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL620306,17764,,8543,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after peroral administration in rats at 2.4 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL620307,4756,,8544,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax at the dose of 2 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL620308,4756,,8545,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax at the dose of 5 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL620309,6402,,8546,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax by administering at 20 mg/kg p.o. in rats,,,N,1,Intermediate,,1,,,
CHEMBL620310,5610,,8547,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in male rat,,,N,1,Intermediate,,1,,,
CHEMBL620311,5207,,8548,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat,,,N,1,Intermediate,,1,,,
CHEMBL620312,6011,,8549,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat,,,N,1,Intermediate,,1,,,
CHEMBL620313,6504,,8550,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat,,,N,1,Intermediate,,1,,,
CHEMBL620314,6046,,8551,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620315,6504,,8552,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat at the dose of 1 mg/kg i.v.,,,N,1,Intermediate,,1,,,
CHEMBL620316,5874,,8553,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat by po administration at a dose of 40 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620317,17686,,8554,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat p.o. at 20 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL620318,5836,,8555,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rats,,,N,1,Intermediate,,1,,,
CHEMBL620319,17596,,8556,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rats,,,N,1,Intermediate,,1,,,
CHEMBL620320,16423,,8557,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was evaluated after 20 uM/kg of peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL620321,17804,,8558,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was measured in rats after peroral administration at 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620322,1908,,8559,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,,N,1,Intermediate,,1,,,
CHEMBL620323,13950,,8560,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,,1,,,
CHEMBL620324,13950,,8561,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Frontal cortex,1,,1870.0,
CHEMBL620325,13950,,8562,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Frontal cortex,1,,1870.0,
CHEMBL620326,13950,,8563,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL620327,13950,,8564,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL620328,13950,,8565,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,,1,,,
CHEMBL620329,13950,,8566,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,,1,,,
CHEMBL620330,13950,,8567,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Midbrain,1,,1891.0,
CHEMBL875286,13950,,8568,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Midbrain,1,,1891.0,
CHEMBL620331,13950,,8569,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,,1,,,
CHEMBL620332,13950,,8570,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,,1,,,
CHEMBL620333,13950,,8571,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL620334,13950,,8572,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL621015,16434,,8573,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621016,16434,,8574,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621191,16434,,8575,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621192,16434,,8576,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621193,16434,,8577,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621194,16434,,8578,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624204,16434,,8579,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624205,16434,,8580,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624206,16435,,8581,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624207,16435,,8582,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624208,16435,,8583,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624209,16435,,8584,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624210,16435,,8585,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624211,16435,,8586,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624212,16435,,8587,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624213,16435,,8588,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL876611,16434,,8589,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624214,16434,,8590,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624215,16434,,8591,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624216,16435,,8592,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624217,16435,,8593,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624218,16435,,8594,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624219,16435,,8595,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624220,16435,,8596,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624221,16435,,8597,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624222,16434,,8598,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL624223,16434,,8599,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL624224,16434,,8600,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL624225,16434,,8601,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622420,17764,,8602,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL622421,5031,,8603,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of steady state distribution after i.v. administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL622422,6215,,8604,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL622423,17671,,8605,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622424,17752,,8606,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vss was determined,,,N,1,Intermediate,,1,,,
CHEMBL622425,6596,,8607,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vss in rat,,,N,1,Intermediate,,1,,,
CHEMBL876612,16423,,8608,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Vss was evaluated after 10 uM/kg of intra arterial administration,,,N,1,Intermediate,,1,,,
CHEMBL622426,15662,,8609,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,volume of distribution at steady state was observed after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL622427,6062,,8610,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622428,5874,,8611,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic (PK) parameter Vz in rat,,,N,1,Intermediate,,1,,,
CHEMBL622429,4942,,8612,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume distribution in rats,,,N,1,Intermediate,,1,,,
CHEMBL622430,17796,,8613,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in rat; No data,,,N,1,Intermediate,,1,,,
CHEMBL622431,4890,,8614,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL622432,15765,,8615,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% absorption predicted from in vitro rat ileum transport studies,,,N,1,Intermediate,Ileum,1,,2116.0,
CHEMBL622433,13569,,8616,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL622434,13569,,8617,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL622435,13569,,8618,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618748,13569,,8619,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL618749,13569,,8620,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618750,13569,,8621,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618751,13569,,8622,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618752,13569,,8623,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL618753,4576,,8624,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618754,750,,8625,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL618755,750,,8626,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618756,4590,,8627,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618757,1716,,8628,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618758,1974,,8629,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621088,4502,,8630,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 30 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL621089,3371,,8631,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (cLogP) in rat,,,N,1,Intermediate,,1,,,
CHEMBL621090,9099,,8632,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621091,9099,,8633,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL876731,4590,,8634,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat.,,,N,1,Intermediate,,1,,,
CHEMBL621092,3184,,8635,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for its clearance when administered intravenously in rat,,,N,1,Intermediate,,1,,,
CHEMBL621093,16456,,8636,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621094,4199,,8637,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood: Brain distribution ratio is determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL621095,4199,,8638,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,,N,1,Intermediate,,1,,,
CHEMBL621096,4199,,8639,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,,N,1,Intermediate,,1,,,
CHEMBL621097,8677,,8640,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621098,7449,,8641,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent dose excreted in 0-48 hours administered ip to male rat,,,N,1,Intermediate,,1,,,
CHEMBL621099,11977,,8642,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL621100,11977,,8643,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL621101,11977,,8644,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL621102,11977,,8645,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL876732,11977,,8646,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL621103,11977,,8647,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL621104,11977,,8648,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL621105,11977,,8649,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,,1,,,
CHEMBL621106,11977,,8650,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL621107,11977,,8651,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL621108,11977,,8652,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL621109,11977,,8653,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL621110,17208,,8654,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621111,17208,,8655,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622541,17208,,8656,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622542,17208,,8657,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622543,17208,,8658,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624412,17208,,8659,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624413,17208,,8660,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624414,17208,,8661,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624415,17208,,8662,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624416,17208,,8663,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624417,17208,,8664,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624418,17208,,8665,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624419,17208,,8666,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624420,17208,,8667,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624421,17208,,8668,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624422,17208,,8669,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624423,17208,,8670,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625123,17208,,8671,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625124,17208,,8672,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625125,17208,,8673,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625126,17208,,8674,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL626947,17208,,8675,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL626948,17208,,8676,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL626949,17208,,8677,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL626950,17208,,8678,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL626951,17208,,8679,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL626952,17208,,8680,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626953,17208,,8681,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626954,17208,,8682,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626955,17208,,8683,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626956,17208,,8684,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626957,17208,,8685,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626958,17208,,8686,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626959,17208,,8687,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626960,17208,,8688,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626961,17208,,8689,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627589,17208,,8690,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627590,17208,,8691,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627591,3132,,8692,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Time taken for EC90 was determined when tested in mouse,,,N,1,Intermediate,,1,,,
CHEMBL627592,3132,,8693,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627593,16597,,8694,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,,N,1,Intermediate,,1,,,
CHEMBL627594,5727,,8695,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half life in mice,,,N,1,Intermediate,,1,,,
CHEMBL876813,5302,,8696,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life period in mouse after 10 mg/Kg dose,,,N,1,Intermediate,,1,,,
CHEMBL627595,5302,,8697,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life period in mouse after 10 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL627596,6348,,8698,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,,N,1,Intermediate,,1,,,
CHEMBL627597,5964,,8699,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value at 5 mg/kg po was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL627598,6078,,8700,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL627599,5206,,8701,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627600,2959,,8702,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value after administration of 20 mg/Kg oral dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL627601,5964,,8703,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value at 1 mg/kg po in rat,,,N,1,Intermediate,,1,,,
CHEMBL627776,5964,,8704,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value at 5 mg/kg po in rat,,,N,1,Intermediate,,1,,,
CHEMBL627777,6757,,8705,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value at a dose of 10 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL627778,6757,,8706,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value at a dose of 100 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL627779,6757,,8707,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value at a dose of 50 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL876814,17617,,8708,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value in rats at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627780,1445,,8709,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value was evaluated in rats at a dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627781,6082,,8710,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value was determined after peroral administration of 20 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627782,1446,,8711,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,N,1,Intermediate,,1,,,
CHEMBL627783,5407,,8712,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627784,2690,,8713,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627785,2661,,8714,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627786,2661,,8715,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627787,4891,,8716,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627788,2807,,8717,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626579,2807,,8718,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626580,2807,,8719,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876815,3634,,8720,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626581,1881,,8721,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626582,1881,,8722,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626583,429,,8723,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626205,5974,,8724,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626206,5974,,8725,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626207,5974,,8726,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL623882,5974,,8727,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL623883,17582,,8728,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,,N,1,Intermediate,,1,,,
CHEMBL623884,17582,,8729,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL623885,3032,,8730,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623886,6295,,8731,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623887,6619,,8732,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal concentration in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL623888,6616,,8733,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal concentration after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL623889,3249,,8734,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623890,17791,,8735,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623891,17791,,8736,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat plasma after oral dose (50 mg/Kg),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623892,1360,,8737,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal plasma concentration was determined.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623893,2552,,8738,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal plasma drug concentration was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877616,6571,,8739,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal concentration in rats after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL623894,6570,,8740,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rat after 2 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL623895,6567,,8741,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623896,3031,,8742,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of compound in rat was evaluated.,,,N,1,Intermediate,,1,,,
CHEMBL623897,3436,,8743,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623898,3436,,8744,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623899,2083,,8745,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,,N,1,Intermediate,,1,,,
CHEMBL623900,3436,,8746,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623901,4527,,8747,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL623902,1974,,8748,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL623903,3307,,8749,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,,N,1,Intermediate,Cerebrospinal fluid,1,,1359.0,
CHEMBL623904,3307,,8750,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877617,1916,,8751,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623905,1500,,8752,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623906,1500,,8753,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623907,4186,,8754,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623908,16434,,8755,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL623909,16434,,8756,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL623910,16434,,8757,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL623911,16434,,8758,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL623912,16435,,8759,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL624616,16435,,8760,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL624617,16435,,8761,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL624618,16435,,8762,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL624619,16435,,8763,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL624794,16435,,8764,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL624795,16435,,8765,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL623921,16435,,8766,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL623922,16434,,8767,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL623923,16434,,8768,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL623924,16434,,8769,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL623925,16435,,8770,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL623926,16435,,8771,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL623927,16435,,8772,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL623928,16435,,8773,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL623929,16435,,8774,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL623930,16435,,8775,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL623931,16434,,8776,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622165,16434,,8777,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621249,16434,,8778,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621250,16434,,8779,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621448,16434,,8780,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621449,16434,,8781,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621450,16434,,8782,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621451,16434,,8783,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621452,16435,,8784,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621453,16435,,8785,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621454,16435,,8786,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621455,16435,,8787,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL621456,16435,,8788,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625145,16435,,8789,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL875847,16435,,8790,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625146,16435,,8791,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625147,16434,,8792,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625148,16434,,8793,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625149,16434,,8794,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625150,16435,,8795,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625151,16435,,8796,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625152,16435,,8797,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625153,16435,,8798,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625154,16435,,8799,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625155,16435,,8800,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625156,11977,,8801,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,,1,,,
CHEMBL624354,11977,,8802,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,,1,,,
CHEMBL624355,11977,,8803,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL624356,11977,,8804,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL624357,11977,,8805,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL624358,11977,,8806,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL624359,11977,,8807,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL624360,11977,,8808,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL624361,11977,,8809,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL624362,11977,,8810,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL624363,11977,,8811,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL624364,11977,,8812,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624365,11977,,8813,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624366,11977,,8814,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624367,11977,,8815,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624368,11977,,8816,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624369,11977,,8817,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624370,11977,,8818,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625069,11977,,8819,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625070,11977,,8820,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626051,11977,,8821,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626052,11977,,8822,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626053,11977,,8823,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626054,11977,,8824,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626055,11977,,8825,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626056,11977,,8826,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626057,11977,,8827,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625193,11977,,8828,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625194,11977,,8829,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625195,11977,,8830,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625196,11977,,8831,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625197,11977,,8832,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625198,11977,,8833,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627929,11977,,8834,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627074,11977,,8835,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627075,11977,,8836,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627076,11977,,8837,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627077,11977,,8838,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627078,11977,,8839,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627079,11977,,8840,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL873824,4573,,8841,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,,N,1,Intermediate,,1,,,
CHEMBL627080,3132,,8842,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in mouse plasma was determined at dose 25 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627081,17718,,8843,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half life was determined,,,N,1,Intermediate,,1,,,
CHEMBL627082,17728,,8844,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL627083,5961,,8845,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half-life in male mice after 1 mg/kg intravenous dose,,,N,1,Intermediate,,1,,,
CHEMBL627085,17731,,8847,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half life in mice plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627086,17592,,8848,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half life in mouse,,,N,1,Intermediate,,1,,,
CHEMBL627087,3132,,8849,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in mouse plasma at dose 25 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627088,17729,,8850,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,,N,1,Intermediate,,1,,,
CHEMBL627089,17729,,8851,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,,N,1,Intermediate,,1,,,
CHEMBL627090,17729,,8852,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,,N,1,Intermediate,,1,,,
CHEMBL627091,3277,,8853,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,,N,1,Intermediate,,1,,,
CHEMBL627092,3760,,8854,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,,N,1,Intermediate,,1,,,
CHEMBL876785,3760,,8855,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,,N,1,Intermediate,,1,,,
CHEMBL627093,2862,,8856,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half-life by iv administration in mouse,,,N,1,Intermediate,,1,,,
CHEMBL627094,2862,,8857,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half-life by oral administration in mouse,,,N,1,Intermediate,,1,,,
CHEMBL627095,5980,,8858,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half-life in mice,,,N,1,Intermediate,,1,,,
CHEMBL627096,6159,,8859,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half-life using mouse brain homogenate,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627097,6254,,8860,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half-life was measured in mice,,,N,1,Intermediate,,1,,,
CHEMBL627098,6062,,8861,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half-life was measured in mouse after an iv dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627099,1574,,8862,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half-life period was determined in mouse blood,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627100,56,,8863,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627101,993,,8864,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma half life in mouse,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627102,6652,,8865,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Stability of the peptide in the presence of mouse serum,,,N,1,Intermediate,,1,,,
CHEMBL627103,17852,,8866,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Terminal half life of compound was determined in mouse,,,N,1,Intermediate,,1,,,
CHEMBL627104,2675,,8867,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Terminal half life was evaluated in mice after intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL627105,2675,,8868,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Terminal half life was evaluated in mice after oral administration,,,N,1,Intermediate,,1,,,
CHEMBL876786,499,,8869,,10090.0,,50594,,A,Mus musculus,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,,N,1,Intermediate,,1,,,
CHEMBL873825,499,,8870,,10090.0,,50594,,A,Mus musculus,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,,N,1,Intermediate,,1,,,
CHEMBL627106,499,,8871,,10090.0,,50594,,A,Mus musculus,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,,N,1,Intermediate,,1,,,
CHEMBL626336,14239,,8872,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,,N,1,Intermediate,,1,,,
CHEMBL877462,5506,,8873,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,,N,1,Intermediate,,1,,,
CHEMBL626337,5506,,8874,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,,N,1,Intermediate,,1,,,
CHEMBL626338,17734,,8875,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Half life after intraperitoneal administration of 100 mg/kg in mice,,,N,1,Intermediate,,1,,,
CHEMBL626339,17728,,8876,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,,N,1,Intermediate,,1,,,
CHEMBL626340,17728,,8877,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL625377,17728,,8878,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,,N,1,Intermediate,,1,,,
CHEMBL625378,17728,,8879,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,,N,1,Intermediate,,1,,,
CHEMBL625379,17728,,8880,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,,N,1,Intermediate,,1,,,
CHEMBL625380,14294,,8881,,9823.0,,22224,,A,Sus scrofa,BAO_0000251,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,,U,0,Autocuration,,1,,,Microsomes
CHEMBL625381,14294,,8882,,9823.0,,22224,,A,Sus scrofa,BAO_0000251,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,,U,0,Autocuration,,1,,,Microsomes
CHEMBL625382,6056,,8883,,9823.0,,22224,,A,Sus scrofa,BAO_0000019,Stability to porcine renal DHP-I,,,U,0,Autocuration,,1,,,
CHEMBL873828,1317,,8884,,9823.0,In vivo,22224,,A,Sus scrofa,BAO_0000218,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,,U,0,Autocuration,,1,,,
CHEMBL625383,1317,,8885,,9823.0,In vivo,22224,,A,Sus scrofa,BAO_0000218,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,,U,0,Autocuration,,1,,,
CHEMBL625384,5229,,8886,,9823.0,,22224,,A,Sus scrofa,BAO_0000019,Half-life of the parent prodrug in porcine esterase solution,,,U,0,Autocuration,,1,,,
CHEMBL625385,4231,,8887,,9823.0,,22224,,A,Sus scrofa,BAO_0000019,"First order rate constant, k was determined in in pig liver Esterase",,,U,0,Autocuration,,1,,,
CHEMBL625386,4231,,8888,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Half life of the in pig liver Esterase,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623571,5318,,8889,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623572,5318,,8890,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623573,5318,,8891,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623574,3305,,8892,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623575,3305,,8893,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623749,2842,,8894,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623750,2842,,8895,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623751,889,,8896,,9823.0,In vitro,22224,,A,Sus scrofa,BAO_0000221,Half-life in vitro in pig liver,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623752,1904,,8897,,9823.0,,22224,,A,Sus scrofa,BAO_0000221,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL623753,4186,,8898,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623754,2774,,8899,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623755,1742,,8900,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rat plasma was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623756,3169,,8901,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rats,,,N,1,Intermediate,,1,,,
CHEMBL623757,3169,,8902,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rats at 1-2 hours,,,N,1,Intermediate,,1,,,
CHEMBL623758,2081,,8903,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL623759,3307,,8904,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623760,4727,,8905,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at the dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL623761,6597,,8906,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL623762,16365,,8907,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877594,16365,,8908,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623763,16365,,8909,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623764,16365,,8910,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623765,16365,,8911,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623766,2591,,8912,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623767,2591,,8913,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623768,2591,,8914,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623769,5978,,8915,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623770,5978,,8916,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623771,5978,,8917,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623772,5978,,8918,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623773,5978,,8919,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623774,5978,,8920,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623775,5978,,8921,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623776,14465,,8922,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat (PO dose),,,N,1,Intermediate,,1,,,
CHEMBL622191,4723,,8923,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622192,4723,,8924,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622193,4576,,8925,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration determined in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622194,12873,,8926,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622195,12873,,8927,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622196,6824,,8928,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622197,17065,,8929,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622198,2932,,8930,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622199,2932,,8931,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622200,2879,,8932,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration of compound was measured in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622201,2864,,8933,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration after 20 mg/kg oral administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623990,16367,,8934,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration after oral administration to rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623991,17717,,8935,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623992,17717,,8936,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623993,17717,,8937,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623994,17717,,8938,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623995,17720,,8939,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623996,17720,,8940,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623997,17720,,8941,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623998,4516,,8942,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration dosed orally in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623999,4516,,8943,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration dosed orally in rats after 6 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624000,4516,,8944,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624001,5199,,8945,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624002,17538,,8946,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration in rat after po administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624003,6685,,8947,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624004,6685,,8948,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624005,16434,,8949,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624006,16434,,8950,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624007,16434,,8951,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624008,16434,,8952,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624009,16434,,8953,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL874387,16434,,8954,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624010,16434,,8955,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624011,16434,,8956,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624012,16435,,8957,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624013,16435,,8958,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624736,16435,,8959,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624737,16435,,8960,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624738,16434,,8961,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624739,16434,,8962,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624740,16434,,8963,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624896,16435,,8964,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624897,16435,,8965,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624108,16435,,8966,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624109,16435,,8967,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624110,16435,,8968,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624111,16435,,8969,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624112,16435,,8970,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624113,16435,,8971,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL619709,16435,,8972,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL619710,16435,,8973,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL619711,16434,,8974,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619712,16434,,8975,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619713,16434,,8976,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619714,16434,,8977,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619715,16434,,8978,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619716,16434,,8979,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619717,16434,,8980,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619718,16434,,8981,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619719,16435,,8982,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL875329,16435,,8983,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619720,16435,,8984,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619721,16435,,8985,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619722,16435,,8986,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619723,16435,,8987,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619724,16435,,8988,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619725,16435,,8989,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619726,16434,,8990,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619727,16434,,8991,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619728,16434,,8992,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619729,16435,,8993,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL619730,11977,,8994,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL619731,11977,,8995,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL619732,11977,,8996,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL619733,11977,,8997,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL619734,11977,,8998,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL619735,11977,,8999,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL875330,11977,,9000,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL628465,11977,,9001,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL628466,11977,,9002,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL628467,11977,,9003,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL628468,11977,,9004,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL628469,11977,,9005,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL628470,11977,,9006,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL628471,11977,,9007,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL628472,11977,,9008,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625191,11977,,9009,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL625192,11977,,9010,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL875337,11977,,9011,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626341,11977,,9012,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626342,11977,,9013,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL621943,11977,,9014,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621944,3748,,9015,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats,,,N,1,Intermediate,,1,,,
CHEMBL621945,15765,,9016,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,,N,1,Intermediate,,1,,,
CHEMBL621946,4871,,9017,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,,N,1,Intermediate,,1,,,
CHEMBL621947,4871,,9018,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,N,1,Intermediate,,1,,,
CHEMBL621948,4872,,9019,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,,N,1,Intermediate,,1,,,
CHEMBL621949,4872,,9020,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,N,1,Intermediate,,1,,,
CHEMBL621950,5413,,9021,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,,N,1,Intermediate,,1,,,
CHEMBL621951,5413,,9022,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,,N,1,Intermediate,,1,,,
CHEMBL621952,15272,,9023,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621953,4689,,9024,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability (%) in rat liver microsomes,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621954,6057,,9025,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was calculated after intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL621955,6057,,9026,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was calculated after iv administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL621956,6057,,9027,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was calculated in rat after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL621957,6211,,9028,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL621958,5710,,9029,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL621959,5710,,9030,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL621960,17853,,9031,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621961,17853,,9032,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621962,15765,,9033,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,p value of the compound,,,N,1,Intermediate,,1,,,
CHEMBL876787,15765,,9034,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,p value of the compound,,,N,1,Intermediate,,1,,,
CHEMBL621963,15765,,9035,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,p value of the compound,,,N,1,Intermediate,,1,,,
CHEMBL622637,6175,,9036,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622638,6175,,9037,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL626561,6175,,9038,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL626562,7991,,9039,,9986.0,,22224,,F,Oryctolagus cuniculus,BAO_0000019,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,,U,0,Autocuration,,1,,,
CHEMBL626563,429,,9040,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,,U,0,Autocuration,,1,,,
CHEMBL626564,429,,9041,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,,U,0,Autocuration,,1,,,
CHEMBL626565,6253,,9042,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,U,0,Autocuration,,1,,,
CHEMBL626566,6253,,9043,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,U,0,Autocuration,,1,,,
CHEMBL626567,3615,,9044,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Clearance rate in rabbits,,,U,0,Autocuration,,1,,,
CHEMBL626568,4059,,9045,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,U,0,Autocuration,,1,,,
CHEMBL626569,5124,,9046,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626570,5124,,9047,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626571,5124,,9048,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626572,429,,9049,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626573,4059,,9050,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626574,9659,,9051,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000251,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,,U,0,Autocuration,Liver,1,,2107.0,Microsomes
CHEMBL626575,9659,,9052,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000251,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,,U,0,Autocuration,Liver,1,,2107.0,Microsomes
CHEMBL626576,3639,,9053,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000218,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,,U,0,Autocuration,,1,,,
CHEMBL626577,3639,,9054,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000218,Dose at which bioavailability of perorally administered compound was tested in rabbit,,,U,0,Autocuration,,1,,,
CHEMBL626578,3639,,9055,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,The compound was tested for its bioavailability in rabbit (by oral dosage).,,,U,0,Autocuration,,1,,,
CHEMBL625263,5124,,9056,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625264,5124,,9057,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625265,5124,,9058,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625266,14294,,9059,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000251,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,,U,0,Autocuration,,1,,,Microsomes
CHEMBL876796,14294,,9060,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000251,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,,U,0,Autocuration,,1,,,Microsomes
CHEMBL625267,429,,9061,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625268,5124,,9062,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL625269,5124,,9063,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL624689,5124,,9064,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL624690,429,,9065,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL624691,429,,9066,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL624692,429,,9067,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL624693,4059,,9068,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,,U,0,Autocuration,,1,,,
CHEMBL624694,4137,,9069,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,,U,0,Autocuration,,1,,,
CHEMBL877596,11672,,9070,,9986.0,In vitro,22224,,A,Oryctolagus cuniculus,BAO_0000221,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,,U,0,Autocuration,,1,,,
CHEMBL624695,12886,,9071,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000019,Time within which only 10% of the drug was degraded,,,U,0,Autocuration,,1,,,
CHEMBL624696,3853,,9072,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000221,Half life period in rabbit liver homogenate,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL624697,3615,,9073,,9986.0,,22224,,A,Oryctolagus cuniculus,BAO_0000019,Half life value in rabbits,,,U,0,Autocuration,,1,,,
CHEMBL624698,6253,,9074,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL624699,6253,,9075,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL624700,6077,,9076,,9986.0,In vivo,22224,,A,Oryctolagus cuniculus,BAO_0000218,Half-life period in rabbits following intravenous administration at 2 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL622903,17617,,9077,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC 0-8 hr value in rats at 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622904,17594,,9078,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC after administration at 2000 mg/kg/day in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622905,6149,,9079,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622906,17260,,9080,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622907,17260,,9081,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622908,6644,,9082,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat after oral administration at 10.5 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622909,6644,,9083,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat after oral administration at 11.2 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622910,6644,,9084,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat after oral administration at 9.7 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622911,6495,,9085,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat brain after oral administration at 10 mg/kg,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622912,6504,,9086,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat p.o.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622913,17686,,9087,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat p.o. at 20 mg/kg concentration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622914,6495,,9088,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat plasma after oral administration at 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622915,216,,9089,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622916,1908,,9090,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC value after IV dose at a dose of 5 mg/kg in rats.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622917,1908,,9091,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC value after oral dose at a dose of 10 mg/kg in rats.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622918,6685,,9092,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622919,216,,9093,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622920,6049,,9094,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration was evaluated in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622921,2463,,9095,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622922,6679,,9096,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622923,6681,,9097,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877604,4890,,9098,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622924,6410,,9099,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622925,6410,,9100,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622926,16366,,9101,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623625,6227,,9102,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623626,3598,,9103,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,Plasma,1,,1969.0,
CHEMBL623627,1465,,9104,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma drug concentration was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623628,4368,,9105,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL623629,15662,,9106,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Mean peak plasma concentration was observed after intravenous administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623630,15662,,9107,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Mean peak plasma concentration was observed after oral administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623804,5355,,9108,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623805,5355,,9109,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL623806,1567,,9110,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak oral plasma concentration was determined in rats by oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623807,4026,,9111,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration (Cmax) was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623808,6193,,9112,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623809,4026,,9113,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration (Cmax) in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623810,6485,,9114,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration at 1 mg/kg peroral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623811,17655,,9115,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623812,14941,,9116,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877605,5394,,9117,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623813,4408,,9118,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Cmax) in rat,,,N,1,Intermediate,,1,,,
CHEMBL623814,5983,,9119,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,N,1,Intermediate,,1,,,
CHEMBL623815,4878,,9120,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat after 3mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL623816,5862,,9121,,10116.0,In vivo,50597,Sprague-Dawley,A,Rattus norvegicus,BAO_0000218,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL623145,4517,,9122,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rats after 20 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL623146,5932,,9123,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat plasma after 30mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623147,5436,,9124,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after oral administration of 100 mg/kg to rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623042,4910,,9125,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623043,4950,,9126,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for the Cmax in rat at 10 mg/kg per orally,,,N,1,Intermediate,,1,,,
CHEMBL623044,15078,,9127,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL623045,15078,,9128,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL623046,3360,,9129,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability as oral Cmax in rats at 30 mins,,,N,1,Intermediate,,1,,,
CHEMBL623226,3360,,9130,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability as oral Cmax in rats at 6hr,,,N,1,Intermediate,,1,,,
CHEMBL623227,15022,,9131,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of compound was measured at the dose of 100 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL623228,15022,,9132,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of compound was measured at the dose of 300 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL623229,15022,,9133,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of compound was measured at the dose of 30 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL623230,5160,,9134,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma levels for the compounds were determined by LC-MS.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623231,15662,,9135,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,mean peak plasma concentration was observed after intravenous administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623232,15662,,9136,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,mean peak plasma concentration was observed after oral administration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623233,4709,,9137,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL623234,3535,,9138,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,,N,1,Intermediate,,1,,,
CHEMBL623235,3535,,9139,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 1 hr,,,N,1,Intermediate,,1,,,
CHEMBL623236,3535,,9140,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 2 hr,,,N,1,Intermediate,,1,,,
CHEMBL623237,3535,,9141,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,,N,1,Intermediate,,1,,,
CHEMBL623238,3535,,9142,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,,N,1,Intermediate,,1,,,
CHEMBL623239,3535,,9143,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,,N,1,Intermediate,,1,,,
CHEMBL623240,5005,,9144,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,,U,0,Intermediate,Plasma,1,,1969.0,
CHEMBL623241,6326,,9145,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL623242,6326,,9146,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL874394,6326,,9147,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,,N,1,Intermediate,,1,,,
CHEMBL623243,6326,,9148,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,,N,1,Intermediate,,1,,,
CHEMBL623244,17411,,9149,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623245,16435,,9150,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623246,16435,,9151,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623247,16435,,9152,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623248,16435,,9153,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623249,16435,,9154,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625072,16434,,9155,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625073,16434,,9156,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625074,16434,,9157,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625075,16434,,9158,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625076,16434,,9159,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625077,16434,,9160,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625078,16434,,9161,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL874395,16434,,9162,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625079,16435,,9163,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625080,16435,,9164,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625081,16435,,9165,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625082,16435,,9166,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625083,16435,,9167,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625084,16435,,9168,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625085,16435,,9169,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625086,16435,,9170,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625087,16434,,9171,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625088,16434,,9172,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622205,16434,,9173,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622206,16435,,9174,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622207,16435,,9175,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622366,16435,,9176,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622367,16435,,9177,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL875331,16435,,9178,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622368,16435,,9179,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622369,16434,,9180,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622370,16434,,9181,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622371,16434,,9182,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622372,16434,,9183,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622373,16434,,9184,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622374,16434,,9185,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622375,16434,,9186,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622376,16434,,9187,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622377,16435,,9188,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622378,16435,,9189,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622379,16435,,9190,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622380,16435,,9191,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622381,16435,,9192,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622382,16435,,9193,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622383,16434,,9194,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL875332,6175,,9195,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622384,6175,,9196,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622385,6175,,9197,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622386,6175,,9198,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622387,10839,,9199,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for the plasma binding in rat,,,N,1,Intermediate,,1,,,
CHEMBL622388,16459,,9200,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,,N,1,Intermediate,,1,,,
CHEMBL622389,16459,,9201,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,,N,1,Intermediate,,1,,,
CHEMBL622390,16459,,9202,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,,N,1,Intermediate,,1,,,
CHEMBL622391,16459,,9203,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622392,16459,,9204,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622393,16459,,9205,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622394,3278,,9206,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma level at 2 hr after administration of the compound,,,N,1,Intermediate,,1,,,
CHEMBL622395,3278,,9207,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,plasma level at 2 hr after administration of the compound,,,N,1,Intermediate,,1,,,
CHEMBL622396,4684,,9208,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 1 min,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624894,4684,,9209,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 10 min,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624895,4684,,9210,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 10 mins,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624058,4684,,9211,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 2 hr,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624059,4684,,9212,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 3 min,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624060,4684,,9213,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 3 mins,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624061,4684,,9214,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 5 min,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624062,4684,,9215,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat serum measured as % recovery at 5 mins,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL624063,16456,,9216,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624064,16456,,9217,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624065,723,,9218,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624066,723,,9219,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877490,5160,,9220,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life tested in mature male rat at a dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL874442,4709,,9221,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after intravenous administration of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL626890,5633,,9222,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after administration (30 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL626891,5302,,9223,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat after 5 mg/Kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626892,5302,,9224,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat after 5 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626893,17791,,9225,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was determined,,,N,1,Intermediate,,1,,,
CHEMBL626894,17791,,9226,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL626895,17791,,9227,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in rat; 0.5-1.0,,,N,1,Intermediate,,1,,,
CHEMBL626896,17791,,9228,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in rat; 5.9-7.5,,,N,1,Intermediate,,1,,,
CHEMBL626897,14512,,9229,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626898,6230,,9230,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life time in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL626899,3364,,9231,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Terminal half-life after iv administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL626900,6874,,9232,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL626901,857,,9233,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626902,858,,9234,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,,N,1,Intermediate,,1,,,
CHEMBL626903,858,,9235,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,,N,1,Intermediate,,1,,,
CHEMBL874443,5355,,9236,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626904,5355,,9237,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626905,6305,,9238,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats,,,N,1,Intermediate,,1,,,
CHEMBL873830,13501,,9239,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626906,17594,,9240,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL631076,4186,,9241,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631077,2932,,9242,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biological half-life was measured in plasma of rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631078,17065,,9243,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,N,1,Intermediate,,1,,,
CHEMBL631079,15765,,9244,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,,N,1,Intermediate,,1,,,
CHEMBL631080,2713,,9245,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL631081,2661,,9246,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL631239,2661,,9247,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL631240,740,,9248,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for plasma half life in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631241,6597,,9249,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC value at a dose of 5 mg/kg (p.o.) in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631242,2959,,9250,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC value after administration of 20 mg/Kg oral dose in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631243,17594,,9251,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL874444,17596,,9252,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC0-96 after administration at 50 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631244,17594,,9253,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631245,3293,,9254,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,,N,1,Intermediate,,1,,,
CHEMBL627162,6757,,9255,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL627163,6757,,9256,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL627164,6757,,9257,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,,N,1,Intermediate,,1,,,
CHEMBL627165,5979,,9258,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627166,5979,,9259,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,,N,1,Intermediate,,1,,,
CHEMBL627167,5979,,9260,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,,N,1,Intermediate,,1,,,
CHEMBL627822,4026,,9261,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) at a dose of 30 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL627823,5355,,9262,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL627824,5355,,9263,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL627825,5355,,9264,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL627826,5633,,9265,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL627827,1716,,9266,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (Pharmacokinetic property) was determined,,,N,1,Intermediate,,1,,,
CHEMBL627828,1716,,9267,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (Pharmacokinetic property) of the compound; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL627829,4689,,9268,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve after intravenous administration (1 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL627830,4527,,9269,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL627831,4527,,9270,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL627832,15662,,9271,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in male SD rats was observed after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL627833,4413,,9272,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL627834,3598,,9273,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL628004,3598,,9274,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL628005,5964,,9275,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at 5 mg/kg po was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL628006,4689,,9276,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in Rat at a oral dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628007,4186,,9277,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,N,1,Intermediate,,1,,,
CHEMBL625676,5510,,9278,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined,,,N,1,Intermediate,,1,,,
CHEMBL631309,17858,,9279,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,,N,1,Intermediate,,1,,,
CHEMBL631310,17804,,9280,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve after intravenous administration at 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL631311,6106,,9281,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,,N,1,Intermediate,,1,,,
CHEMBL631312,5964,,9282,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at 4 hr in rat,,,N,1,Intermediate,,1,,,
CHEMBL631313,4026,,9283,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at a dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL631314,4756,,9284,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL631315,4756,,9285,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL631316,5862,,9286,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve for a 2-mpk po dose in SD rats,,,N,1,Intermediate,,1,,,
CHEMBL631317,5862,,9287,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in SD rats,,,N,1,Intermediate,,1,,,
CHEMBL874471,6644,,9288,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat after oral administration at 13 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL631318,5871,,9289,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat by po administration at 0-24 hr,,,N,1,Intermediate,,1,,,
CHEMBL631319,5919,,9290,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631320,5939,,9291,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL631321,5939,,9292,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL631322,10,,9293,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,,N,1,Intermediate,,1,,,
CHEMBL631323,11149,,9294,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,,N,1,Intermediate,,1,,,
CHEMBL631324,5302,,9295,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve value in rat at a dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL631325,17796,,9296,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined after oral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL631326,4890,,9297,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL631327,6011,,9298,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined after peroral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL631328,5375,,9299,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined at a dose 30 mpk administered orally.,,,N,1,Intermediate,,1,,,
CHEMBL631329,17764,,9300,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL627217,4368,,9301,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL626352,5610,,9302,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in male rat,,,N,1,Intermediate,,1,,,
CHEMBL626353,5833,,9303,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in rat after PO administration,,,N,1,Intermediate,,1,,,
CHEMBL626354,4257,,9304,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in rat after a 3 mg/kg of oral dose,,,N,1,Intermediate,,1,,,
CHEMBL626355,5937,,9305,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626356,5932,,9306,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626357,5932,,9307,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,,N,1,Intermediate,,1,,,
CHEMBL626358,17411,,9308,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626359,17411,,9309,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626360,17771,,9310,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration in rat at a dose of 3 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626361,1628,,9311,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration at 2 hr in rats was evaluated.,,,N,1,Intermediate,,1,,,
CHEMBL626362,1628,,9312,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration at 2 hr in rats was evaluated; Not available,,,N,1,Intermediate,,1,,,
CHEMBL626363,17411,,9313,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626970,4910,,9314,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,,1,,,
CHEMBL626971,4910,,9315,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,,1,,,
CHEMBL626972,4910,,9316,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626973,4910,,9317,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626974,4910,,9318,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL874592,4910,,9319,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626975,5510,,9320,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,,N,1,Intermediate,,1,,,
CHEMBL626976,5510,,9321,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,,N,1,Intermediate,,1,,,
CHEMBL626977,5510,,9322,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL626978,5510,,9323,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL626979,16427,,9324,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,PK study was carried to determine the relative absorption ranking in rat.,,,N,1,Intermediate,,1,,,
CHEMBL626980,4689,,9325,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626981,11450,,9326,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626982,11450,,9327,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626983,11450,,9328,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622522,11450,,9329,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622523,11450,,9330,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622524,11450,,9331,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622525,11450,,9332,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622526,11450,,9333,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619849,11450,,9334,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL619850,11450,,9335,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623864,11450,,9336,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623865,11450,,9337,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623866,11450,,9338,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623867,11450,,9339,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL877615,11450,,9340,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623868,11450,,9341,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623869,11450,,9342,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623870,11450,,9343,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623871,16434,,9344,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL623872,16434,,9345,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622129,16435,,9346,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622130,16435,,9347,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622131,16435,,9348,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622132,16435,,9349,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622133,16435,,9350,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622134,16435,,9351,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622135,16435,,9352,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622136,16435,,9353,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622137,16434,,9354,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622138,16434,,9355,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623017,16434,,9356,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623018,16434,,9357,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623019,16434,,9358,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623020,16434,,9359,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623021,16434,,9360,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623022,16434,,9361,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623023,16435,,9362,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623024,16435,,9363,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623025,16435,,9364,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620545,16435,,9365,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620546,16435,,9366,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620547,16435,,9367,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620548,16435,,9368,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620549,16435,,9369,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620550,16434,,9370,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620551,16434,,9371,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620552,16434,,9372,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620553,16435,,9373,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620554,16435,,9374,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL875845,16435,,9375,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620555,16435,,9376,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620556,16435,,9377,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620557,16435,,9378,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620558,16434,,9379,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL620559,16434,,9380,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622939,16434,,9381,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL622940,16434,,9382,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622941,16434,,9383,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL622942,16434,,9384,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622943,16434,,9385,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL622944,16434,,9386,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622945,16435,,9387,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL622946,16435,,9388,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622947,3341,,9389,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for terminal half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622948,3634,,9390,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622949,3634,,9391,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622950,4839,,9392,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for its half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622951,5005,,9393,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,,U,0,Intermediate,Plasma,1,,1969.0,
CHEMBL622952,5005,,9394,,10116.0,,22224,,A,Rattus norvegicus,BAO_0000366,Compound was tested for its plasma half life in Sprague Dawley rats,,,U,0,Intermediate,Plasma,1,,1969.0,
CHEMBL622953,5005,,9395,,10116.0,,22224,,A,Rattus norvegicus,BAO_0000366,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,,U,0,Intermediate,Plasma,1,,1969.0,
CHEMBL873818,1094,,9396,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma half-life period in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622954,5031,,9397,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Elimination half life after i.v. administration of compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL622955,6518,,9398,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL875229,6518,,9399,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Elimination half-life after IV dosing at 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL622956,6518,,9400,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL622957,6518,,9401,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL622958,5408,,9402,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622959,5408,,9403,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622960,5408,,9404,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622961,5408,,9405,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622962,4687,,9406,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for the half life in rat (in vivo),,,N,1,Intermediate,,1,,,
CHEMBL622963,6640,,9407,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Hafl life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622964,6640,,9408,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Hafl life rat,,,N,1,Intermediate,,1,,,
CHEMBL622965,6641,,9409,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Hafl life rat,,,N,1,Intermediate,,1,,,
CHEMBL622966,6640,,9410,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Hafl life rat; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL622967,6641,,9411,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Hafl life rat; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL622968,17411,,9412,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622969,17411,,9413,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL875327,17411,,9414,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL628638,6570,,9415,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after 1 mg/kg i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL628639,6570,,9416,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after 2 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL625840,17411,,9417,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625841,4722,,9418,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of 10 mg/kg oral dose determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL625842,5978,,9419,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625843,5978,,9420,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625844,5978,,9421,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL873822,5978,,9422,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625845,5978,,9423,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL627059,5978,,9424,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL627060,5978,,9425,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL627061,5978,,9426,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL627709,4762,,9427,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound at 5 mg/kg after po administration was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL627710,5327,,9428,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound determined after intravenous administration to rat,,,N,1,Intermediate,,1,,,
CHEMBL627711,4847,,9429,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life of compound was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL627712,17720,,9430,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627713,4723,,9431,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL627714,4723,,9432,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL627889,4256,,9433,,9541.0,In vivo,22224,,A,Macaca fascicularis,BAO_0000218,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,,U,0,Intermediate,,1,,,
CHEMBL627890,4256,,9434,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Half life determined in rat by intravenous administration,,,U,0,Intermediate,,1,,,
CHEMBL627891,4722,,9435,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life determined in rats after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL627892,6535,,9436,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat plasma after administration of 2 mg/kg iv,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627893,6535,,9437,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat plasma after administration of 2 mg/kg iv,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627894,1435,,9438,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat plasma was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627895,1435,,9439,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat plasma was determined; NA means not applicable,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627896,5206,,9440,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat was tested,,,N,1,Intermediate,,1,,,
CHEMBL627897,6080,,9441,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life measured in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627898,4449,,9442,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life recorded in rats,,,N,1,Intermediate,,1,,,
CHEMBL627899,6057,,9443,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was calculated,,,N,1,Intermediate,,1,,,
CHEMBL873823,6057,,9444,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was calculated in rat,,,N,1,Intermediate,,1,,,
CHEMBL627900,3747,,9445,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was determined,,,N,1,Intermediate,,1,,,
CHEMBL627901,17858,,9446,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after 10 mg/kg oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL627902,16365,,9447,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL627903,16365,,9448,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after administering orally a dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627904,5031,,9449,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL627905,4722,,9450,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,,N,1,Intermediate,,1,,,
CHEMBL627906,6078,,9451,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627907,6078,,9452,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL876783,6078,,9453,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627908,6078,,9454,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,,N,1,Intermediate,,1,,,
CHEMBL627909,17065,,9455,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,N,1,Intermediate,,1,,,
CHEMBL627910,1353,,9456,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,,N,1,Intermediate,,1,,,
CHEMBL627911,1353,,9457,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,,N,1,Intermediate,,1,,,
CHEMBL627912,1353,,9458,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,,N,1,Intermediate,,1,,,
CHEMBL627913,1353,,9459,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,,N,1,Intermediate,,1,,,
CHEMBL627914,1353,,9460,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,,N,1,Intermediate,,1,,,
CHEMBL627915,16423,,9461,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,,N,1,Intermediate,,1,,,
CHEMBL627916,16423,,9462,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was evaluated after 20 uM/kg of peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL627917,6062,,9463,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627918,6056,,9464,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627919,5182,,9465,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL627920,6410,,9466,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627921,6410,,9467,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve was evaluated at an oral dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627922,4723,,9468,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL876784,4723,,9469,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL627923,4723,,9470,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL626208,4723,,9471,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL626209,4723,,9472,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL626210,4723,,9473,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL627994,2463,,9474,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627995,4709,,9475,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627996,4075,,9476,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,,N,1,Intermediate,,1,,,
CHEMBL627997,5394,,9477,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,,N,1,Intermediate,,1,,,
CHEMBL627998,2661,,9478,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL628640,2661,,9479,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL628641,2661,,9480,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL628642,2661,,9481,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL628643,17791,,9482,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for area under the curve expressed as (h*ug/ml),,,N,1,Intermediate,,1,,,
CHEMBL628644,2591,,9483,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for area under curve in rat,,,N,1,Intermediate,,1,,,
CHEMBL628645,6567,,9484,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,,N,1,Intermediate,,1,,,
CHEMBL628646,6211,,9485,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL628647,5529,,9486,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL628648,5408,,9487,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,N,1,Intermediate,,1,,,
CHEMBL625358,5408,,9488,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,N,1,Intermediate,,1,,,
CHEMBL625359,5408,,9489,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,N,1,Intermediate,,1,,,
CHEMBL625360,5408,,9490,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,N,1,Intermediate,,1,,,
CHEMBL625361,429,,9491,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,,N,1,Intermediate,,1,,,
CHEMBL625362,429,,9492,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,,N,1,Intermediate,,1,,,
CHEMBL625363,429,,9493,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,,N,1,Intermediate,,1,,,
CHEMBL625364,4796,,9494,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,N,1,Intermediate,,1,,,
CHEMBL625365,5974,,9495,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625366,5974,,9496,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625367,5974,,9497,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625368,11450,,9498,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625369,11450,,9499,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625370,11450,,9500,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625371,11450,,9501,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625372,11450,,9502,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625373,11450,,9503,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625374,11450,,9504,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL877593,11450,,9505,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625375,11450,,9506,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625376,11450,,9507,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621973,11450,,9508,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621974,11450,,9509,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621975,11450,,9510,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622166,11450,,9511,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622167,11450,,9512,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622168,11450,,9513,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622169,11450,,9514,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622170,11450,,9515,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622171,11450,,9516,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622172,11450,,9517,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622173,11450,,9518,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622174,11450,,9519,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622175,11450,,9520,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622176,11450,,9521,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622177,11450,,9522,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622178,11450,,9523,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622179,11450,,9524,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622180,11450,,9525,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622181,16435,,9526,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL622182,16435,,9527,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622183,16435,,9528,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL622184,16435,,9529,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622185,16435,,9530,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL622186,16435,,9531,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622187,16434,,9532,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL625002,16434,,9533,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL622090,16434,,9534,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL622091,16435,,9535,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL622092,16435,,9536,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL622093,16435,,9537,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL622094,16435,,9538,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL622095,16435,,9539,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL622264,16435,,9540,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL622265,16434,,9541,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622266,16434,,9542,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622267,16434,,9543,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622268,16434,,9544,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622269,16434,,9545,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625071,16434,,9546,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621621,16434,,9547,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621622,16434,,9548,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621623,16435,,9549,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621624,16435,,9550,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621625,16435,,9551,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621626,16435,,9552,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621627,16435,,9553,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621628,16435,,9554,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL875328,16435,,9555,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621629,16435,,9556,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621630,16434,,9557,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621631,16434,,9558,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621632,16434,,9559,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621633,16435,,9560,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621634,16435,,9561,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621635,16435,,9562,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621636,16435,,9563,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621637,16435,,9564,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL621638,16435,,9565,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL618883,16434,,9566,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL618884,16434,,9567,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL628627,16434,,9568,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL628628,16434,,9569,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL628629,16434,,9570,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL628630,16365,,9571,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after administering orally a dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628631,16365,,9572,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL628632,16365,,9573,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after administering intravenously a dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628633,526,,9574,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after oral dosing in rats,,,N,1,Intermediate,,1,,,
CHEMBL628634,16365,,9575,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL627789,4368,,9576,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life by intravenous administration of 3.4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627790,3371,,9577,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL627791,6448,,9578,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL627792,6453,,9579,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL627793,4353,,9580,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after intravenous administration of the compound,,,N,1,Intermediate,,1,,,
CHEMBL627794,4353,,9581,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627795,4353,,9582,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after po administration of the compound,,,N,1,Intermediate,,1,,,
CHEMBL627796,4353,,9583,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after po administration of the compound; ND means Not determined,,,N,1,Intermediate,,1,,,
CHEMBL875335,4353,,9584,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627797,4353,,9585,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627798,5789,,9586,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat i.v.,,,N,1,Intermediate,,1,,,
CHEMBL627799,17686,,9587,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat i.v. at 2 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL627800,6495,,9588,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats,,,N,1,Intermediate,,1,,,
CHEMBL627801,484,,9589,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats after intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL627802,6467,,9590,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rats at the dose of 1.0 mpk by i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL627803,6642,,9591,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat,,,N,1,Expert,,1,,,
CHEMBL873820,16367,,9592,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was evaluated after intravenous administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL627804,1369,,9593,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,,N,1,Intermediate,,1,,,
CHEMBL627805,5472,,9594,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL627806,6049,,9595,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL627107,5472,,9596,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was evaluated in rat; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL627108,16366,,9597,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,,N,1,Intermediate,,1,,,
CHEMBL627109,11149,,9598,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,,N,1,Intermediate,,1,,,
CHEMBL627110,11149,,9599,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627111,2891,,9600,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,U,0,Intermediate,,1,,,
CHEMBL627112,2891,,9601,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,U,0,Intermediate,,1,,,
CHEMBL627113,2891,,9602,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Half life was measured in rat at dose of 30 mg/kg by iv administration,,,U,0,Intermediate,,1,,,
CHEMBL627114,2891,,9603,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Half life was measured in rat at dose of 30 mg/kg by po administration,,,U,0,Intermediate,,1,,,
CHEMBL627115,4026,,9604,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life (t1/2) was determined,,,N,1,Intermediate,,1,,,
CHEMBL627116,4527,,9605,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period at a dose of 10 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL627117,4527,,9606,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,,N,1,Intermediate,,1,,,
CHEMBL627118,5503,,9607,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was determined,,,N,1,Intermediate,,1,,,
CHEMBL627119,4426,,9608,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after intravenous administration at 20 mpk in rats,,,N,1,Intermediate,,1,,,
CHEMBL627120,4426,,9609,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,,N,1,Intermediate,,1,,,
CHEMBL626922,6109,,9610,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL626923,5654,,9611,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL626924,5654,,9612,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL626925,4755,,9613,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in 80% rat plasma at 37 degree Centigrade,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626926,5862,,9614,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in SD rats,,,N,1,Intermediate,,1,,,
CHEMBL626927,1515,,9615,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626928,1515,,9616,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626929,1515,,9617,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626930,1515,,9618,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626931,5960,,9619,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat,,,N,1,Intermediate,,1,,,
CHEMBL626932,6103,,9620,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat,,,N,1,Intermediate,,1,,,
CHEMBL626933,6317,,9621,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat,,,N,1,Intermediate,,1,,,
CHEMBL873826,6644,,9622,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat after oral administration at 10.5 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626934,6644,,9623,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat after oral administration at 11.2 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626935,6644,,9624,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat after oral administration at 13 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626936,6644,,9625,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat after oral administration at 9.7 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626937,5974,,9626,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625906,6295,,9627,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625907,6296,,9628,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625908,16427,,9629,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,PK study was carried to determine AUC (area under curve) value in rat,,,N,1,Intermediate,,1,,,
CHEMBL625909,16367,,9630,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC after intravenous administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL625910,16367,,9631,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC after oral administration to rats,,,N,1,Intermediate,,1,,,
CHEMBL625911,16365,,9632,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625912,16365,,9633,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL626538,16365,,9634,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL876794,16365,,9635,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,,N,1,Intermediate,,1,,,
CHEMBL626539,16365,,9636,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,,N,1,Intermediate,,1,,,
CHEMBL626540,16365,,9637,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL626541,5394,,9638,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626542,5394,,9639,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626543,2792,,9640,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL626544,2792,,9641,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL626545,2792,,9642,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL626546,2792,,9643,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL626547,5334,,9644,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter area under curve was reported,,,N,1,Intermediate,,1,,,
CHEMBL626548,4408,,9645,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (AUC) in rat,,,N,1,Intermediate,,1,,,
CHEMBL626549,5983,,9646,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,,N,1,Intermediate,,1,,,
CHEMBL626550,4397,,9647,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,,N,1,Intermediate,,1,,,
CHEMBL626551,4397,,9648,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL623777,5491,,9649,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property was determined,,,N,1,Intermediate,,1,,,
CHEMBL623778,5491,,9650,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623779,5491,,9651,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL623780,4199,,9652,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622015,4199,,9653,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622016,4199,,9654,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622017,5173,,9655,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,,N,1,Intermediate,,1,,,
CHEMBL622018,5173,,9656,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,,N,1,Intermediate,,1,,,
CHEMBL622019,5173,,9657,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,,N,1,Intermediate,,1,,,
CHEMBL622020,5173,,9658,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,,N,1,Intermediate,,1,,,
CHEMBL622021,16366,,9659,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,,N,1,Intermediate,,1,,,
CHEMBL622022,16366,,9660,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,,N,1,Intermediate,,1,,,
CHEMBL622023,5327,,9661,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL622024,6681,,9662,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL622693,12873,,9663,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,,N,1,Intermediate,,1,,,
CHEMBL622694,12873,,9664,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,,N,1,Intermediate,,1,,,
CHEMBL622695,6685,,9665,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622696,6685,,9666,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,N,1,Intermediate,,1,,,
CHEMBL622697,6685,,9667,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,,N,1,Intermediate,,1,,,
CHEMBL622874,6619,,9668,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,,N,1,Intermediate,,1,,,
CHEMBL622875,6619,,9669,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,,N,1,Intermediate,,1,,,
CHEMBL622876,10363,,9670,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,N,1,Intermediate,,1,,,
CHEMBL622877,4796,,9671,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,N,1,Intermediate,,1,,,
CHEMBL622878,4910,,9672,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,N,1,Intermediate,,1,,,
CHEMBL622879,4910,,9673,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877602,4839,,9674,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,,N,1,Intermediate,,1,,,
CHEMBL622880,15078,,9675,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622881,15078,,9676,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622882,15078,,9677,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622883,15078,,9678,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL622884,11450,,9679,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622885,11450,,9680,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622886,8151,,9681,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,N,1,Intermediate,,1,,,
CHEMBL622887,8151,,9682,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL622888,8151,,9683,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622889,8677,,9684,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622890,8677,,9685,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622891,8677,,9686,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL877603,8677,,9687,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622892,8677,,9688,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622893,8677,,9689,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622894,8677,,9690,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622895,8677,,9691,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622896,8677,,9692,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622897,8677,,9693,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622898,8677,,9694,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622899,8677,,9695,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622900,8677,,9696,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624114,8677,,9697,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624115,8677,,9698,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624116,8677,,9699,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624117,8677,,9700,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624118,8677,,9701,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624119,8677,,9702,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624120,8677,,9703,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624121,8677,,9704,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624122,8677,,9705,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624123,8677,,9706,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624124,8677,,9707,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624125,8677,,9708,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624126,8677,,9709,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624127,8677,,9710,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624128,8677,,9711,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624129,8677,,9712,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL624130,8677,,9713,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL622340,8677,,9714,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL622341,8677,,9715,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL622342,8677,,9716,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622343,8677,,9717,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622344,8677,,9718,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622345,8677,,9719,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622346,8677,,9720,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622347,8677,,9721,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622348,8677,,9722,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622349,8677,,9723,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622350,16434,,9724,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622351,16434,,9725,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL622352,16434,,9726,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622353,16435,,9727,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL622354,16435,,9728,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622355,16435,,9729,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL622356,16435,,9730,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622357,16435,,9731,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL622358,16435,,9732,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,N,1,Intermediate,,1,,,
CHEMBL622359,16435,,9733,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL874393,16435,,9734,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL622872,16434,,9735,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL622873,16434,,9736,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL623047,16434,,9737,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL623048,16435,,9738,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL623049,16435,,9739,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL623050,16435,,9740,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL623051,16435,,9741,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL623052,16435,,9742,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL626343,16435,,9743,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL626344,16434,,9744,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,N,1,Intermediate,,1,,,
CHEMBL626345,16434,,9745,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,N,1,Intermediate,,1,,,
CHEMBL626346,16434,,9746,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,N,1,Intermediate,,1,,,
CHEMBL626347,16434,,9747,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL626348,16434,,9748,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL626349,16434,,9749,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL626350,16435,,9750,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL626351,16435,,9751,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL627650,16435,,9752,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL627651,16435,,9753,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,N,1,Intermediate,,1,,,
CHEMBL627652,16435,,9754,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,N,1,Intermediate,,1,,,
CHEMBL627653,16435,,9755,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL627654,13091,,9756,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL627835,13091,,9757,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,,N,1,Intermediate,,1,,,
CHEMBL627836,13091,,9758,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL627837,13091,,9759,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL627838,13091,,9760,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL875338,13091,,9761,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,,N,1,Intermediate,,1,,,
CHEMBL627839,13091,,9762,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL627840,13091,,9763,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL627841,13091,,9764,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL627842,13091,,9765,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,,N,1,Intermediate,,1,,,
CHEMBL627843,13091,,9766,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL627844,13091,,9767,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL627845,13091,,9768,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL627846,5874,,9769,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat by iv administration at a dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627847,1515,,9770,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL873821,1515,,9771,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626079,1515,,9772,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626080,1515,,9773,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626081,5491,,9774,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL875344,5491,,9775,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in rat plasma; Not tested,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626082,1918,,9776,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL626250,1918,,9777,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half life period was evaluated in rats, iv",,,N,1,Intermediate,,1,,,
CHEMBL626251,6113,,9778,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period after intravenous administration at 5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL626252,5546,,9779,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,N,1,Intermediate,,1,,,
CHEMBL626253,5553,,9780,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626254,4188,,9781,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life stability of compound was evaluated in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626255,6215,,9782,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL626256,6141,,9783,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL626257,5182,,9784,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL626258,5182,,9785,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,,N,1,Intermediate,,1,,,
CHEMBL626259,5710,,9786,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,,N,1,Intermediate,,1,,,
CHEMBL626260,5789,,9787,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half in rat i.v.,,,N,1,Intermediate,,1,,,
CHEMBL875345,6011,,9788,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half period in rat after intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL626261,17594,,9789,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626262,12357,,9790,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Half-life measured in in vitro Cathepsin B assay in rat liver,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626263,5210,,9791,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life of compound was determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL625270,17596,,9792,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life at 10 mg/kg in rat upon intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL625271,6672,,9793,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL625272,6673,,9794,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL625273,4910,,9795,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625274,3741,,9796,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625275,17671,,9797,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625276,4910,,9798,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625277,17537,,9799,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625278,4965,,9800,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625279,17537,,9801,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma; Not tested,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625280,6124,,9802,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat serum,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL876797,6124,,9803,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat serum; na is not available,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL625281,6078,,9804,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was calculated in rat,,,N,1,Intermediate,,1,,,
CHEMBL873827,17668,,9805,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was calculated in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625282,3185,,9806,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined,,,N,1,Intermediate,,1,,,
CHEMBL625283,4883,,9807,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined,,,N,1,Intermediate,,1,,,
CHEMBL625284,2959,,9808,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life after administration of 20 mg/Kg oral dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL625285,4029,,9809,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life after administration of 3.2 mg/kg intravenously in male rat,,,N,1,Intermediate,,1,,,
CHEMBL625286,4029,,9810,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life after intravenous administration in female rat,,,N,1,Intermediate,,1,,,
CHEMBL625287,4029,,9811,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life after intravenous administration in male rat,,,N,1,Intermediate,,1,,,
CHEMBL625288,6180,,9812,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life after intravenous dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL625289,1557,,9813,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in a rat liver homogenate preparation,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625290,12500,,9814,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in plasma of rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876798,12500,,9815,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in plasma of rat at dose of 3-10 mgkg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625291,5064,,9816,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL625292,5145,,9817,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL625293,5147,,9818,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622832,5833,,9819,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622833,6596,,9820,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622834,17655,,9821,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL622835,6495,,9822,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat after oral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622836,17538,,9823,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat after po administration at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622837,17538,,9824,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,N,1,Intermediate,,1,,,
CHEMBL622838,10,,9825,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat at 3 mg/kg dose administered intravenously,,,N,1,Intermediate,,1,,,
CHEMBL622839,17669,,9826,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat brain homogenate,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622840,17065,,9827,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622841,4333,,9828,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rats,,,N,1,Intermediate,,1,,,
CHEMBL622842,6827,,9829,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL622843,889,,9830,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in vitro in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622844,889,,9831,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622845,3747,,9832,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,,N,1,Intermediate,,1,,,
CHEMBL622846,15022,,9833,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The area under the curve of compound was measured at the dose of 100 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL622847,15022,,9834,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The area under the curve of compound was measured at the dose of 300 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL622848,15022,,9835,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The area under the curve of compound was measured at the dose of 30 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL622849,3360,,9836,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability as oral AUC in rats,,,N,1,Intermediate,,1,,,
CHEMBL622850,5334,,9837,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The plasma concentration versus time curve (AUC) was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876807,17411,,9838,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622851,17411,,9839,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622852,17411,,9840,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622853,6570,,9841,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,,N,1,Intermediate,,1,,,
CHEMBL622854,6570,,9842,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,,N,1,Intermediate,,1,,,
CHEMBL622855,17411,,9843,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622856,14941,,9844,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622857,14941,,9845,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622858,17538,,9846,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat after po administration at a dose of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622859,17752,,9847,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622860,17509,,9848,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL622861,17509,,9849,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL622862,17509,,9850,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL622863,17509,,9851,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL623817,17509,,9852,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve value 6 hr after po administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL623818,17717,,9853,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,N,1,Intermediate,,1,,,
CHEMBL623819,17717,,9854,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,,N,1,Intermediate,,1,,,
CHEMBL623820,17717,,9855,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,N,1,Intermediate,,1,,,
CHEMBL623821,17717,,9856,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,,N,1,Intermediate,,1,,,
CHEMBL623822,6642,,9857,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC normalized for dose (AUCN) in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623823,6640,,9858,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat after p.o. administration,,,N,1,Intermediate,,1,,,
CHEMBL623824,6641,,9859,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat after p.o. administration,,,N,1,Intermediate,,1,,,
CHEMBL623825,6641,,9860,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat after p.o. administration; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL622070,6641,,9861,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in rat after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL622071,3603,,9862,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (carotid artery) value of the compound,,,N,1,Intermediate,,1,,,
CHEMBL622072,3550,,9863,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability expressed as the area under curve of rat carotid artery,,,N,1,Intermediate,,1,,,
CHEMBL622073,15662,,9864,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve in male SD rats was observed after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL622074,17720,,9865,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve of the compound was determined,,,N,1,Intermediate,,1,,,
CHEMBL622075,5407,,9866,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,,N,1,Intermediate,,1,,,
CHEMBL622076,17752,,9867,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622077,17752,,9868,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622078,3603,,9869,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (portal vein) value of the compound,,,N,1,Intermediate,,1,,,
CHEMBL622079,3550,,9870,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability expressed as the area under curve of rat portal vein,,,N,1,Intermediate,,1,,,
CHEMBL622080,17655,,9871,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area Under plasma concentration time curve in rat upon peroral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877612,17582,,9872,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL622081,17582,,9873,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL622082,17791,,9874,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats,,,N,1,Intermediate,,1,,,
CHEMBL622083,17791,,9875,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL622084,17791,,9876,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 30-80,,,N,1,Intermediate,,1,,,
CHEMBL622085,17791,,9877,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 50-60,,,N,1,Intermediate,,1,,,
CHEMBL622086,17791,,9878,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats; no data,,,N,1,Intermediate,,1,,,
CHEMBL622087,17791,,9879,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats; peptide,,,N,1,Intermediate,,1,,,
CHEMBL622088,7768,,9880,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622089,7768,,9881,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623685,7768,,9882,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623686,7768,,9883,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623687,8677,,9884,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL623688,8677,,9885,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL623689,8677,,9886,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622485,8677,,9887,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL622486,8677,,9888,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL877613,8677,,9889,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622487,8677,,9890,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622488,8677,,9891,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622489,8677,,9892,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622490,6899,,9893,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622491,6899,,9894,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622492,6899,,9895,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622493,6899,,9896,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622494,6899,,9897,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622495,8677,,9898,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622496,6899,,9899,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,,N,1,Intermediate,,1,,,
CHEMBL622497,6899,,9900,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622498,2189,,9901,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,,N,1,Intermediate,,1,,,
CHEMBL624918,2189,,9902,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624919,2189,,9903,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624920,10839,,9904,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat blood after 5 min of administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624921,10839,,9905,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat blood after 5 min of administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624922,10839,,9906,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat brain after 5 min of administration,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624923,10839,,9907,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat heart after 5 min of administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624924,10839,,9908,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat heart after 5 min of administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624925,10839,,9909,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat kidney after 5 min of administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624926,10839,,9910,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat kidney after 5 min of administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624927,10839,,9911,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat liver after 5 min of administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL874402,10839,,9912,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat liver after 5 min of administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624928,10839,,9913,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat lung after 5 min of administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624929,10839,,9914,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat lung after 5 min of administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624930,10839,,9915,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624931,10839,,9916,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624932,4043,,9917,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624933,4043,,9918,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624934,4043,,9919,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624935,4043,,9920,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624936,4043,,9921,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,,1,,,
CHEMBL624937,4043,,9922,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,,1,,,
CHEMBL624938,4043,,9923,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL624939,4043,,9924,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL624940,4043,,9925,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,,1,,,
CHEMBL874403,4043,,9926,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,N,1,Intermediate,,1,,,
CHEMBL624941,1446,,9927,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,,N,1,Intermediate,,1,,,
CHEMBL624942,9971,,9928,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624943,9971,,9929,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624944,5765,,9930,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,% Bioavailability after 1 day of the drug administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL624945,5765,,9931,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,% Bioavailability after 4 day of the drug administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL624946,4257,,9932,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Absolute bioavailability was evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL624947,13091,,9933,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,,N,1,Intermediate,,1,,,
CHEMBL624948,13091,,9934,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL624949,13091,,9935,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL622025,13091,,9936,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622026,13091,,9937,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622027,13091,,9938,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622028,13091,,9939,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622029,13091,,9940,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622208,13091,,9941,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622209,13091,,9942,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622210,13091,,9943,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622211,13091,,9944,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL622212,13091,,9945,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,,N,1,Intermediate,,1,,,
CHEMBL622213,13091,,9946,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL874404,13091,,9947,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL620452,13091,,9948,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620453,13091,,9949,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL620454,13091,,9950,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624067,13091,,9951,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624068,13091,,9952,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL624069,13091,,9953,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL624070,13091,,9954,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL624071,13091,,9955,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL624072,13091,,9956,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL624073,13091,,9957,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL624788,13091,,9958,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL624789,13091,,9959,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL624790,13091,,9960,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,,N,1,Intermediate,,1,,,
CHEMBL624791,13091,,9961,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,,N,1,Intermediate,,1,,,
CHEMBL624792,13091,,9962,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL624793,13091,,9963,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,,N,1,Intermediate,,1,,,
CHEMBL877491,13091,,9964,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624957,13091,,9965,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624958,13091,,9966,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624959,13091,,9967,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624960,11977,,9968,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dissociation constant was determined,,,N,1,Intermediate,,1,,,
CHEMBL624961,14941,,9969,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,,N,1,Intermediate,,1,,,
CHEMBL624962,15078,,9970,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL624963,15078,,9971,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL624964,4755,,9972,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,,N,1,Intermediate,,1,,,
CHEMBL624965,589,,9973,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,LogP value was evaluated in the in situ rat gut perfusion assay,,,N,1,Intermediate,,1,,,
CHEMBL624966,17582,,9974,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL624967,5031,,9975,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL624968,17764,,9976,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL624969,17720,,9977,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL624970,2862,,9978,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,,N,1,Expert,,1,,,
CHEMBL624971,16423,,9979,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated after 10 uM/kg of intra arterial administration,,,N,1,Intermediate,,1,,,
CHEMBL624972,16423,,9980,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated after 20 uM/kg of peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL624973,6005,,9981,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624974,2938,,9982,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated in plasma of rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL624975,6410,,9983,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL877492,6410,,9984,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624976,6062,,9985,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was measured in rat after an iv dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624977,6571,,9986,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period of compound in rats after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL626848,3136,,9987,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period of compound was measured in rat plasma.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626849,3136,,9988,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period of compound was measured in rat plasma; ND is not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626850,3136,,9989,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period of compound was measured in rat plasma; not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626851,4521,,9990,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL626852,5871,,9991,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period in rat by iv administration,,,N,1,Intermediate,,1,,,
CHEMBL626853,6077,,9992,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period in rats following intravenous administration at 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626854,6679,,9993,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,N,1,Intermediate,,1,,,
CHEMBL627486,5144,,9994,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period was determined for the compound in rat,,,N,1,Intermediate,,1,,,
CHEMBL627487,4498,,9995,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,,N,1,Intermediate,,1,,,
CHEMBL627488,4498,,9996,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,,N,1,Intermediate,,1,,,
CHEMBL627489,1908,,9997,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,,N,1,Intermediate,,1,,,
CHEMBL627490,6211,,9998,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL873829,5529,,9999,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL627655,6444,,10000,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.,,,N,1,Intermediate,,1,,,
CHEMBL625994,6444,,10001,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,N,1,Intermediate,,1,,,
CHEMBL625995,6444,,10002,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,N,1,Intermediate,,1,,,
CHEMBL625996,5207,,10003,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life in rat,,,N,1,Intermediate,,1,,,
CHEMBL625850,530,,10004,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,In vitro half life in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625851,1116,,10005,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625852,3219,,10006,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,In vitro half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL625853,6109,,10007,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo half life period after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL625854,17582,,10008,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL874450,17582,,10009,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL625855,5974,,10010,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625856,5974,,10011,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625857,5974,,10012,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL873831,5974,,10013,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL625858,17853,,10014,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Longer half-life in rat (i.v.) at 0.5 mpk,,,N,1,Intermediate,,1,,,
CHEMBL625859,17853,,10015,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Longer half-life in rat (p.o.) at 2.0 mpk,,,N,1,Intermediate,,1,,,
CHEMBL625860,3457,,10016,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (half life) in rat,,,N,1,Intermediate,,1,,,
CHEMBL625861,2792,,10017,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL625862,2792,,10018,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL625863,2792,,10019,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL625864,2792,,10020,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL625865,5739,,10021,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL625866,15765,,10022,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic half time was determined intravenously in rats.,,,N,1,Intermediate,,1,,,
CHEMBL625867,6567,,10023,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625868,2448,,10024,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half life of hydrolysis of the compound,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625869,5423,,10025,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL874451,4853,,10026,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half life period was calculated in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625870,4514,,10027,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life in Sprague-Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625871,4514,,10028,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life in Sprague-Dawley rats; Not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625872,1500,,10029,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625873,1500,,10030,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life in rats; <MQL,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625874,5334,,10031,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life period (0-8 h) was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625875,5334,,10032,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625876,5334,,10033,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631258,5334,,10034,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631259,4956,,10035,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631260,4956,,10036,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631261,7768,,10037,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631262,7768,,10038,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631263,7768,,10039,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631264,7768,,10040,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,,N,1,Intermediate,,1,,,
CHEMBL631265,7768,,10041,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,,N,1,Intermediate,,1,,,
CHEMBL631266,7768,,10042,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,,N,1,Intermediate,,1,,,
CHEMBL631267,7768,,10043,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,,N,1,Intermediate,,1,,,
CHEMBL631268,7768,,10044,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,,N,1,Intermediate,,1,,,
CHEMBL631269,7768,,10045,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,,N,1,Intermediate,,1,,,
CHEMBL631270,7768,,10046,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,,N,1,Intermediate,,1,,,
CHEMBL631271,7768,,10047,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631272,7768,,10048,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631273,7768,,10049,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631274,7768,,10050,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631275,7768,,10051,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626984,7768,,10052,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626985,7768,,10053,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626986,7768,,10054,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626987,7768,,10055,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626988,7768,,10056,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626989,7768,,10057,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626990,7768,,10058,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626991,7768,,10059,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626992,7768,,10060,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626993,7768,,10061,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL874593,7768,,10062,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626994,7768,,10063,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626995,7768,,10064,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626190,7768,,10065,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626191,7768,,10066,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626364,7768,,10067,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626365,7768,,10068,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626366,7768,,10069,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626367,7768,,10070,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626368,7768,,10071,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626369,7768,,10072,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626370,7768,,10073,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626371,4498,,10074,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,,N,1,Intermediate,,1,,,
CHEMBL626372,4498,,10075,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,,N,1,Intermediate,,1,,,
CHEMBL626373,3603,,10076,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after a dose of 10 mg/kg p.o.,,,N,1,Intermediate,,1,,,
CHEMBL626374,6215,,10077,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL626375,5710,,10078,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,,N,1,Intermediate,,1,,,
CHEMBL626376,5710,,10079,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL626377,5676,,10080,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat po was determined,,,N,1,Intermediate,,1,,,
CHEMBL626378,17667,,10081,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability of compound at 10 mg/kg in rat after oral administration,,,N,1,Intermediate,,1,,,
CHEMBL626379,17667,,10082,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL626380,6848,,10083,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL626381,6848,,10084,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL626382,17267,,10085,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626383,6362,,10086,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (female),,,N,1,Intermediate,,1,,,
CHEMBL874652,17671,,10087,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626384,17671,,10088,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL626385,4333,,10089,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,,N,1,Intermediate,,1,,,
CHEMBL626386,6077,,10090,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat at an oral dose of 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626387,3278,,10091,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626388,5964,,10092,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626389,4884,,10093,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626390,4905,,10094,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626391,4884,,10095,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,,N,1,Intermediate,,1,,,
CHEMBL626392,6850,,10096,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626393,2864,,10097,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623026,5780,,10098,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL623027,1465,,10099,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL623028,5199,,10100,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL623029,5765,,10101,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after 1 day dosing,,,N,1,Intermediate,,1,,,
CHEMBL623030,5765,,10102,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after 4 day dosing,,,N,1,Intermediate,,1,,,
CHEMBL623031,6518,,10103,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,,N,1,Intermediate,,1,,,
CHEMBL623032,6518,,10104,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,,N,1,Intermediate,,1,,,
CHEMBL623033,6518,,10105,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL623034,6518,,10106,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL623035,2083,,10107,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,,N,1,Intermediate,,1,,,
CHEMBL623036,17260,,10108,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL623037,4956,,10109,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL623038,4368,,10110,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL874385,17752,,10111,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623039,1446,,10112,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Fisher) (fasted),,,N,1,Intermediate,,1,,,
CHEMBL623040,2891,,10113,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Bioavailability in monkey after po administration of 10 mg/kg dose,,,U,0,Intermediate,,1,,,
CHEMBL623041,2891,,10114,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Oral bioavailability in monkey (dose 10 mg/kg),,,U,0,Intermediate,,1,,,
CHEMBL623741,6672,,10115,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623742,6673,,10116,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623743,17655,,10117,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623744,17796,,10118,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623745,17853,,10119,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 2.0 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL623746,4521,,10120,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL623747,4940,,10121,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL623748,2891,,10122,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after po administration of 30 mg/kg dose,,,U,0,Intermediate,,1,,,
CHEMBL623916,2891,,10123,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after po administration of 30 mg/kg dose,,,U,0,Intermediate,,1,,,
CHEMBL623917,4521,,10124,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL623918,17686,,10125,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 2 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL874386,17796,,10126,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623919,17796,,10127,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat; Only traces detected in rat plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623920,5064,,10128,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623148,5147,,10129,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability upon oral administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL623149,1916,,10130,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623150,6049,,10131,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623151,1445,,10132,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,,N,1,Intermediate,,1,,,
CHEMBL623152,1445,,10133,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,,N,1,Intermediate,,1,,,
CHEMBL623153,2862,,10134,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,,N,1,Expert,,1,,,
CHEMBL623154,2862,,10135,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,,N,1,Expert,,1,,,
CHEMBL623155,4194,,10136,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro and metabolic stability was determined,,,N,1,Intermediate,,1,,,
CHEMBL623156,4194,,10137,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolic stability in rat hepatocytes,,,N,1,Intermediate,,1,,,
CHEMBL623157,5486,,10138,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,,N,1,Intermediate,,1,,,
CHEMBL623158,17582,,10139,Hepatocyte,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Metabolic rate for compound was observed in rat hepatocytes,401.0,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623159,5600,,10140,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,,N,1,Intermediate,,1,,,
CHEMBL874390,14294,,10141,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,,N,1,Intermediate,,1,,,
CHEMBL623160,14294,,10142,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,,N,1,Intermediate,,1,,,
CHEMBL623161,14294,,10143,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Metabolism of compound in rat S9 microsomes; Trace,,,N,1,Intermediate,,1,,,
CHEMBL623162,17847,,10144,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,,N,1,Intermediate,,1,,,
CHEMBL623163,11020,,10145,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL623164,11020,,10146,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL623165,11020,,10147,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,,N,1,Intermediate,,1,,,
CHEMBL623166,11020,,10148,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,,N,1,Intermediate,,1,,,
CHEMBL624983,11020,,10149,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,,N,1,Intermediate,,1,,,
CHEMBL624984,11020,,10150,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,,N,1,Intermediate,,1,,,
CHEMBL624985,11020,,10151,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL622970,11020,,10152,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL622971,11020,,10153,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL622972,11020,,10154,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL622973,11020,,10155,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL622974,11020,,10156,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL622975,11020,,10157,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL622976,11020,,10158,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL622977,11020,,10159,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,,N,1,Intermediate,,1,,,
CHEMBL624351,11020,,10160,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL624352,11020,,10161,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL624353,11020,,10162,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,N,1,Intermediate,,1,,,
CHEMBL622397,11020,,10163,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,,N,1,Intermediate,,1,,,
CHEMBL622398,11020,,10164,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,,N,1,Intermediate,,1,,,
CHEMBL622399,11020,,10165,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,,N,1,Intermediate,,1,,,
CHEMBL622400,11020,,10166,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,N,1,Intermediate,,1,,,
CHEMBL628428,11020,,10167,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL628590,11020,,10168,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL628591,11020,,10169,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL628592,11020,,10170,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL628593,11020,,10171,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL875333,11020,,10172,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL628594,11020,,10173,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL628595,4969,,10174,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628596,6737,,10175,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat plasma was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628597,6737,,10176,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Stability in rat plasma was determined; ND= no data,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628598,5089,,10177,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma half life period in rat (0-8 hr),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628599,5089,,10178,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for plasma half life period in rat (0-8 hr); Not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628600,1466,,10179,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL628601,1466,,10180,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL628602,4950,,10181,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for the half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL628603,2412,,10182,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,,N,1,Intermediate,,1,,,
CHEMBL628604,2412,,10183,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,,N,1,Intermediate,,1,,,
CHEMBL628605,2412,,10184,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,,N,1,Intermediate,,1,,,
CHEMBL628606,2412,,10185,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,,N,1,Intermediate,,1,,,
CHEMBL628607,2412,,10186,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,,N,1,Intermediate,,1,,,
CHEMBL628608,15022,,10187,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The biological half life the compound was measured at the dose of 100 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL628609,15022,,10188,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The biological half life the compound was measured at the dose of 30 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL628610,406,,10189,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was evaluated for plasma half life period in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL873819,15078,,10190,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL628611,15078,,10191,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL628612,5247,,10192,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The pharmacokinetic parameter half-life period in vivo in rats,,,N,1,Intermediate,,1,,,
CHEMBL628613,5041,,10193,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The pharmacokinetic property, Half-life was determined",,,N,1,Intermediate,,1,,,
CHEMBL628614,5041,,10194,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The pharmacokinetic property, Half-life in rat in vivo",,,N,1,Intermediate,,1,,,
CHEMBL628615,5041,,10195,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,,N,1,Intermediate,,1,,,
CHEMBL628616,5041,,10196,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,,N,1,Intermediate,,1,,,
CHEMBL627924,3918,,10197,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The plasma half life period in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627925,2906,,10198,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627926,6467,,10199,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,N,1,Intermediate,,1,,,
CHEMBL627927,5510,,10200,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,t1/2 (apparent elimination)of the compound was determined,,,N,1,Intermediate,,1,,,
CHEMBL627928,3788,,10201,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,t1/2 value in rat,,,N,1,Intermediate,,1,,,
CHEMBL627539,17796,,10202,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life in rat,,,N,1,Intermediate,,1,,,
CHEMBL876790,12873,,10203,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL858186,5983,,10204,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,,N,1,Intermediate,,1,,,
CHEMBL627540,15765,,10205,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half-life period in fasted rats,,,N,1,Intermediate,,1,,,
CHEMBL627541,2661,,10206,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627715,2661,,10207,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627716,429,,10208,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627717,17655,,10209,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Maximum time required to achieve Cmax was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL627718,17717,,10210,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,N,1,Intermediate,,1,,,
CHEMBL627719,17717,,10211,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,N,1,Intermediate,,1,,,
CHEMBL627720,17717,,10212,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,,N,1,Intermediate,,1,,,
CHEMBL627721,6570,,10213,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL627722,6570,,10214,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,,N,1,Intermediate,,1,,,
CHEMBL627723,5978,,10215,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626058,5978,,10216,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626059,5978,,10217,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626060,5978,,10218,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL626061,17720,,10219,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876791,4723,,10220,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL626062,4723,,10221,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,N,1,Intermediate,,1,,,
CHEMBL626063,4756,,10222,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax at the dose of 2 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL626064,4756,,10223,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tmax at the dose of 5 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL626065,17720,,10224,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626066,17720,,10225,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626067,1466,,10226,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL626068,7449,,10227,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,,N,1,Intermediate,,1,,,
CHEMBL626069,7449,,10228,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,,N,1,Intermediate,,1,,,
CHEMBL626070,7449,,10229,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of 3-methoxyacetaminophen glucuronide,,,N,1,Intermediate,,1,,,
CHEMBL626071,7449,,10230,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of N-methoxyacetaminophen glucuronide,,,N,1,Intermediate,,1,,,
CHEMBL626072,7449,,10231,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of N-methoxyacetaminophen sulfate,,,N,1,Intermediate,,1,,,
CHEMBL626073,7449,,10232,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of acetaminophen,,,N,1,Intermediate,,1,,,
CHEMBL626741,7768,,10233,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626742,17655,,10234,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,,N,1,Intermediate,,1,,,
CHEMBL626743,17735,,10235,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,,N,1,Intermediate,,1,,,
CHEMBL876792,5960,,10236,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,,N,1,Intermediate,,1,,,
CHEMBL626744,17735,,10237,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,N,1,Intermediate,,1,,,
CHEMBL626745,7116,,10238,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for antidiuretic activity in rats,,,N,1,Intermediate,,1,,,
CHEMBL626746,4878,,10239,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rat after 3mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626747,5939,,10240,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626748,5939,,10241,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626749,16367,,10242,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability administered orally at a dose of 10 mg/kg to rats,,,N,1,Intermediate,,1,,,
CHEMBL626750,16366,,10243,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral Bioavailability was determined,,,N,1,Intermediate,,1,,,
CHEMBL626751,4426,,10244,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL626913,4426,,10245,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat; Not performed.,,,N,1,Intermediate,,1,,,
CHEMBL626914,5041,,10246,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL626915,5041,,10247,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was determined; ND denotes no data,,,N,1,Intermediate,,1,,,
CHEMBL626916,1500,,10248,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626917,1500,,10249,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626918,17409,,10250,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Binding towards rat plasma protein at 10 uM,,,N,1,Intermediate,,1,,,
CHEMBL626919,17409,,10251,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Binding towards rat plasma protein at 100 uM,,,N,1,Intermediate,,1,,,
CHEMBL626920,2959,,10252,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 20 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL621976,13501,,10253,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,N,1,Intermediate,,1,,,
CHEMBL877599,6567,,10254,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after 5 mg/kg oral gavage,,,N,1,Intermediate,,1,,,
CHEMBL621977,6571,,10255,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621978,6715,,10256,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL621979,6715,,10257,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 3 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL621980,2932,,10258,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621981,4171,,10259,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability of the compound in rats after administration of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL621982,17509,,10260,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after administration of 10 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL882953,17509,,10261,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability after administration of 2 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL621983,4527,,10262,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL621984,4026,,10263,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in dogs was determined; high,,,N,1,Intermediate,,1,,,
CHEMBL621985,6659,,10264,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in monkey after intravenous administration at 1 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621986,6659,,10265,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in monkey after peroral administration at 10 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621987,6659,,10266,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after intravenous administration at 1 mpk,,,N,1,Intermediate,,1,,,
CHEMBL877600,6659,,10267,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,Bioavailability in rat after intravenous administration at 2 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621988,6659,,10268,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after peroral administration at 30 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621989,6659,,10269,,10116.0,In vivo,50597,,F,Rattus norvegicus,BAO_0000218,Bioavailability in rat after peroral administration at at 100 mpk,,,N,1,Intermediate,,1,,,
CHEMBL621990,6597,,10270,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rats was evaluated,,,N,1,Intermediate,,1,,,
CHEMBL621991,1202,,10271,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,,N,1,Intermediate,,1,,,
CHEMBL621992,1202,,10272,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,,N,1,Intermediate,,1,,,
CHEMBL621993,1202,,10273,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,,N,1,Intermediate,,1,,,
CHEMBL621994,1202,,10274,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,,N,1,Intermediate,,1,,,
CHEMBL621995,5207,,10275,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621996,5970,,10276,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621997,17538,,10277,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL621998,17538,,10278,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,N,1,Intermediate,,1,,,
CHEMBL621999,1466,,10279,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL622000,2879,,10280,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622001,2879,,10281,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was measured in rat after oral administration; 2-4,,,N,1,Intermediate,,1,,,
CHEMBL622002,2879,,10282,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was measured in rat after oral administration; 3-7,,,N,1,Intermediate,,1,,,
CHEMBL622003,3777,,10283,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (intraduodenal administration),,,N,1,Intermediate,,1,,,
CHEMBL877601,3777,,10284,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (intraduodenal administration),,,N,1,Intermediate,,1,,,
CHEMBL624871,3777,,10285,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622004,3777,,10286,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL882954,5423,,10287,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL622005,16365,,10288,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,,N,1,Intermediate,,1,,,
CHEMBL622006,16365,,10289,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,,N,1,Intermediate,,1,,,
CHEMBL622007,4239,,10290,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was measured in rat,,,N,1,Intermediate,,1,,,
CHEMBL622008,5438,,10291,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was reported,,,N,1,Intermediate,,1,,,
CHEMBL622009,5334,,10292,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL622010,5334,,10293,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622011,4199,,10294,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,N,1,Intermediate,,1,,,
CHEMBL622012,4199,,10295,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,,N,1,Intermediate,,1,,,
CHEMBL622013,4199,,10296,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,,N,1,Intermediate,,1,,,
CHEMBL622014,4890,,10297,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL624749,2792,,10298,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was determined at 3 mg/kg po dose in rats,,,N,1,Intermediate,,1,,,
CHEMBL624750,5529,,10299,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL624751,6685,,10300,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL624752,6685,,10301,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,N,1,Intermediate,,1,,,
CHEMBL624753,6685,,10302,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,N,1,Intermediate,,1,,,
CHEMBL624754,6005,,10303,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624755,6410,,10304,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,N,1,Intermediate,,1,,,
CHEMBL624756,6410,,10305,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624757,6103,,10306,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL624758,6410,,10307,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,N,1,Intermediate,,1,,,
CHEMBL622270,6410,,10308,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622271,5353,,10309,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley),,,N,1,Intermediate,,1,,,
CHEMBL622272,4727,,10310,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat at the dose of 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622273,17804,,10311,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622274,5809,,10312,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (cannulated) (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622275,17804,,10313,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability value of compound in rats was determined after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL622276,3634,,10314,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622277,3341,,10315,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622278,2690,,10316,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622279,3184,,10317,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622280,740,,10318,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL624083,1806,,10319,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 15-27 %,,,N,1,Intermediate,,1,,,
CHEMBL624084,4891,,10320,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,,N,1,Intermediate,,1,,,
CHEMBL624085,3634,,10321,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,,N,1,Intermediate,,1,,,
CHEMBL624086,64,,10322,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for bioavailability in rats,,,N,1,Intermediate,,1,,,
CHEMBL624087,4839,,10323,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL624088,1094,,10324,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL624089,5005,,10325,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,,U,0,Intermediate,,1,,,
CHEMBL624090,5005,,10326,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,U,0,Intermediate,,1,,,
CHEMBL624091,4687,,10327,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for the bioavailability in rat (in vivo),,,N,1,Intermediate,,1,,,
CHEMBL624092,17804,,10328,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,F value of compound in rats was determined after peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL624093,5974,,10329,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624094,5974,,10330,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624095,5974,,10331,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624096,5974,,10332,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL624097,1088,,10333,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,,N,1,Intermediate,,1,,,
CHEMBL624098,1742,,10334,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum fall in carotid flow in rat,,,N,1,Intermediate,,1,,,
CHEMBL874392,4689,,10335,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL624099,2463,,10336,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL624100,5654,,10337,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL624101,5654,,10338,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL624102,6874,,10339,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (male Wistar),,,N,1,Intermediate,,1,,,
CHEMBL624103,5633,,10340,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability after administration (30 mg/kg) in rat; good,,,N,1,Intermediate,,1,,,
CHEMBL624104,5496,,10341,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability at the dose of 2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL624105,2358,,10342,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL624106,16456,,10343,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL624107,5302,,10344,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose single 10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623943,5302,,10345,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose single 10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623944,5302,,10346,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623945,11020,,10347,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL623946,11020,,10348,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,,N,1,Intermediate,,1,,,
CHEMBL623947,11020,,10349,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL623948,11020,,10350,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL623949,11020,,10351,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,,N,1,Intermediate,,1,,,
CHEMBL623950,11020,,10352,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,,N,1,Intermediate,,1,,,
CHEMBL874398,11020,,10353,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,,N,1,Intermediate,,1,,,
CHEMBL623951,11020,,10354,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,,N,1,Intermediate,,1,,,
CHEMBL623952,11020,,10355,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL623953,11020,,10356,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL623954,11020,,10357,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL623955,11020,,10358,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL623956,11020,,10359,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL627807,11020,,10360,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL627808,11020,,10361,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL627809,11020,,10362,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,,N,1,Intermediate,,1,,,
CHEMBL627810,11020,,10363,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,,N,1,Intermediate,,1,,,
CHEMBL627811,11020,,10364,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,,N,1,Intermediate,,1,,,
CHEMBL627812,11020,,10365,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,,N,1,Intermediate,,1,,,
CHEMBL627813,11020,,10366,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,,N,1,Intermediate,,1,,,
CHEMBL627814,11020,,10367,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,,N,1,Intermediate,,1,,,
CHEMBL875336,11020,,10368,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,,N,1,Intermediate,,1,,,
CHEMBL627815,11020,,10369,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,,N,1,Intermediate,,1,,,
CHEMBL627816,11020,,10370,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,,N,1,Intermediate,,1,,,
CHEMBL627817,11020,,10371,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,,N,1,Intermediate,,1,,,
CHEMBL627818,11020,,10372,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,,N,1,Intermediate,,1,,,
CHEMBL627819,11020,,10373,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,,N,1,Intermediate,,1,,,
CHEMBL627820,11020,,10374,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,,N,1,Intermediate,,1,,,
CHEMBL627821,11020,,10375,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,,N,1,Intermediate,,1,,,
CHEMBL628464,11020,,10376,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL626239,11020,,10377,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,,N,1,Intermediate,,1,,,
CHEMBL626240,11020,,10378,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,,N,1,Intermediate,,1,,,
CHEMBL626241,11020,,10379,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,,N,1,Intermediate,,1,,,
CHEMBL626242,11020,,10380,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,,N,1,Intermediate,,1,,,
CHEMBL626243,11020,,10381,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,,N,1,Intermediate,,1,,,
CHEMBL626244,11020,,10382,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,N,1,Intermediate,,1,,,
CHEMBL626907,11020,,10383,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL626908,11020,,10384,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL626909,11020,,10385,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL626910,11020,,10386,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,N,1,Intermediate,,1,,,
CHEMBL875342,7449,,10387,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of acetaminophen cysteine conjugate,,,N,1,Intermediate,,1,,,
CHEMBL626911,7449,,10388,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of acetaminophen glucuronide,,,N,1,Intermediate,,1,,,
CHEMBL626912,7449,,10389,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of acetaminophen sulfate,,,N,1,Intermediate,,1,,,
CHEMBL627065,7449,,10390,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,Percent total excretion of acetaminophen-mercapturic acid,,,N,1,Intermediate,,1,,,
CHEMBL627066,3172,,10391,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627067,16456,,10392,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627068,10839,,10393,,8656.0,In vivo,22224,,A,ratrat,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627069,10839,,10394,,8656.0,In vivo,22224,,A,ratrat,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration.,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627070,5334,,10395,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,U,0,Autocuration,,1,,,
CHEMBL627071,5334,,10396,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,U,0,Autocuration,,1,,,
CHEMBL627072,5334,,10397,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,U,0,Autocuration,,1,,,
CHEMBL627073,5334,,10398,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,U,0,Autocuration,,1,,,
CHEMBL625387,5334,,10399,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,U,0,Autocuration,,1,,,
CHEMBL625388,5334,,10400,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,U,0,Autocuration,,1,,,
CHEMBL625389,5334,,10401,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL875343,5334,,10402,,9940.0,In vivo,22224,,A,Ovis aries,BAO_0000218,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL876795,1735,,10403,,8570.0,,50497,,A,Serpentes,BAO_0000218,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,,N,1,Intermediate,,1,,,
CHEMBL626552,1469,,10404,,8570.0,,50497,,A,Serpentes,BAO_0000218,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,,N,1,Intermediate,,1,,,
CHEMBL626553,1336,,10405,,8570.0,,50497,,A,Serpentes,BAO_0000218,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,,N,1,Intermediate,,1,,,
CHEMBL626554,12403,,10406,,9606.0,,22224,,A,Homo sapiens,BAO_0000366,The human biological plasma half life of the compound,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626555,8151,,10407,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626556,8004,,10408,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,,N,1,Intermediate,,1,,,
CHEMBL626557,8004,,10409,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL626558,8004,,10410,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,,N,1,Intermediate,,1,,,
CHEMBL626559,8004,,10411,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL626560,8004,,10412,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL876803,8004,,10413,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL627964,8004,,10414,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,,N,1,Intermediate,,1,,,
CHEMBL627965,8004,,10415,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL627966,8004,,10416,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,,N,1,Intermediate,,1,,,
CHEMBL627967,8004,,10417,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL627968,8004,,10418,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL627969,8004,,10419,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL627970,8004,,10420,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,,N,1,Intermediate,,1,,,
CHEMBL627971,8004,,10421,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627972,8004,,10422,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL856029,15917,,10423,,9606.0,,180,,B,Homo sapiens,BAO_0000357,Dissociation constant against binding to human cyclophilin A,,,D,9,Expert,,1,,,
CHEMBL627973,12396,,10424,,9913.0,,11591,,B,Bos taurus,BAO_0000019,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,,H,8,Expert,,1,,,
CHEMBL627974,7065,,10425,,,,22224,,A,,BAO_0000019,-Log C was determined by performing the electroshock minimum test,,,U,0,Autocuration,,1,,,
CHEMBL627975,7065,,10426,,,,22224,,A,,BAO_0000019,-Log C was determined by performing the foot shock test,,,U,0,Autocuration,,1,,,
CHEMBL627976,7065,,10427,,,,22224,,A,,BAO_0000019,-Log C was determined by performing the incl screen test,,,U,0,Autocuration,,1,,,
CHEMBL627977,7065,,10428,,,,22224,,A,,BAO_0000019,-Log C was determined by performing the maximum electroshock test,,,U,0,Autocuration,,1,,,
CHEMBL627978,7065,,10429,,,,22224,,A,,BAO_0000019,-Log C was determined by performing the pentylenetetrazole test,,,U,0,Autocuration,,1,,,
CHEMBL627979,12415,,10430,,,,22224,,A,,BAO_0000019,Tested for experimental arotinoid inhibitory dose,,,U,0,Autocuration,,1,,,
CHEMBL876804,10256,,10431,,,,22224,,A,,BAO_0000019,Negative log transformed activity,,,U,0,Autocuration,,1,,,
CHEMBL627980,7991,,10432,,,,22224,,A,,BAO_0000019,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,U,0,Autocuration,,1,,,
CHEMBL627981,14342,,10433,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,,N,1,Intermediate,,1,,,
CHEMBL627982,14342,,10434,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,,N,1,Intermediate,,1,,,
CHEMBL627983,14342,,10435,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,,N,1,Intermediate,,1,,,
CHEMBL627984,14342,,10436,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,,N,1,Intermediate,Ileum,1,,2116.0,
CHEMBL627985,6047,,10437,,,,22229,,P,,BAO_0000100,Solubility in water was determined; values expressed as -log,,,U,0,Autocuration,,1,,,
CHEMBL627986,17269,,10438,,,,22224,,A,,BAO_0000019,Ratio of Kcat to that of Km was determined,,,U,0,Autocuration,,1,,,
CHEMBL627987,10026,,10439,,,,22224,,A,,BAO_0000019,Observed first order rate constant,,,U,0,Autocuration,,1,,,
CHEMBL627988,14583,,10440,,,,22224,,A,,BAO_0000019,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,U,0,Autocuration,,1,,,
CHEMBL627989,2661,,10441,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627990,2661,,10442,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL876805,4029,,10443,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral Bioavailability after administration of 10 mg/kg in male rat,,,N,1,Intermediate,,1,,,
CHEMBL627991,17735,,10444,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL627992,4576,,10445,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL627993,17582,,10446,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,N,1,Intermediate,,1,,,
CHEMBL622817,17651,,10447,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability at 1 mg/kg was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL622818,17651,,10448,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability at 10 mg/kg was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL622819,17670,,10449,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,,N,1,Intermediate,,1,,,
CHEMBL872267,5045,,10450,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622820,1696,,10451,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622821,17764,,10452,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,,N,1,Intermediate,,1,,,
CHEMBL622822,6448,,10453,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622823,6596,,10454,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622824,17547,,10455,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622825,17771,,10456,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat at a dose of 3 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622901,6495,,10457,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after oral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622902,4558,,10458,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621844,17596,,10459,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL621845,6827,,10460,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL621846,4026,,10461,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL621847,10,,10462,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 30 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL877609,17717,,10463,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,N,1,Intermediate,,1,,,
CHEMBL621848,17717,,10464,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 3 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL621849,17717,,10465,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,N,1,Intermediate,,1,,,
CHEMBL622030,17717,,10466,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL622031,4796,,10467,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Percent oral bioavailability determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL622032,4883,,10468,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622033,2137,,10469,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was evaluated for bioavailability in rats; 32-51,,,N,1,Intermediate,,1,,,
CHEMBL622034,2959,,10470,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 20 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL622035,1361,,10471,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL882966,4727,,10472,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability percent in rat at the dose of 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622036,16423,,10473,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated after 20 uM/kg of peroral administration,,,N,1,Intermediate,,1,,,
CHEMBL622037,5206,,10474,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622038,6448,,10475,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622039,17723,,10476,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rats,,,N,1,Intermediate,,1,,,
CHEMBL622040,17738,,10477,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622041,17738,,10478,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622042,17738,,10479,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622043,17738,,10480,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622044,17738,,10481,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622045,17738,,10482,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL622046,17738,,10483,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL622047,17738,,10484,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL877610,17738,,10485,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL622048,17738,,10486,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622049,17738,,10487,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622050,17738,,10488,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622051,17738,,10489,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622052,17738,,10490,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,,1,,,
CHEMBL622053,17738,,10491,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,,1,,,
CHEMBL622054,17738,,10492,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,,1,,,
CHEMBL622055,17738,,10493,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,,1,,,
CHEMBL622056,5237,,10494,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rats was determined; High,,,N,1,Intermediate,,1,,,
CHEMBL622057,5503,,10495,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in the rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL628008,15765,,10496,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,,N,1,Intermediate,,1,,,
CHEMBL622058,15660,,10497,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL622059,5978,,10498,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL622060,5978,,10499,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL622061,5978,,10500,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL622062,5978,,10501,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,N,1,Intermediate,,1,,,
CHEMBL622063,5656,,10502,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL877611,3598,,10503,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,,N,1,Expert,,1,,,
CHEMBL622064,4216,,10504,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound in Sprague Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL622065,17839,,10505,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound in rat,,,N,1,Intermediate,,1,,,
CHEMBL622066,6570,,10506,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622067,5334,,10507,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL622068,6886,,10508,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL622069,5210,,10509,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound was determined in rats,,,N,1,Intermediate,,1,,,
CHEMBL624796,4170,,10510,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability at a dose of 30 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL624797,6028,,10511,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623053,6028,,10512,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623054,6078,,10513,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL623055,6168,,10514,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in fasted rat,,,N,1,Intermediate,,1,,,
CHEMBL623056,6168,,10515,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in fed rat,,,N,1,Intermediate,,1,,,
CHEMBL623057,5160,,10516,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623058,6057,,10517,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623059,6535,,10518,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL623060,6535,,10519,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after administration of 10 mg/kg po,,,N,1,Intermediate,,1,,,
CHEMBL623061,4194,,10520,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623062,6230,,10521,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623063,6619,,10522,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623064,17607,,10523,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623065,4942,,10524,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in ratrs,,,N,1,Intermediate,,1,,,
CHEMBL623066,4942,,10525,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623067,6646,,10526,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623068,5237,,10527,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rats was determined; High,,,N,1,Intermediate,,1,,,
CHEMBL623069,6646,,10528,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623070,4449,,10529,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623071,6057,,10530,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was calculated in rat,,,N,1,Intermediate,,1,,,
CHEMBL623072,2552,,10531,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL623073,5496,,10532,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL623074,6484,,10533,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL623075,6485,,10534,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL623076,6616,,10535,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL623077,4969,,10536,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL623078,5862,,10537,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),,,N,1,Intermediate,,1,,,
CHEMBL623079,4514,,10538,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL623080,4514,,10539,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL623081,4514,,10540,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL623082,5546,,10541,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,,N,1,Intermediate,,1,,,
CHEMBL874400,6168,,10542,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in fasted rat,,,N,1,Intermediate,,1,,,
CHEMBL623083,6168,,10543,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in fed rat,,,N,1,Intermediate,,1,,,
CHEMBL623084,3624,,10544,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623085,5213,,10545,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623086,5496,,10546,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623087,5553,,10547,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623088,5833,,10548,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623089,5836,,10549,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623090,5865,,10550,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623091,5960,,10551,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623092,6249,,10552,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623093,6448,,10553,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL874401,6453,,10554,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623094,6640,,10555,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623095,17607,,10556,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL623096,5939,,10557,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after peroral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624913,5939,,10558,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after peroral administration at 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624914,6281,,10559,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL624915,5874,,10560,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624916,5213,,10561,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat; Not measured,,,N,1,Intermediate,,1,,,
CHEMBL624917,4964,,10562,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625157,11020,,10563,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,,N,1,Intermediate,,1,,,
CHEMBL625158,6251,,10564,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolic potential in rat liver microsomes,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625159,1568,,10565,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,,N,1,Intermediate,,1,,,
CHEMBL625160,3032,,10566,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,,N,1,Intermediate,,1,,,
CHEMBL625161,3748,,10567,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,,N,1,Intermediate,,1,,,
CHEMBL625162,401,,10568,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625163,6512,,10569,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625164,17617,,10570,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rats at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625165,6679,,10571,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,N,1,Intermediate,,1,,,
CHEMBL625166,6742,,10572,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625167,589,,10573,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,,N,1,Intermediate,,1,,,
CHEMBL625168,589,,10574,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,,N,1,Intermediate,,1,,,
CHEMBL625169,3185,,10575,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance of the compound,,,N,1,Intermediate,,1,,,
CHEMBL626264,17596,,10576,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,,N,1,Intermediate,,1,,,
CHEMBL626265,2713,,10577,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626266,12500,,10578,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626267,12500,,10579,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626268,2713,,10580,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration upon oral administration of 1 mg/Kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626269,1446,,10581,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,,N,1,Intermediate,,1,,,
CHEMBL626270,6227,,10582,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,,N,1,Intermediate,,1,,,
CHEMBL626271,4709,,10583,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL626272,5510,,10584,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,,N,1,Intermediate,,1,,,
CHEMBL626273,5510,,10585,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,N,1,Intermediate,,1,,,
CHEMBL875346,5510,,10586,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,N,1,Intermediate,,1,,,
CHEMBL626274,5510,,10587,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,,N,1,Intermediate,,1,,,
CHEMBL626275,4514,,10588,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for protein binding in rat plasma,,,N,1,Intermediate,,1,,,
CHEMBL624646,2713,,10589,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,,N,1,Intermediate,,1,,,
CHEMBL624647,2713,,10590,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,,N,1,Intermediate,,1,,,
CHEMBL624648,5340,,10591,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624649,12058,,10592,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve ratio was determined (po/iv) in rat,,,N,1,Intermediate,,1,,,
CHEMBL624650,11195,,10593,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL624651,11195,,10594,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL624652,11195,,10595,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,,N,1,Intermediate,,1,,,
CHEMBL624653,6495,,10596,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624654,6078,,10597,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio of AUCbrain to AUCplasma,,,N,1,Intermediate,,1,,,
CHEMBL624655,5656,,10598,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio of brain to plasma,,,N,1,Intermediate,,1,,,
CHEMBL624656,4910,,10599,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,,N,1,Intermediate,,1,,,
CHEMBL624657,4910,,10600,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,N,1,Intermediate,,1,,,
CHEMBL624658,4910,,10601,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,N,1,Intermediate,,1,,,
CHEMBL624659,10130,,10602,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,,N,1,Intermediate,,1,,,
CHEMBL624660,10130,,10603,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,,N,1,Intermediate,,1,,,
CHEMBL624661,10130,,10604,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,,N,1,Intermediate,,1,,,
CHEMBL624662,5213,,10605,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Steady state brain :blood ratio was determined,,,N,1,Intermediate,,1,,,
CHEMBL625199,4910,,10606,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,,1,,,
CHEMBL625200,4910,,10607,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,N,1,Intermediate,,1,,,
CHEMBL625201,4910,,10608,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,N,1,Intermediate,,1,,,
CHEMBL625202,4910,,10609,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,N,1,Intermediate,,1,,,
CHEMBL625203,2083,,10610,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage recovery after 3h incubation with rat hapatocytes was determined,,,N,1,Intermediate,,1,,,
CHEMBL625204,2082,,10611,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,,N,1,Intermediate,,1,,,
CHEMBL625205,2082,,10612,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,,N,1,Intermediate,,1,,,
CHEMBL625206,6351,,10613,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL625207,14583,,10614,,,,22224,,A,,BAO_0000019,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,U,0,Autocuration,,1,,,
CHEMBL625208,14583,,10615,,,,22224,,A,,BAO_0000019,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,U,0,Autocuration,,1,,,
CHEMBL625209,4608,,10616,Caco-2,9606.0,,50587,,A,Homo sapiens,BAO_0000218,In vivo absorption in Caco-2 cell line monolayers was determined,495.0,,N,1,Intermediate,,1,,,
CHEMBL625210,13668,,10617,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625211,5669,,10618,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determine after peroral administration at 10 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL625212,5669,,10619,,9544.0,,50797,,A,Macaca mulatta,BAO_0000218,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,,N,1,Intermediate,,1,,,
CHEMBL625213,5669,,10620,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determine after peroral administration at 160 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL625214,5669,,10621,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determine after peroral administration at 20 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL874542,5669,,10622,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve was determine after peroral administration at 50 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL625215,6472,,10623,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (AlogP),,,U,0,Autocuration,,1,,,
CHEMBL625216,15106,,10624,,,,22224,,A,,BAO_0000019,Activated partial thromboplastin time measured,,,U,0,Autocuration,,1,,,
CHEMBL625217,15207,,10625,,,,22224,,P,,BAO_0000100,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,U,0,Autocuration,,1,,,
CHEMBL625218,15207,,10626,,,,22224,,P,,BAO_0000100,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,U,0,Autocuration,,1,,,
CHEMBL622864,13941,,10627,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622865,13941,,10628,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622866,13941,,10629,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622867,13941,,10630,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876808,15240,,10631,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627725,10655,,10632,,,,22224,,A,,BAO_0000019,AUC in brain,,,U,0,Autocuration,Brain,1,,955.0,
CHEMBL627726,10655,,10633,,,,22224,,A,,BAO_0000019,AUC in serum,,,U,0,Autocuration,Serum,1,,1977.0,
CHEMBL627727,6504,,10634,,,,22224,,A,,BAO_0000019,AUC was determined,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627728,10615,,10635,,,,22224,,A,,BAO_0000019,AUC of the compound.,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627729,10353,,10636,,,,22224,,A,,BAO_0000019,AUC value (0-4 hr),,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627730,14907,,10637,,,,22224,,A,,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627731,14907,,10638,,,,22224,,A,,BAO_0000019,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627732,14907,,10639,,,,22224,,A,,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627733,14907,,10640,,,,22224,,A,,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627734,16359,,10641,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC(area under curve) was determined after intravenous administration in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627735,16359,,10642,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC(area under curve) was determined after oral administration in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627736,15240,,10643,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876809,15240,,10644,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627737,15469,,10645,,,,22224,,A,,BAO_0000019,Area Under Curve after oral dosing of 100 uM/Kg,,,U,0,Autocuration,,1,,,
CHEMBL627738,15469,,10646,,,,22224,,A,,BAO_0000019,Area Under Curve after oral dosing of 30 uM/Kg,,,U,0,Autocuration,,1,,,
CHEMBL627739,13520,,10647,,,,22224,,A,,BAO_0000019,Area Under Curve was measured by ploting the graph between concentration verses time,,,U,0,Autocuration,,1,,,
CHEMBL626143,17025,,10648,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,,N,1,Intermediate,,1,,,
CHEMBL626144,17025,,10649,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL626145,17025,,10650,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,,N,1,Intermediate,,1,,,
CHEMBL626146,17025,,10651,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,,N,1,Intermediate,,1,,,
CHEMBL626147,12032,,10652,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626148,10291,,10653,,,,22224,,A,,BAO_0000019,Area under curve (AUC) was determined,,,U,0,Autocuration,,1,,,
CHEMBL626149,5767,,10654,,,,22224,,A,,BAO_0000218,Area under curve (AUC) following ip administration at 1 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626150,1434,,10655,,,,22224,,A,,BAO_0000019,Area under curve (AUC) was determined; ND is Not determined,,,U,0,Autocuration,,1,,,
CHEMBL626151,14925,,10656,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,,N,1,Intermediate,,1,,,
CHEMBL626152,14925,,10657,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,,N,1,Intermediate,,1,,,
CHEMBL626153,14925,,10658,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,,N,1,Intermediate,,1,,,
CHEMBL626154,1434,,10659,,,,22224,,A,,BAO_0000019,Area under curve (AUR) was determined,,,U,0,Autocuration,,1,,,
CHEMBL626155,11883,,10660,,,,22224,,A,,BAO_0000019,Area under curve at 1 uM/dg administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626156,11883,,10661,,,,22224,,A,,BAO_0000019,Area under curve at 10 uM/dg administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626157,11883,,10662,,,,22224,,A,,BAO_0000019,Area under curve at 2 uM/dg administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626158,11883,,10663,,,,22224,,A,,BAO_0000019,Area under curve at 20 uM/dg administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626159,15233,,10664,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve at a peroral dose of 3 mg/kg in dog,,,N,1,Intermediate,,1,,,
CHEMBL626160,15233,,10665,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at a peroral dose of 3 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL626161,15233,,10666,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve at an iv dose of 1 mg/kg in dog,,,N,1,Intermediate,,1,,,
CHEMBL626162,15233,,10667,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under curve at an iv dose of 1 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL626163,12978,,10668,,,,22224,,A,,BAO_0000019,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,U,0,Autocuration,,1,,,
CHEMBL626164,12978,,10669,,,,22224,,A,,BAO_0000019,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,U,0,Autocuration,,1,,,
CHEMBL626165,11355,,10670,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve measured as conc vs time after intravenous administration to mice.,,,N,1,Intermediate,,1,,,
CHEMBL626166,11355,,10671,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Area under curve measured as conc vs time after peroral administration to mice.,,,N,1,Intermediate,,1,,,
CHEMBL626167,12923,,10672,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,N,1,Intermediate,,1,,,
CHEMBL626168,12923,,10673,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,,N,1,Intermediate,,1,,,
CHEMBL877463,12923,,10674,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,,N,1,Intermediate,,1,,,
CHEMBL626169,12923,,10675,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,,N,1,Intermediate,,1,,,
CHEMBL626170,17738,,10676,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626171,17738,,10677,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626172,17738,,10678,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626173,17738,,10679,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626174,17738,,10680,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626175,17738,,10681,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626176,17738,,10682,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626177,17738,,10683,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622499,17738,,10684,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622500,17738,,10685,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622501,17738,,10686,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622502,17738,,10687,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622503,17738,,10688,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL877614,17738,,10689,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624839,17738,,10690,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624840,17738,,10691,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624841,17738,,10692,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624842,17738,,10693,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624843,17738,,10694,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624844,17738,,10695,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624845,17738,,10696,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621904,17738,,10697,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL621905,11195,,10698,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL874382,11195,,10699,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621906,11195,,10700,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL621907,11195,,10701,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622096,11195,,10702,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622097,11195,,10703,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622098,11195,,10704,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622099,11195,,10705,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622100,11195,,10706,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622101,11195,,10707,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622102,11195,,10708,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622103,11195,,10709,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622104,11195,,10710,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622105,11195,,10711,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622106,11195,,10712,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622107,11195,,10713,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622108,11195,,10714,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622109,11195,,10715,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622110,11195,,10716,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622111,11195,,10717,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL874383,11195,,10718,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622112,11195,,10719,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL622113,11195,,10720,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL622114,11195,,10721,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL622115,11195,,10722,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622116,11195,,10723,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622117,6193,,10724,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622118,6803,,10725,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622119,6647,,10726,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rats at 6 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622120,6647,,10727,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 6 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL622121,6647,,10728,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL622122,6640,,10729,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622123,6641,,10730,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622124,6641,,10731,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622125,6642,,10732,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL622126,5472,,10733,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL620455,6141,,10734,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL620456,4390,,10735,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620457,5472,,10736,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620458,5472,,10737,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was evaluated; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL620459,5438,,10738,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL620460,4883,,10739,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat by oral dosing,,,N,1,Intermediate,,1,,,
CHEMBL620461,1908,,10740,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL620462,4853,,10741,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),,,N,1,Intermediate,,1,,,
CHEMBL620463,4853,,10742,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL620464,4853,,10743,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL620465,4853,,10744,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL620466,4853,,10745,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL620467,4853,,10746,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620468,4853,,10747,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL620469,12873,,10748,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,,N,1,Intermediate,,1,,,
CHEMBL620470,12873,,10749,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,,N,1,Intermediate,,1,,,
CHEMBL620471,3169,,10750,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620472,6305,,10751,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620473,4762,,10752,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,,N,1,Intermediate,,1,,,
CHEMBL620474,17847,,10753,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620475,6211,,10754,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL620476,6011,,10755,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620477,6317,,10756,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL620478,6644,,10757,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL618768,6644,,10758,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL618769,6644,,10759,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL618770,6644,,10760,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL618771,6113,,10761,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability (dose 20 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL618772,5937,,10762,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL618773,5711,,10763,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat at 10 mg/kg of the compound,,,N,1,Intermediate,,1,,,
CHEMBL875842,17717,,10764,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,N,1,Intermediate,,1,,,
CHEMBL618774,17717,,10765,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 3 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL618775,17717,,10766,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,N,1,Intermediate,,1,,,
CHEMBL618776,17717,,10767,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL618777,4722,,10768,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Percent bioavailability (F) in rats after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL618778,4722,,10769,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL618779,4353,,10770,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 5 uM/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL618780,15662,,10771,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability,,,N,1,Intermediate,,1,,,
CHEMBL618781,4756,,10772,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 2 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL618782,4756,,10773,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL618783,3436,,10774,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL618784,17800,,10775,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618785,15762,,10776,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Percent oral bioavailability evaluated in rat,,,N,1,Intermediate,,1,,,
CHEMBL618786,5089,,10777,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618787,5089,,10778,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Percent oral bioavailability in rat; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL618788,3185,,10779,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618789,5145,,10780,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL618790,3457,,10781,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,,N,1,Intermediate,,1,,,
CHEMBL618791,3457,,10782,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,,N,1,Intermediate,,1,,,
CHEMBL875843,5983,,10783,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL618792,5739,,10784,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg p.o.),,,N,1,Intermediate,,1,,,
CHEMBL623395,3579,,10785,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax at a dose of 30 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL623396,17788,,10786,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Cmax in monkeys at a dose of 1 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL623397,14956,,10787,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat,,,N,1,Intermediate,,1,,,
CHEMBL623398,17788,,10788,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rats at a dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL623399,9750,,10789,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Cmax was measured in mice after an oral dose of 50 mg/kg.,,,N,1,Intermediate,,1,,,
CHEMBL623400,12767,,10790,,,In vivo,22224,,A,,BAO_0000218,"Cmax value at a dose of 12.7 uM/kg, po",,,U,0,Autocuration,,1,,,
CHEMBL623401,12767,,10791,,,In vivo,22224,,A,,BAO_0000218,"Cmax value at a dose of 6.3 uM/kg, iv",,,U,0,Autocuration,,1,,,
CHEMBL623402,12767,,10792,,,In vivo,22224,,A,,BAO_0000218,"Cmax value at a dose of 7.1 uM/kg, iv",,,U,0,Autocuration,,1,,,
CHEMBL623403,12703,,10793,,,In vivo,22224,,A,,BAO_0000218,Cmax value of compound was determined after 1 hr,,,U,0,Autocuration,,1,,,
CHEMBL623404,15778,,10794,,,In vivo,22224,,A,,BAO_0000218,Cmax value of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625997,12818,,10795,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value administered intraintestinal in rats.,,,N,1,Intermediate,,1,,,
CHEMBL625998,14964,,10796,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value administered perorally was determined in rat; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL625999,15808,,10797,,,In vivo,22224,,A,,BAO_0000218,Cmax value at the dose of 2.3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626000,15808,,10798,,,In vivo,22224,,A,,BAO_0000218,Cmax value at the dose of 5 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626001,15778,,10799,,,In vivo,22224,,A,,BAO_0000218,Cmax value in the period of 8 hr after dosing. ,,,U,0,Autocuration,,1,,,
CHEMBL626002,3715,,10800,,,In vivo,22224,,A,,BAO_0000218,Cmax value at a oral dose of 20 mg/kg; Not tested,,,U,0,Autocuration,,1,,,
CHEMBL626003,3715,,10801,,,In vivo,22224,,A,,BAO_0000218,Cmax value at a oral dose of 20 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626004,1446,,10802,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,N,1,Intermediate,,1,,,
CHEMBL626005,15240,,10803,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,,N,1,Intermediate,,1,,,
CHEMBL626006,15240,,10804,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,,N,1,Intermediate,,1,,,
CHEMBL626007,14810,,10805,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626008,14239,,10806,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626009,12555,,10807,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626010,10754,,10808,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,,N,1,Intermediate,,1,,,
CHEMBL626011,10754,,10809,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626012,10754,,10810,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626013,10754,,10811,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626014,10754,,10812,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL877496,10754,,10813,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626015,14600,,10814,,9615.0,In vivo,50588,,F,Canis lupus familiaris,BAO_0000218,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL626016,14600,,10815,,9615.0,In vivo,50588,,F,Canis lupus familiaris,BAO_0000218,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL626017,14600,,10816,,9615.0,In vivo,50588,,F,Canis lupus familiaris,BAO_0000218,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL626018,13543,,10817,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Bioavailability as maximal plasma concentration in dogs,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626692,13543,,10818,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Bioavailability as maximal plasma concentration in dogs,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626693,13543,,10819,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability as maximal plasma concentration in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626694,13543,,10820,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability as maximal plasma concentration in rats,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626695,14600,,10821,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626696,14600,,10822,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626697,14600,,10823,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626859,14600,,10824,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626860,14600,,10825,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626861,14600,,10826,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626296,14681,,10827,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,N,1,Intermediate,,1,,,
CHEMBL626297,15905,,10828,,,In vivo,22224,,A,,BAO_0000218,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626298,15905,,10829,,,In vivo,22224,,A,,BAO_0000218,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626299,13304,,10830,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626300,15137,,10831,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626301,15137,,10832,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626962,15137,,10833,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626963,15137,,10834,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626964,15137,,10835,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626965,14839,,10836,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626966,14839,,10837,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626967,14839,,10838,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626968,14839,,10839,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626969,8418,,10840,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627126,8418,,10841,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631276,8418,,10842,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631277,8418,,10843,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631278,8418,,10844,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL874457,8418,,10845,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631279,8418,,10846,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631280,8418,,10847,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631281,8418,,10848,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631968,8418,,10849,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631969,8418,,10850,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631970,8418,,10851,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631971,8418,,10852,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL631972,8418,,10853,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630435,8418,,10854,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630436,8418,,10855,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630437,8418,,10856,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630438,8418,,10857,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630439,8418,,10858,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630440,8418,,10859,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630441,8418,,10860,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630442,8418,,10861,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625234,8418,,10862,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625235,8418,,10863,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625236,8418,,10864,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625237,8418,,10865,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626125,8418,,10866,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626126,8418,,10867,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626127,8418,,10868,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626128,8418,,10869,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626129,8418,,10870,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626130,8418,,10871,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626131,8418,,10872,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626132,8418,,10873,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626752,8418,,10874,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626753,8418,,10875,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626754,8418,,10876,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626755,8418,,10877,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626756,8418,,10878,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626757,8418,,10879,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626758,8418,,10880,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626759,8418,,10881,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626760,8418,,10882,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626394,6996,,10883,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL626395,6996,,10884,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL626396,6996,,10885,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL626397,6996,,10886,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL626398,6996,,10887,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,N,1,Intermediate,,1,,,
CHEMBL626399,6996,,10888,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL874653,6996,,10889,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL626400,6996,,10890,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL626401,6996,,10891,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL626402,6996,,10892,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL626403,6996,,10893,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL626404,6996,,10894,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL626405,6996,,10895,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL625529,6996,,10896,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625530,6996,,10897,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625531,6996,,10898,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625532,6996,,10899,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL625533,6996,,10900,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL875474,6996,,10901,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL625534,6996,,10902,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625535,6996,,10903,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625536,6996,,10904,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625537,6996,,10905,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL625538,6996,,10906,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625539,6996,,10907,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL625540,6996,,10908,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625541,6996,,10909,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625542,6996,,10910,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625543,6996,,10911,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL625544,6996,,10912,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL625545,6996,,10913,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL625546,6996,,10914,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625547,6996,,10915,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL625548,6996,,10916,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625549,6996,,10917,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625550,6996,,10918,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625551,6996,,10919,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL875475,6996,,10920,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625552,6996,,10921,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625553,6996,,10922,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625554,6996,,10923,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL625555,6996,,10924,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,N,1,Intermediate,,1,,,
CHEMBL625556,6996,,10925,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624986,6996,,10926,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624987,6996,,10927,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624988,6996,,10928,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624989,9025,,10929,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624990,9025,,10930,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL874391,9025,,10931,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624991,9025,,10932,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624992,9025,,10933,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624993,9025,,10934,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624994,9025,,10935,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624995,9025,,10936,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624996,9025,,10937,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624997,9025,,10938,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624998,9025,,10939,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624999,9025,,10940,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL882955,9025,,10941,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625000,9025,,10942,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625001,9025,,10943,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625089,9025,,10944,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625090,9025,,10945,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625091,9025,,10946,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625092,9025,,10947,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625093,9025,,10948,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625094,9025,,10949,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625095,9025,,10950,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL625096,2249,,10951,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for its bioavailability in the dogs,,,N,1,Intermediate,,1,,,
CHEMBL625097,2249,,10952,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for its bioavailability in the rats,,,N,1,Intermediate,,1,,,
CHEMBL882956,17515,,10953,,,In vivo,22224,,A,,BAO_0000218,Compound was evaluated for oral bioavailability,,,U,0,Autocuration,,1,,,
CHEMBL625098,14541,,10954,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percentage of Oral bioavailability in rats,,,N,1,Intermediate,,1,,,
CHEMBL625099,12797,,10955,,10141.0,In vivo,22224,,A,Cavia porcellus,BAO_0000218,Bioavailability in guinea pig,,,U,0,Autocuration,,1,,,
CHEMBL625100,12797,,10956,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625101,12797,,10957,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for the oral bioavailability in dog,,,N,1,Intermediate,,1,,,
CHEMBL874396,12797,,10958,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the oral bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625102,11727,,10959,,9615.0,In vivo,22224,,F,Canis lupus familiaris,BAO_0000218,Bioavailability in dog (dosed i.v.),,,U,0,Autocuration,,1,,,
CHEMBL625103,13249,,10960,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for in vivo bioavailability in dog,,,N,1,Intermediate,,1,,,
CHEMBL625104,13249,,10961,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Compound was tested for in vivo bioavailability in hamsters,,,N,1,Intermediate,,1,,,
CHEMBL625105,13249,,10962,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Compound was tested for in vivo bioavailability in monkey,,,U,0,Autocuration,,1,,,
CHEMBL625106,13249,,10963,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for in vivo bioavailability in rat,,,N,1,Intermediate,,1,,,
CHEMBL625107,9552,,10964,,10090.0,In vivo,22224,,A,Mus musculus,BAO_0000218,Oral bioavailability in mouse,,,U,0,Autocuration,,1,,,
CHEMBL625108,9552,,10965,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was tested for percent of oral bioavailability in mice; 56-74,,,N,1,Intermediate,,1,,,
CHEMBL625109,14839,,10966,,10090.0,In vivo,22224,,A,Mus musculus,BAO_0000218,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,,U,0,Autocuration,,1,,,
CHEMBL625110,14839,,10967,,9541.0,In vivo,22224,,A,Macaca fascicularis,BAO_0000218,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,,U,0,Autocuration,,1,,,
CHEMBL625111,14839,,10968,,9541.0,In vivo,22224,,A,Macaca fascicularis,BAO_0000218,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,,U,0,Autocuration,,1,,,
CHEMBL625112,14839,,10969,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,,N,1,Intermediate,,1,,,
CHEMBL875334,14839,,10970,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Oral bioavailability in nude mice,,,N,1,Intermediate,,1,,,
CHEMBL628617,11219,,10971,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Bioavailability in monkey (i.d. dosing),,,U,0,Autocuration,,1,,,
CHEMBL628618,9552,,10972,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL628619,11732,,10973,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,U,0,Autocuration,,1,,,
CHEMBL628620,11732,,10974,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,U,0,Autocuration,,1,,,
CHEMBL628621,14839,,10975,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,N,1,Intermediate,,1,,,
CHEMBL628622,14839,,10976,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,N,1,Intermediate,,1,,,
CHEMBL628623,14839,,10977,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,N,1,Intermediate,,1,,,
CHEMBL628624,14839,,10978,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628625,14839,,10979,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628626,14839,,10980,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627041,14839,,10981,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627042,14839,,10982,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627043,14839,,10983,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627044,13932,,10984,,,In vivo,22224,,A,,BAO_0000218,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627045,11637,,10985,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Cmax in mouse plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627046,11637,,10986,,,In vivo,22224,,A,,BAO_0000218,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL627047,13960,,10987,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal plasma concentration in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627048,15905,,10988,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627049,14062,,10989,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627050,14062,,10990,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627051,14062,,10991,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627052,14062,,10992,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627053,14062,,10993,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627054,14062,,10994,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627055,15011,,10995,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627056,15011,,10996,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL627057,15011,,10997,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,N,1,Intermediate,,1,,,
CHEMBL627058,15011,,10998,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626211,15011,,10999,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626212,10291,,11000,,,In vivo,22224,,A,,BAO_0000218,Maximum Concentration of the compound.,,,U,0,Autocuration,,1,,,
CHEMBL626213,14599,,11001,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum Concentration was measured after iv administration into Beagle dog,,,N,1,Intermediate,,1,,,
CHEMBL626214,14599,,11002,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum Concentration was measured after iv administration into Beagle dog.,,,N,1,Intermediate,,1,,,
CHEMBL626215,14599,,11003,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum Concentration was measured after po administration into Beagle dog,,,N,1,Intermediate,,1,,,
CHEMBL626216,14599,,11004,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum Concentration was measured after po administration into Beagle dog.,,,N,1,Intermediate,,1,,,
CHEMBL626217,12767,,11005,,,In vivo,22224,,A,,BAO_0000218,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL626218,12767,,11006,,,In vivo,22224,,A,,BAO_0000218,Maximum blood level reached after an iv dose of 12.2 uM/kg,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL626219,12767,,11007,,,In vivo,22224,,A,,BAO_0000218,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL626220,12767,,11008,,,In vivo,22224,,A,,BAO_0000218,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL626221,12767,,11009,,,In vivo,22224,,A,,BAO_0000218,Maximum blood level reached after an oral dose of 5.0 mg/kg,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL626222,12767,,11010,,,In vivo,22224,,A,,BAO_0000218,Maximum blood level reached at dose of 10.6 uM/kg orally,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL626223,14706,,11011,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,,N,1,Intermediate,,1,,,
CHEMBL626224,14706,,11012,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,,N,1,Intermediate,,1,,,
CHEMBL626225,14793,,11013,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626226,14793,,11014,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626227,14793,,11015,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626228,14793,,11016,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626229,14793,,11017,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626921,14793,,11018,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL876793,14793,,11019,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625309,14793,,11020,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625310,10524,,11021,,1423.0,In vivo,50278,,A,Bacillus subtilis,BAO_0000218,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL625311,11871,,11022,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625312,11871,,11023,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625313,3437,,11024,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,U,0,Autocuration,,1,,,
CHEMBL625314,12038,,11025,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625315,12038,,11026,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in male rats after iv administration of 20 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625316,8418,,11027,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625317,8418,,11028,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625318,8418,,11029,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625319,8418,,11030,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625320,8418,,11031,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625321,8418,,11032,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625322,8418,,11033,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL876801,8418,,11034,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625323,8418,,11035,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625324,8418,,11036,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625325,8418,,11037,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625326,8418,,11038,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625327,8418,,11039,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625328,8418,,11040,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625329,8418,,11041,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625330,8418,,11042,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627774,8418,,11043,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627775,8418,,11044,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627949,8418,,11045,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627950,8418,,11046,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627951,8418,,11047,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627952,8418,,11048,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627953,8418,,11049,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627954,8418,,11050,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627955,8418,,11051,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627956,8418,,11052,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL876802,8418,,11053,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627957,8418,,11054,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627958,8418,,11055,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627959,8418,,11056,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627960,8418,,11057,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627961,8418,,11058,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627962,8418,,11059,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627963,9796,,11060,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,N,1,Intermediate,,1,,,
CHEMBL624759,9796,,11061,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,,1,,,
CHEMBL624760,9796,,11062,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,,1,,,
CHEMBL624761,9796,,11063,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,,1,,,
CHEMBL877607,9796,,11064,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,,1,,,
CHEMBL624762,9796,,11065,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624763,9796,,11066,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624764,9796,,11067,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624765,9796,,11068,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624766,9796,,11069,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624767,6996,,11070,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624768,6996,,11071,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624769,6996,,11072,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624770,6996,,11073,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624771,6996,,11074,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,N,1,Intermediate,,1,,,
CHEMBL624772,6996,,11075,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624773,6996,,11076,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624774,6996,,11077,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624775,6996,,11078,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624776,6996,,11079,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624777,6996,,11080,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL624778,6996,,11081,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624779,6996,,11082,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624780,6996,,11083,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624781,6996,,11084,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL877608,6996,,11085,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624782,6996,,11086,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624783,6996,,11087,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624784,6996,,11088,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624785,6996,,11089,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624786,6996,,11090,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL624787,6996,,11091,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL628676,6996,,11092,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL621842,6996,,11093,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL621843,6996,,11094,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL623873,6996,,11095,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL623874,6996,,11096,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL623875,6996,,11097,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL623876,6996,,11098,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL623877,6996,,11099,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL623878,6996,,11100,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623879,6996,,11101,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL623880,6996,,11102,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623881,6996,,11103,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623957,6996,,11104,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623958,6996,,11105,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623959,6996,,11106,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623960,6996,,11107,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623961,6996,,11108,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL623962,6996,,11109,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624676,6996,,11110,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,N,1,Intermediate,,1,,,
CHEMBL624677,6996,,11111,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624678,6996,,11112,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624679,6996,,11113,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624680,6996,,11114,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624849,11732,,11115,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,U,0,Autocuration,,1,,,
CHEMBL624850,11732,,11116,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,U,0,Autocuration,,1,,,
CHEMBL874399,11732,,11117,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,U,0,Autocuration,,1,,,
CHEMBL624851,11732,,11118,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,U,0,Autocuration,,1,,,
CHEMBL624852,11732,,11119,,,In vivo,22224,,A,,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,U,0,Autocuration,,1,,,
CHEMBL624853,13359,,11120,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),,,U,0,Autocuration,,1,,,
CHEMBL624854,16618,,11121,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),,,U,0,Autocuration,,1,,,
CHEMBL624855,13960,,11122,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL624856,13917,,11123,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rats was determined in vivo,,,U,0,Autocuration,,1,,,
CHEMBL882957,14266,,11124,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in dog,,,U,0,Autocuration,,1,,,
CHEMBL624857,12359,,11125,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Oral bioavailability of compound in monkey,,,U,0,Autocuration,,1,,,
CHEMBL622202,12359,,11126,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound in rat,,,N,1,Intermediate,,1,,,
CHEMBL622203,12359,,11127,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat of PMEA prodrug,,,U,0,Autocuration,,1,,,
CHEMBL625522,12359,,11128,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,,N,1,Intermediate,,1,,,
CHEMBL622868,10791,,11129,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Serum conc at 3 hours following 25 mg/kg dose,,,U,0,Autocuration,,1,,,
CHEMBL622869,10791,,11130,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Urine conc 0-5 hours following 25 mg/kg dose,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL622870,10791,,11131,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Urine conc 0-24 hours following 25 mg/kg dose,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL622871,138,,11132,,9534.0,In vivo,22224,,A,Chlorocebus aethiops,BAO_0000218,Oral bioavailability in African green monkeys; 20-25,,,U,0,Autocuration,,1,,,
CHEMBL620560,14521,,11133,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Oral bioavailability in cynomolgus monkey.,,,N,1,Intermediate,,1,,,
CHEMBL620561,13953,,11134,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in dog,,,U,0,Autocuration,,1,,,
CHEMBL620562,12836,,11135,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in dog at 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL620563,12836,,11136,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Oral bioavailability in hamster at 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL620564,12836,,11137,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat at 10 mg/kg oral dose,,,N,1,Intermediate,,1,,,
CHEMBL872265,14521,,11138,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL620565,13953,,11139,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL620566,6799,,11140,,9347.0,In vivo,22224,,A,Eutheria,BAO_0000218,Oral bioavailability,,,U,0,Autocuration,,1,,,
CHEMBL620567,11311,,11141,,,In vivo,22224,,A,,BAO_0000218,Oral bioavailability was determined; range 49-102%,,,U,0,Autocuration,,1,,,
CHEMBL620568,4013,,11142,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability was determined in dogs,,,N,1,Intermediate,,1,,,
CHEMBL620569,4013,,11143,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL620570,17591,,11144,,9347.0,In vivo,22224,,A,Eutheria,BAO_0000218,Oral bioavailability,,,U,0,Autocuration,,1,,,
CHEMBL620571,17591,,11145,,,In vivo,22224,,A,,BAO_0000218,Oral bioavailability was determined; Not orally available,,,U,0,Autocuration,,1,,,
CHEMBL620572,15011,,11146,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,,N,1,Intermediate,,1,,,
CHEMBL620573,15011,,11147,,10090.0,In vivo,22224,,A,Mus musculus,BAO_0000218,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,,U,0,Autocuration,,1,,,
CHEMBL620574,15011,,11148,,10090.0,In vivo,22224,,A,Mus musculus,BAO_0000218,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL620575,9552,,11149,,9544.0,In vivo,22224,,A,Macaca mulatta,BAO_0000218,Oral bioavailability in Rhesus monkey,,,U,0,Autocuration,,1,,,
CHEMBL620576,9552,,11150,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in dog (female mongrel),,,U,0,Autocuration,,1,,,
CHEMBL875846,3639,,11151,,,In vivo,22224,,A,,BAO_0000218,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,U,0,Autocuration,,1,,,
CHEMBL620577,13397,,11152,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in dog,,,U,0,Autocuration,,1,,,
CHEMBL620578,3031,,11153,,,In vivo,22224,,A,,BAO_0000218,Percentage Bioavailability was evaluated.,,,U,0,Autocuration,,1,,,
CHEMBL620579,12818,,11154,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat administered i.d.,,,U,0,Autocuration,,1,,,
CHEMBL621248,4847,,11155,,9347.0,In vivo,22224,,A,Eutheria,BAO_0000218,Bioavailability,,,U,0,Autocuration,,1,,,
CHEMBL625390,12421,,11156,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Bioavailability in dog (male Beagle) i.v. administration,,,U,0,Autocuration,,1,,,
CHEMBL625391,11966,,11157,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,,U,0,Autocuration,,1,,,
CHEMBL872266,11218,,11158,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,,U,0,Autocuration,,1,,,
CHEMBL625392,13129,,11159,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (male),,,U,0,Autocuration,,1,,,
CHEMBL625393,12350,,11160,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The oral bioavailability was measured on rats after oral administration,,,N,1,Intermediate,,1,,,
CHEMBL625394,2231,,11161,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625395,2231,,11162,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625396,12187,,11163,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 10 mg/kg i.d.),,,U,0,Autocuration,,1,,,
CHEMBL625397,12421,,11164,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Bioavailability in dog (male Beagle) i.v. administration,,,U,0,Autocuration,,1,,,
CHEMBL625398,13256,,11165,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL625399,13256,,11166,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626074,13256,,11167,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL626075,13256,,11168,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL626076,2231,,11169,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626077,2231,,11170,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626078,12178,,11171,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625846,12178,,11172,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL625847,12178,,11173,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL625848,15633,,11174,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,,N,1,Expert,,1,,,
CHEMBL625849,14258,,11175,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of compound in plasma administered orally to rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626023,14224,,11176,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626024,14224,,11177,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626025,14224,,11178,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626026,5566,,11179,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration after 10 mg/kg by oral administration,,,U,0,Autocuration,,1,,,
CHEMBL626027,16935,,11180,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration at a dose of 1.5 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626028,16935,,11181,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration at a dose of 2.0 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626029,14224,,11182,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum concentration in dog plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626030,12536,,11183,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626031,12536,,11184,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626032,12536,,11185,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626033,12536,,11186,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626034,12536,,11187,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626035,9994,,11188,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626036,1434,,11189,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma at Tmax,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626037,12836,,11190,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,,N,1,Expert,Plasma,1,,1969.0,
CHEMBL626038,12836,,11191,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626039,12836,,11192,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626040,12545,,11193,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626041,13856,,11194,,9986.0,In vivo,50592,,A,Oryctolagus cuniculus,BAO_0000218,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626042,3550,,11195,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration was calculated,,,U,0,Autocuration,,1,,,
CHEMBL626043,2632,,11196,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration was calculated.,,,U,0,Autocuration,,1,,,
CHEMBL626044,5566,,11197,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration at a peroral dose of 10 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626045,11883,,11198,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration of the drug at 10 uM/dg administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626046,11883,,11199,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626047,14122,,11200,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626048,14122,,11201,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626049,14122,,11202,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626050,12542,,11203,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL874541,12542,,11204,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622826,12542,,11205,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622827,12542,,11206,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622828,12542,,11207,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622829,14080,,11208,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL876806,11911,,11209,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration reached following intravenous administration in male rat,,,N,1,Intermediate,,1,,,
CHEMBL622830,13204,,11210,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,,N,1,Intermediate,,1,,,
CHEMBL622831,13204,,11211,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,,N,1,Intermediate,,1,,,
CHEMBL626794,14346,,11212,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL626795,14346,,11213,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL626796,14346,,11214,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL626797,14346,,11215,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL626798,14127,,11216,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum drug concentration is determined after oral dosing in rats.,,,N,1,Intermediate,,1,,,
CHEMBL626799,14339,,11217,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,,N,1,Intermediate,,1,,,
CHEMBL626800,14339,,11218,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum observed concentration in oral (5 mg/kg) fed dogs,,,N,1,Intermediate,,1,,,
CHEMBL626801,13494,,11219,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL876816,14925,,11220,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626802,14474,,11221,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626803,14474,,11222,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626804,13917,,11223,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration following oral administration of 30 umol/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626805,9796,,11224,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626309,9796,,11225,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626310,9796,,11226,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626311,9796,,11227,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626312,9796,,11228,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626313,9796,,11229,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626314,9796,,11230,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626315,9796,,11231,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626316,9796,,11232,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626317,9796,,11233,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626318,8363,,11234,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,,N,1,Intermediate,,1,,,
CHEMBL626319,8363,,11235,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,,N,1,Intermediate,,1,,,
CHEMBL626320,8363,,11236,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,,N,1,Intermediate,,1,,,
CHEMBL875053,8363,,11237,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,,N,1,Intermediate,,1,,,
CHEMBL626321,8363,,11238,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,,N,1,Intermediate,,1,,,
CHEMBL626322,8363,,11239,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,,N,1,Intermediate,,1,,,
CHEMBL626323,8363,,11240,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,,N,1,Intermediate,,1,,,
CHEMBL626324,8363,,11241,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,,N,1,Intermediate,,1,,,
CHEMBL626325,8363,,11242,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,,N,1,Intermediate,,1,,,
CHEMBL626326,8363,,11243,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,,N,1,Intermediate,,1,,,
CHEMBL626327,8363,,11244,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,,N,1,Intermediate,,1,,,
CHEMBL626328,8363,,11245,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,,N,1,Intermediate,,1,,,
CHEMBL626329,8684,,11246,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626330,8684,,11247,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626331,8684,,11248,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626332,8684,,11249,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626333,8684,,11250,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626334,8684,,11251,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626335,8684,,11252,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624798,8684,,11253,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624799,8684,,11254,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624800,8684,,11255,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624801,8684,,11256,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624802,8684,,11257,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624803,8684,,11258,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624804,8684,,11259,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624805,8684,,11260,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624806,8684,,11261,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL624807,8684,,11262,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624808,8684,,11263,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624809,8684,,11264,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624810,8684,,11265,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL877618,8684,,11266,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624811,8684,,11267,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624812,8684,,11268,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624813,8684,,11269,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624814,8684,,11270,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624815,8684,,11271,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624816,8684,,11272,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624817,8684,,11273,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624818,6996,,11274,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624819,6996,,11275,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL624820,6996,,11276,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624821,6996,,11277,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624822,6996,,11278,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,N,1,Intermediate,,1,,,
CHEMBL624823,6996,,11279,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL624824,15599,,11280,,562.0,,50212,,A,Escherichia coli,BAO_0000218,Observed diffusion coefficient in organic solvent for Escherichia coli,,,N,1,Intermediate,,1,,,
CHEMBL624825,9614,,11281,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624826,9614,,11282,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL876817,9614,,11283,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,Cardiac atrium,1,,2081.0,
CHEMBL624827,9614,,11284,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,Cardiac atrium,1,,2081.0,
CHEMBL624828,9614,,11285,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,,1,,,
CHEMBL624829,9614,,11286,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,,1,,,
CHEMBL624830,9614,,11287,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624831,9614,,11288,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624832,9614,,11289,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,Cardiac atrium,1,,2081.0,
CHEMBL624833,9614,,11290,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,Cardiac atrium,1,,2081.0,
CHEMBL624834,9614,,11291,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,,1,,,
CHEMBL624835,9614,,11292,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,,1,,,
CHEMBL624836,9614,,11293,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL624837,9614,,11294,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL624838,9071,,11295,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622188,9071,,11296,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL622189,9071,,11297,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622190,9071,,11298,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625170,9071,,11299,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625171,9071,,11300,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625172,9071,,11301,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625173,9071,,11302,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625174,9071,,11303,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625175,9071,,11304,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625176,9071,,11305,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625177,9071,,11306,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625178,9071,,11307,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625179,9071,,11308,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625180,9071,,11309,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625181,10677,,11310,,,,22224,,A,,BAO_0000218,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,U,0,Autocuration,,1,,,
CHEMBL625182,9750,,11311,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625183,8319,,11312,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL875848,8319,,11313,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL622260,8319,,11314,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL622261,8319,,11315,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL622262,8319,,11316,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL622263,8319,,11317,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622418,8319,,11318,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622419,8319,,11319,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623388,13256,,11320,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL623389,13256,,11321,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623390,13256,,11322,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL623391,13256,,11323,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL623392,13256,,11324,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623393,13256,,11325,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL623394,13256,,11326,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL618885,13256,,11327,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL618886,13256,,11328,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618887,13256,,11329,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL619535,13256,,11330,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL619536,13256,,11331,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL619537,13256,,11332,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL619705,13256,,11333,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL619706,13256,,11334,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL619707,13256,,11335,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL619708,13256,,11336,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL625219,13256,,11337,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL625220,13256,,11338,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625221,13256,,11339,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL625222,13256,,11340,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL625223,13256,,11341,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL625224,13256,,11342,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625225,13256,,11343,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,N,1,Intermediate,,1,,,
CHEMBL625226,8829,,11344,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat blood after 24 hours of iv administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625227,8829,,11345,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625228,8829,,11346,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat blood after 30 minutes of iv administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL875354,8829,,11347,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625229,8829,,11348,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat blood after 5 minutes of iv administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625230,8829,,11349,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625231,8829,,11350,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat heart after 24 hours of iv administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625900,8829,,11351,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625901,8829,,11352,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat heart after 30 minutes of iv administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625902,8829,,11353,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625903,8829,,11354,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat heart after 5 minutes of iv administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625904,8829,,11355,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625905,8829,,11356,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 24 hours of iv administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627861,8829,,11357,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627862,8829,,11358,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627863,8829,,11359,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627769,8829,,11360,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627770,13249,,11361,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627771,13622,,11362,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Cmax in cynomolgus monkey (PO dose),,,N,1,Intermediate,,1,,,
CHEMBL627772,13622,,11363,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat (PO dose),,,N,1,Intermediate,,1,,,
CHEMBL627773,13622,,11364,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat (PO dose),,,N,1,Intermediate,,1,,,
CHEMBL621922,13494,,11365,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621923,12170,,11366,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat plasma after oral dose (10 mg/kg),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621924,12170,,11367,,,In vivo,22224,,A,,BAO_0000218,Cmax in plasma after oral dose (10 mg/kg),,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621925,17025,,11368,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621926,17025,,11369,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621927,17025,,11370,,9986.0,In vivo,50592,,A,Oryctolagus cuniculus,BAO_0000218,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621928,17025,,11371,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621929,14187,,11372,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621930,14816,,11373,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621931,17820,,11374,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration after oral dosing in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621932,14380,,11375,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621933,14380,,11376,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621934,14691,,11377,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621935,14691,,11378,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621936,13375,,11379,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL621937,6236,,11380,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was determined,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621938,14380,,11381,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621939,14380,,11382,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621940,14380,,11383,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621941,14380,,11384,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL621942,14380,,11385,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626178,14380,,11386,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626179,14380,,11387,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626180,14380,,11388,,,In vivo,22224,,A,,BAO_0000218,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626181,13622,,11389,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma Cmax in rat (PO dose),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626182,15372,,11390,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626183,15372,,11391,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626184,15372,,11392,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626185,15372,,11393,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,,N,1,Intermediate,,1,,,
CHEMBL626186,14925,,11394,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL877589,14925,,11395,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626187,11883,,11396,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626188,11883,,11397,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration of the drug at 20 uM/dg administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626189,13391,,11398,,,In vivo,22224,,A,,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL626855,13391,,11399,,,In vivo,22224,,A,,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL623781,13391,,11400,,,In vivo,22224,,A,,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL623782,13391,,11401,,,In vivo,22224,,A,,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL623783,16360,,11402,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623784,3673,,11403,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Cmax in dog plasma after 1mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623785,14431,,11404,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623786,14431,,11405,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623787,14964,,11406,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral maximum concentration in rat,,,N,1,Intermediate,,1,,,
CHEMBL623788,14964,,11407,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral maximum concentration in rat,,,N,1,Intermediate,,1,,,
CHEMBL623789,14209,,11408,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623790,11355,,11409,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Peak concentration in blood after intravenous administration to mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623791,11355,,11410,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Peak concentration in blood after peroral administration to mice,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623792,11966,,11411,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak concentration in rat plasma was determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623793,8918,,11412,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623794,8918,,11413,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623795,8918,,11414,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623796,8684,,11415,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623797,8684,,11416,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623798,8684,,11417,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623799,8684,,11418,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624490,8684,,11419,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624491,8684,,11420,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624492,8684,,11421,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624493,8684,,11422,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL877595,8684,,11423,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624494,8684,,11424,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624495,8684,,11425,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624681,8684,,11426,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624682,8684,,11427,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624683,8684,,11428,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624684,8684,,11429,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624685,8684,,11430,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624686,8684,,11431,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624687,8684,,11432,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624688,8684,,11433,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL627161,8684,,11434,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL622127,8684,,11435,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL622128,8684,,11436,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL874384,8684,,11437,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624898,8684,,11438,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624899,8684,,11439,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624900,8684,,11440,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624901,8684,,11441,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624902,8684,,11442,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624903,8684,,11443,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624904,8684,,11444,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624905,8684,,11445,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624906,8684,,11446,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624907,8684,,11447,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624908,8684,,11448,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624909,8684,,11449,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624910,8684,,11450,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL624911,8684,,11451,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL874388,8684,,11452,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624912,8684,,11453,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622930,8684,,11454,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623121,8684,,11455,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623122,8684,,11456,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623123,8684,,11457,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623124,8684,,11458,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623125,8684,,11459,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623126,8684,,11460,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623127,8684,,11461,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623128,8684,,11462,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623129,8684,,11463,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623130,8684,,11464,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623131,8684,,11465,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623132,8684,,11466,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL623133,8319,,11467,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623134,8319,,11468,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL874389,8319,,11469,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL623135,8319,,11470,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL623136,8319,,11471,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL623137,8319,,11472,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL623138,8319,,11473,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL623139,8319,,11474,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623140,8319,,11475,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623141,8319,,11476,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623142,8319,,11477,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623143,8319,,11478,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL623144,14571,,11479,,10090.0,,50594,,A,Mus musculus,BAO_0000218,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623405,14571,,11480,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624074,8319,,11481,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624075,8319,,11482,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL624076,8319,,11483,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624077,8319,,11484,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL624078,8319,,11485,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624079,8319,,11486,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624261,8319,,11487,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624262,8319,,11488,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL624263,8319,,11489,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624264,8319,,11490,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624265,8319,,11491,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624266,8319,,11492,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL624267,8319,,11493,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624268,8319,,11494,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL875227,8319,,11495,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624269,8319,,11496,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624270,8319,,11497,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624271,8319,,11498,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,N,1,Intermediate,,1,,,
CHEMBL624272,8319,,11499,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624273,8319,,11500,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,N,1,Intermediate,,1,,,
CHEMBL624274,12064,,11501,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624275,12064,,11502,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624276,12064,,11503,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624277,12038,,11504,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624278,14314,,11505,,,,22224,,A,,BAO_0000019,% dose converted to 2-amino-5-chlorophenyl sulfate,,,U,0,Autocuration,,1,,,
CHEMBL624279,14314,,11506,,,,22224,,A,,BAO_0000019,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,U,0,Autocuration,,1,,,
CHEMBL624280,11488,,11507,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL624281,11488,,11508,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL622933,11488,,11509,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL622934,11488,,11510,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL622935,8829,,11511,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622936,8829,,11512,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 5 minutes of iv administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL875228,8829,,11513,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622937,8829,,11514,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat lung after 24 hours of iv administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622938,8829,,11515,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL619736,8829,,11516,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat lung after 30 minutes of iv administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625117,8829,,11517,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625118,8829,,11518,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat lung after 5 minutes of iv administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625119,8829,,11519,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625120,14972,,11520,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL625121,14972,,11521,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,,N,1,Intermediate,,1,,,
CHEMBL625122,14972,,11522,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,,N,1,Intermediate,Thalamus,1,,10000006.0,
CHEMBL622204,14608,,11523,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL877503,14608,,11524,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627127,14608,,11525,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627128,14608,,11526,,,In vivo,22224,,A,,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,U,0,Autocuration,Hippocampus,1,,10000000.0,
CHEMBL627129,14608,,11527,,,In vivo,22224,,A,,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,U,0,Autocuration,Hippocampus,1,,10000000.0,
CHEMBL627130,14608,,11528,,,In vivo,22224,,A,,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,U,0,Autocuration,Hippocampus,1,,10000000.0,
CHEMBL627131,14608,,11529,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627132,14608,,11530,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627133,14608,,11531,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL627134,14608,,11532,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL627135,14608,,11533,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL627136,14608,,11534,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL628435,14608,,11535,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,,1,,,
CHEMBL628436,14608,,11536,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,,1,,,
CHEMBL628437,14608,,11537,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,,1,,,
CHEMBL628438,14608,,11538,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL628439,14608,,11539,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL628440,14608,,11540,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL628441,14608,,11541,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL628442,14608,,11542,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL628443,14608,,11543,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL628444,14608,,11544,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628445,14608,,11545,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL877504,14608,,11546,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628446,14608,,11547,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626874,14608,,11548,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626875,14608,,11549,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626876,14608,,11550,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626877,14608,,11551,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626878,14608,,11552,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626879,14608,,11553,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL626880,8918,,11554,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626881,8918,,11555,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626882,8918,,11556,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626883,14470,,11557,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Peak plasma concentration was measured in dogs,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626884,14393,,11558,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL626885,14886,,11559,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626886,14886,,11560,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626887,14886,,11561,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626888,14393,,11562,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL626889,13465,,11563,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,,N,1,Intermediate,,1,,,
CHEMBL626761,13465,,11564,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,,U,0,Autocuration,,1,,,
CHEMBL626762,13465,,11565,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,,N,1,Intermediate,,1,,,
CHEMBL626763,13465,,11566,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,,N,1,Intermediate,,1,,,
CHEMBL626764,13465,,11567,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,,N,1,Intermediate,,1,,,
CHEMBL626765,13465,,11568,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,,N,1,Intermediate,,1,,,
CHEMBL626766,13465,,11569,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,,N,1,Intermediate,,1,,,
CHEMBL626767,13465,,11570,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,,N,1,Intermediate,,1,,,
CHEMBL626768,13465,,11571,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,,N,1,Intermediate,,1,,,
CHEMBL626769,13465,,11572,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,,N,1,Intermediate,,1,,,
CHEMBL874463,13465,,11573,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,,N,1,Intermediate,,1,,,
CHEMBL626770,13465,,11574,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,,U,0,Autocuration,,1,,,
CHEMBL626771,13465,,11575,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,,U,0,Autocuration,,1,,,
CHEMBL626772,13465,,11576,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,,N,1,Intermediate,,1,,,
CHEMBL626773,14731,,11577,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,N,1,Intermediate,,1,,,
CHEMBL626774,14731,,11578,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,,N,1,Intermediate,,1,,,
CHEMBL626775,13376,,11579,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626776,13376,,11580,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626777,14443,,11581,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Maximum concentration (Cmax) in rat when administered orally,,,N,1,Intermediate,,1,,,
CHEMBL626778,13465,,11582,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626779,16359,,11583,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,,U,0,Autocuration,,1,,,
CHEMBL626780,16359,,11584,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,,U,0,Autocuration,,1,,,
CHEMBL626781,15618,,11585,,,In vivo,22224,,A,,BAO_0000218,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL632164,14554,,11586,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic profile Cmax was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL632165,11537,,11587,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL632166,11537,,11588,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL632167,11537,,11589,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL632168,11537,,11590,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,,N,1,Intermediate,,1,,,
CHEMBL632169,2021,,11591,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Cmax in rat plasma,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL632170,5932,,11592,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Cmax in dog plasma after 30mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632171,5932,,11593,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax in rat plasma after 30mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632172,17320,,11594,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma level in rats at 30 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632173,15831,,11595,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Tested for maximum plasma concentration in mice,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632174,15078,,11596,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL632175,14941,,11597,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The Cmax values in female wistar rats.,,,N,1,Intermediate,,1,,,
CHEMBL632176,15343,,11598,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632177,15343,,11599,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632178,14856,,11600,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632179,13129,,11601,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,,N,1,Intermediate,,1,,,
CHEMBL632180,13098,,11602,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632181,13098,,11603,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632182,13098,,11604,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632183,15478,,11605,,10090.0,In vivo,22224,,A,Mus musculus,BAO_0000218,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL632184,15341,,11606,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,,N,1,Intermediate,,1,,,
CHEMBL874470,15341,,11607,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,,N,1,Intermediate,,1,,,
CHEMBL631302,8684,,11608,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL631303,8684,,11609,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL631304,8684,,11610,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL631305,8684,,11611,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL631306,8684,,11612,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL631307,8684,,11613,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL631308,8684,,11614,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL625557,8684,,11615,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,,1,,,
CHEMBL625558,8684,,11616,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625559,8684,,11617,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625560,8684,,11618,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625561,8684,,11619,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625562,8684,,11620,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL875320,8684,,11621,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625563,8684,,11622,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625564,8684,,11623,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625565,8684,,11624,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL625566,8684,,11625,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL625567,8684,,11626,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL625568,8684,,11627,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL628217,8684,,11628,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL628218,8684,,11629,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL628219,8684,,11630,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL628220,8684,,11631,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL628221,8926,,11632,,,,22224,,A,,BAO_0000019,Distribution in the blood after 120 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628222,8926,,11633,,,,22224,,A,,BAO_0000019,Distribution in the blood after 15 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628223,8926,,11634,,,,22224,,A,,BAO_0000019,Distribution in the blood after 30 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628224,8926,,11635,,,,22224,,A,,BAO_0000019,Distribution in the blood after 5 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628225,8926,,11636,,,,22224,,A,,BAO_0000019,Distribution in the blood after 60 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628226,8926,,11637,,,,22224,,A,,BAO_0000019,Distribution in the blood after 90 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628227,8926,,11638,,,,22224,,A,,BAO_0000019,Distribution in the bone after 120 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL875481,8926,,11639,,,,22224,,A,,BAO_0000019,Distribution in the bone after 15 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628228,8926,,11640,,,,22224,,A,,BAO_0000019,Distribution in the bone after 30 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628229,8926,,11641,,,,22224,,A,,BAO_0000019,Distribution in the bone after 5 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628230,8926,,11642,,,,22224,,A,,BAO_0000019,Distribution in the bone after 60 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628231,8926,,11643,,,,22224,,A,,BAO_0000019,Distribution in the bone after 90 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628232,8926,,11644,,,,22224,,A,,BAO_0000019,Distribution in the heart after 120 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628233,8926,,11645,,,,22224,,A,,BAO_0000019,Distribution in the heart after 15 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628234,8926,,11646,,,,22224,,A,,BAO_0000019,Distribution in the heart after 30 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628235,8926,,11647,,,,22224,,A,,BAO_0000019,Distribution in the heart after 5 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628236,8926,,11648,,,,22224,,A,,BAO_0000019,Distribution in the heart after 60 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628237,8926,,11649,,,,22224,,A,,BAO_0000019,Distribution in the heart after 90 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628238,8926,,11650,,,,22224,,A,,BAO_0000019,Distribution in the kidneys after 120 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628239,8926,,11651,,,,22224,,A,,BAO_0000019,Distribution in the kidneys after 15 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628240,8926,,11652,,,,22224,,A,,BAO_0000019,Distribution in the kidneys after 30 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628241,8926,,11653,,,,22224,,A,,BAO_0000019,Distribution in the kidneys after 5 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628242,8926,,11654,,,,22224,,A,,BAO_0000019,Distribution in the kidneys after 60 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL875482,8926,,11655,,,,22224,,A,,BAO_0000019,Distribution in the kidneys after 90 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628243,8926,,11656,,,,22224,,A,,BAO_0000019,Distribution in the liver after 120 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628244,8926,,11657,,,,22224,,A,,BAO_0000019,Distribution in the liver after 15 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628245,8926,,11658,,,,22224,,A,,BAO_0000019,Distribution in the liver after 30 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628246,8926,,11659,,,,22224,,A,,BAO_0000019,Distribution in the liver after 5 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628247,8926,,11660,,,,22224,,A,,BAO_0000019,Distribution in the liver after 60 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628248,8926,,11661,,,,22224,,A,,BAO_0000019,Distribution in the liver after 90 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628249,8926,,11662,,,,22224,,A,,BAO_0000019,Distribution in the lung after 120 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL625452,14839,,11663,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,,N,1,Intermediate,,1,,,
CHEMBL625453,14839,,11664,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,,N,1,Intermediate,,1,,,
CHEMBL625454,14839,,11665,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,,N,1,Intermediate,,1,,,
CHEMBL623844,14839,,11666,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,,N,1,Intermediate,,1,,,
CHEMBL623845,12178,,11667,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,,N,1,Intermediate,,1,,,
CHEMBL623846,12178,,11668,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,,N,1,Intermediate,,1,,,
CHEMBL623847,12178,,11669,,,,22224,,A,,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,U,0,Autocuration,,1,,,
CHEMBL623848,12186,,11670,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,N,1,Intermediate,,1,,,
CHEMBL623849,12186,,11671,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,N,1,Intermediate,,1,,,
CHEMBL623850,12186,,11672,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,N,1,Intermediate,,1,,,
CHEMBL623851,12186,,11673,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,N,1,Intermediate,,1,,,
CHEMBL623852,12187,,11674,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,U,0,Autocuration,,1,,,
CHEMBL624551,12187,,11675,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,N,1,Intermediate,,1,,,
CHEMBL624552,12187,,11676,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,N,1,Intermediate,,1,,,
CHEMBL624553,12187,,11677,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,U,0,Autocuration,,1,,,
CHEMBL624554,12187,,11678,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,,U,0,Autocuration,,1,,,
CHEMBL624555,12187,,11679,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL624741,12187,,11680,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,N,1,Intermediate,,1,,,
CHEMBL624742,14122,,11681,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,,N,1,Intermediate,,1,,,
CHEMBL624743,14122,,11682,,10026.0,,100712,,A,Cricetinae,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,,N,1,Intermediate,,1,,,
CHEMBL877606,14122,,11683,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,,N,1,Intermediate,,1,,,
CHEMBL624744,13391,,11684,,,,22224,,A,,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL624745,13391,,11685,,,,22224,,A,,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL624746,13391,,11686,,,,22224,,A,,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL624747,13391,,11687,,,,22224,,A,,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL624748,16360,,11688,,,,22224,,A,,BAO_0000019,Oral absorption expressed as Area under curve was determined,,,U,0,Autocuration,,1,,,
CHEMBL622504,3673,,11689,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,,N,1,Intermediate,,1,,,
CHEMBL622505,14122,,11690,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,,N,1,Intermediate,,1,,,
CHEMBL622506,14122,,11691,,10026.0,,100712,,A,Cricetinae,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,N,1,Intermediate,,1,,,
CHEMBL622507,14122,,11692,,10026.0,,100712,,A,Cricetinae,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,N,1,Intermediate,,1,,,
CHEMBL622508,14122,,11693,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,,N,1,Intermediate,,1,,,
CHEMBL622509,13889,,11694,,,,22224,,A,,BAO_0000019,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,U,0,Autocuration,,1,,,
CHEMBL622510,14393,,11695,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL622511,17279,,11696,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,,N,1,Intermediate,,1,,,
CHEMBL622512,14548,,11697,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622513,14548,,11698,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622514,14548,,11699,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622515,14548,,11700,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622516,14548,,11701,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622517,14548,,11702,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622518,14548,,11703,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622519,14548,,11704,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL622520,14608,,11705,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622521,14608,,11706,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625113,14608,,11707,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL625114,14608,,11708,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL874397,14608,,11709,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL625115,14608,,11710,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625116,14608,,11711,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623932,14608,,11712,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623933,14608,,11713,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL623934,14608,,11714,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL623935,14608,,11715,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL623936,14608,,11716,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL623937,14608,,11717,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL623938,14608,,11718,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL623939,15383,,11719,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,,1,,,
CHEMBL623940,15383,,11720,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL623941,15383,,11721,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL627216,15383,,11722,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL623942,15383,,11723,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL618793,15383,,11724,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL618794,15383,,11725,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL618795,15383,,11726,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL618796,15383,,11727,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL618797,15383,,11728,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL618798,15383,,11729,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618799,15383,,11730,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618800,15383,,11731,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618801,15383,,11732,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618802,15383,,11733,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618803,15383,,11734,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL618804,15383,,11735,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618805,15383,,11736,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618806,15383,,11737,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618807,15383,,11738,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618808,15383,,11739,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618809,15383,,11740,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL618810,15383,,11741,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL618811,15383,,11742,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL875844,15383,,11743,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL618812,15383,,11744,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL618813,15383,,11745,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL618814,15383,,11746,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,,1,,,
CHEMBL618815,15383,,11747,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL618816,15383,,11748,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL618817,15383,,11749,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL620544,15383,,11750,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL626230,15341,,11751,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,,N,1,Intermediate,,1,,,
CHEMBL626231,15341,,11752,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,,N,1,Intermediate,,1,,,
CHEMBL626232,15341,,11753,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,,N,1,Intermediate,,1,,,
CHEMBL626233,14906,,11754,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626234,14906,,11755,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL875341,14906,,11756,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626235,14215,,11757,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,The maximum plasma concentration (100 mg/kg) administered orally in human,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626236,14215,,11758,,9481.0,In vivo,22224,,A,Callithrix,BAO_0000218,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626237,14215,,11759,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626238,14215,,11760,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622412,14215,,11761,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,The maximum plasma concentration (200 mg/kg) administered orally in human,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623114,14215,,11762,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623115,14215,,11763,,9481.0,In vivo,22224,,A,Callithrix,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623116,14215,,11764,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623117,14215,,11765,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,The maximum plasma concentration (30 mg/kg) administered orally in dog,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623118,14215,,11766,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,The maximum plasma concentration (400 mg/kg) administered orally in human,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623119,14215,,11767,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623120,14215,,11768,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration (50 mg/kg) administered orally in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623286,14215,,11769,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,The maximum plasma concentration (800 mg/kg) administered orally in human,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623287,14067,,11770,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration was measured on rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623288,12350,,11771,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The maximum plasma concentration was measured on rats after oral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623289,14813,,11772,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma drug Cmax in rat (PO dose),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623290,12536,,11773,,,In vivo,22224,,A,,BAO_0000218,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,U,0,Autocuration,,1,,,
CHEMBL623291,14169,,11774,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,maximum Plasma concentration in Dog was determined after Peroral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623292,14169,,11775,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,maximum Plasma concentration in Rats was determined after Peroral administration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623293,15604,,11776,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623294,15604,,11777,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623295,15604,,11778,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623296,14387,,11779,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,maximum concentration was measured when administered through oral route in mice,,,N,1,Intermediate,,1,,,
CHEMBL875349,15115,,11780,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,,N,1,Intermediate,,1,,,
CHEMBL623297,15115,,11781,,314293.0,,22224,,A,Simiiformes,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,,U,0,Autocuration,,1,,,
CHEMBL623298,15115,,11782,,314293.0,,22224,,A,Simiiformes,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,,U,0,Autocuration,,1,,,
CHEMBL623299,15115,,11783,,314293.0,,22224,,A,Simiiformes,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,,U,0,Autocuration,,1,,,
CHEMBL623300,16359,,11784,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL623301,12829,,11785,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,N,1,Intermediate,,1,,,
CHEMBL623302,12829,,11786,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,,N,1,Intermediate,,1,,,
CHEMBL623303,12829,,11787,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,N,1,Intermediate,,1,,,
CHEMBL623304,12829,,11788,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,,N,1,Intermediate,,1,,,
CHEMBL623305,12829,,11789,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,,N,1,Intermediate,,1,,,
CHEMBL623306,15137,,11790,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623307,15137,,11791,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623308,15137,,11792,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623309,15137,,11793,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623310,13509,,11794,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma Concentration after 120 min of oral administration to mice,,,N,1,Intermediate,,1,,,
CHEMBL623311,13509,,11795,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma Concentration after 30 min of oral administration to mice,,,N,1,Intermediate,,1,,,
CHEMBL623312,13509,,11796,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Plasma Concentration after 60 min of oral administration to mice,,,N,1,Intermediate,,1,,,
CHEMBL875350,13509,,11797,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma Concentration after 60 min of oral administration to mice; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL628635,13509,,11798,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Plasma Concentration after 90 min of oral administration to mice,,,N,1,Intermediate,,1,,,
CHEMBL628636,12064,,11799,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628637,12064,,11800,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628058,12064,,11801,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628059,10677,,11802,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,,N,1,Intermediate,,1,,,
CHEMBL628060,10677,,11803,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,,N,1,Intermediate,,1,,,
CHEMBL628061,8926,,11804,,,,22224,,A,,BAO_0000019,Distribution in the lung after 15 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628062,8926,,11805,,,,22224,,A,,BAO_0000019,Distribution in the lung after 30 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628063,8926,,11806,,,,22224,,A,,BAO_0000019,Distribution in the lung after 5 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628064,8926,,11807,,,,22224,,A,,BAO_0000019,Distribution in the lung after 60 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628065,8926,,11808,,,,22224,,A,,BAO_0000019,Distribution in the lung after 90 min of intravenous administration,,,U,0,Autocuration,,1,,,
CHEMBL628066,8926,,11809,,,,22224,,A,,BAO_0000019,Distribution in the muscle after 120 min of intravenous administration,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL628067,8926,,11810,,,,22224,,A,,BAO_0000019,Distribution in the muscle after 15 min of intravenous administration,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL874646,8926,,11811,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution in the muscle after 30 min of intravenous administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL628068,8926,,11812,,,,22224,,A,,BAO_0000019,Distribution in the muscle after 5 min of intravenous administration,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL628069,8926,,11813,,,,22224,,A,,BAO_0000019,Distribution in the muscle after 60 min of intravenous administration,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL628070,8926,,11814,,,,22224,,A,,BAO_0000019,Distribution in the muscle after 90 min of intravenous administration,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL628071,8926,,11815,,,,22224,,A,,BAO_0000019,Distribution in the spleen after 120 min of intravenous administration,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL628072,8926,,11816,,,,22224,,A,,BAO_0000019,Distribution in the spleen after 15 min of intravenous administration,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL628073,8926,,11817,,,,22224,,A,,BAO_0000019,Distribution in the spleen after 30 min of intravenous administration,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL628074,8926,,11818,,,,22224,,A,,BAO_0000019,Distribution in the spleen after 5 min of intravenous administration,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL628075,8926,,11819,,,,22224,,A,,BAO_0000019,Distribution in the spleen after 60 min of intravenous administration,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL628076,8926,,11820,,,,22224,,A,,BAO_0000019,Distribution in the spleen after 90 min of intravenous administration,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL628077,7570,,11821,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,N,1,Intermediate,Adrenal cortex,1,,1235.0,
CHEMBL628078,7570,,11822,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628079,7570,,11823,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628080,7570,,11824,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL628081,7570,,11825,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL628082,7570,,11826,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,N,1,Intermediate,Adrenal cortex,1,,1235.0,
CHEMBL874647,7570,,11827,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626406,7570,,11828,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626407,7570,,11829,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL626408,7570,,11830,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626409,8608,,11831,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626410,8608,,11832,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626411,8608,,11833,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626412,8608,,11834,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626413,8608,,11835,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626414,8608,,11836,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626415,8608,,11837,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626416,8608,,11838,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627062,8608,,11839,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627063,8608,,11840,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627064,8608,,11841,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627227,8608,,11842,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627228,8608,,11843,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627229,8608,,11844,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625792,8608,,11845,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625793,8608,,11846,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625794,8608,,11847,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625795,8608,,11848,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625796,13792,,11849,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,,N,1,Intermediate,,1,,,
CHEMBL625797,13376,,11850,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625798,13376,,11851,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL875613,14380,,11852,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625799,14380,,11853,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625800,14380,,11854,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625801,14380,,11855,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625802,14380,,11856,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625803,14380,,11857,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625804,14380,,11858,,,,22224,,A,,BAO_0000019,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,U,0,Autocuration,,1,,,
CHEMBL622530,14380,,11859,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL622531,13701,,11860,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,,N,1,Intermediate,,1,,,
CHEMBL622532,13701,,11861,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL623176,13701,,11862,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL623177,13701,,11863,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL623178,13701,,11864,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL623179,13701,,11865,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,,N,1,Intermediate,,1,,,
CHEMBL623180,13701,,11866,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL623181,13701,,11867,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL624131,13701,,11868,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL624132,13701,,11869,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL624133,13701,,11870,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL624846,13701,,11871,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,,N,1,Intermediate,,1,,,
CHEMBL624847,13701,,11872,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL624848,13701,,11873,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625012,13701,,11874,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625013,13701,,11875,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625014,13701,,11876,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,,N,1,Intermediate,,1,,,
CHEMBL625015,13701,,11877,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625016,13701,,11878,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625017,13701,,11879,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,,N,1,Intermediate,,1,,,
CHEMBL625018,13701,,11880,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625019,13701,,11881,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625020,13701,,11882,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL625021,13701,,11883,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,,N,1,Intermediate,,1,,,
CHEMBL625022,14393,,11884,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL625023,14731,,11885,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,,N,1,Intermediate,,1,,,
CHEMBL625024,14731,,11886,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,,N,1,Intermediate,,1,,,
CHEMBL627626,14731,,11887,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,N,1,Intermediate,,1,,,
CHEMBL627627,13758,,11888,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,U,0,Autocuration,Brain,1,,955.0,
CHEMBL627628,13758,,11889,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,U,0,Autocuration,Serum,1,,1977.0,
CHEMBL627629,13758,,11890,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,U,0,Autocuration,Brain,1,,955.0,
CHEMBL627630,13758,,11891,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,U,0,Autocuration,Serum,1,,1977.0,
CHEMBL627631,16359,,11892,,,,22224,,A,,BAO_0000019,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,U,0,Autocuration,,1,,,
CHEMBL629515,16359,,11893,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,U,0,Autocuration,,1,,,
CHEMBL629516,15383,,11894,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL629517,15383,,11895,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL629518,15383,,11896,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL877499,15383,,11897,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,N,1,Intermediate,,1,,,
CHEMBL629519,15383,,11898,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL629520,15383,,11899,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL629521,15383,,11900,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,N,1,Intermediate,,1,,,
CHEMBL629522,14439,,11901,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,,N,1,Intermediate,,1,,,
CHEMBL629523,14439,,11902,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,,N,1,Intermediate,,1,,,
CHEMBL629524,14439,,11903,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,,N,1,Intermediate,,1,,,
CHEMBL629525,14439,,11904,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,,N,1,Intermediate,,1,,,
CHEMBL629526,14439,,11905,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,,N,1,Intermediate,,1,,,
CHEMBL629527,14439,,11906,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,,N,1,Intermediate,,1,,,
CHEMBL629528,14439,,11907,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,,N,1,Intermediate,,1,,,
CHEMBL629529,14439,,11908,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,,N,1,Intermediate,,1,,,
CHEMBL629530,14439,,11909,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,,N,1,Intermediate,,1,,,
CHEMBL629531,14439,,11910,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,,N,1,Intermediate,,1,,,
CHEMBL628656,14439,,11911,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,,N,1,Intermediate,,1,,,
CHEMBL628657,14439,,11912,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,,N,1,Intermediate,,1,,,
CHEMBL628658,13751,,11913,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628659,13751,,11914,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL877500,13751,,11915,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628660,13751,,11916,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628661,13751,,11917,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628662,13751,,11918,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628663,13751,,11919,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628664,13751,,11920,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL628665,13751,,11921,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628666,13751,,11922,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628667,13751,,11923,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628668,13751,,11924,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628669,13751,,11925,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628670,13751,,11926,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628671,13751,,11927,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628672,13751,,11928,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL630300,13751,,11929,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL629787,13751,,11930,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL629788,13751,,11931,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL629789,13751,,11932,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629790,13751,,11933,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629791,13751,,11934,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629792,13751,,11935,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629793,13751,,11936,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629794,13751,,11937,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL874459,10677,,11938,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,,N,1,Intermediate,,1,,,
CHEMBL629795,10677,,11939,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,,N,1,Intermediate,,1,,,
CHEMBL629796,10677,,11940,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,,N,1,Intermediate,,1,,,
CHEMBL629797,10677,,11941,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,,N,1,Intermediate,,1,,,
CHEMBL629798,10677,,11942,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,,N,1,Intermediate,,1,,,
CHEMBL629799,10911,,11943,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Adrenal gland,1,,2369.0,
CHEMBL629800,10911,,11944,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Adrenal gland,1,,2369.0,
CHEMBL629801,10911,,11945,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Adrenal gland,1,,2369.0,
CHEMBL629802,10911,,11946,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,,N,1,Intermediate,Adrenal gland,1,,2369.0,
CHEMBL629803,10911,,11947,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Adrenal gland,1,,2369.0,
CHEMBL629804,10911,,11948,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629805,10911,,11949,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629806,10911,,11950,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629807,10911,,11951,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629808,10911,,11952,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629809,10911,,11953,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629810,10911,,11954,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629811,10911,,11955,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629812,10911,,11956,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629813,10911,,11957,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL874460,10911,,11958,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629814,10911,,11959,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,,1,,,
CHEMBL629815,10911,,11960,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,,1,,,
CHEMBL629816,10911,,11961,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,,1,,,
CHEMBL629817,10911,,11962,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,,1,,,
CHEMBL626643,10911,,11963,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626644,10911,,11964,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626806,10911,,11965,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL626807,10911,,11966,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627261,10911,,11967,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627262,10911,,11968,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627263,10911,,11969,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627264,10911,,11970,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627265,10911,,11971,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627266,10911,,11972,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627267,10911,,11973,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627268,10911,,11974,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627269,10911,,11975,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627270,10911,,11976,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627271,8608,,11977,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,,N,1,Intermediate,,1,,,
CHEMBL627946,8608,,11978,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,,N,1,Intermediate,,1,,,
CHEMBL875472,8608,,11979,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,,N,1,Intermediate,,1,,,
CHEMBL627947,8608,,11980,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,,N,1,Intermediate,,1,,,
CHEMBL627948,8608,,11981,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,,N,1,Intermediate,,1,,,
CHEMBL628113,8608,,11982,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,,N,1,Intermediate,,1,,,
CHEMBL628114,8608,,11983,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,,N,1,Intermediate,,1,,,
CHEMBL628115,8608,,11984,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,,N,1,Intermediate,,1,,,
CHEMBL628116,8608,,11985,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,,N,1,Intermediate,,1,,,
CHEMBL628117,8608,,11986,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,,N,1,Intermediate,,1,,,
CHEMBL628118,8608,,11987,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,,N,1,Intermediate,,1,,,
CHEMBL628119,8608,,11988,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,,N,1,Intermediate,,1,,,
CHEMBL628120,8608,,11989,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,,N,1,Intermediate,,1,,,
CHEMBL628121,8608,,11990,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,,N,1,Intermediate,,1,,,
CHEMBL628122,8608,,11991,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,,N,1,Intermediate,,1,,,
CHEMBL627297,8608,,11992,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,,N,1,Intermediate,,1,,,
CHEMBL627298,8608,,11993,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,,N,1,Intermediate,,1,,,
CHEMBL627299,8608,,11994,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,,N,1,Intermediate,,1,,,
CHEMBL627300,8608,,11995,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,,N,1,Intermediate,,1,,,
CHEMBL627301,8608,,11996,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,,N,1,Intermediate,,1,,,
CHEMBL627302,8608,,11997,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,,N,1,Intermediate,,1,,,
CHEMBL627303,8608,,11998,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,,N,1,Intermediate,,1,,,
CHEMBL627304,8608,,11999,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,,N,1,Intermediate,,1,,,
CHEMBL627305,8608,,12000,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,,N,1,Intermediate,,1,,,
CHEMBL627306,8608,,12001,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,N,1,Intermediate,,1,,,
CHEMBL623982,8608,,12002,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,,N,1,Intermediate,,1,,,
CHEMBL623983,8608,,12003,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,,N,1,Intermediate,,1,,,
CHEMBL623984,8608,,12004,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,,N,1,Intermediate,,1,,,
CHEMBL623985,8608,,12005,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,,N,1,Intermediate,,1,,,
CHEMBL623986,8608,,12006,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,,N,1,Intermediate,,1,,,
CHEMBL623987,8608,,12007,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,,N,1,Intermediate,,1,,,
CHEMBL623988,8608,,12008,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,,N,1,Intermediate,,1,,,
CHEMBL623989,8608,,12009,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,,N,1,Intermediate,,1,,,
CHEMBL622215,8608,,12010,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,,N,1,Intermediate,,1,,,
CHEMBL622216,8608,,12011,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,,N,1,Intermediate,,1,,,
CHEMBL877481,8608,,12012,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,,N,1,Intermediate,,1,,,
CHEMBL622217,16359,,12013,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,U,0,Autocuration,,1,,,
CHEMBL622218,13701,,12014,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,N,1,Intermediate,,1,,,
CHEMBL622219,14554,,12015,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic profile AUC was evaluated in rats,,,N,1,Intermediate,,1,,,
CHEMBL622220,6241,,12016,,,,22224,,A,,BAO_0000019,Pharmacokinetic property (Area under curve),,,U,0,Autocuration,,1,,,
CHEMBL622221,11537,,12017,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,,N,1,Intermediate,,1,,,
CHEMBL622222,11537,,12018,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,,N,1,Intermediate,,1,,,
CHEMBL622223,11537,,12019,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,,N,1,Intermediate,,1,,,
CHEMBL622224,11537,,12020,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,,N,1,Intermediate,,1,,,
CHEMBL622225,13118,,12021,,,,22224,,A,,BAO_0000019,Plasma concentration (AUC) was determined,,,U,0,Autocuration,,1,,,
CHEMBL622226,13118,,12022,,,,22224,,A,,BAO_0000019,Plasma concentration (AUC) was determined; Not detectable,,,U,0,Autocuration,,1,,,
CHEMBL624154,9562,,12023,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,,N,1,Intermediate,,1,,,
CHEMBL624155,10363,,12024,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624156,10363,,12025,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,N,1,Intermediate,,1,,,
CHEMBL624157,10363,,12026,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624158,10363,,12027,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL624159,12504,,12028,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,,N,1,Intermediate,,1,,,
CHEMBL624160,12504,,12029,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,,N,1,Intermediate,,1,,,
CHEMBL624161,12504,,12030,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,,N,1,Intermediate,,1,,,
CHEMBL624162,12504,,12031,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,,N,1,Intermediate,,1,,,
CHEMBL624163,13317,,12032,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,,N,1,Intermediate,,1,,,
CHEMBL624164,15078,,12033,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL624165,14941,,12034,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The AUC(0-infinity) values in female wistar rats.,,,N,1,Intermediate,,1,,,
CHEMBL624166,15078,,12035,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL624167,15078,,12036,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,,N,1,Intermediate,,1,,,
CHEMBL624168,14941,,12037,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The AUC(0-t)values in female wistar rats.,,,N,1,Intermediate,,1,,,
CHEMBL624169,14067,,12038,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The Area under the concentration time curve of compound was measured on rats,,,N,1,Intermediate,,1,,,
CHEMBL624170,14215,,12039,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The area under curve (100 mg/kg) administered orally in humans,,,N,1,Intermediate,,1,,,
CHEMBL624171,14215,,12040,,9481.0,,22224,,A,Callithrix,BAO_0000218,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,,U,0,Autocuration,,1,,,
CHEMBL624172,14215,,12041,,314293.0,,22224,,A,Simiiformes,BAO_0000218,The area under curve (12.5 mg/kg) administered intravenously in monkey,,,U,0,Autocuration,,1,,,
CHEMBL624173,14215,,12042,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,The area under curve (15 mg/kg) administered intravenously in dog,,,N,1,Intermediate,,1,,,
CHEMBL877488,14215,,12043,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The area under curve (200 mg/kg) administered orally in humans,,,N,1,Intermediate,,1,,,
CHEMBL624174,14215,,12044,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The area under curve (25 mg/kg) administered intravenously in rat,,,N,1,Intermediate,,1,,,
CHEMBL624175,14215,,12045,,9481.0,,22224,,A,Callithrix,BAO_0000218,The area under curve (25 mg/kg) administered orally in marmoset,,,U,0,Autocuration,,1,,,
CHEMBL624176,14215,,12046,,314293.0,,22224,,A,Simiiformes,BAO_0000218,The area under curve (25 mg/kg) administered orally in monkey,,,U,0,Autocuration,,1,,,
CHEMBL624177,14215,,12047,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,The area under curve (30 mg/kg) administered orally in dog,,,N,1,Intermediate,,1,,,
CHEMBL624178,14215,,12048,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The area under curve (400 mg/kg) administered orally in humans,,,N,1,Intermediate,,1,,,
CHEMBL624179,14215,,12049,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The area under curve (50 mg/kg) administered orally in fasted rat,,,N,1,Intermediate,,1,,,
CHEMBL627689,14215,,12050,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The area under curve (50 mg/kg) administered orally in rat,,,N,1,Intermediate,,1,,,
CHEMBL627690,14215,,12051,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The area under curve (800 mg/kg) administered orally in humans,,,N,1,Intermediate,,1,,,
CHEMBL627691,11324,,12052,,,,22224,,A,,BAO_0000019,The compound was evaluated for area under the curve,,,U,0,Autocuration,,1,,,
CHEMBL627692,11324,,12053,,9481.0,,22224,,A,Callithrix,BAO_0000019,The compound was evaluated for area under the curve in marmosets,,,U,0,Autocuration,,1,,,
CHEMBL627693,11324,,12054,,9481.0,,22224,,A,Callithrix,BAO_0000019,The compound was evaluated for area under the curve in marmosets,,,U,0,Autocuration,,1,,,
CHEMBL627694,13875,,12055,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,N,1,Intermediate,,1,,,
CHEMBL627695,13875,,12056,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,,N,1,Intermediate,,1,,,
CHEMBL627696,13875,,12057,,,,22224,,A,,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,U,0,Autocuration,,1,,,
CHEMBL627697,13875,,12058,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,N,1,Intermediate,,1,,,
CHEMBL627698,13875,,12059,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,N,1,Intermediate,,1,,,
CHEMBL627699,13875,,12060,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,,N,1,Intermediate,,1,,,
CHEMBL627700,13807,,12061,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,,N,1,Intermediate,,1,,,
CHEMBL627701,14127,,12062,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total drug exposure is determined after oral dosing in rats.,,,N,1,Intermediate,,1,,,
CHEMBL627702,15116,,12063,,,,22224,,A,,BAO_0000218,Total drug exposure (5 mg/kg) when administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL627703,15116,,12064,,,,22224,,A,,BAO_0000218,Total drug exposure (5 mg/kg) when administered orally,,,U,0,Autocuration,,1,,,
CHEMBL626873,15604,,12065,,314293.0,,22224,,A,Simiiformes,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,U,0,Autocuration,,1,,,
CHEMBL629583,15604,,12066,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL629584,15604,,12067,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,N,1,Intermediate,,1,,,
CHEMBL629585,15604,,12068,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,N,1,Intermediate,,1,,,
CHEMBL629586,13751,,12069,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629587,13751,,12070,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629588,13751,,12071,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629589,13751,,12072,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629590,13751,,12073,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629591,13751,,12074,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629592,13751,,12075,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629593,13751,,12076,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629594,13751,,12077,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL629595,13751,,12078,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630290,13751,,12079,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627137,13751,,12080,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627138,13751,,12081,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627139,13751,,12082,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627140,13751,,12083,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627141,13751,,12084,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627142,13751,,12085,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627143,13751,,12086,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL874449,13751,,12087,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627144,13751,,12088,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627145,13751,,12089,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627146,13751,,12090,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627147,13751,,12091,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627148,13751,,12092,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627149,13751,,12093,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL632160,13751,,12094,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL632161,13751,,12095,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL632162,13751,,12096,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL632163,13751,,12097,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL874469,13751,,12098,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627182,13751,,12099,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627183,13751,,12100,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627184,13751,,12101,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627185,13751,,12102,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627186,13751,,12103,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627187,13751,,12104,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627188,13751,,12105,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627189,13751,,12106,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627190,13751,,12107,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,,1,,,
CHEMBL627191,13751,,12108,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627192,13751,,12109,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627193,13751,,12110,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL874590,10911,,12111,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627194,10911,,12112,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627195,10911,,12113,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627196,10911,,12114,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL627197,10911,,12115,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL627198,10911,,12116,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL627199,10911,,12117,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL627200,10911,,12118,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Female gonad,1,,992.0,
CHEMBL627201,10911,,12119,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627202,10911,,12120,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627203,10911,,12121,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627204,10911,,12122,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627205,10911,,12123,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627206,10911,,12124,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627207,10911,,12125,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627208,10911,,12126,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627209,10911,,12127,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627210,10911,,12128,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627211,10911,,12129,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627212,10911,,12130,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627213,10911,,12131,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626599,10911,,12132,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626600,10911,,12133,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL626601,10911,,12134,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL627484,8081,,12135,,,,22224,,A,,BAO_0000019,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,U,0,Autocuration,,1,,,
CHEMBL627485,17248,,12136,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628147,17248,,12137,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628148,17248,,12138,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628149,17248,,12139,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628150,17248,,12140,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628318,17248,,12141,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628319,17248,,12142,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL875609,15592,,12143,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,N,1,Intermediate,,1,,,
CHEMBL628320,7040,,12144,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,U,0,Autocuration,,1,,,
CHEMBL628321,7040,,12145,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,U,0,Autocuration,,1,,,
CHEMBL628322,7040,,12146,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,U,0,Autocuration,,1,,,
CHEMBL628323,7040,,12147,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,U,0,Autocuration,,1,,,
CHEMBL628324,7040,,12148,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,U,0,Autocuration,,1,,,
CHEMBL628325,7040,,12149,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,U,0,Autocuration,,1,,,
CHEMBL628326,7040,,12150,,,,22224,,A,,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,U,0,Autocuration,,1,,,
CHEMBL628327,9614,,12151,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,,N,1,Intermediate,Adrenal medulla,1,,1236.0,
CHEMBL628328,9614,,12152,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,,N,1,Intermediate,Adrenal medulla,1,,1236.0,
CHEMBL628329,9614,,12153,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in blood of dog 1, after administering intravenously",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628330,8608,,12154,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628331,8608,,12155,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628332,8608,,12156,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628333,8608,,12157,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628334,8608,,12158,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628335,8608,,12159,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628336,8608,,12160,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628337,8608,,12161,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628338,8608,,12162,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL875610,8608,,12163,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628339,8608,,12164,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628340,8608,,12165,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628341,8608,,12166,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622214,8608,,12167,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623167,8608,,12168,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623168,8608,,12169,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623169,8608,,12170,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623170,8608,,12171,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627224,8608,,12172,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL875634,8608,,12173,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627225,8608,,12174,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627226,8608,,12175,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626083,8608,,12176,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626084,8608,,12177,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626085,8608,,12178,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626086,8608,,12179,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626087,8608,,12180,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626088,8608,,12181,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626089,8608,,12182,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626090,8608,,12183,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626091,8608,,12184,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626092,8608,,12185,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626093,8608,,12186,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626094,8608,,12187,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626095,8608,,12188,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626096,8608,,12189,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL626097,15604,,12190,,314293.0,,22224,,A,Simiiformes,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,U,0,Autocuration,,1,,,
CHEMBL626098,15604,,12191,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL626099,1806,,12192,,,,22224,,A,,BAO_0000218,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626100,1806,,12193,,,,22224,,A,,BAO_0000218,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL626101,17237,,12194,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,AUC 0-inf in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626102,17237,,12195,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,AUC 0-inf in guinea pig,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626103,17237,,12196,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,AUC 0-t in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628391,17237,,12197,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,AUC 0-t in guinea pig,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628392,15194,,12198,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for brain to plasma partition in rat,,,N,1,Intermediate,,1,,,
CHEMBL628393,15194,,12199,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for brain to plasma partition in rat.,,,N,1,Intermediate,,1,,,
CHEMBL628394,8787,,12200,,,,22224,,A,,BAO_0000019,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL628395,17025,,12201,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL628396,17025,,12202,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,,U,0,Autocuration,,1,,,
CHEMBL628397,17025,,12203,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL628398,17025,,12204,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL628399,4236,,12205,,9544.0,,50797,,A,Macaca mulatta,BAO_0000218,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,,N,1,Intermediate,,1,,,
CHEMBL628400,15343,,12206,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL874907,15343,,12207,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL628401,17720,,12208,,,,22224,,A,,BAO_0000019,Area under curve of the compound was determined,,,U,0,Autocuration,,1,,,
CHEMBL628402,17788,,12209,,314293.0,,22224,,A,Simiiformes,BAO_0000218,AUC in monkeys at a dose of 1 mg/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL628403,17788,,12210,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,AUC in rats at a dose of 1 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628404,8778,,12211,,,,22224,,A,,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 2,,,U,0,Autocuration,,1,,,
CHEMBL628405,8778,,12212,,,,22224,,A,,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 4,,,U,0,Autocuration,,1,,,
CHEMBL628406,8778,,12213,,,,22224,,A,,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 7,,,U,0,Autocuration,,1,,,
CHEMBL628407,2249,,12214,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for its absorption in the rats,,,N,1,Intermediate,,1,,,
CHEMBL628408,8881,,12215,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629171,8881,,12216,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629172,8881,,12217,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629173,8881,,12218,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629174,15286,,12219,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum,,,N,1,Intermediate,,1,,,
CHEMBL629175,15286,,12220,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-17,,,N,1,Intermediate,,1,,,
CHEMBL629176,15286,,12221,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-18,,,N,1,Intermediate,,1,,,
CHEMBL629177,15286,,12222,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-19,,,N,1,Intermediate,,1,,,
CHEMBL629178,15286,,12223,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 12-15,,,N,1,Intermediate,,1,,,
CHEMBL631869,15286,,12224,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 13-19,,,N,1,Intermediate,,1,,,
CHEMBL631870,15286,,12225,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 14-17,,,N,1,Intermediate,,1,,,
CHEMBL631871,15286,,12226,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 15-18,,,N,1,Intermediate,,1,,,
CHEMBL631872,15286,,12227,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 2-5,,,N,1,Intermediate,,1,,,
CHEMBL875775,15286,,12228,,,,22224,,A,,BAO_0000221,In vitro percent permeability into rat ileum; Range is 23-42,,,U,0,Autocuration,Ileum,1,,2116.0,
CHEMBL631873,15286,,12229,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 28-36,,,N,1,Intermediate,,1,,,
CHEMBL631874,15286,,12230,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 29-35,,,N,1,Intermediate,,1,,,
CHEMBL631875,15286,,12231,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 46-66,,,N,1,Intermediate,,1,,,
CHEMBL631876,15286,,12232,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 50-68,,,N,1,Intermediate,,1,,,
CHEMBL631877,15286,,12233,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; Range is 78-81,,,N,1,Intermediate,,1,,,
CHEMBL631878,15286,,12234,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,,N,1,Intermediate,,1,,,
CHEMBL631879,15286,,12235,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; nd indicates not detected,,,N,1,Intermediate,,1,,,
CHEMBL631880,15286,,12236,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; nt indicates not detected,,,N,1,Intermediate,,1,,,
CHEMBL631881,15286,,12237,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro percent permeability into rat ileum; nt indicates not tested,,,N,1,Intermediate,,1,,,
CHEMBL631882,13770,,12238,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for oral absorption in bile-duct cannulated rats,,,N,1,Intermediate,,1,,,
CHEMBL630749,13770,,12239,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for oral absorption in bile-duct cannulated rats.,,,N,1,Intermediate,,1,,,
CHEMBL630750,5202,,12240,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Oral absorption using Caco-2 cell monolayers.,,,N,1,Intermediate,,1,,,
CHEMBL630253,14920,,12241,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Percent of the drug absorbed after administration to humans was determined,,,N,1,Intermediate,,1,,,
CHEMBL630254,14103,,12242,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL630255,14103,,12243,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL630256,14103,,12244,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL875781,13751,,12245,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630257,13751,,12246,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630258,13751,,12247,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630259,15807,,12248,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,,N,1,Intermediate,,1,,,
CHEMBL630260,15807,,12249,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL630261,15807,,12250,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL630262,14950,,12251,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,,N,1,Intermediate,,1,,,
CHEMBL630263,14950,,12252,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,,N,1,Intermediate,,1,,,
CHEMBL630264,14950,,12253,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,,N,1,Intermediate,,1,,,
CHEMBL630265,14950,,12254,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,,N,1,Intermediate,,1,,,
CHEMBL630266,14950,,12255,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,,N,1,Intermediate,,1,,,
CHEMBL630267,14950,,12256,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630268,14950,,12257,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630269,14950,,12258,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,,N,1,Intermediate,,1,,,
CHEMBL630270,14950,,12259,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,,N,1,Intermediate,,1,,,
CHEMBL630141,14950,,12260,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630142,14950,,12261,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630143,14950,,12262,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630144,14950,,12263,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630145,14950,,12264,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,,N,1,Intermediate,Prostate gland,1,,2367.0,
CHEMBL630146,14950,,12265,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,,N,1,Intermediate,Prostate gland,1,,2367.0,
CHEMBL630147,14950,,12266,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,,N,1,Intermediate,,1,,,
CHEMBL630148,14950,,12267,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,,N,1,Intermediate,,1,,,
CHEMBL630149,14950,,12268,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,,N,1,Intermediate,,1,,,
CHEMBL630150,14950,,12269,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630151,14950,,12270,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL632031,14950,,12271,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL632032,14950,,12272,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL632033,14950,,12273,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,,N,1,Intermediate,,1,,,
CHEMBL632034,14950,,12274,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,,N,1,Intermediate,,1,,,
CHEMBL632035,14950,,12275,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL632036,14950,,12276,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,,N,1,Intermediate,,1,,,
CHEMBL632037,14950,,12277,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL632038,8631,,12278,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632039,8631,,12279,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632040,8631,,12280,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632041,8631,,12281,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632042,9614,,12282,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in blood of dog 2, after administering intravenously",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL632043,9614,,12283,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,,N,1,Intermediate,,1,,,
CHEMBL632044,9614,,12284,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,,N,1,Intermediate,,1,,,
CHEMBL632045,9614,,12285,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in liver of dog 1, after administering intravenously",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632046,9614,,12286,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in liver of dog 2, after administering intravenously",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632047,9614,,12287,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in lung of dog 1, after administering intravenously",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL632048,9614,,12288,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in lung of dog 2, after administering intravenously",,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL632049,9614,,12289,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in muscle of dog 1, after administering intravenously",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL876418,9614,,12290,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in muscle of dog 2, after administering intravenously",,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL632050,9614,,12291,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in spleen of dog 1,after administering intravenously",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL632051,9614,,12292,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration of compound in spleen of dog 2, after administering intravenously",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL632052,10353,,12293,,,,22224,,F,,BAO_0000218,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,U,0,Autocuration,,1,,,
CHEMBL632053,10353,,12294,,,,22224,,F,,BAO_0000218,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,U,0,Autocuration,,1,,,
CHEMBL632054,10353,,12295,,,,22224,,A,,BAO_0000218,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,U,0,Autocuration,,1,,,
CHEMBL632055,10353,,12296,,,,22224,,F,,BAO_0000218,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,U,0,Autocuration,,1,,,
CHEMBL631181,10353,,12297,,,,22224,,F,,BAO_0000218,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,U,0,Autocuration,,1,,,
CHEMBL631182,9196,,12298,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL631183,9196,,12299,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL631184,9196,,12300,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL629774,9196,,12301,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL629775,9196,,12302,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL876549,9196,,12303,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628172,9196,,12304,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628173,9196,,12305,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628174,9196,,12306,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628175,9196,,12307,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628176,9196,,12308,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628177,9196,,12309,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628178,9196,,12310,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628179,9196,,12311,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628180,9196,,12312,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,U,0,Autocuration,,1,,,
CHEMBL628181,9196,,12313,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628182,9196,,12314,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628183,9196,,12315,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628184,9196,,12316,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,U,0,Autocuration,,1,,,
CHEMBL628185,9196,,12317,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL875617,9196,,12318,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628186,9196,,12319,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,U,0,Autocuration,,1,,,
CHEMBL628187,9196,,12320,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628188,9196,,12321,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628189,9196,,12322,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628190,9196,,12323,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,U,0,Autocuration,,1,,,
CHEMBL628191,9196,,12324,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626513,9196,,12325,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,U,0,Autocuration,,1,,,
CHEMBL626514,8608,,12326,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626515,8608,,12327,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626516,8608,,12328,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626517,8608,,12329,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626518,8608,,12330,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626519,8608,,12331,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626520,8608,,12332,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626521,8608,,12333,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626522,8608,,12334,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626523,8608,,12335,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626524,8608,,12336,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626688,8608,,12337,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626689,8608,,12338,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626690,8608,,12339,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626691,8608,,12340,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627319,8608,,12341,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL624052,8608,,12342,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL624053,8608,,12343,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL624054,8085,,12344,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL624055,8085,,12345,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL624056,8085,,12346,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL624057,8085,,12347,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622281,8085,,12348,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622282,8085,,12349,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622283,8085,,12350,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622284,8085,,12351,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622285,8085,,12352,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622286,8085,,12353,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL622287,7657,,12354,,,,22224,,P,,BAO_0000100,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL622288,8935,,12355,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Partition coefficient (logD7.4),,,N,1,Intermediate,,1,,,
CHEMBL622289,13792,,12356,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,N,1,Intermediate,,1,,,
CHEMBL622290,13792,,12357,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622291,13792,,12358,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,N,1,Intermediate,,1,,,
CHEMBL622292,13792,,12359,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622293,13792,,12360,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,N,1,Intermediate,,1,,,
CHEMBL622294,13792,,12361,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL622295,13792,,12362,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,N,1,Intermediate,,1,,,
CHEMBL622296,13792,,12363,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL874409,14103,,12364,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622297,14103,,12365,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622298,14103,,12366,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622299,14103,,12367,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622300,14103,,12368,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622301,14103,,12369,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622302,14103,,12370,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622303,14103,,12371,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622304,14103,,12372,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622305,14103,,12373,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622306,14103,,12374,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626864,14103,,12375,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626865,14103,,12376,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626866,14103,,12377,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626867,14103,,12378,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626868,14103,,12379,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626869,14103,,12380,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626870,14103,,12381,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626871,14103,,12382,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626872,14103,,12383,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632185,14103,,12384,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL632186,14103,,12385,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL629310,12904,,12386,,,,22224,,A,,BAO_0000019,Amount of acetic acid produced by the compound,,,U,0,Autocuration,,1,,,
CHEMBL629311,12904,,12387,,,,22224,,A,,BAO_0000019,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,U,0,Autocuration,,1,,,
CHEMBL629312,9663,,12388,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Log of (Cbrain/Cblood) in rats,,,N,1,Intermediate,,1,,,
CHEMBL629313,7652,,12389,,,,22224,,A,,BAO_0000221,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629314,7652,,12390,,,,22224,,A,,BAO_0000221,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629315,7652,,12391,,,,22224,,A,,BAO_0000221,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629316,7652,,12392,,,,22224,,B,,BAO_0000219,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629317,7652,,12393,,,,22224,,A,,BAO_0000221,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629318,7652,,12394,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL877497,7652,,12395,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629319,7652,,12396,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629320,7652,,12397,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629496,7652,,12398,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629497,7652,,12399,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629498,7652,,12400,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629499,7652,,12401,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629500,7652,,12402,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629501,7652,,12403,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629502,7652,,12404,,,,22224,,A,,BAO_0000019,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,U,0,Autocuration,,1,,,
CHEMBL629503,8267,,12405,,,In vivo,22224,,F,,BAO_0000218,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,U,0,Autocuration,,1,,,
CHEMBL629504,8267,,12406,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL629505,14479,,12407,,,,22224,,A,,BAO_0000019,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,U,0,Autocuration,,1,,,
CHEMBL629506,17515,,12408,,,,22224,,A,,BAO_0000019,Compound was evaluated for total body clearance,,,U,0,Autocuration,,1,,,
CHEMBL629507,17515,,12409,,,,22224,,A,,BAO_0000019,Compound was evaluated for volume of distribution at steady state,,,U,0,Autocuration,,1,,,
CHEMBL877498,8142,,12410,,,,22224,,A,,BAO_0000019,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,U,0,Autocuration,,1,,,
CHEMBL629508,14849,,12411,,,,22224,,A,,BAO_0000019,Percentage of the diamine which is monoprotonated at pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL629509,7653,,12412,,,,22224,,A,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,U,0,Autocuration,,1,,,
CHEMBL629510,8631,,12413,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629511,8631,,12414,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629512,8631,,12415,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629513,8631,,12416,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629514,8631,,12417,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628447,8631,,12418,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628448,8631,,12419,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628449,8631,,12420,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631119,8631,,12421,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631120,8631,,12422,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631121,8631,,12423,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL874458,8631,,12424,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631122,8631,,12425,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631123,8631,,12426,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631124,8631,,12427,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631125,8631,,12428,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631290,8631,,12429,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631291,8631,,12430,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631292,8631,,12431,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631293,8631,,12432,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631294,8631,,12433,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631295,8631,,12434,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631296,8631,,12435,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631297,8631,,12436,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631298,10263,,12437,,,,22224,,A,,BAO_0000218,Maximum biodistribution (Bmax) was determined.,,,U,0,Autocuration,,1,,,
CHEMBL631299,12364,,12438,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,,N,1,Intermediate,,1,,,
CHEMBL631300,12364,,12439,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,,N,1,Intermediate,,1,,,
CHEMBL631301,12364,,12440,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,,N,1,Intermediate,,1,,,
CHEMBL630291,12364,,12441,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,,N,1,Intermediate,,1,,,
CHEMBL630292,14793,,12442,,,,22224,,A,,BAO_0000218,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,U,0,Autocuration,,1,,,
CHEMBL630293,14793,,12443,,,,22224,,A,,BAO_0000218,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL630294,14793,,12444,,,,22224,,A,,BAO_0000218,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL630295,14793,,12445,,,,22224,,A,,BAO_0000218,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,U,0,Autocuration,,1,,,
CHEMBL630296,14793,,12446,,,,22224,,A,,BAO_0000218,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626782,14793,,12447,,,,22224,,A,,BAO_0000218,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626783,14793,,12448,,,,22224,,A,,BAO_0000218,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626784,14793,,12449,,,,22224,,A,,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,U,0,Autocuration,,1,,,
CHEMBL626785,14793,,12450,,,,22224,,A,,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626786,14793,,12451,,,,22224,,A,,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626787,9196,,12452,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626788,9196,,12453,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,U,0,Autocuration,,1,,,
CHEMBL625927,9196,,12454,,,,22224,,A,,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL625928,8374,,12455,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625929,8374,,12456,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625930,8374,,12457,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625931,8374,,12458,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627230,8374,,12459,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627231,8374,,12460,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627232,8374,,12461,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627233,8374,,12462,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL875470,8374,,12463,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627234,8374,,12464,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627235,8374,,12465,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627236,8374,,12466,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627237,8374,,12467,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627238,8374,,12468,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627239,8374,,12469,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627240,8374,,12470,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627241,8374,,12471,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627242,8374,,12472,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627243,8374,,12473,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627244,8374,,12474,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627245,8374,,12475,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627246,8374,,12476,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627247,8374,,12477,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627248,8374,,12478,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627249,8374,,12479,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625569,8374,,12480,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625570,8374,,12481,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625571,8374,,12482,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625572,8374,,12483,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625573,8374,,12484,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625574,8374,,12485,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626245,8374,,12486,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626246,8374,,12487,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626247,9196,,12488,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626248,9196,,12489,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626249,9196,,12490,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626420,9196,,12491,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626421,9196,,12492,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626422,9196,,12493,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626423,9196,,12494,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626424,9196,,12495,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626425,12023,,12496,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,,N,1,Intermediate,,1,,,
CHEMBL875476,12023,,12497,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,,N,1,Intermediate,,1,,,
CHEMBL626426,12023,,12498,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,,N,1,Intermediate,,1,,,
CHEMBL626427,10580,,12499,,,,22224,,P,,BAO_0000100,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,U,0,Autocuration,,1,,,
CHEMBL626428,10580,,12500,,,,22224,,P,,BAO_0000100,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,U,0,Autocuration,,1,,,
CHEMBL626429,16032,,12501,,,,22224,,A,,BAO_0000019,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,U,0,Autocuration,,1,,,
CHEMBL625025,16032,,12502,,,,22224,,A,,BAO_0000019,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL625026,8594,,12503,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625027,8594,,12504,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL874410,8594,,12505,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625028,8594,,12506,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625029,8594,,12507,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625030,8594,,12508,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625031,8594,,12509,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625032,8594,,12510,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625033,8594,,12511,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625034,8594,,12512,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624872,8594,,12513,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624873,8594,,12514,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624874,8594,,12515,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624875,8594,,12516,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624876,8594,,12517,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624877,8594,,12518,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624878,8594,,12519,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624879,8594,,12520,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624880,8594,,12521,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624881,8594,,12522,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624882,8594,,12523,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL624883,8594,,12524,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624884,8594,,12525,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624885,8594,,12526,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624886,8594,,12527,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624887,8594,,12528,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624888,8594,,12529,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624889,8594,,12530,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL624890,8594,,12531,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621964,8594,,12532,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621965,8594,,12533,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL621966,8594,,12534,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL621967,8594,,12535,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL622164,8594,,12536,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623097,7653,,12537,,,,22224,,A,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,U,0,Autocuration,,1,,,
CHEMBL623098,7653,,12538,,,,22224,,A,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,U,0,Autocuration,,1,,,
CHEMBL623099,7653,,12539,,,,22224,,A,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,U,0,Autocuration,,1,,,
CHEMBL623100,7653,,12540,,,,22224,,A,,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,U,0,Autocuration,,1,,,
CHEMBL628673,9104,,12541,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,,N,1,Intermediate,,1,,,
CHEMBL628674,9104,,12542,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,,N,1,Intermediate,,1,,,
CHEMBL628675,9104,,12543,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,,N,1,Intermediate,,1,,,
CHEMBL627644,9104,,12544,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,,N,1,Intermediate,,1,,,
CHEMBL627645,9104,,12545,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,,N,1,Intermediate,,1,,,
CHEMBL627646,9104,,12546,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,,N,1,Intermediate,,1,,,
CHEMBL627647,9104,,12547,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,,N,1,Intermediate,,1,,,
CHEMBL627648,9104,,12548,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,,N,1,Intermediate,,1,,,
CHEMBL627649,12902,,12549,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Free level in rat plasma,,,N,1,Intermediate,,1,,,
CHEMBL628313,6614,,12550,,,,22224,,A,,BAO_0000019,Level reaching in blood plasma of rat or human was determined,,,U,0,Autocuration,,1,,,
CHEMBL628314,9663,,12551,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Log (Cbrain/Cblood) in rats,,,N,1,Intermediate,,1,,,
CHEMBL628315,17658,,12552,,,,22224,,A,,BAO_0000019,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,U,0,Autocuration,,1,,,
CHEMBL628316,17658,,12553,,,,22224,,A,,BAO_0000019,Mean percentage of compound transport through membrane; expressed as membrane transport,,,U,0,Autocuration,,1,,,
CHEMBL628317,14314,,12554,,,,22224,,A,,BAO_0000218,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,U,0,Autocuration,,1,,,
CHEMBL628473,7385,,12555,,,,22224,,A,,BAO_0000019,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,U,0,Autocuration,,1,,,
CHEMBL628474,7385,,12556,,,,22224,,A,,BAO_0000019,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,U,0,Autocuration,,1,,,
CHEMBL628475,7385,,12557,,,,22224,,A,,BAO_0000019,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,U,0,Autocuration,,1,,,
CHEMBL628476,1329,,12558,,,,22224,,A,,BAO_0000019,Net water uptake by a carrier mediated transport (%cm) mechanism,,,U,0,Autocuration,,1,,,
CHEMBL628477,12187,,12559,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,U,0,Autocuration,,1,,,
CHEMBL628478,12187,,12560,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,N,1,Intermediate,,1,,,
CHEMBL628479,12187,,12561,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,N,1,Intermediate,,1,,,
CHEMBL628480,12187,,12562,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,U,0,Autocuration,,1,,,
CHEMBL628481,12187,,12563,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,,U,0,Autocuration,,1,,,
CHEMBL628482,12187,,12564,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL628483,12187,,12565,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,N,1,Intermediate,,1,,,
CHEMBL628484,9278,,12566,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628485,9278,,12567,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628486,9278,,12568,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628487,9278,,12569,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628488,9278,,12570,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628489,9278,,12571,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628490,9278,,12572,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628491,12186,,12573,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,N,1,Intermediate,,1,,,
CHEMBL877507,12186,,12574,,9541.0,,100710,,A,Macaca fascicularis,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,N,1,Intermediate,,1,,,
CHEMBL628492,12186,,12575,,,,22224,,A,,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,U,0,Autocuration,,1,,,
CHEMBL628493,12041,,12576,,314293.0,,22224,,A,Simiiformes,BAO_0000019,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,,U,0,Autocuration,,1,,,
CHEMBL628494,12041,,12577,,314293.0,,22224,,A,Simiiformes,BAO_0000019,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,,U,0,Autocuration,,1,,,
CHEMBL628495,12041,,12578,,314293.0,,22224,,A,Simiiformes,BAO_0000019,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,,U,0,Autocuration,,1,,,
CHEMBL628496,6737,,12579,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Permeability in Caco-2 assay at 10E-6,,,N,1,Intermediate,,1,,,
CHEMBL628497,13758,,12580,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,U,0,Autocuration,Brain,1,,955.0,
CHEMBL628498,13758,,12581,,,,22224,,A,,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,U,0,Autocuration,Brain,1,,955.0,
CHEMBL628499,5676,,12582,,,,22224,,A,,BAO_0000019,Plasma protein binding was determined,,,U,0,Autocuration,,1,,,
CHEMBL627656,14793,,12583,,,,22224,,A,,BAO_0000218,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL627657,14793,,12584,,,,22224,,A,,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,U,0,Autocuration,,1,,,
CHEMBL626808,14793,,12585,,,,22224,,A,,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626809,14793,,12586,,,,22224,,A,,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626810,14793,,12587,,,,22224,,A,,BAO_0000218,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626811,14793,,12588,,,,22224,,A,,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,U,0,Autocuration,,1,,,
CHEMBL874465,14793,,12589,,,,22224,,A,,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,U,0,Autocuration,,1,,,
CHEMBL626812,14793,,12590,,,,22224,,A,,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626813,14793,,12591,,,,22224,,A,,BAO_0000218,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626814,14793,,12592,,,,22224,,A,,BAO_0000218,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,U,0,Autocuration,,1,,,
CHEMBL626815,14000,,12593,,,,22224,,A,,BAO_0000019,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,U,0,Autocuration,,1,,,
CHEMBL628566,5948,,12594,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL628567,13824,,12595,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,U,0,Autocuration,,1,,,
CHEMBL628568,10778,,12596,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL628569,17237,,12597,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,C max in dog,,,N,1,Intermediate,,1,,,
CHEMBL628570,17237,,12598,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,C max in guinea pig,,,N,1,Intermediate,,1,,,
CHEMBL628571,2809,,12599,,,In vivo,22224,,A,,BAO_0000218,C max value was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL628572,11954,,12600,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 0.1 mg//kg,,,U,0,Autocuration,,1,,,
CHEMBL628573,11954,,12601,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 0.3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL628574,11954,,12602,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 1 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL628575,11954,,12603,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 10 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL628576,11954,,12604,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 23.4 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL628577,11954,,12605,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL628578,11954,,12606,,,In vivo,22224,,A,,BAO_0000218,Cmax value after oral dose of 3.87 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL874466,12768,,12607,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Cmax value in female Beagle dogs,,,N,1,Intermediate,,1,,,
CHEMBL628579,12768,,12608,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value in male rats,,,N,1,Intermediate,,1,,,
CHEMBL628580,12780,,12609,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax value in rat plasma when administered 20 mg/kg perorally,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628581,15592,,12610,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628582,15592,,12611,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628583,17025,,12612,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL625782,17025,,12613,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,,U,0,Autocuration,,1,,,
CHEMBL625783,17025,,12614,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL625784,17025,,12615,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL625785,4236,,12616,,9544.0,,50797,,A,Macaca mulatta,BAO_0000218,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625786,15791,,12617,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL874467,11149,,12618,,,,22224,,A,,BAO_0000019,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,U,0,Autocuration,,1,,,
CHEMBL625787,15592,,12619,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,N,1,Intermediate,,1,,,
CHEMBL625964,15778,,12620,,12721.0,,50677,,A,Human immunodeficiency virus,BAO_0000218,cytotoxicity against HIV protease enzyme.,,,N,1,Intermediate,,1,,,
CHEMBL625965,12745,,12621,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,,N,1,Intermediate,,1,,,
CHEMBL625966,12745,,12622,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,,N,1,Intermediate,,1,,,
CHEMBL625967,13941,,12623,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The plasma clearance in dog.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625968,13941,,12624,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The plasma clearance in rat.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625969,16449,,12625,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance from plasma in male Sprague-Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625970,16449,,12626,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Clearance from plasma in male cynomolgus monkeys,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625971,14224,,12627,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625972,14224,,12628,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Clearance of compound in dog plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625973,14224,,12629,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,Clearance of compound in human plasma,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625974,14317,,12630,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,,N,1,Intermediate,,1,,,
CHEMBL625975,14317,,12631,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Clearance of compound when administered intravenously as an individual dose to a single dog.,,,N,1,Intermediate,,1,,,
CHEMBL625976,14224,,12632,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Clearance (10 mg/kg, intravenously) in dog plasma",,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625977,17237,,12633,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Clearance value in dog,,,N,1,Intermediate,,1,,,
CHEMBL625978,17237,,12634,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Clearance value in guinea pig,,,N,1,Intermediate,,1,,,
CHEMBL874468,14187,,12635,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance values in rats after iv administration.,,,N,1,Intermediate,,1,,,
CHEMBL625421,4806,,12636,,,In vivo,22224,,A,,BAO_0000218,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL625422,15025,,12637,,9986.0,In vivo,50592,,A,Oryctolagus cuniculus,BAO_0000218,In vivo clearance (5 mg/kg) was determined in rabbits,,,N,1,Intermediate,,1,,,
CHEMBL625423,13197,,12638,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma Clearance rate was determined for the compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL625424,13197,,12639,,9520.0,In vivo,22224,,A,Saimiri,BAO_0000218,Plasma Clearance rate was determined for the compound in squirrel monkeys,,,U,0,Autocuration,,1,,,
CHEMBL625425,13960,,12640,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL625426,17820,,12641,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625427,14706,,12642,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL625428,14706,,12643,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,,N,1,Intermediate,,1,,,
CHEMBL625429,6504,,12644,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance was determined,,,U,0,Autocuration,,1,,,
CHEMBL625430,14925,,12645,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,,N,1,Intermediate,,1,,,
CHEMBL625431,13197,,12646,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance rate was determined for the compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL627307,13197,,12647,,9520.0,In vivo,22224,,A,Saimiri,BAO_0000218,Plasma clearance rate was determined for the compound in squirrel monkeys,,,U,0,Autocuration,,1,,,
CHEMBL627308,3437,,12648,,,In vivo,22224,,A,,BAO_0000218,Slow clearance (CL) was determined,,,U,0,Autocuration,,1,,,
CHEMBL627309,9196,,12649,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL627310,9196,,12650,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,U,0,Autocuration,,1,,,
CHEMBL627311,9196,,12651,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL627312,9196,,12652,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL627313,9196,,12653,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL627314,9196,,12654,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL627315,9196,,12655,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL627316,9196,,12656,,,,22224,,A,,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL627317,9196,,12657,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL627318,9196,,12658,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL627999,9196,,12659,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628000,9196,,12660,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL628001,9196,,12661,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL628002,9196,,12662,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL625610,9196,,12663,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL625611,9196,,12664,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL625612,9196,,12665,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL625613,9196,,12666,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL875479,9196,,12667,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL625614,9196,,12668,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL625615,9196,,12669,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626302,9196,,12670,,,,22224,,A,,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626303,8374,,12671,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627420,8374,,12672,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627421,13477,,12673,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,,N,1,Intermediate,,1,,,
CHEMBL625695,13477,,12674,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,,N,1,Intermediate,,1,,,
CHEMBL625696,13477,,12675,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,,N,1,Intermediate,,1,,,
CHEMBL875606,10009,,12676,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice brain was measured after 1 hr,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625697,10009,,12677,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice brain was measured after 24 hr r,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625698,10009,,12678,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice brain was measured after 2 hr,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625699,10009,,12679,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice brain was measured after 3 hr,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625700,10009,,12680,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice brain was measured after 6 hr,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625701,10009,,12681,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice liver was measured after 1 hr,,,N,1,Intermediate,,1,,,
CHEMBL625702,10009,,12682,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,,N,1,Intermediate,,1,,,
CHEMBL625703,10009,,12683,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice liver was measured after 2 hr,,,N,1,Intermediate,,1,,,
CHEMBL625704,10009,,12684,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice liver was measured after 3 hr,,,N,1,Intermediate,,1,,,
CHEMBL625705,10009,,12685,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of compound in mice liver was measured after 6 hr,,,N,1,Intermediate,,1,,,
CHEMBL625706,8170,,12686,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in dog adrenal medulla 30 min after administration.,,,N,1,Intermediate,Adrenal medulla,1,,1236.0,
CHEMBL625707,8170,,12687,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in dog adrenal medulla 72 hours after administration.,,,N,1,Intermediate,Adrenal medulla,1,,1236.0,
CHEMBL625708,8170,,12688,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog Ovary 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL625709,8170,,12689,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog Ovary 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624180,8170,,12690,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog adipose 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624181,8170,,12691,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog adipose 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624182,8170,,12692,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog adrenal cortex 72 hours after administration.,,,N,1,Intermediate,Adrenal cortex,1,,1235.0,
CHEMBL624183,8170,,12693,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog adrenal cortex 72 hours after administration.,,,N,1,Intermediate,Adrenal cortex,1,,1235.0,
CHEMBL624184,8594,,12694,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL877489,8594,,12695,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624185,8594,,12696,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624186,8594,,12697,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624187,8594,,12698,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624188,8594,,12699,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL624189,8594,,12700,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624190,8594,,12701,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624191,8594,,12702,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624192,8594,,12703,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624193,8594,,12704,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624194,8594,,12705,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624891,8594,,12706,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624892,8594,,12707,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL624893,8594,,12708,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627632,8594,,12709,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627633,8594,,12710,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL627634,8594,,12711,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL627635,8594,,12712,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,,1,,,
CHEMBL627636,8594,,12713,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL626816,8594,,12714,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,,1,,,
CHEMBL626817,8594,,12715,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL626818,8594,,12716,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,,1,,,
CHEMBL626819,8594,,12717,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL626820,8594,,12718,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,,1,,,
CHEMBL626821,8594,,12719,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL626822,8594,,12720,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626823,8594,,12721,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626824,8594,,12722,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626825,8594,,12723,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626826,8594,,12724,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626827,8594,,12725,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626828,8594,,12726,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626829,8594,,12727,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL626830,8594,,12728,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL627150,8594,,12729,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,,1,,,
CHEMBL627151,8594,,12730,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL627152,8594,,12731,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,N,1,Intermediate,,1,,,
CHEMBL627153,8594,,12732,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL627154,12904,,12733,,,,22224,,A,,BAO_0000019,Rate of acetate production by the compound was determined,,,U,0,Autocuration,,1,,,
CHEMBL627155,12904,,12734,,,,22224,,A,,BAO_0000019,Rate of acetate production by the compound was determined; Not determined,,,U,0,Autocuration,,1,,,
CHEMBL627156,3730,,12735,,,,22224,,A,,BAO_0000019,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,U,0,Autocuration,,1,,,
CHEMBL627157,3627,,12736,,,,22224,,A,,BAO_0000019,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,U,0,Autocuration,,1,,,
CHEMBL627158,13799,,12737,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,N,1,Intermediate,,1,,,
CHEMBL627159,13799,,12738,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627160,13799,,12739,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,N,1,Intermediate,,1,,,
CHEMBL628540,13799,,12740,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,N,1,Intermediate,,1,,,
CHEMBL628541,13799,,12741,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628542,13799,,12742,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628543,6629,,12743,,,,22229,,P,,BAO_0000100,Solubility after at a pH 1.2,,,U,0,Autocuration,,1,,,
CHEMBL628544,6629,,12744,,,,22229,,P,,BAO_0000100,Solubility after at pH 1.2,,,U,0,Autocuration,,1,,,
CHEMBL628545,6629,,12745,,,,22229,,P,,BAO_0000100,Solubility after injection of water,,,U,0,Autocuration,,1,,,
CHEMBL628546,14000,,12746,,,,22224,,A,,BAO_0000019,Statistical significance of IC 50 values; Expressed as R value,,,U,0,Autocuration,,1,,,
CHEMBL874455,8267,,12747,,,,22224,,A,,BAO_0000019,Systemic availability with respect to methyldopa was determined,,,U,0,Autocuration,,1,,,
CHEMBL628547,13799,,12748,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,,N,1,Intermediate,,1,,,
CHEMBL628548,13799,,12749,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL628549,7132,,12750,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628550,7132,,12751,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628551,7132,,12752,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628552,7132,,12753,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628553,7132,,12754,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628554,7132,,12755,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628555,7132,,12756,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628556,7132,,12757,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628557,7132,,12758,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628558,7132,,12759,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628559,7132,,12760,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628560,7132,,12761,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL874456,7132,,12762,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628561,7132,,12763,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628562,7132,,12764,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL628563,7132,,12765,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628564,7132,,12766,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628565,7132,,12767,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631248,7132,,12768,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631249,7132,,12769,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627214,7132,,12770,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL874591,7132,,12771,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL627215,7132,,12772,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL625471,7132,,12773,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL625472,7132,,12774,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,,N,1,Intermediate,,1,,,
CHEMBL625473,7132,,12775,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,,N,1,Intermediate,,1,,,
CHEMBL625474,13317,,12776,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,,N,1,Intermediate,,1,,,
CHEMBL625475,15341,,12777,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,,N,1,Intermediate,,1,,,
CHEMBL625476,15341,,12778,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,,N,1,Intermediate,,1,,,
CHEMBL625477,15341,,12779,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,,N,1,Intermediate,,1,,,
CHEMBL625478,15341,,12780,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,,N,1,Intermediate,,1,,,
CHEMBL625479,12801,,12781,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,,N,1,Intermediate,esophageal tunica muscularis mucosae,1,,,
CHEMBL625480,12801,,12782,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,,N,1,Intermediate,esophageal tunica muscularis mucosae,1,,,
CHEMBL625481,14856,,12783,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625482,14062,,12784,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL625483,14062,,12785,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL625484,14062,,12786,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL625485,14062,,12787,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL625486,14346,,12788,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625487,14346,,12789,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625488,14346,,12790,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625489,14346,,12791,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625490,14346,,12792,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625491,14346,,12793,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625492,14346,,12794,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625493,15711,,12795,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,plasma clearance in human,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625494,14886,,12796,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625495,14886,,12797,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625496,14886,,12798,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625497,4115,,12799,,,,22229,,P,,BAO_0000100,1-Octanol/water partition coefficient measured at 7.4,,,U,0,Autocuration,,1,,,
CHEMBL625498,13733,,12800,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625499,12102,,12801,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL625500,12676,,12802,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625501,13733,,12803,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625502,13740,,12804,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625503,12766,,12805,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,U,0,Autocuration,,1,,,
CHEMBL625504,2764,,12806,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625505,12355,,12807,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625506,11314,,12808,,,,22229,,P,,BAO_0000100,Calculated partition coefficient of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625507,12706,,12809,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL625508,12645,,12810,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625509,13668,,12811,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625510,12819,,12812,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL883125,13668,,12813,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625511,13017,,12814,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL874650,2448,,12815,,,,22224,,A,,BAO_0000019,Partition coefficient of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625512,11526,,12816,,,,22224,,A,,BAO_0000019,Partition coefficient of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625513,12426,,12817,,,,22224,,A,,BAO_0000019,Partition coefficient of compound was determined,,,U,0,Autocuration,,1,,,
CHEMBL625514,2448,,12818,,,,22224,,A,,BAO_0000019,Partition coefficient was determined,,,U,0,Autocuration,,1,,,
CHEMBL625515,12001,,12819,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625516,12426,,12820,,,,22229,,P,,BAO_0000100,partition coefficient of compound was determined,,,U,0,Autocuration,,1,,,
CHEMBL625517,13204,,12821,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The total body administered intravenously in dog,,,N,1,Intermediate,,1,,,
CHEMBL625518,13204,,12822,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The total body administered intravenously in rats,,,N,1,Intermediate,,1,,,
CHEMBL625519,13889,,12823,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Time taken for the administration to female NIH mice weighing 25-30 g.,,,N,1,Intermediate,,1,,,
CHEMBL625520,13889,,12824,,,,22224,,A,,BAO_0000019,Time taken for the administration,,,U,0,Autocuration,,1,,,
CHEMBL874651,17025,,12825,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL625521,17025,,12826,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,,U,0,Autocuration,,1,,,
CHEMBL623171,17025,,12827,,9986.0,In vivo,50592,,A,Oryctolagus cuniculus,BAO_0000218,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL623853,17025,,12828,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,,N,1,Intermediate,,1,,,
CHEMBL623854,15067,,12829,,,,22224,,A,,BAO_0000019,Plasma clearance for the compound was determined.,,,U,0,Autocuration,,1,,,
CHEMBL874405,3091,,12830,,,,22224,,P,,BAO_0000100,CLog P value of the compound,,,U,0,Autocuration,,1,,,
CHEMBL623855,15592,,12831,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL623856,14738,,12832,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL623857,14738,,12833,,,,22224,,P,,BAO_0000100,ClogP value of the compound; nd ='no data',,,U,0,Autocuration,,1,,,
CHEMBL623858,14738,,12834,,,,22224,,P,,BAO_0000100,ClogP value of the compound; nd ='not determined',,,U,0,Autocuration,,1,,,
CHEMBL623859,6076,,12835,,,,22224,,P,,BAO_0000100,CLog P was determined,,,U,0,Autocuration,,1,,,
CHEMBL839829,17840,,12836,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL623860,13589,,12837,,,,22224,,A,,BAO_0000019,CLogP was calculated,,,U,0,Autocuration,,1,,,
CHEMBL623861,17655,,12838,,,,22224,,A,,BAO_0000019,CLogP value was determined,,,U,0,Autocuration,,1,,,
CHEMBL623862,5867,,12839,,,,22224,,A,,BAO_0000019,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,U,0,Autocuration,,1,,,
CHEMBL874406,5867,,12840,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL623863,10783,,12841,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624021,14849,,12842,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624022,8170,,12843,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog adrenal medulla 24 hours after administration.,,,N,1,Intermediate,Adrenal medulla,1,,1236.0,
CHEMBL624023,8170,,12844,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog adrenal medulla 72 hours after administration.,,,N,1,Intermediate,Adrenal medulla,1,,1236.0,
CHEMBL624024,8170,,12845,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog bile 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624025,8170,,12846,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog bile 72 hr after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624026,8170,,12847,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog blood 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624027,8170,,12848,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog blood 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624028,8170,,12849,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog heart 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624029,8170,,12850,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog heart 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624030,8170,,12851,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog kidney 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624031,8170,,12852,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog kidney 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624032,8170,,12853,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog large intestine 24 hours after administration.,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL874407,8170,,12854,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog large intestine 72 hours after administration.,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624033,8170,,12855,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog liver 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624034,8170,,12856,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog liver 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624035,8170,,12857,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog lung 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624036,8170,,12858,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog lung 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624037,8170,,12859,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog muscle 24 hours after administration.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624038,8170,,12860,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog muscle 72 hours after administration.,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL624039,8170,,12861,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog pancreas 24 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624040,8170,,12862,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog pancreas 72 hours after administration.,,,N,1,Intermediate,,1,,,
CHEMBL624041,8170,,12863,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog small intestine 24 hours after administration.,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624042,8170,,12864,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog small intestine 72 hours after administration.,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL624043,8170,,12865,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog spleen 24 hours after administration.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL624044,8170,,12866,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog spleen 72 hours after administration.,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL624045,8170,,12867,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog stomach 24 hours after administration.,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL624046,8170,,12868,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog stomach 72 hours after administration.,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL624047,8170,,12869,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog thyroid 24 hours after administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL624048,8170,,12870,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog thyroid 72 hours after administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL874408,8170,,12871,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog urine 24 hours after administration.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624049,8170,,12872,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Distribution in female dog urine 72 hr after administration.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624050,14283,,12873,,,,22224,,A,,BAO_0000218,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL624051,5623,,12874,,,,22224,,A,,BAO_0000019,Plasma concentration at 7 hr after intravenous dosing,,,U,0,Autocuration,,1,,,
CHEMBL623278,13477,,12875,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL623279,13477,,12876,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL623280,13477,,12877,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL623963,13477,,12878,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL623964,13477,,12879,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL623965,13477,,12880,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL623966,13477,,12881,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,,N,1,Intermediate,,1,,,
CHEMBL874415,13477,,12882,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,,N,1,Intermediate,,1,,,
CHEMBL623967,13477,,12883,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,,N,1,Intermediate,,1,,,
CHEMBL623968,13477,,12884,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,,N,1,Intermediate,,1,,,
CHEMBL623969,13477,,12885,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,,N,1,Intermediate,,1,,,
CHEMBL628409,13477,,12886,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,,N,1,Intermediate,,1,,,
CHEMBL628410,13477,,12887,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,,N,1,Intermediate,,1,,,
CHEMBL628411,13477,,12888,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,,N,1,Intermediate,,1,,,
CHEMBL628412,13477,,12889,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,,N,1,Intermediate,,1,,,
CHEMBL628413,12553,,12890,,,,22224,,A,,BAO_0000019,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,U,0,Autocuration,,1,,,
CHEMBL628414,14548,,12891,,,,22224,,A,,BAO_0000019,The concentration in plasmat; Not determined,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL628415,14393,,12892,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in blood,,,N,1,Intermediate,,1,,,
CHEMBL628416,14393,,12893,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,,N,1,Intermediate,,1,,,
CHEMBL628417,14393,,12894,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in heart,,,N,1,Intermediate,,1,,,
CHEMBL874908,14393,,12895,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in liver,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628418,14393,,12896,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in plasma,,,N,1,Intermediate,,1,,,
CHEMBL628419,14393,,12897,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL628420,14393,,12898,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,,N,1,Intermediate,,1,,,
CHEMBL628421,1629,,12899,,,,22224,,A,,BAO_0000019,Water solubility at 37 degree C.,,,U,0,Autocuration,,1,,,
CHEMBL626726,8194,,12900,,,,22229,,P,,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626727,8194,,12901,,,,22229,,P,,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626728,8594,,12902,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626729,8594,,12903,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626730,8594,,12904,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626731,8594,,12905,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626732,8594,,12906,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL626733,8594,,12907,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626734,8594,,12908,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626735,8594,,12909,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL874909,8594,,12910,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626736,8594,,12911,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL626737,8594,,12912,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630999,8594,,12913,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631000,8594,,12914,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631001,8594,,12915,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631002,8594,,12916,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631003,8594,,12917,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631004,8594,,12918,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631005,8594,,12919,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631006,8594,,12920,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631007,8594,,12921,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631008,8594,,12922,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL631009,8594,,12923,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL631010,8594,,12924,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL631011,8594,,12925,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL631012,8594,,12926,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630271,8594,,12927,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630272,8594,,12928,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630273,8594,,12929,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630274,8594,,12930,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630275,8594,,12931,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL875782,8594,,12932,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL630276,8594,,12933,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL630277,8594,,12934,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL630278,8594,,12935,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL630279,8594,,12936,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,,N,1,Intermediate,,1,,,
CHEMBL630280,8151,,12937,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL630281,8151,,12938,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL630282,7132,,12939,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,,N,1,Intermediate,,1,,,
CHEMBL630283,7132,,12940,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,,N,1,Intermediate,,1,,,
CHEMBL630284,5797,,12941,,,,22224,,A,,BAO_0000019,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,U,0,Autocuration,,1,,,
CHEMBL630285,7849,,12942,,,,22224,,A,,BAO_0000019,Alkylating activity was determined,,,U,0,Autocuration,,1,,,
CHEMBL630286,14220,,12943,,,,22224,,A,,BAO_0000251,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,,U,0,Autocuration,,1,,,Microsomes
CHEMBL630069,8650,,12944,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,,N,1,Intermediate,,1,,,
CHEMBL630070,8650,,12945,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,,N,1,Intermediate,,1,,,
CHEMBL630071,8650,,12946,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,,N,1,Intermediate,,1,,,
CHEMBL630072,8650,,12947,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,,N,1,Intermediate,,1,,,
CHEMBL875110,8650,,12948,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,,N,1,Intermediate,,1,,,
CHEMBL630073,7116,,12949,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for antidiuretic activity in rats,,,N,1,Intermediate,,1,,,
CHEMBL630074,14131,,12950,,,,22224,,A,,BAO_0000019,Compound was tested for inactivation kinetic values,,,U,0,Autocuration,,1,,,
CHEMBL630075,7415,,12951,,,In vivo,22224,,A,,BAO_0000218,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,U,0,Autocuration,,1,,,
CHEMBL630076,13178,,12952,,,,22224,,A,,BAO_0000019,Dissociation rate calculated from the first-order equation using the t1/2 value,,,U,0,Autocuration,,1,,,
CHEMBL630077,8815,,12953,,,,22229,,P,,BAO_0000100,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,U,0,Autocuration,,1,,,
CHEMBL630078,1450,,12954,,,,22229,,P,,BAO_0000100,Aqueous solubility was measured,,,U,0,Autocuration,,1,,,
CHEMBL630079,1450,,12955,,,,22229,,P,,BAO_0000100,Aqueous solubility was measured at a pH 4,,,U,0,Autocuration,,1,,,
CHEMBL630080,1450,,12956,,,,22229,,P,,BAO_0000100,Aqueous solubility (pH 7),,,U,0,Autocuration,,1,,,
CHEMBL630081,1450,,12957,,,,22229,,P,,BAO_0000100,Aqueous solubility was measured at a pH 9,,,U,0,Autocuration,,1,,,
CHEMBL630082,12711,,12958,,,,22224,,A,,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,U,0,Autocuration,,1,,,
CHEMBL630083,12711,,12959,,,,22224,,A,,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,U,0,Autocuration,,1,,,
CHEMBL630084,12711,,12960,,,,22224,,A,,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,U,0,Autocuration,,1,,,
CHEMBL629198,15032,,12961,,,,22229,,P,,BAO_0000100,Aqueous solubility of the compound,,,U,0,Autocuration,,1,,,
CHEMBL629199,9964,,12962,,,,22229,,P,,BAO_0000100,Aqueous solubility at 37 degree Celsius at pH 7.38,,,U,0,Autocuration,,1,,,
CHEMBL629200,14962,,12963,,,,22229,,P,,BAO_0000100,Aqueous solubility in pH 7.4 phosphate buffer,,,U,0,Autocuration,,1,,,
CHEMBL629201,12487,,12964,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,,N,1,Intermediate,,1,,,
CHEMBL629202,12487,,12965,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,,N,1,Intermediate,,1,,,
CHEMBL875111,10026,,12966,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,,N,1,Intermediate,,1,,,
CHEMBL629203,10026,,12967,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,,N,1,Intermediate,,1,,,
CHEMBL629204,10026,,12968,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,,N,1,Intermediate,,1,,,
CHEMBL629205,10026,,12969,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,,N,1,Intermediate,,1,,,
CHEMBL629206,10026,,12970,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,,N,1,Intermediate,,1,,,
CHEMBL631185,10026,,12971,,,,22224,,A,,BAO_0000019,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,U,0,Autocuration,,1,,,
CHEMBL631186,7415,,12972,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the average bile flow rat in rats,,,N,1,Intermediate,,1,,,
CHEMBL631187,17025,,12973,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,N,1,Intermediate,,1,,,
CHEMBL631188,17025,,12974,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,N,1,Intermediate,,1,,,
CHEMBL876419,10184,,12975,,,,22224,,A,,BAO_0000019,Average half life period was determined,,,U,0,Autocuration,,1,,,
CHEMBL631189,10184,,12976,,,,22224,,A,,BAO_0000019,Average half life period was determined,,,U,0,Autocuration,,1,,,
CHEMBL631190,8613,,12977,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL631191,8613,,12978,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL631192,8613,,12979,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL632400,8613,,12980,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL630564,8613,,12981,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL630565,8613,,12982,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL630566,8613,,12983,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL631229,8613,,12984,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL631230,8613,,12985,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL876428,6030,,12986,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631231,6147,,12987,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631232,14556,,12988,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (MacLogP),,,U,0,Autocuration,,1,,,
CHEMBL631233,768,,12989,,,,22224,,A,,BAO_0000019,Hydrophilicity was determined,,,U,0,Autocuration,,1,,,
CHEMBL631234,14452,,12990,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL883126,5237,,12991,,,,22224,,A,,BAO_0000019,Increased absorption was determined,,,U,0,Autocuration,,1,,,
CHEMBL631235,14378,,12992,,,,22224,,P,,BAO_0000100,Lipophilicity value was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL631236,14418,,12993,,,,22224,,P,,BAO_0000100,Log P value of the compound.,,,U,0,Autocuration,,1,,,
CHEMBL631237,5249,,12994,,,,22224,,A,,BAO_0000019,Partition coefficient of compound was determined,,,U,0,Autocuration,,1,,,
CHEMBL631238,14621,,12995,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL876429,12542,,12996,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631414,12542,,12997,,,,22224,,A,,BAO_0000019,Partition coefficient was measured by medchem software; Not calculated,,,U,0,Autocuration,,1,,,
CHEMBL631415,12542,,12998,,,,22224,,P,,BAO_0000100,Partition coefficient was measured by octanol-water using standard shake-flask method,,,U,0,Autocuration,,1,,,
CHEMBL631416,15462,,12999,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631417,14884,,13000,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL631418,16526,,13001,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631419,13693,,13002,,,,22229,,P,,BAO_0000100,The Octanol/Water partition coefficient CLogP,,,U,0,Autocuration,,1,,,
CHEMBL631420,13693,,13003,,,,22224,,A,,BAO_0000019,The pharmacokinetic parameter C Log p was reported,,,U,0,Autocuration,,1,,,
CHEMBL631421,13779,,13004,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631422,14772,,13005,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL631423,14393,,13006,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL876430,14793,,13007,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631424,14793,,13008,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631425,13744,,13009,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was administered intravenously in dog to evaluate plasma clearance values,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631426,13744,,13010,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Compound was administered intravenously in monkey to evaluate plasma clearance values,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL631427,13744,,13011,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Compound was administered intravenously in mouse to evaluate plasma clearance values,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631428,13207,,13012,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631429,5669,,13013,,9544.0,In vitro,50797,,A,Macaca mulatta,BAO_0000218,Intrinsic clearance in Rhesus liver microsome,,,N,1,Intermediate,Liver,1,,2107.0,Microsomes
CHEMBL631430,5669,,13014,,9615.0,In vitro,50588,,A,Canis lupus familiaris,BAO_0000218,Intrinsic clearance in dog liver microsome,,,N,1,Intermediate,Liver,1,,2107.0,Microsomes
CHEMBL631431,5669,,13015,,10116.0,In vitro,50597,,A,Rattus norvegicus,BAO_0000218,Intrinsic clearance in rat liver microsome,,,N,1,Intermediate,Liver,1,,2107.0,Microsomes
CHEMBL631432,4853,,13016,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Low plasma clearance was calculated in rhesus monkey,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL631433,16452,,13017,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,,N,1,Intermediate,,1,,,
CHEMBL631434,11954,,13018,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance after intravenous dose of 0.3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL631435,11954,,13019,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance after intravenous dose of 1 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL631436,11954,,13020,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance after intravenous dose of 3 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL631437,11954,,13021,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance after intravenous dose of 3.87 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL631438,5669,,13022,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL876431,5669,,13023,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in Rhesus,,,N,1,Intermediate,,1,,,
CHEMBL631439,5669,,13024,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in dog,,,N,1,Intermediate,,1,,,
CHEMBL631440,13662,,13025,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,,N,1,Intermediate,,1,,,
CHEMBL631441,8272,,13026,,,,22224,,A,,BAO_0000019,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,U,0,Autocuration,,1,,,
CHEMBL631442,13410,,13027,,,,22224,,A,,BAO_0000019,Critical Micellar concentration was determined,,,U,0,Autocuration,,1,,,
CHEMBL626525,13410,,13028,,,,22224,,A,,BAO_0000019,Critical Micellar concentration of the compound. was determined,,,U,0,Autocuration,,1,,,
CHEMBL627168,12628,,13029,,,,22224,,A,,BAO_0000019,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,U,0,Autocuration,,1,,,
CHEMBL875618,9675,,13030,,,,22224,,A,,BAO_0000019,Critical micellar concentration was measured in water by the dye solubilization method,,,U,0,Autocuration,,1,,,
CHEMBL626612,12628,,13031,,,,22224,,B,,BAO_0000019,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,U,0,Autocuration,,1,,,
CHEMBL626613,12766,,13032,,,,22224,,A,,BAO_0000019,CMR value (relative to BAY K 8644),,,U,0,Autocuration,,1,,,
CHEMBL626614,7849,,13033,,,,22224,,A,,BAO_0000019,Carbamoylating activity was determined,,,U,0,Autocuration,,1,,,
CHEMBL626615,12187,,13034,,314293.0,,22224,,A,Simiiformes,BAO_0000218,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,,U,0,Autocuration,,1,,,
CHEMBL626616,2040,,13035,,,,22224,,A,,BAO_0000019,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,U,0,Autocuration,,1,,,
CHEMBL626617,2040,,13036,,,,22224,,A,,BAO_0000019,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,U,0,Autocuration,,1,,,
CHEMBL626618,14180,,13037,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626619,14180,,13038,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626620,14474,,13039,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,"Clearance rate at 0.46 mg/kg, iv, in dogs",,,N,1,Intermediate,,1,,,
CHEMBL626621,14474,,13040,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Clearance rate at 5.5 mg/kg, iv, in rat",,,N,1,Intermediate,,1,,,
CHEMBL626622,14548,,13041,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL626623,14548,,13042,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL626624,14548,,13043,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL626625,14548,,13044,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL626626,6125,,13045,,10116.0,Ex vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL626627,6874,,13046,,,In vivo,22224,,A,,BAO_0000218,Tested for the total clearance of the compound,,,U,0,Autocuration,,1,,,
CHEMBL626628,15343,,13047,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL626629,6236,,13048,,,In vivo,22224,,A,,BAO_0000218,Total body clearance was determined,,,U,0,Autocuration,,1,,,
CHEMBL626630,11510,,13049,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626631,11510,,13050,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626632,8194,,13051,,,,22229,,P,,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626633,8194,,13052,,,,22229,,P,,BAO_0000100,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626634,8194,,13053,,,,22229,,P,,BAO_0000100,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626635,8194,,13054,,,,22229,,P,,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL626636,8194,,13055,,,,22229,,P,,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626637,8194,,13056,,,,22229,,P,,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,U,0,Autocuration,,1,,,
CHEMBL626638,13273,,13057,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,,N,1,Intermediate,,1,,,
CHEMBL626639,13273,,13058,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,,N,1,Intermediate,,1,,,
CHEMBL626640,13273,,13059,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,,N,1,Intermediate,,1,,,
CHEMBL626641,13273,,13060,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,,N,1,Intermediate,,1,,,
CHEMBL627272,13273,,13061,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,,N,1,Intermediate,,1,,,
CHEMBL627273,13273,,13062,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,,N,1,Intermediate,,1,,,
CHEMBL627441,13273,,13063,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,,N,1,Intermediate,,1,,,
CHEMBL628355,13273,,13064,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,,N,1,Intermediate,,1,,,
CHEMBL628356,13273,,13065,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,,N,1,Intermediate,,1,,,
CHEMBL628357,13273,,13066,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,,N,1,Intermediate,,1,,,
CHEMBL628358,13273,,13067,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,,N,1,Intermediate,,1,,,
CHEMBL622307,13273,,13068,,4754.0,,50339,,A,Pneumocystis carinii,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,,N,1,Intermediate,,1,,,
CHEMBL622527,13118,,13069,,,,22224,,A,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,U,0,Autocuration,,1,,,
CHEMBL622528,13118,,13070,,,,22224,,A,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,U,0,Autocuration,,1,,,
CHEMBL622529,13118,,13071,,,,22224,,A,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,U,0,Autocuration,,1,,,
CHEMBL622992,13118,,13072,,,,22224,,A,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,U,0,Autocuration,,1,,,
CHEMBL622993,13118,,13073,,,,22224,,A,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,U,0,Autocuration,,1,,,
CHEMBL622994,13118,,13074,,,,22224,,A,,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,U,0,Autocuration,,1,,,
CHEMBL622995,10633,,13075,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,,N,1,Intermediate,,1,,,
CHEMBL622996,10633,,13076,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,,N,1,Intermediate,,1,,,
CHEMBL622997,10633,,13077,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,,N,1,Intermediate,,1,,,
CHEMBL622998,10633,,13078,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,,N,1,Intermediate,,1,,,
CHEMBL622999,5767,,13079,,,,22224,,A,,BAO_0000218,Cp max following ip administration at 1 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL623000,3302,,13080,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma was reported at 0.5 hour,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623001,3302,,13081,,,In vivo,22224,,A,,BAO_0000218,Maximum concentration in plasma was reported at 2 hour,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL623002,12467,,13082,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,,N,1,Intermediate,,1,,,
CHEMBL623003,11778,,13083,,,,22229,,P,,BAO_0000100,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,U,0,Autocuration,,1,,,
CHEMBL623004,4321,,13084,,,,22224,,A,,BAO_0000019,Steady state concentration was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL623005,14884,,13085,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL623006,15234,,13086,,,,22224,,A,,BAO_0000019,Partition coefficient (logD7.4),,,U,0,Autocuration,,1,,,
CHEMBL623007,14198,,13087,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623008,14198,,13088,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL876654,14198,,13089,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL623009,14198,,13090,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL623010,14198,,13091,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL623011,14198,,13092,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623012,14198,,13093,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL623013,8151,,13094,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL623014,8151,,13095,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL623015,8151,,13096,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL623016,8151,,13097,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL624858,8151,,13098,,,,22224,,A,,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL624859,8151,,13099,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,,N,1,Intermediate,,1,,,
CHEMBL624860,8151,,13100,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL624861,8151,,13101,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,N,1,Intermediate,,1,,,
CHEMBL624862,8151,,13102,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,N,1,Intermediate,,1,,,
CHEMBL624863,8151,,13103,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,,N,1,Intermediate,,1,,,
CHEMBL876655,8151,,13104,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,N,1,Intermediate,,1,,,
CHEMBL624864,6996,,13105,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,N,1,Intermediate,,1,,,
CHEMBL624865,6996,,13106,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,N,1,Intermediate,,1,,,
CHEMBL624866,6996,,13107,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,N,1,Intermediate,,1,,,
CHEMBL624867,6996,,13108,,9615.0,,50588,,F,Canis lupus familiaris,BAO_0000218,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,,N,1,Expert,,1,,,
CHEMBL624868,6996,,13109,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,N,1,Intermediate,,1,,,
CHEMBL628450,6996,,13110,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,,N,1,Intermediate,,1,,,
CHEMBL628451,6996,,13111,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,N,1,Intermediate,,1,,,
CHEMBL628452,6996,,13112,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,N,1,Intermediate,,1,,,
CHEMBL628453,6996,,13113,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,N,1,Intermediate,,1,,,
CHEMBL628454,6996,,13114,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL628455,6996,,13115,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,N,1,Intermediate,,1,,,
CHEMBL628456,6996,,13116,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,N,1,Intermediate,,1,,,
CHEMBL628457,6996,,13117,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,N,1,Intermediate,,1,,,
CHEMBL877505,6996,,13118,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,,N,1,Intermediate,,1,,,
CHEMBL628458,6996,,13119,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,,N,1,Intermediate,,1,,,
CHEMBL628459,6996,,13120,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,N,1,Intermediate,,1,,,
CHEMBL628460,6996,,13121,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,N,1,Intermediate,,1,,,
CHEMBL628461,6996,,13122,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,N,1,Intermediate,,1,,,
CHEMBL628462,6996,,13123,,,,22224,,B,,BAO_0000218,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,U,0,Autocuration,,1,,,
CHEMBL628463,6996,,13124,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,N,1,Intermediate,,1,,,
CHEMBL625666,6996,,13125,,10116.0,,50597,,F,Rattus norvegicus,BAO_0000218,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,,N,1,Expert,,1,,,
CHEMBL625667,6996,,13126,,,,22224,,B,,BAO_0000218,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,U,0,Autocuration,,1,,,
CHEMBL625668,6996,,13127,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,N,1,Expert,,1,,,
CHEMBL625669,6996,,13128,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,N,1,Intermediate,,1,,,
CHEMBL625670,7114,,13129,,,,22224,,A,,BAO_0000019,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,U,0,Autocuration,,1,,,
CHEMBL625671,7114,,13130,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,,N,1,Intermediate,,1,,,
CHEMBL625672,8613,,13131,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,,N,1,Intermediate,,1,,,
CHEMBL625673,8613,,13132,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,,N,1,Intermediate,,1,,,
CHEMBL625674,8613,,13133,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,,N,1,Intermediate,,1,,,
CHEMBL625675,8613,,13134,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,,N,1,Intermediate,,1,,,
CHEMBL627637,8613,,13135,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,N,1,Intermediate,,1,,,
CHEMBL627638,8613,,13136,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,,N,1,Intermediate,,1,,,
CHEMBL627639,8613,,13137,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,,N,1,Intermediate,,1,,,
CHEMBL627640,8613,,13138,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,,N,1,Intermediate,,1,,,
CHEMBL627641,8613,,13139,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,,N,1,Intermediate,,1,,,
CHEMBL627642,8613,,13140,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,N,1,Intermediate,,1,,,
CHEMBL877506,8613,,13141,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,N,1,Intermediate,,1,,,
CHEMBL627275,8613,,13142,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,N,1,Intermediate,,1,,,
CHEMBL627643,11219,,13143,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,,N,1,Intermediate,,1,,,
CHEMBL631246,11219,,13144,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,N,1,Intermediate,,1,,,
CHEMBL631247,11219,,13145,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,N,1,Intermediate,,1,,,
CHEMBL629532,11219,,13146,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,N,1,Intermediate,,1,,,
CHEMBL629533,11219,,13147,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,,N,1,Intermediate,,1,,,
CHEMBL629534,11219,,13148,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,N,1,Intermediate,,1,,,
CHEMBL629535,11219,,13149,,9669.0,,50506,,A,Mustela putorius furo,BAO_0000218,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,,N,1,Intermediate,,1,,,
CHEMBL625932,14837,,13150,,,,22224,,A,,BAO_0000019,Pharmacokinetic parameter :drug bound to plasma was reported,,,U,0,Autocuration,,1,,,
CHEMBL625933,14837,,13151,,,,22224,,A,,BAO_0000019,compound was evaluated for drug bound in plasma,,,U,0,Autocuration,,1,,,
CHEMBL625934,15343,,13152,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,,N,1,Intermediate,,1,,,
CHEMBL625935,13761,,13153,,9347.0,,22224,,A,Eutheria,BAO_0000218,Bioavailability,,,U,0,Autocuration,,1,,,
CHEMBL625936,14810,,13154,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,,N,1,Intermediate,,1,,,
CHEMBL625937,14810,,13155,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,,N,1,Intermediate,,1,,,
CHEMBL625938,13249,,13156,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,N,1,Intermediate,,1,,,
CHEMBL625939,9267,,13157,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,,N,1,Intermediate,Bile,1,,1970.0,
CHEMBL625940,9267,,13158,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,,N,1,Intermediate,Bile,1,,1970.0,
CHEMBL874464,9267,,13159,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,,N,1,Intermediate,Bile,1,,1970.0,
CHEMBL625941,9267,,13160,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,,N,1,Intermediate,Bile,1,,1970.0,
CHEMBL625942,9267,,13161,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,,N,1,Intermediate,Bile,1,,1970.0,
CHEMBL625943,9267,,13162,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,,N,1,Intermediate,Bile,1,,1970.0,
CHEMBL625944,15549,,13163,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,In vitro protein binding in human serum at 5 ug/ml,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL625945,10929,,13164,,,,22224,,A,,BAO_0000019,Serum protein binding ability was measured,,,U,0,Autocuration,,1,,,
CHEMBL625946,15444,,13165,,,,22224,,A,,BAO_0000019,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,U,0,Autocuration,,1,,,
CHEMBL625947,12860,,13166,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Oral bioavailability in dog,,,U,0,Autocuration,,1,,,
CHEMBL625948,12170,,13167,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,N,1,Intermediate,,1,,,
CHEMBL625949,15173,,13168,,,In vivo,22224,,A,,BAO_0000218,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625950,15173,,13169,,,In vivo,22224,,A,,BAO_0000218,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL625951,15173,,13170,,9347.0,In vivo,22224,,A,Eutheria,BAO_0000218,Oral bioavailability (dose 15 mg/kg i.v.),,,U,0,Autocuration,,1,,,
CHEMBL625952,15173,,13171,,,In vivo,22224,,A,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,U,0,Autocuration,,1,,,
CHEMBL625953,15173,,13172,,,In vivo,22224,,A,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,U,0,Autocuration,,1,,,
CHEMBL625954,15173,,13173,,,In vivo,22224,,A,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,U,0,Autocuration,,1,,,
CHEMBL882959,15173,,13174,,,In vivo,22224,,A,,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,U,0,Autocuration,,1,,,
CHEMBL625955,11767,,13175,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,,N,1,Intermediate,,1,,,
CHEMBL625956,11219,,13176,,9669.0,In vivo,22224,,A,Mustela putorius furo,BAO_0000218,Bioavailability in ferret,,,U,0,Autocuration,,1,,,
CHEMBL625957,12186,,13177,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,,N,1,Intermediate,,1,,,
CHEMBL625958,11510,,13178,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL625959,11510,,13179,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626642,11510,,13180,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL631330,11510,,13181,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL631331,11510,,13182,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL631332,11510,,13183,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL631333,11510,,13184,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632018,11510,,13185,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632019,11510,,13186,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632020,11510,,13187,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632021,11510,,13188,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632022,11510,,13189,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632023,11510,,13190,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632024,11510,,13191,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL874472,11510,,13192,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632025,11510,,13193,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632026,11510,,13194,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632027,11510,,13195,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL632028,11510,,13196,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626430,11510,,13197,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626431,11510,,13198,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626432,11510,,13199,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626433,11510,,13200,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL626434,11510,,13201,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627280,11510,,13202,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627281,11510,,13203,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627282,11510,,13204,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627283,7199,,13205,,,,22224,,A,,BAO_0000019,Total body clearance was measured at given dose,,,U,0,Autocuration,,1,,,
CHEMBL627284,7199,,13206,,,,22224,,A,,BAO_0000218,Total body clearance was measured at given dose.,,,U,0,Autocuration,,1,,,
CHEMBL627285,7095,,13207,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Metabolic clearance from the body in rat,,,N,1,Intermediate,,1,,,
CHEMBL627286,7095,,13208,,,In vivo,22224,,A,,BAO_0000218,Renal clearance from the body,,,U,0,Autocuration,,1,,,
CHEMBL875477,7095,,13209,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Renal clearance from the body in rat,,,N,1,Intermediate,,1,,,
CHEMBL627287,12528,,13210,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL627288,12528,,13211,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,,N,1,Intermediate,,1,,,
CHEMBL627289,7095,,13212,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total clearance from the body in rat,,,N,1,Intermediate,,1,,,
CHEMBL627290,14223,,13213,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance into cortex from rat plasma or PBS,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627291,13569,,13214,,,In vivo,22224,,A,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL627292,13569,,13215,,,In vivo,22224,,A,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL627293,13569,,13216,,,In vivo,22224,,A,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL627294,13569,,13217,,,In vivo,22224,,A,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL875478,13569,,13218,,,In vivo,22224,,A,,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,U,0,Autocuration,,1,,,
CHEMBL627295,13979,,13219,,,In vivo,22224,,A,,BAO_0000218,Clearance was determined,,,U,0,Autocuration,,1,,,
CHEMBL627296,14315,,13220,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,,N,1,Intermediate,,1,,,
CHEMBL626119,14315,,13221,,9986.0,In vivo,50592,,A,Oryctolagus cuniculus,BAO_0000218,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,,N,1,Intermediate,,1,,,
CHEMBL626120,14315,,13222,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,,N,1,Intermediate,,1,,,
CHEMBL626121,12174,,13223,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance in rat after iv dose (100 ug/kg),,,N,1,Intermediate,,1,,,
CHEMBL626122,12797,,13224,,10141.0,In vivo,22224,,A,Cavia porcellus,BAO_0000218,Clearance in guinea pig,,,U,0,Autocuration,,1,,,
CHEMBL626123,12797,,13225,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL623456,12797,,13226,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for the clearance in dog,,,N,1,Intermediate,,1,,,
CHEMBL623457,12797,,13227,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the clearance in rat,,,N,1,Intermediate,,1,,,
CHEMBL623458,11500,,13228,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested in vivo for clearance after iv administration in the rat,,,N,1,Intermediate,,1,,,
CHEMBL623459,15173,,13229,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an iv dose of 14 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL875484,15173,,13230,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an iv dose of 15.2 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL623460,15173,,13231,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an iv dose of 15 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL623461,15173,,13232,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an peroral dose of 30 mg/kg.,,,U,0,Autocuration,,1,,,
CHEMBL623462,15173,,13233,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,U,0,Autocuration,,1,,,
CHEMBL627386,15173,,13234,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,U,0,Autocuration,,1,,,
CHEMBL627387,14198,,13235,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627388,14198,,13236,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627389,14198,,13237,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627390,14198,,13238,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627391,14198,,13239,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL627392,14198,,13240,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627393,14198,,13241,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627394,14198,,13242,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,,N,1,Intermediate,Trachea,1,,3126.0,
CHEMBL627395,14198,,13243,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL875485,14198,,13244,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL627396,14198,,13245,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627397,14198,,13246,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL627398,14198,,13247,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL627399,14198,,13248,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL627400,14198,,13249,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627401,14198,,13250,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627402,14198,,13251,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627403,14198,,13252,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL627404,14198,,13253,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL623101,14198,,13254,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL877480,14198,,13255,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623102,14198,,13256,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,,N,1,Intermediate,Trachea,1,,3126.0,
CHEMBL623103,14198,,13257,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL623104,14198,,13258,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL623105,14198,,13259,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL623106,14198,,13260,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL623107,14198,,13261,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL623108,14198,,13262,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL623109,14198,,13263,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL623110,14198,,13264,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL623111,14198,,13265,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625060,14198,,13266,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625061,14198,,13267,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625062,14198,,13268,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL625063,14198,,13269,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625064,14198,,13270,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,,N,1,Intermediate,Trachea,1,,3126.0,
CHEMBL625065,14198,,13271,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL625066,14198,,13272,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL625067,14198,,13273,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL625068,14198,,13274,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL622159,14198,,13275,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL622160,14198,,13276,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL622161,14198,,13277,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL622162,14198,,13278,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL622163,14198,,13279,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL622313,14198,,13280,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622314,14198,,13281,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL622315,14198,,13282,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622316,14198,,13283,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,,N,1,Intermediate,Trachea,1,,3126.0,
CHEMBL877486,15599,,13284,,562.0,,50212,,A,Escherichia coli,BAO_0000218,Normal diffusion coefficient in water for Escherichia coli,,,N,1,Intermediate,,1,,,
CHEMBL622317,8204,,13285,,,,22224,,A,,BAO_0000019,Average max percent decrease in RVR (renal vascular resistance) was determined,,,U,0,Autocuration,,1,,,
CHEMBL622318,8204,,13286,,,,22224,,A,,BAO_0000019,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,U,0,Autocuration,,1,,,
CHEMBL622319,6154,,13287,,,,22224,,A,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL622320,6154,,13288,,,,22224,,A,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL622321,6154,,13289,,,,22224,,A,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,U,0,Autocuration,,1,,,
CHEMBL622322,6154,,13290,,,,22224,,A,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL622323,7114,,13291,,,,22224,,A,,BAO_0000019,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,U,0,Autocuration,,1,,,
CHEMBL622324,7114,,13292,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,,N,1,Intermediate,,1,,,
CHEMBL622325,8133,,13293,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622326,8133,,13294,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL877487,8133,,13295,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622327,8133,,13296,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622328,8133,,13297,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622329,8133,,13298,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622330,8133,,13299,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622331,8133,,13300,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622332,8133,,13301,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622333,8133,,13302,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627658,8133,,13303,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630428,8133,,13304,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630429,8133,,13305,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630430,8133,,13306,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630431,8133,,13307,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630432,8133,,13308,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630433,8133,,13309,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630434,8133,,13310,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629372,8133,,13311,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629553,8133,,13312,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629554,8133,,13313,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874447,8133,,13314,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629555,8133,,13315,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629556,8133,,13316,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629557,8133,,13317,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629558,8133,,13318,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629559,8133,,13319,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629560,8133,,13320,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629561,8133,,13321,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629562,8133,,13322,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629563,8133,,13323,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629564,8133,,13324,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629565,8133,,13325,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629566,8133,,13326,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629567,8133,,13327,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629568,8133,,13328,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629569,8133,,13329,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629570,8133,,13330,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629571,8133,,13331,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL629572,12170,,13332,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,U,0,Autocuration,,1,,,
CHEMBL629573,12170,,13333,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,U,0,Autocuration,,1,,,
CHEMBL629574,4985,,13334,,9347.0,In vivo,22224,,A,Eutheria,BAO_0000218,Bioavailability (dose 20 mg/kg),,,U,0,Autocuration,,1,,,
CHEMBL629575,15145,,13335,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Bioavailability in dog,,,U,0,Autocuration,,1,,,
CHEMBL874448,14080,,13336,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male),,,U,0,Autocuration,,1,,,
CHEMBL629576,11219,,13337,,9443.0,In vivo,22224,,A,Primates,BAO_0000218,Bioavailability in monkey (dose 10 mg/kg i.d.),,,U,0,Autocuration,,1,,,
CHEMBL629577,15145,,13338,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL629578,15145,,13339,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL629579,1202,,13340,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Bioavailability in dog (dose 3.0 mg/kg p.o.),,,U,0,Autocuration,,1,,,
CHEMBL882958,1202,,13341,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,,U,0,Autocuration,,1,,,
CHEMBL629580,1202,,13342,,9598.0,In vivo,50505,,A,Pan troglodytes,BAO_0000218,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,,N,1,Intermediate,,1,,,
CHEMBL629581,4026,,13343,,9347.0,In vivo,22224,,A,Eutheria,BAO_0000218,Bioavailability,,,U,0,Autocuration,,1,,,
CHEMBL629582,1492,,13344,,9520.0,In vivo,22224,,A,Saimiri,BAO_0000218,Bioavailability in squirrel monkey,,,U,0,Autocuration,,1,,,
CHEMBL628522,12793,,13345,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Bioavailability was evaluated in dog,,,N,1,Intermediate,,1,,,
CHEMBL625432,12793,,13346,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Bioavailability was evaluated in hamster,,,N,1,Intermediate,,1,,,
CHEMBL625433,12793,,13347,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat,,,U,0,Autocuration,,1,,,
CHEMBL625434,14793,,13348,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625435,14793,,13349,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL625436,14793,,13350,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 10 mg/kg p.o.),,,U,0,Autocuration,,1,,,
CHEMBL874588,14731,,13351,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Bioavailability was measured in cynomolgus monkeys.,,,N,1,Intermediate,,1,,,
CHEMBL625437,14731,,13352,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Bioavailability was measured in nude mice.,,,N,1,Intermediate,,1,,,
CHEMBL625438,12187,,13353,,9669.0,In vivo,22224,,A,Mustela putorius furo,BAO_0000218,Bioavailability in ferret (dose 10 mg/kg i.d.),,,U,0,Autocuration,,1,,,
CHEMBL625439,12187,,13354,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,,U,0,Autocuration,,1,,,
CHEMBL625440,12187,,13355,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,,U,0,Autocuration,,1,,,
CHEMBL625441,12187,,13356,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,,U,0,Autocuration,,1,,,
CHEMBL625442,12187,,13357,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Bioavailability in rat (dose 10 mg/kg i.d.),,,U,0,Autocuration,,1,,,
CHEMBL625443,12187,,13358,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,N,1,Intermediate,,1,,,
CHEMBL625444,17431,,13359,,,In vivo,22224,,A,,BAO_0000218,Bioavailability was determined; extremely poor,,,U,0,Autocuration,,1,,,
CHEMBL625445,13318,,13360,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,% bioavailability in mice after oral administration of prodrug,,,N,1,Intermediate,,1,,,
CHEMBL625446,9025,,13361,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,,N,1,Intermediate,,1,,,
CHEMBL882960,9025,,13362,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,,N,1,Intermediate,,1,,,
CHEMBL625447,9025,,13363,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,,N,1,Intermediate,,1,,,
CHEMBL625448,9025,,13364,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,,N,1,Intermediate,,1,,,
CHEMBL625449,9025,,13365,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,,N,1,Intermediate,,1,,,
CHEMBL874589,9025,,13366,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,,N,1,Intermediate,,1,,,
CHEMBL625450,9025,,13367,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,,N,1,Intermediate,,1,,,
CHEMBL625451,9025,,13368,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,,N,1,Intermediate,,1,,,
CHEMBL626584,9025,,13369,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,,N,1,Intermediate,,1,,,
CHEMBL626585,9025,,13370,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,,N,1,Intermediate,,1,,,
CHEMBL626586,9025,,13371,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,,N,1,Intermediate,,1,,,
CHEMBL626587,9025,,13372,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,,N,1,Intermediate,,1,,,
CHEMBL626588,9025,,13373,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,,N,1,Intermediate,,1,,,
CHEMBL626589,9025,,13374,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,,N,1,Intermediate,,1,,,
CHEMBL626590,9025,,13375,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,,N,1,Intermediate,,1,,,
CHEMBL626591,9025,,13376,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,,N,1,Intermediate,,1,,,
CHEMBL627181,9025,,13377,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,,N,1,Intermediate,,1,,,
CHEMBL628083,9025,,13378,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,,N,1,Intermediate,,1,,,
CHEMBL628084,15173,,13379,,,In vivo,22224,,A,,BAO_0000218,IV clearance determined at an peroral dose of 15 mg/kg.,,,U,0,Autocuration,,1,,,
CHEMBL628085,7732,,13380,,102285.0,In vivo,50064,,F,Hymenolepis nana,BAO_0000218,Mouse oral clearance was measured against Hymenolepiasis nana.,,,N,1,Expert,,1,,,
CHEMBL628086,7732,,13381,,6339.0,In vivo,50545,,F,Heligmosomoides polygyrus,BAO_0000218,Mouse oral clearance was measured against Nematospiroides dubius,,,N,1,Expert,,1,,,
CHEMBL628087,7732,,13382,,,In vivo,22224,,F,,BAO_0000218,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,U,0,Autocuration,,1,,,
CHEMBL628088,7732,,13383,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,N,1,Intermediate,,1,,,
CHEMBL628089,7732,,13384,,,In vivo,22224,,B,,BAO_0000218,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,U,0,Autocuration,,1,,,
CHEMBL628090,8328,,13385,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL628091,8328,,13386,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL628092,8328,,13387,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL628093,8328,,13388,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL875607,8328,,13389,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL625710,8328,,13390,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL625711,8328,,13391,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL625712,8328,,13392,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL625713,8328,,13393,,,In vivo,22224,,A,,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,U,0,Autocuration,,1,,,
CHEMBL625714,13376,,13394,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL625715,13477,,13395,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,,N,1,Intermediate,,1,,,
CHEMBL625716,13477,,13396,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,,N,1,Intermediate,,1,,,
CHEMBL625717,13477,,13397,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,,N,1,Intermediate,,1,,,
CHEMBL625718,13313,,13398,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance was determined for the compound in rats,,,N,1,Intermediate,,1,,,
CHEMBL625719,12504,,13399,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,,N,1,Intermediate,,1,,,
CHEMBL625720,12504,,13400,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,,N,1,Intermediate,,1,,,
CHEMBL625721,12504,,13401,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,,N,1,Intermediate,,1,,,
CHEMBL625722,12504,,13402,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,,N,1,Intermediate,,1,,,
CHEMBL625723,13129,,13403,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,,N,1,Intermediate,,1,,,
CHEMBL625724,7732,,13404,,6339.0,In vivo,50545,,A,Heligmosomoides polygyrus,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,,N,1,Intermediate,,1,,,
CHEMBL625725,7732,,13405,,6339.0,In vivo,50545,,A,Heligmosomoides polygyrus,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,,N,1,Intermediate,,1,,,
CHEMBL625726,7732,,13406,,6339.0,In vivo,50545,,A,Heligmosomoides polygyrus,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,,N,1,Intermediate,,1,,,
CHEMBL875608,7732,,13407,,6339.0,In vivo,50545,,A,Heligmosomoides polygyrus,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,,N,1,Intermediate,,1,,,
CHEMBL625727,7732,,13408,,6339.0,In vivo,50545,,A,Heligmosomoides polygyrus,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,,N,1,Intermediate,,1,,,
CHEMBL625728,9278,,13409,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL625729,9278,,13410,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,U,0,Autocuration,,1,,,
CHEMBL625730,9278,,13411,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,,U,0,Autocuration,,1,,,
CHEMBL625731,9278,,13412,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL626417,9278,,13413,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Urinary clearance was determined in rat at 25 mg/kg os dosage,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL626418,9278,,13414,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,Urinary clearance was determined at 100 mg/kg oral dosage in human,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626419,9278,,13415,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626592,5932,,13416,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626593,5932,,13417,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626594,5182,,13418,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,N,1,Intermediate,,1,,,
CHEMBL625035,10499,,13419,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Clearance rate in dogs,,,N,1,Intermediate,,1,,,
CHEMBL625036,6051,,13420,,,In vitro,22224,,A,,BAO_0000019,Compound was measured for intrinsic clearance,,,U,0,Autocuration,,1,,,
CHEMBL625037,17508,,13421,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625038,6228,,13422,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625039,6231,,13423,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625040,17740,,13424,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625041,6495,,13425,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625042,2171,,13426,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL874411,3255,,13427,,,,22224,,A,,BAO_0000019,Partition coefficient of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625043,6821,,13428,,,,22224,,A,,BAO_0000019,Permeability,,,U,0,Autocuration,,1,,,
CHEMBL625044,2685,,13429,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625045,17584,,13430,,,,22224,,A,,BAO_0000019,Partition coefficient (logD),,,U,0,Autocuration,,1,,,
CHEMBL625046,13824,,13431,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,U,0,Autocuration,,1,,,
CHEMBL625047,13824,,13432,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,U,0,Autocuration,,1,,,
CHEMBL625048,16479,,13433,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625049,11997,,13434,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625050,2988,,13435,,,,22229,,P,,BAO_0000100,Calculated logarithm of partition coefficient (P) was determined,,,U,0,Autocuration,,1,,,
CHEMBL625051,931,,13436,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL874412,4381,,13437,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625052,4397,,13438,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL625053,5889,,13439,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL623250,6154,,13440,,,,22224,,A,,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL623251,6154,,13441,,,,22224,,A,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL623252,6154,,13442,,,,22224,,A,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL623253,6154,,13443,,,,22224,,A,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,U,0,Autocuration,,1,,,
CHEMBL623254,6154,,13444,,,,22224,,A,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL623255,6154,,13445,,,,22224,,A,,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,U,0,Autocuration,,1,,,
CHEMBL626831,6887,,13446,,,,22224,,A,,BAO_0000019,Percent degradation of compound at a pH of 1 over a 18 hr period,,,U,0,Autocuration,,1,,,
CHEMBL877494,6887,,13447,,,,22224,,A,,BAO_0000019,Percent degradation of compound at pH of 1 over an 18 hr period,,,U,0,Autocuration,,1,,,
CHEMBL626832,14116,,13448,,,,22224,,A,,BAO_0000019,Delta Logarithm of Partition Coefficient value was determined.,,,U,0,Autocuration,,1,,,
CHEMBL626833,11137,,13449,,,,22224,,A,,BAO_0000019,Delta logPoct-cyc,,,U,0,Autocuration,,1,,,
CHEMBL626834,7230,,13450,,,,22224,,P,,BAO_0000100,Lipophilicity estimated on reversed phase TLC,,,U,0,Autocuration,,1,,,
CHEMBL626835,15741,,13451,,,,22224,,A,,BAO_0000019,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,U,0,Autocuration,,1,,,
CHEMBL626836,9663,,13452,,,,22224,,A,,BAO_0000019,Delta logPoct-cyc,,,U,0,Autocuration,,1,,,
CHEMBL626837,9663,,13453,,,,22229,,P,,BAO_0000100,Change in logarithm of partition coefficient of the compound,,,U,0,Autocuration,,1,,,
CHEMBL626838,13807,,13454,,,,22224,,A,,BAO_0000019,Delta logD (pH 6.5),,,U,0,Autocuration,,1,,,
CHEMBL626839,13807,,13455,,,,22224,,P,,BAO_0000100,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,U,0,Autocuration,,1,,,
CHEMBL626840,17425,,13456,,,,22224,,A,,BAO_0000019,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,U,0,Autocuration,,1,,,
CHEMBL626841,12143,,13457,,,,22224,,A,,BAO_0000019,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,U,0,Autocuration,,1,,,
CHEMBL626842,12608,,13458,,,,22224,,A,,BAO_0000219,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,U,0,Autocuration,,1,,,
CHEMBL626843,12608,,13459,,,,22224,,A,,BAO_0000219,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,U,0,Autocuration,,1,,,
CHEMBL626844,8649,,13460,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,,N,1,Intermediate,,1,,,
CHEMBL877495,8649,,13461,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of deuterium retained was reported after normal workup in rats,,,N,1,Intermediate,,1,,,
CHEMBL626845,8649,,13462,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,,N,1,Intermediate,,1,,,
CHEMBL626846,8649,,13463,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,,N,1,Intermediate,,1,,,
CHEMBL626847,8649,,13464,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,N,1,Intermediate,,1,,,
CHEMBL628677,8649,,13465,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,N,1,Intermediate,,1,,,
CHEMBL628678,8649,,13466,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,,N,1,Intermediate,,1,,,
CHEMBL628679,9659,,13467,,,,22224,,A,,BAO_0000019,Compound was subjected to electrochemical oxidation,,,U,0,Autocuration,,1,,,
CHEMBL628680,9659,,13468,,,,22224,,A,,BAO_0000019,Compound was subjected to photochemical oxidation,,,U,0,Autocuration,,1,,,
CHEMBL628681,9659,,13469,,,,22224,,A,,BAO_0000019,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,U,0,Autocuration,,1,,,
CHEMBL628682,9659,,13470,,,,22224,,A,,BAO_0000019,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,U,0,Autocuration,,1,,,
CHEMBL628683,9659,,13471,,,,22224,,A,,BAO_0000019,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,U,0,Autocuration,,1,,,
CHEMBL628684,9607,,13472,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent diffusion through fuzzy rat skin after 48 h of incubation,,,N,1,Intermediate,,1,,,
CHEMBL877501,7057,,13473,,,,22229,,P,,BAO_0000100,Dissociation constant (pKa),,,U,0,Autocuration,,1,,,
CHEMBL628685,7057,,13474,,,,22224,,P,,BAO_0000100,Dissociation constant value of the compound; ND means not determined.,,,U,0,Autocuration,,1,,,
CHEMBL628686,7911,,13475,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628687,7911,,13476,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL628688,7911,,13477,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,,N,1,Intermediate,,1,,,
CHEMBL628689,7911,,13478,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,N,1,Intermediate,,1,,,
CHEMBL628690,7911,,13479,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL629363,7911,,13480,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL629364,7911,,13481,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL629365,7911,,13482,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL629366,7911,,13483,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,,N,1,Intermediate,,1,,,
CHEMBL629367,7911,,13484,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629368,7911,,13485,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL877502,7911,,13486,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629369,13792,,13487,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL629370,13792,,13488,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL629371,8133,,13489,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL626276,8133,,13490,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL626277,8133,,13491,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL631250,8133,,13492,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL631251,8133,,13493,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631252,8133,,13494,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631253,8133,,13495,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631254,8133,,13496,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631255,8133,,13497,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631256,8133,,13498,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631257,8133,,13499,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628009,8133,,13500,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628010,8133,,13501,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628011,8133,,13502,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628012,8133,,13503,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628013,8133,,13504,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628014,8133,,13505,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628015,8133,,13506,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628016,8133,,13507,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874461,8133,,13508,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628017,8133,,13509,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628018,8133,,13510,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628019,8133,,13511,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628020,8133,,13512,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628021,8133,,13513,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628022,8133,,13514,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628023,8133,,13515,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628024,8133,,13516,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL628025,8133,,13517,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL628026,8133,,13518,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL628027,8133,,13519,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL628028,8133,,13520,,314293.0,,22224,,A,Simiiformes,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL628029,8133,,13521,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628030,8133,,13522,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628031,8133,,13523,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628032,8133,,13524,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628033,8133,,13525,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628034,8133,,13526,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628035,8133,,13527,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628036,8133,,13528,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874462,8133,,13529,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628037,9025,,13530,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,,N,1,Intermediate,,1,,,
CHEMBL628123,9025,,13531,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,,N,1,Intermediate,,1,,,
CHEMBL628124,9025,,13532,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,,N,1,Intermediate,,1,,,
CHEMBL628125,9025,,13533,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,,N,1,Intermediate,,1,,,
CHEMBL628126,9025,,13534,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,,N,1,Intermediate,,1,,,
CHEMBL628127,9025,,13535,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,,N,1,Intermediate,,1,,,
CHEMBL628128,9025,,13536,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,,N,1,Intermediate,,1,,,
CHEMBL628129,9025,,13537,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,,N,1,Intermediate,,1,,,
CHEMBL628130,9025,,13538,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,,N,1,Intermediate,,1,,,
CHEMBL628131,9025,,13539,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,,N,1,Intermediate,,1,,,
CHEMBL628132,9025,,13540,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,,N,1,Intermediate,,1,,,
CHEMBL628133,9025,,13541,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,,N,1,Intermediate,,1,,,
CHEMBL628134,9025,,13542,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,,N,1,Intermediate,,1,,,
CHEMBL628135,9025,,13543,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,,N,1,Intermediate,,1,,,
CHEMBL628136,9025,,13544,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,,N,1,Intermediate,,1,,,
CHEMBL628137,9025,,13545,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,,N,1,Intermediate,,1,,,
CHEMBL628138,9025,,13546,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,,N,1,Intermediate,,1,,,
CHEMBL628139,9025,,13547,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,,N,1,Intermediate,,1,,,
CHEMBL628140,9025,,13548,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,,N,1,Intermediate,,1,,,
CHEMBL628141,9025,,13549,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,,N,1,Intermediate,,1,,,
CHEMBL628142,9025,,13550,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,,N,1,Intermediate,,1,,,
CHEMBL628143,9025,,13551,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,,N,1,Intermediate,,1,,,
CHEMBL628144,9025,,13552,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,,N,1,Intermediate,,1,,,
CHEMBL628145,9025,,13553,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,,N,1,Intermediate,,1,,,
CHEMBL628146,9025,,13554,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,,N,1,Intermediate,,1,,,
CHEMBL625355,9025,,13555,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,,N,1,Intermediate,,1,,,
CHEMBL625356,9025,,13556,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,,N,1,Intermediate,,1,,,
CHEMBL625357,9025,,13557,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,,N,1,Intermediate,,1,,,
CHEMBL625527,9025,,13558,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,,N,1,Intermediate,,1,,,
CHEMBL875473,9025,,13559,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,,N,1,Intermediate,,1,,,
CHEMBL625528,9025,,13560,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,,N,1,Intermediate,,1,,,
CHEMBL626304,9025,,13561,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,,N,1,Intermediate,,1,,,
CHEMBL624138,9025,,13562,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,,N,1,Intermediate,Artery,1,,1637.0,
CHEMBL624139,6448,,13563,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624140,17221,,13564,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624141,6545,,13565,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624142,577,,13566,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624143,6285,,13567,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624144,6500,,13568,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624145,6716,,13569,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624146,13658,,13570,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624147,6549,,13571,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL883123,14685,,13572,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (MacLogP),,,U,0,Autocuration,,1,,,
CHEMBL624148,6893,,13573,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL874416,3687,,13574,,,,22224,,A,,BAO_0000019,Kinetic parameter was determined,,,U,0,Autocuration,,1,,,
CHEMBL624149,4207,,13575,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624150,4626,,13576,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL624151,1021,,13577,,,,22224,,P,,BAO_0000100,Lipophilicity was determined,,,U,0,Autocuration,,1,,,
CHEMBL624152,3777,,13578,,,,22224,,P,,BAO_0000100,Lipophilicity was determined,,,U,0,Autocuration,,1,,,
CHEMBL622139,17533,,13579,,,,22224,,P,,BAO_0000100,Lipophilicity was determined,,,U,0,Autocuration,,1,,,
CHEMBL622140,6524,,13580,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL622141,17533,,13581,,,,22224,,P,,BAO_0000100,Lipophilicity was determined,,,U,0,Autocuration,,1,,,
CHEMBL622142,6480,,13582,,,,22224,,P,,BAO_0000100,Lipophilicity in octanol-water,,,U,0,Autocuration,,1,,,
CHEMBL622143,17606,,13583,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL622144,6863,,13584,,,,22229,,P,,BAO_0000100,Octanol-water partition coefficient was determined,,,U,0,Autocuration,,1,,,
CHEMBL877473,1356,,13585,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL622145,3326,,13586,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL622146,1356,,13587,,,,22224,,A,,BAO_0000019,Partition coefficient was determined; ND means not determined,,,U,0,Autocuration,,1,,,
CHEMBL622147,12984,,13588,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP),,,U,0,Autocuration,,1,,,
CHEMBL622148,17363,,13589,,,,22224,,A,,BAO_0000019,Partition coefficient of the compound,,,U,0,Autocuration,,1,,,
CHEMBL883124,6827,,13590,,,,22224,,A,,BAO_0000019,Permeability was determined,,,U,0,Autocuration,,1,,,
CHEMBL622149,261,,13591,,,,22229,,P,,BAO_0000100,The compound was evaluated for the partition coefficient,,,U,0,Autocuration,,1,,,
CHEMBL622150,2685,,13592,,,,22224,,A,,BAO_0000019,Partition coefficient (logP),,,U,0,Autocuration,,1,,,
CHEMBL622151,414,,13593,,,,22224,,P,,BAO_0000100,The lipophilicity was reported,,,U,0,Autocuration,,1,,,
CHEMBL622152,15769,,13594,,,,22229,,P,,BAO_0000100,logarithm of the octanol-water partition coefficient for the compound,,,U,0,Autocuration,,1,,,
CHEMBL622153,17248,,13595,,,,22224,,A,,BAO_0000019,Clogp value was determined,,,U,0,Autocuration,,1,,,
CHEMBL877474,16935,,13596,,,In vivo,22224,,A,,BAO_0000218,Clp at a dose of 1.5 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL622154,16935,,13597,,,In vivo,22224,,A,,BAO_0000218,Clp at a dose of 2.0 mg/kg,,,U,0,Autocuration,,1,,,
CHEMBL622155,14832,,13598,,,In vivo,22224,,A,,BAO_0000218,"Clp, plasma clearance at a dose of 10 mg/kg",,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL622156,14832,,13599,,,In vivo,22224,,A,,BAO_0000218,"Clp, plasma clearance at a dose of 50 mg/kg",,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL622157,2399,,13600,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma clearance in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622158,2399,,13601,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for plasma clearance in rat; Not determined,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622807,6227,,13602,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622808,6227,,13603,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL622809,5623,,13604,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,U,0,Autocuration,,1,,,
CHEMBL622810,4854,,13605,,,In vivo,22224,,A,,BAO_0000218,Plasma clearance determined,,,U,0,Autocuration,,1,,,
CHEMBL876653,4493,,13606,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Plasma clearance after iv administration at 3 mg/kg in hamster,,,N,1,Intermediate,,1,,,
CHEMBL622811,4493,,13607,,10026.0,In vivo,100712,,A,Cricetinae,BAO_0000218,Plasma clearance after iv administration at 4 mg/kg in hamster,,,N,1,Intermediate,,1,,,
CHEMBL622986,14956,,13608,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Rate of clearance in rat was determined,,,N,1,Intermediate,,1,,,
CHEMBL622987,15372,,13609,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622988,15372,,13610,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622989,15372,,13611,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622990,15372,,13612,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622991,15604,,13613,,314293.0,In vivo,22224,,A,Simiiformes,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,U,0,Autocuration,Plasma,1,,1969.0,
CHEMBL622227,15604,,13614,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622228,15604,,13615,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL622229,14964,,13616,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Clpl value in rat,,,N,1,Intermediate,,1,,,
CHEMBL622230,15240,,13617,,10141.0,In vivo,50512,,A,Cavia porcellus,BAO_0000218,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,,N,1,Intermediate,,1,,,
CHEMBL622231,16449,,13618,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,,N,1,Intermediate,,1,,,
CHEMBL622232,16449,,13619,,9541.0,In vivo,100710,,A,Macaca fascicularis,BAO_0000218,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,,N,1,Intermediate,,1,,,
CHEMBL622233,12902,,13620,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622234,12902,,13621,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622235,12902,,13622,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622236,12902,,13623,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622237,12902,,13624,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL877482,12902,,13625,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622238,12902,,13626,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622239,12902,,13627,,,In vivo,22224,,A,,BAO_0000218,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,U,0,Autocuration,,1,,,
CHEMBL622240,11149,,13628,,,In vivo,22224,,A,,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL622241,11149,,13629,,,In vivo,22224,,A,,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL631013,5669,,13630,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL631014,5669,,13631,,9544.0,In vivo,50797,,A,Macaca mulatta,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in Rhesus,,,N,1,Intermediate,,1,,,
CHEMBL631015,5669,,13632,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in dog,,,N,1,Intermediate,,1,,,
CHEMBL631016,5669,,13633,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was determine after peroral administration at 160 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL631017,5669,,13634,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was determine after peroral administration at 20 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL631018,5669,,13635,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Cmax was determine after peroral administration at 50 mpk in Rat,,,N,1,Intermediate,,1,,,
CHEMBL631019,4236,,13636,,,In vivo,22224,,A,,BAO_0000218,Cmax was determined,,,U,0,Autocuration,,1,,,
CHEMBL875761,13792,,13637,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL631020,13792,,13638,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL631669,13792,,13639,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL631670,13792,,13640,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL631671,13792,,13641,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL631672,8418,,13642,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631673,8418,,13643,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631856,8418,,13644,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631857,8418,,13645,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631858,8418,,13646,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631859,8418,,13647,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631860,8418,,13648,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631861,8418,,13649,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631862,8418,,13650,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631863,8418,,13651,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631864,8418,,13652,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631865,8418,,13653,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631866,8418,,13654,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629360,8418,,13655,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629361,8418,,13656,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL629362,8418,,13657,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630740,8418,,13658,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630741,8418,,13659,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630742,8418,,13660,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630743,8418,,13661,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,,N,1,Intermediate,,1,,,
CHEMBL630744,8418,,13662,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,,N,1,Intermediate,,1,,,
CHEMBL630745,8418,,13663,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,,N,1,Intermediate,,1,,,
CHEMBL630746,8418,,13664,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,,N,1,Intermediate,,1,,,
CHEMBL630747,8418,,13665,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,,N,1,Intermediate,,1,,,
CHEMBL630748,8418,,13666,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,,N,1,Intermediate,,1,,,
CHEMBL632056,8418,,13667,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,,N,1,Intermediate,,1,,,
CHEMBL632057,8418,,13668,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,,N,1,Intermediate,,1,,,
CHEMBL632058,8418,,13669,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,,N,1,Intermediate,,1,,,
CHEMBL632059,8418,,13670,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,,N,1,Intermediate,,1,,,
CHEMBL632060,8418,,13671,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,,N,1,Intermediate,,1,,,
CHEMBL632061,8418,,13672,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,,N,1,Intermediate,,1,,,
CHEMBL629207,8418,,13673,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,,N,1,Intermediate,,1,,,
CHEMBL629208,8418,,13674,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,,N,1,Intermediate,,1,,,
CHEMBL629209,8418,,13675,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,,N,1,Intermediate,,1,,,
CHEMBL629210,8418,,13676,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,,N,1,Intermediate,,1,,,
CHEMBL629211,8418,,13677,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,,N,1,Intermediate,,1,,,
CHEMBL629212,8418,,13678,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,,N,1,Intermediate,,1,,,
CHEMBL629213,8418,,13679,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,,N,1,Intermediate,,1,,,
CHEMBL629214,8133,,13680,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629215,8133,,13681,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL635154,8133,,13682,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629216,6996,,13683,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL629217,6996,,13684,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL629218,6996,,13685,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL629219,6996,,13686,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL629220,6996,,13687,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL629221,6996,,13688,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL631127,6996,,13689,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631128,6996,,13690,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL631129,6996,,13691,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631130,6996,,13692,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631131,6996,,13693,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631132,6996,,13694,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL631133,6996,,13695,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631134,6996,,13696,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL875120,6996,,13697,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631135,6996,,13698,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631136,6996,,13699,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631137,6996,,13700,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL631138,6996,,13701,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631139,6996,,13702,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL631140,6996,,13703,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631141,6996,,13704,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631142,6996,,13705,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631143,6996,,13706,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,N,1,Intermediate,,1,,,
CHEMBL631144,6996,,13707,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,N,1,Intermediate,,1,,,
CHEMBL631145,6996,,13708,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL631146,6996,,13709,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631147,6996,,13710,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL631148,6996,,13711,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631149,6996,,13712,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631150,6996,,13713,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631151,6996,,13714,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631152,6996,,13715,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631443,6996,,13716,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631444,6996,,13717,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631445,6996,,13718,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631446,6996,,13719,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,N,1,Intermediate,,1,,,
CHEMBL631447,6996,,13720,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631448,6996,,13721,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL631449,6996,,13722,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,,N,1,Intermediate,,1,,,
CHEMBL631450,6996,,13723,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,N,1,Intermediate,,1,,,
CHEMBL629724,6996,,13724,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,N,1,Intermediate,,1,,,
CHEMBL629725,9716,,13725,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL629726,9716,,13726,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL629727,9716,,13727,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630404,9716,,13728,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630405,9716,,13729,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630406,9716,,13730,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630407,9716,,13731,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL630573,9716,,13732,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL630574,9716,,13733,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL630575,9716,,13734,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL630576,9716,,13735,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,,1,,,
CHEMBL630577,9716,,13736,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,,1,,,
CHEMBL630578,9716,,13737,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,,1,,,
CHEMBL630579,9716,,13738,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,N,1,Intermediate,,1,,,
CHEMBL630580,12192,,13739,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630581,12192,,13740,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630582,12192,,13741,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630583,12192,,13742,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,,N,1,Intermediate,,1,,,
CHEMBL630584,12192,,13743,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,,N,1,Intermediate,,1,,,
CHEMBL630585,12192,,13744,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,,N,1,Intermediate,,1,,,
CHEMBL630586,12192,,13745,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,,N,1,Intermediate,,1,,,
CHEMBL630587,12192,,13746,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,,N,1,Intermediate,,1,,,
CHEMBL630588,12192,,13747,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,,N,1,Intermediate,,1,,,
CHEMBL630589,12192,,13748,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,,N,1,Intermediate,,1,,,
CHEMBL630590,12192,,13749,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,,N,1,Intermediate,,1,,,
CHEMBL630591,12192,,13750,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in feces at 24 h,,,U,0,Autocuration,Feces,1,,1988.0,
CHEMBL630592,12192,,13751,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,U,0,Autocuration,Feces,1,,1988.0,
CHEMBL630593,12192,,13752,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,U,0,Autocuration,,1,,,
CHEMBL630594,12192,,13753,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,U,0,Autocuration,,1,,,
CHEMBL630595,12192,,13754,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630596,12192,,13755,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630597,12192,,13756,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630598,12192,,13757,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630599,12192,,13758,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630600,12192,,13759,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630601,12192,,13760,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630602,12192,,13761,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630603,12192,,13762,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL630604,12192,,13763,,,,22224,,A,,BAO_0000019,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL624869,12017,,13764,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL624870,12017,,13765,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623189,12017,,13766,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623190,12017,,13767,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623191,12017,,13768,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623192,12017,,13769,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL623193,12017,,13770,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL623194,12017,,13771,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,,1,,,
CHEMBL623195,12017,,13772,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL623196,12017,,13773,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL623197,11836,,13774,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,,N,1,Intermediate,,1,,,
CHEMBL623198,11836,,13775,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,,1,,,
CHEMBL623199,11836,,13776,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,N,1,Intermediate,,1,,,
CHEMBL623200,11836,,13777,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623201,11836,,13778,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623202,11836,,13779,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623203,11836,,13780,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623204,11836,,13781,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623205,11836,,13782,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623206,11836,,13783,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623207,11836,,13784,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623208,11836,,13785,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623209,11836,,13786,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623210,11836,,13787,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL623211,11836,,13788,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,,1,,,
CHEMBL623212,11836,,13789,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL623213,12640,,13790,,,,22224,,A,,BAO_0000019,Tested in vitro for intrinsic activity relative to quinpirole,,,U,0,Autocuration,,1,,,
CHEMBL623214,14218,,13791,,,,22224,,A,,BAO_0000019,"Relative ion enhancement, determined in pulsed ultrafiltration",,,U,0,Autocuration,,1,,,
CHEMBL623215,11296,,13792,,,,22224,,A,,BAO_0000019,% ionization at the pH 7.4 at 37 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL623216,10929,,13793,,,,22224,,A,,BAO_0000019,Percentage ionization was measured,,,U,0,Autocuration,,1,,,
CHEMBL623217,13841,,13794,,9913.0,,50591,,A,Bos taurus,BAO_0000218,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,,N,1,Intermediate,,1,,,
CHEMBL623218,10431,,13795,,,,22224,,A,,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,U,0,Autocuration,,1,,,
CHEMBL623913,10431,,13796,,,,22224,,A,,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,U,0,Autocuration,,1,,,
CHEMBL623914,10431,,13797,,,,22224,,A,,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,U,0,Autocuration,,1,,,
CHEMBL623915,8826,,13798,,,,22229,,P,,BAO_0000100,Compound was evaluated for the partition coefficient in octanol/water,,,U,0,Autocuration,,1,,,
CHEMBL624080,8826,,13799,,,,22229,,P,,BAO_0000100,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,U,0,Autocuration,,1,,,
CHEMBL624081,9884,,13800,,,,22224,,A,,BAO_0000019,Equilibrium constant measured by the pulse radiolysis at pH 7,,,U,0,Autocuration,,1,,,
CHEMBL624082,9827,,13801,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,In vitro hydrolytic rate constant determined in human blood,,,N,1,Intermediate,,1,,,
CHEMBL625054,10009,,13802,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,,N,1,Intermediate,,1,,,
CHEMBL877485,10009,,13803,,,,22224,,A,,BAO_0000019,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,U,0,Autocuration,,1,,,
CHEMBL625055,10009,,13804,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,,N,1,Intermediate,,1,,,
CHEMBL625056,10009,,13805,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,,N,1,Intermediate,,1,,,
CHEMBL625057,10009,,13806,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,In vitro oxidation of compound in presence of human plasma,,,N,1,Intermediate,,1,,,
CHEMBL625058,10009,,13807,,,,22224,,A,,BAO_0000019,In vitro oxidation of compound in presence of hydrogen peroxide,,,U,0,Autocuration,,1,,,
CHEMBL625059,10009,,13808,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro oxidation of compound in presence of mouse brain homogenate,,,N,1,Intermediate,,1,,,
CHEMBL629536,10009,,13809,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro oxidation of compound in presence of mouse liver homogenate,,,N,1,Intermediate,,1,,,
CHEMBL629537,11510,,13810,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629538,11510,,13811,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629539,11510,,13812,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL874445,11510,,13813,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629540,11510,,13814,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629541,11510,,13815,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629542,11510,,13816,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL630243,11510,,13817,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL630244,11510,,13818,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL630245,11510,,13819,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL630246,11510,,13820,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL630247,11510,,13821,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL630248,11510,,13822,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL630249,13100,,13823,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood at 240 minutes after dose administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630250,13100,,13824,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood at 30 minutes after dose administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630251,13100,,13825,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood at 360 minutes after dose administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630252,13100,,13826,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood at 3 hr after dose administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630408,13100,,13827,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood at 60 minutes after dose administration.,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630409,13100,,13828,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL874446,13100,,13829,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630410,13100,,13830,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630411,13100,,13831,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630412,13100,,13832,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630413,13100,,13833,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630414,13100,,13834,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 3 hr after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630415,13100,,13835,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL630416,13100,,13836,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 120 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630417,13100,,13837,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 1440 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630418,13100,,13838,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 15 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630419,13100,,13839,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 240 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630420,13100,,13840,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 30 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630421,13100,,13841,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 360 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630422,13100,,13842,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 3 hr after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630423,13100,,13843,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat cortex at 60 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL630424,13100,,13844,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 120 minutes after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630425,13100,,13845,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 15 minutes after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL629462,13100,,13846,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 240 minutes after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630426,13100,,13847,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 30 minutes after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630427,13100,,13848,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 360 minutes after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625877,13100,,13849,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 3 hr after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625878,13100,,13850,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart at 60 minutes after dose administration.,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625879,13100,,13851,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625880,13100,,13852,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625881,13100,,13853,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625882,13100,,13854,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625883,13100,,13855,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625884,13100,,13856,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 120 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625885,13100,,13857,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 1440 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628649,13100,,13858,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 15 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628650,13100,,13859,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 240 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628651,13100,,13860,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 30 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628652,13100,,13861,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 360 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628653,13100,,13862,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney at 60 minutes after dose administration.,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL628654,13100,,13863,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 120 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL628655,13100,,13864,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 1440 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625238,13100,,13865,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 15 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625239,13100,,13866,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 240 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625240,13100,,13867,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 30 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625241,13100,,13868,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 360 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625242,13100,,13869,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver at 60 minutes after dose administration.,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL874587,13100,,13870,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 120 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625405,13100,,13871,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 1440 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625406,13100,,13872,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 15 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625407,13100,,13873,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 240 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625408,13100,,13874,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 30 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625409,13100,,13875,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 360 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625410,12361,,13876,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625411,12361,,13877,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625412,12361,,13878,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625413,12361,,13879,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625414,12361,,13880,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625415,12361,,13881,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625416,12361,,13882,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,,N,1,Intermediate,Thoracic aorta,1,,1515.0,
CHEMBL625417,12712,,13883,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625418,7415,,13884,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL625419,7415,,13885,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625420,7415,,13886,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626996,7415,,13887,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,,N,1,Intermediate,,1,,,
CHEMBL626997,7415,,13888,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL626998,7415,,13889,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626999,7415,,13890,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,,N,1,Intermediate,,1,,,
CHEMBL627000,8050,,13891,,10090.0,,50594,,A,Mus musculus,BAO_0000218,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,,N,1,Intermediate,,1,,,
CHEMBL627001,8050,,13892,,10090.0,,50594,,A,Mus musculus,BAO_0000218,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,,N,1,Intermediate,,1,,,
CHEMBL627002,8050,,13893,,10090.0,,50594,,A,Mus musculus,BAO_0000218,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,,N,1,Intermediate,,1,,,
CHEMBL627003,8050,,13894,,10090.0,,50594,,A,Mus musculus,BAO_0000218,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,,N,1,Intermediate,,1,,,
CHEMBL627004,8050,,13895,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627005,8050,,13896,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874594,8050,,13897,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627006,8050,,13898,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627007,8050,,13899,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627884,8050,,13900,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627885,8050,,13901,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627886,8050,,13902,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627887,8050,,13903,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627888,8050,,13904,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628057,8050,,13905,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627405,8050,,13906,,10090.0,,50594,,A,Mus musculus,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627406,12582,,13907,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627407,12582,,13908,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627408,12582,,13909,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627409,12582,,13910,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875486,12582,,13911,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627410,12582,,13912,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627411,12582,,13913,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627412,12582,,13914,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627413,12582,,13915,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627414,12582,,13916,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627415,12582,,13917,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627416,12582,,13918,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627417,12582,,13919,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627418,12582,,13920,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627419,12582,,13921,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627320,12582,,13922,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627321,12582,,13923,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627322,12017,,13924,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627323,12017,,13925,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627491,12017,,13926,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627492,12017,,13927,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627493,12017,,13928,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL627494,12017,,13929,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627495,12017,,13930,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627496,12017,,13931,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627497,12017,,13932,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627498,12017,,13933,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627499,12017,,13934,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627500,12017,,13935,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627501,12017,,13936,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625616,12017,,13937,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625617,12017,,13938,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625618,12017,,13939,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625619,12017,,13940,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625620,12017,,13941,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625621,12017,,13942,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625622,12017,,13943,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625788,12017,,13944,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625789,12017,,13945,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625790,12017,,13946,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625791,12017,,13947,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622334,12017,,13948,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL622335,12017,,13949,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622336,12017,,13950,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622337,12017,,13951,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622338,12017,,13952,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL622339,12017,,13953,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL624153,12017,,13954,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL628430,12017,,13955,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL628431,12017,,13956,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,,1,,,
CHEMBL628432,12017,,13957,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL628433,12017,,13958,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL628434,12017,,13959,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626789,12017,,13960,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626790,12017,,13961,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626791,12017,,13962,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626792,12017,,13963,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL626793,12017,,13964,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627436,11510,,13965,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627437,11510,,13966,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627438,11510,,13967,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627439,11510,,13968,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627440,11510,,13969,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627602,11510,,13970,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627603,11510,,13971,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627604,11510,,13972,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627605,11510,,13973,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627606,11510,,13974,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627607,11510,,13975,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627608,11510,,13976,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627609,11510,,13977,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627610,11510,,13978,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627611,11510,,13979,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627612,11510,,13980,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL627613,8362,,13981,,,,22229,,P,,BAO_0000100,Octanol:water partition coefficient is evaluated,,,U,0,Autocuration,,1,,,
CHEMBL627614,8257,,13982,,,,22224,,P,,BAO_0000100,Partition coefficient in 1-octanol/water system,,,U,0,Autocuration,,1,,,
CHEMBL627615,8257,,13983,,,,22224,,P,,BAO_0000100,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,U,0,Autocuration,,1,,,
CHEMBL627616,9468,,13984,,,,22224,,P,,BAO_0000100,Partition coefficient in octanol/water system was determined,,,U,0,Autocuration,,1,,,
CHEMBL627617,9468,,13985,,,,22224,,P,,BAO_0000100,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,U,0,Autocuration,,1,,,
CHEMBL627618,10568,,13986,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL627619,10568,,13987,,,,22224,,A,,BAO_0000019,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL627620,15359,,13988,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant of the compound,,,U,0,Autocuration,,1,,,
CHEMBL627621,15359,,13989,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant with 1-min time point,,,U,0,Autocuration,,1,,,
CHEMBL627622,15359,,13990,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant without 1-min time point,,,U,0,Autocuration,,1,,,
CHEMBL627623,10431,,13991,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,U,0,Autocuration,,1,,,
CHEMBL627624,10431,,13992,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,U,0,Autocuration,,1,,,
CHEMBL627625,10431,,13993,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,U,0,Autocuration,,1,,,
CHEMBL628523,15704,,13994,,,,22224,,A,,BAO_0000019,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL628524,15287,,13995,,,,22224,,A,,BAO_0000019,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,U,0,Autocuration,,1,,,
CHEMBL628525,7516,,13996,,,,22224,,A,,BAO_0000019,The efflux rate constant of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625732,12973,,13997,,,,22224,,A,,BAO_0000019,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,U,0,Autocuration,,1,,,
CHEMBL625733,12973,,13998,,,,22224,,A,,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,U,0,Autocuration,,1,,,
CHEMBL625734,12973,,13999,,,,22224,,F,,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,U,0,Autocuration,,1,,,
CHEMBL625913,12973,,14000,,,,22224,,A,,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,U,0,Autocuration,,1,,,
CHEMBL625914,8696,,14001,,,,22224,,A,,BAO_0000019,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,U,0,Autocuration,,1,,,
CHEMBL625915,15052,,14002,,,,22224,,A,,BAO_0000019,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,U,0,Autocuration,,1,,,
CHEMBL625916,15052,,14003,,,,22224,,A,,BAO_0000019,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,U,0,Autocuration,,1,,,
CHEMBL625917,10503,,14004,,,,22224,,A,,BAO_0000019,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,U,0,Autocuration,,1,,,
CHEMBL625918,8354,,14005,,,,22224,,A,,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625919,8354,,14006,,,,22224,,A,,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625920,8354,,14007,,,,22224,,A,,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL874453,8354,,14008,,,,22224,,A,,BAO_0000019,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625921,8354,,14009,,,,22224,,A,,BAO_0000019,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625922,10503,,14010,,,,22224,,A,,BAO_0000019,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,U,0,Autocuration,,1,,,
CHEMBL625923,8354,,14011,,,,22224,,A,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625924,8354,,14012,,,,22224,,A,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625925,8354,,14013,,,,22224,,A,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL625926,8354,,14014,,,,22224,,A,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL627704,13100,,14015,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung at 60 minutes after dose administration.,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627705,13100,,14016,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL627706,13100,,14017,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL627707,13100,,14018,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL627708,13100,,14019,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL628361,13100,,14020,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL628362,13100,,14021,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,,N,1,Intermediate,,1,,,
CHEMBL628363,13100,,14022,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 120 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628364,13100,,14023,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 1440 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628365,13100,,14024,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 15 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL874454,13100,,14025,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 240 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628531,13100,,14026,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 30 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628532,13100,,14027,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 360 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628533,13100,,14028,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 3 hr after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628534,13100,,14029,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat striatum at 60 minutes after dose administration.,,,N,1,Intermediate,Striatum,1,,2435.0,
CHEMBL628535,13100,,14030,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 120 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL628536,13100,,14031,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL628537,13100,,14032,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 15 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL628538,13100,,14033,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 240 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL628539,13100,,14034,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 30 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630297,13100,,14035,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 360 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630298,13100,,14036,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat thyroid at 60 minutes after dose administration.,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630299,13100,,14037,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL628094,13100,,14038,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL628095,13100,,14039,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL874648,13100,,14040,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL628096,13100,,14041,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL628097,13100,,14042,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL628098,13100,,14043,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL628099,13331,,14044,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,U,0,Autocuration,,1,,,
CHEMBL628100,13331,,14045,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,U,0,Autocuration,,1,,,
CHEMBL628101,13331,,14046,,,,22224,,A,,BAO_0000019,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,U,0,Autocuration,,1,,,
CHEMBL628102,13331,,14047,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,U,0,Autocuration,,1,,,
CHEMBL628103,13331,,14048,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,U,0,Autocuration,,1,,,
CHEMBL628104,13331,,14049,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,U,0,Autocuration,,1,,,
CHEMBL628105,13331,,14050,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,U,0,Autocuration,,1,,,
CHEMBL628106,13331,,14051,,,,22224,,A,,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,U,0,Autocuration,,1,,,
CHEMBL628107,10086,,14052,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628108,10086,,14053,,,,22224,,F,,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL628109,10086,,14054,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625299,10086,,14055,,,,22224,,F,,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,U,0,Autocuration,Urine,1,,1088.0,
CHEMBL625300,10086,,14056,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625301,10086,,14057,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625302,10086,,14058,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874649,10086,,14059,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625303,13248,,14060,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,,N,1,Intermediate,,1,,,
CHEMBL625463,13248,,14061,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,,N,1,Intermediate,,1,,,
CHEMBL625464,14527,,14062,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,In vitro metabolism in human liver microsomes,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625465,3008,,14063,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,,N,1,Intermediate,,1,,,
CHEMBL625466,12582,,14064,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625467,12582,,14065,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625468,12582,,14066,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625469,12582,,14067,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625470,12582,,14068,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL632418,12582,,14069,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627250,12582,,14070,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627251,12582,,14071,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627252,12582,,14072,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627253,12582,,14073,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627254,12582,,14074,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875471,12582,,14075,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627255,12582,,14076,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627256,12582,,14077,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627257,12582,,14078,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627258,12582,,14079,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627259,12582,,14080,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627260,12582,,14081,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623256,12582,,14082,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874413,12582,,14083,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623257,12582,,14084,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623258,12582,,14085,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623259,12582,,14086,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623260,12582,,14087,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623261,12582,,14088,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623262,12582,,14089,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623263,12582,,14090,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623264,12582,,14091,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623265,12582,,14092,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623266,12582,,14093,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623267,12582,,14094,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623268,12582,,14095,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623269,12582,,14096,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623270,12582,,14097,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623271,12582,,14098,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623272,12582,,14099,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623273,12582,,14100,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623274,12582,,14101,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL874414,12582,,14102,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623275,12582,,14103,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629150,12582,,14104,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623276,12582,,14105,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623277,12582,,14106,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623112,12582,,14107,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623113,12582,,14108,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623800,12582,,14109,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623801,12582,,14110,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623802,12017,,14111,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL623803,12017,,14112,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL623970,12017,,14113,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL623971,12017,,14114,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Uterus,1,,995.0,
CHEMBL623972,14045,,14115,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623973,14045,,14116,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623974,14045,,14117,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623975,14045,,14118,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL623976,14045,,14119,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623977,14045,,14120,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623978,14045,,14121,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623979,14045,,14122,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL623980,14045,,14123,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,,N,1,Intermediate,,1,,,
CHEMBL623981,14045,,14124,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,,N,1,Intermediate,,1,,,
CHEMBL626278,14045,,14125,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,,N,1,Intermediate,,1,,,
CHEMBL626279,14045,,14126,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,,N,1,Intermediate,,1,,,
CHEMBL626280,14045,,14127,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in mice bladder plus excreted urine was determined,,,N,1,Intermediate,,1,,,
CHEMBL626281,14045,,14128,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse blood, 10 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626282,14045,,14129,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse blood, 30 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626283,14045,,14130,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse blood, 5 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626284,14045,,14131,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse blood, 60 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626285,14045,,14132,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse brain, 10 minutes post injection",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626286,14045,,14133,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse brain, 30 minutes post injection",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626287,14045,,14134,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse brain, 5 minutes post injection",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626288,14045,,14135,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse brain, 60 minutes post injection",,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL626289,14045,,14136,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse heart, 10 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626290,14045,,14137,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse heart, 30 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626291,14045,,14138,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse heart, 5 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL839888,14045,,14139,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse heart, 60 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL626292,14045,,14140,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL626293,14045,,14141,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL626294,14045,,14142,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL626295,14045,,14143,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,,N,1,Intermediate,Intestine,1,,160.0,
CHEMBL627659,14045,,14144,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse liver, 10 minutes post injection",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627660,14045,,14145,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627661,14045,,14146,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse liver, 5 minutes post injection",,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627662,14045,,14147,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in mice liver at 60 minutes of post injection,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL627663,14045,,14148,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in mice lungs at 10 min of post injection,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627664,14045,,14149,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mouse lung, 30 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL627665,14045,,14150,,10090.0,,50594,,A,Mus musculus,BAO_0000218,"Percentage biodistribution in mousee lung, 5 minutes post injection",,,N,1,Intermediate,,1,,,
CHEMBL627666,14045,,14151,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in mice lungs at 60 min of post injection,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL627667,14045,,14152,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percentage biodistribution in mouse spleen,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL627668,14045,,14153,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Percentage biodistribution in mouse stomach,,,N,1,Intermediate,Stomach,1,,945.0,
CHEMBL627669,11745,,14154,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627670,13257,,14155,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,,U,0,Autocuration,Urinary bladder,1,,1255.0,
CHEMBL627671,13257,,14156,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL627672,13257,,14157,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,,U,0,Autocuration,Bone element,1,,1474.0,
CHEMBL627673,13257,,14158,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,U,0,Autocuration,,1,,,
CHEMBL627674,13257,,14159,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,,U,0,Autocuration,Kidney,1,,2113.0,
CHEMBL627675,13257,,14160,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL627676,13257,,14161,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,,U,0,Autocuration,Lung,1,,2048.0,
CHEMBL627677,13257,,14162,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627678,8354,,14163,,,,22224,,A,,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL627679,7095,,14164,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Affinity for protein binding expressed as association constant in fresh rat serum,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL627680,12185,,14165,,,,22224,,A,,BAO_0000019,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,U,0,Autocuration,,1,,,
CHEMBL627681,12185,,14166,,,,22224,,A,,BAO_0000019,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,U,0,Autocuration,,1,,,
CHEMBL627682,12185,,14167,,,,22224,,A,,BAO_0000019,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,U,0,Autocuration,,1,,,
CHEMBL627683,12185,,14168,,,,22224,,A,,BAO_0000019,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,U,0,Autocuration,,1,,,
CHEMBL627684,12686,,14169,,,,22224,,A,,BAO_0000019,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,U,0,Autocuration,,1,,,
CHEMBL874441,12686,,14170,,,,22224,,A,,BAO_0000019,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,U,0,Autocuration,,1,,,
CHEMBL627685,12686,,14171,,,,22224,,A,,BAO_0000019,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,U,0,Autocuration,,1,,,
CHEMBL627686,12686,,14172,,,,22224,,A,,BAO_0000019,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,U,0,Autocuration,,1,,,
CHEMBL627687,8057,,14173,,,,22224,,A,,BAO_0000019,Apparent rate constant Koff for inactivation of dTMP synthase.,,,U,0,Autocuration,,1,,,
CHEMBL627688,15778,,14174,,,,22224,,A,,BAO_0000019,The irreversible inhibitor activity by second order rate equation.,,,U,0,Autocuration,,1,,,
CHEMBL628038,12375,,14175,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL628039,12375,,14176,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,,N,1,Intermediate,,1,,,
CHEMBL628040,12375,,14177,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,,N,1,Intermediate,,1,,,
CHEMBL628041,13588,,14178,,,,22224,,A,,BAO_0000019,Dissociation rate calculated from the first-order equation using t1/2 value,,,U,0,Autocuration,,1,,,
CHEMBL630226,15039,,14179,,,,22224,,A,,BAO_0000019,The compound was tested for Binding constant against DNA,,,U,0,Autocuration,,1,,,
CHEMBL628042,9500,,14180,,,,22224,,A,,BAO_0000019,First order rate constant for cyclization of the compound,,,U,0,Autocuration,,1,,,
CHEMBL625232,10014,,14181,,,,22224,,A,,BAO_0000019,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,U,0,Autocuration,,1,,,
CHEMBL625233,10014,,14182,,,,22224,,A,,BAO_0000019,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,U,0,Autocuration,,1,,,
CHEMBL625979,568,,14183,,,,22224,,A,,BAO_0000019,Hydrolysis rate constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL625980,10026,,14184,,,,22224,,A,,BAO_0000019,Observed first order rate constant,,,U,0,Autocuration,,1,,,
CHEMBL625981,10281,,14185,,,,22224,,A,,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL625982,10281,,14186,,,,22224,,A,,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL625983,9680,,14187,,,,22224,,A,,BAO_0000019,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL625984,13028,,14188,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625985,13028,,14189,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625986,13028,,14190,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625987,13028,,14191,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625988,13028,,14192,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625989,13028,,14193,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625990,13028,,14194,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625991,13028,,14195,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625992,13028,,14196,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL625993,13028,,14197,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL631973,13028,,14198,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632143,13028,,14199,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632144,13028,,14200,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632145,13028,,14201,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632146,13028,,14202,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632147,13028,,14203,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632148,13028,,14204,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632149,13028,,14205,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632150,13028,,14206,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632151,13028,,14207,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL632152,3008,,14208,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,,N,1,Intermediate,,1,,,
CHEMBL632153,4509,,14209,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,N,1,Intermediate,,1,,,
CHEMBL632154,4509,,14210,,9606.0,,50587,,A,Homo sapiens,BAO_0000218,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,N,1,Intermediate,,1,,,
CHEMBL632155,8613,,14211,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL632156,8613,,14212,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,,N,1,Intermediate,,1,,,
CHEMBL632157,8613,,14213,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL632158,8613,,14214,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL632159,8613,,14215,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,,N,1,Intermediate,,1,,,
CHEMBL626305,8613,,14216,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL626306,8613,,14217,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,,N,1,Intermediate,,1,,,
CHEMBL626307,8613,,14218,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL626308,8613,,14219,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL626479,8613,,14220,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL626480,8613,,14221,,10298.0,,50602,,A,Human herpesvirus 1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,,N,1,Intermediate,,1,,,
CHEMBL626481,6021,,14222,,,,22229,,P,,BAO_0000100,Calculated partition coefficient (clogP) (MlogP),,,U,0,Autocuration,,1,,,
CHEMBL626482,9348,,14223,,,,22224,,A,,BAO_0000019,Equipotent potent ratio relative to carbachol (nicotinic activity),,,U,0,Autocuration,,1,,,
CHEMBL626483,15592,,14224,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,,N,1,Intermediate,,1,,,
CHEMBL626484,15592,,14225,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,,N,1,Intermediate,,1,,,
CHEMBL626485,15592,,14226,,,,22229,,P,,BAO_0000100,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,U,0,Autocuration,,1,,,
CHEMBL626486,15592,,14227,,,,22229,,P,,BAO_0000100,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,U,0,Autocuration,,1,,,
CHEMBL626487,15592,,14228,,,,22229,,P,,BAO_0000100,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,U,0,Autocuration,,1,,,
CHEMBL626488,15592,,14229,,9615.0,In vivo,50588,,A,Canis lupus familiaris,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626489,7095,,14230,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,,N,1,Intermediate,Serum,1,,1977.0,
CHEMBL626490,16618,,14231,,,,22224,,A,,BAO_0000019,Area under the MAP curve measured over 5 min; ND means Not determined,,,U,0,Autocuration,,1,,,
CHEMBL626491,16835,,14232,,,,22224,,P,,BAO_0000100,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,U,0,Autocuration,,1,,,
CHEMBL626492,15284,,14233,,,,22229,,P,,BAO_0000100,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,U,0,Autocuration,,1,,,
CHEMBL626493,15750,,14234,,,,22224,,A,,BAO_0000019,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,U,0,Autocuration,,1,,,
CHEMBL626494,16618,,14235,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,,N,1,Intermediate,,1,,,
CHEMBL626495,16618,,14236,,,In vivo,22224,,A,,BAO_0000218,Half life after oral tested,,,U,0,Autocuration,,1,,,
CHEMBL626496,15812,,14237,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Half life was determined in plasma of rat; NT indicates not tested,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626497,16618,,14238,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,,N,1,Intermediate,,1,,,
CHEMBL626498,16618,,14239,,,In vivo,22224,,A,,BAO_0000218,Oral bioavailability after oral tested,,,U,0,Autocuration,,1,,,
CHEMBL626499,13098,,14240,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,,N,1,Intermediate,,1,,,
CHEMBL626500,13098,,14241,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,,N,1,Intermediate,,1,,,
CHEMBL626501,15812,,14242,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,half life was determined in plasma of rat; NT indicates not tested,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626502,15812,,14243,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,half life was determined in plasma of rat; NT means not tested,,,N,1,Intermediate,Plasma,1,,1969.0,
CHEMBL626503,11510,,14244,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,,N,1,Intermediate,,1,,,
CHEMBL626504,11510,,14245,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,,N,1,Intermediate,,1,,,
CHEMBL626505,11510,,14246,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,,N,1,Intermediate,,1,,,
CHEMBL626506,11510,,14247,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,,N,1,Intermediate,,1,,,
CHEMBL626507,11510,,14248,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,,N,1,Intermediate,,1,,,
CHEMBL626508,11510,,14249,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,,N,1,Intermediate,,1,,,
CHEMBL626509,11510,,14250,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,,N,1,Intermediate,,1,,,
CHEMBL875480,11510,,14251,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,,N,1,Intermediate,,1,,,
CHEMBL626510,11510,,14252,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,,N,1,Intermediate,,1,,,
CHEMBL626511,11510,,14253,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,,N,1,Intermediate,,1,,,
CHEMBL626512,11510,,14254,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,,N,1,Intermediate,,1,,,
CHEMBL628208,11510,,14255,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,,N,1,Intermediate,,1,,,
CHEMBL628209,11510,,14256,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,,N,1,Intermediate,,1,,,
CHEMBL628210,11510,,14257,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,,N,1,Intermediate,,1,,,
CHEMBL628211,11510,,14258,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,,N,1,Intermediate,,1,,,
CHEMBL628212,11510,,14259,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,,N,1,Intermediate,,1,,,
CHEMBL628213,11510,,14260,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,,N,1,Intermediate,,1,,,
CHEMBL628214,12582,,14261,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628215,12582,,14262,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628216,12582,,14263,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626595,12582,,14264,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626596,12582,,14265,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626597,12582,,14266,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626598,12582,,14267,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622242,12582,,14268,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622243,12582,,14269,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622244,12582,,14270,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622245,12582,,14271,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622246,12582,,14272,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622247,12582,,14273,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622248,12582,,14274,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL877483,12582,,14275,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622249,12582,,14276,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622250,12582,,14277,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622251,12582,,14278,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622252,12582,,14279,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622253,12582,,14280,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622254,12582,,14281,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622255,12582,,14282,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622256,12582,,14283,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622257,12582,,14284,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622258,12582,,14285,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622259,12582,,14286,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622927,12582,,14287,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622928,12582,,14288,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL622929,12582,,14289,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623182,12582,,14290,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623183,12582,,14291,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623184,12582,,14292,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623185,12582,,14293,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL877484,12582,,14294,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627274,12582,,14295,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623186,12582,,14296,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623187,12582,,14297,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL623188,12582,,14298,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628055,12582,,14299,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628056,12582,,14300,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628200,12582,,14301,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628201,12582,,14302,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628202,12582,,14303,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628203,12582,,14304,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628204,12582,,14305,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628205,12582,,14306,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628206,12582,,14307,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628207,13257,,14308,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627220,13257,,14309,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627221,13257,,14310,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627222,13257,,14311,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627223,13257,,14312,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,U,0,Autocuration,,1,,,
CHEMBL632062,13257,,14313,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL632063,13257,,14314,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL632064,13257,,14315,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,,U,0,Autocuration,Urinary bladder,1,,1255.0,
CHEMBL632065,13257,,14316,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL632066,13257,,14317,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,,U,0,Autocuration,Bone element,1,,1474.0,
CHEMBL632067,13257,,14318,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,U,0,Autocuration,,1,,,
CHEMBL629188,13257,,14319,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,,U,0,Autocuration,Kidney,1,,2113.0,
CHEMBL629189,13257,,14320,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL629190,13257,,14321,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,,U,0,Autocuration,Lung,1,,2048.0,
CHEMBL629191,13257,,14322,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629192,13257,,14323,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL629193,13257,,14324,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629194,13257,,14325,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL629195,13257,,14326,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,U,0,Autocuration,,1,,,
CHEMBL629373,13257,,14327,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629374,13257,,14328,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL629375,13257,,14329,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL629376,13257,,14330,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,,U,0,Autocuration,Urinary bladder,1,,1255.0,
CHEMBL629377,13257,,14331,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL629378,13257,,14332,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,,U,0,Autocuration,Bone element,1,,1474.0,
CHEMBL629379,13257,,14333,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,U,0,Autocuration,,1,,,
CHEMBL629151,13257,,14334,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,,U,0,Autocuration,Kidney,1,,2113.0,
CHEMBL629152,13257,,14335,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL629153,13257,,14336,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,,U,0,Autocuration,Lung,1,,2048.0,
CHEMBL629154,13257,,14337,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629155,13257,,14338,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL629156,13257,,14339,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL629157,13257,,14340,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629158,13257,,14341,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL629159,13257,,14342,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,U,0,Autocuration,,1,,,
CHEMBL629160,13257,,14343,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629161,13257,,14344,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL629162,13257,,14345,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,,U,0,Autocuration,Urinary bladder,1,,1255.0,
CHEMBL629163,13257,,14346,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL629164,13257,,14347,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,,U,0,Autocuration,Bone element,1,,1474.0,
CHEMBL629165,13257,,14348,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,U,0,Autocuration,,1,,,
CHEMBL629166,13257,,14349,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL629167,13257,,14350,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,,U,0,Autocuration,Lung,1,,2048.0,
CHEMBL629168,13257,,14351,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL629169,2193,,14352,,,,22224,,A,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,U,0,Autocuration,,1,,,
CHEMBL629170,2193,,14353,,,,22224,,A,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,U,0,Autocuration,,1,,,
CHEMBL631153,2193,,14354,,,,22224,,A,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,U,0,Autocuration,,1,,,
CHEMBL875121,2193,,14355,,,,22224,,A,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,U,0,Autocuration,,1,,,
CHEMBL631154,2193,,14356,,,,22224,,A,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,U,0,Autocuration,,1,,,
CHEMBL631155,2193,,14357,,,,22224,,A,,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,U,0,Autocuration,,1,,,
CHEMBL631156,568,,14358,,,,22224,,A,,BAO_0000019,Hydrolysis rate constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL631157,9680,,14359,,,,22224,,A,,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL631158,9680,,14360,,,,22224,,A,,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL631159,9680,,14361,,,,22224,,A,,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL631160,10026,,14362,,,,22224,,A,,BAO_0000019,Observed second order rate constant,,,U,0,Autocuration,,1,,,
CHEMBL631161,10281,,14363,,,,22224,,A,,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL631162,10014,,14364,,,,22224,,A,,BAO_0000019,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,U,0,Autocuration,,1,,,
CHEMBL630313,10014,,14365,,,,22224,,A,,BAO_0000019,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,U,0,Autocuration,,1,,,
CHEMBL630314,9680,,14366,,,,22224,,A,,BAO_0000019,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL630315,9680,,14367,,,,22224,,A,,BAO_0000019,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL630316,13028,,14368,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630986,13028,,14369,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630987,13028,,14370,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630988,13028,,14371,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630989,13028,,14372,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630990,13028,,14373,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630991,13028,,14374,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630992,13028,,14375,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630993,13028,,14376,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630994,13028,,14377,,,,22224,,A,,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,U,0,Autocuration,,1,,,
CHEMBL630995,10014,,14378,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,,N,1,Intermediate,,1,,,
CHEMBL629252,9962,,14379,,,,22224,,A,,BAO_0000019,Association constant for compound at 31 degree C was determined,,,U,0,Autocuration,,1,,,
CHEMBL629253,12029,,14380,,,,22224,,A,,BAO_0000019,Calculated antagonist equilibrium dissociation constant of the compound,,,U,0,Autocuration,,1,,,
CHEMBL629944,12029,,14381,,,,22224,,A,,BAO_0000019,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,U,0,Autocuration,,1,,,
CHEMBL629945,10583,,14382,,10141.0,,50512,,A,Cavia porcellus,BAO_0000218,Dissociation constants vs LTE4 on guinea pig trachea,,,N,1,Intermediate,Trachea,1,,3126.0,
CHEMBL629946,568,,14383,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,U,0,Autocuration,,1,,,
CHEMBL629947,568,,14384,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,U,0,Autocuration,,1,,,
CHEMBL629948,568,,14385,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,U,0,Autocuration,,1,,,
CHEMBL856024,568,,14386,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,U,0,Autocuration,,1,,,
CHEMBL629949,7493,,14387,,,,22224,,A,,BAO_0000019,Affinity constant KD value was derived from TMP,,,U,0,Autocuration,,1,,,
CHEMBL629950,8371,,14388,,,,22224,,A,,BAO_0000019,Apparent dissociation (binding) rate constant was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL630127,13114,,14389,,,,22224,,P,,BAO_0000100,Dissociation constant (KD) of the compound,,,U,0,Autocuration,,1,,,
CHEMBL630128,15515,,14390,,,,22224,,P,,BAO_0000100,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,U,0,Autocuration,,1,,,
CHEMBL630129,522,,14391,,,,22224,,P,,BAO_0000100,Dissociation constant from ESR titration experiments,,,U,0,Autocuration,,1,,,
CHEMBL630130,13888,,14392,,,,22224,,,,BAO_0000019,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,U,0,Autocuration,,1,,,
CHEMBL875234,2616,,14393,,,,22224,,P,,BAO_0000100,Dissociation constant was evaluated.,,,U,0,Autocuration,,1,,,
CHEMBL630131,3798,,14394,,,,22224,,P,,BAO_0000100,Dissociation constant was reported,,,U,0,Autocuration,,1,,,
CHEMBL630132,8731,,14395,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Dissociation constant was determined in rat pituitary cells.,,,N,1,Intermediate,,1,,,
CHEMBL630133,11892,,14396,,,,22224,,A,,BAO_0000019,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,U,0,Autocuration,,1,,,
CHEMBL630134,11892,,14397,,,,22224,,A,,BAO_0000019,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,U,0,Autocuration,,1,,,
CHEMBL630135,2582,,14398,,,,22224,,A,,BAO_0000019,Equilibrium dissociation constant of the compound,,,U,0,Autocuration,,1,,,
CHEMBL630136,11892,,14399,,,,22224,,A,,BAO_0000019,Equilibrium dissociation constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL630137,13396,,14400,,,,22224,,A,,BAO_0000019,Kinetic constant KD was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL630138,603,,14401,,,,22224,,A,,BAO_0000019,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,U,0,Autocuration,,1,,,
CHEMBL630139,15673,,14402,,,,22224,,A,,BAO_0000019,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL630140,10368,,14403,,,,22224,,A,,BAO_0000019,Rate constant for hydrolysis in aqueous acetone.,,,U,0,Autocuration,,1,,,
CHEMBL875235,14228,,14404,,,,22224,,A,,BAO_0000019,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,U,0,Autocuration,,1,,,
CHEMBL876439,11510,,14405,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,,N,1,Intermediate,,1,,,
CHEMBL630605,11510,,14406,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,,N,1,Intermediate,,1,,,
CHEMBL630606,11510,,14407,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,,N,1,Intermediate,,1,,,
CHEMBL630607,11510,,14408,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,,N,1,Intermediate,,1,,,
CHEMBL630608,11510,,14409,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,,N,1,Intermediate,,1,,,
CHEMBL630609,11510,,14410,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,,N,1,Intermediate,,1,,,
CHEMBL630610,11510,,14411,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,,N,1,Intermediate,,1,,,
CHEMBL630611,11510,,14412,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,,N,1,Intermediate,,1,,,
CHEMBL629552,11510,,14413,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,,N,1,Intermediate,,1,,,
CHEMBL629733,11510,,14414,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629734,11510,,14415,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629735,11510,,14416,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629736,11510,,14417,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629737,11510,,14418,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629738,11510,,14419,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629739,11510,,14420,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629740,11510,,14421,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,N,1,Intermediate,,1,,,
CHEMBL629741,11510,,14422,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629742,11510,,14423,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629743,11510,,14424,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629744,11510,,14425,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629745,11510,,14426,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629746,11510,,14427,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629747,11510,,14428,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629748,11510,,14429,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629749,11510,,14430,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629750,11510,,14431,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629751,11510,,14432,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629752,11510,,14433,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629753,11510,,14434,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629754,11510,,14435,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629755,11510,,14436,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629756,11510,,14437,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629757,11510,,14438,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629758,11510,,14439,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629759,11510,,14440,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629760,11510,,14441,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL876443,11510,,14442,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,N,1,Intermediate,,1,,,
CHEMBL629761,8310,,14443,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,,N,1,Intermediate,,1,,,
CHEMBL629762,8310,,14444,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,,N,1,Intermediate,,1,,,
CHEMBL629763,8310,,14445,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629764,8310,,14446,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629765,8310,,14447,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629766,8310,,14448,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629767,8310,,14449,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629768,8310,,14450,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,,N,1,Intermediate,,1,,,
CHEMBL629769,8310,,14451,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629770,8310,,14452,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,,N,1,Intermediate,,1,,,
CHEMBL629771,8310,,14453,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629772,8310,,14454,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL629773,8310,,14455,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL625455,8310,,14456,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL625456,8310,,14457,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL625457,8310,,14458,,10090.0,,50594,,A,Mus musculus,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,,N,1,Intermediate,,1,,,
CHEMBL625458,12582,,14459,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625459,12582,,14460,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875483,12582,,14461,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL634779,12582,,14462,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625460,12582,,14463,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626117,12582,,14464,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626118,12582,,14465,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628342,12582,,14466,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628343,12582,,14467,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628344,12582,,14468,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628345,12582,,14469,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628346,12582,,14470,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628347,12582,,14471,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628348,12582,,14472,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628349,12582,,14473,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875611,12582,,14474,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628350,12582,,14475,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628351,12582,,14476,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628352,12582,,14477,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628353,12582,,14478,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628354,12582,,14479,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626667,12582,,14480,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626668,12582,,14481,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626669,12582,,14482,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626670,12582,,14483,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626671,12582,,14484,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626672,12582,,14485,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626673,12582,,14486,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626674,12582,,14487,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626675,12582,,14488,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626676,12582,,14489,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626677,12582,,14490,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626678,12582,,14491,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626679,12582,,14492,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875612,12582,,14493,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626680,12582,,14494,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626681,12582,,14495,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626682,12582,,14496,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626683,12582,,14497,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626684,12582,,14498,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626685,12582,,14499,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626686,12582,,14500,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626687,12582,,14501,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624978,12582,,14502,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624979,12582,,14503,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624980,12582,,14504,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624981,12582,,14505,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL624982,12582,,14506,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627564,13257,,14507,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627565,13257,,14508,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627566,13257,,14509,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,U,0,Autocuration,,1,,,
CHEMBL627567,13257,,14510,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627568,13257,,14511,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL627569,13257,,14512,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,,U,0,Autocuration,Kidney,1,,2113.0,
CHEMBL627570,13257,,14513,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,,U,0,Autocuration,Urinary bladder,1,,1255.0,
CHEMBL627571,13257,,14514,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,,U,0,Autocuration,Blood,1,,178.0,
CHEMBL627572,13257,,14515,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,,U,0,Autocuration,Bone element,1,,1474.0,
CHEMBL627573,13257,,14516,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,U,0,Autocuration,,1,,,
CHEMBL627574,13257,,14517,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,,U,0,Autocuration,Kidney,1,,2113.0,
CHEMBL627575,13257,,14518,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,,U,0,Autocuration,Liver,1,,2107.0,
CHEMBL627576,13257,,14519,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,,U,0,Autocuration,Lung,1,,2048.0,
CHEMBL627577,13257,,14520,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627578,13257,,14521,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627579,13257,,14522,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627580,13257,,14523,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627581,13257,,14524,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627582,13257,,14525,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,U,0,Autocuration,,1,,,
CHEMBL627583,13257,,14526,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627584,13257,,14527,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,,U,0,Autocuration,Spleen,1,,2106.0,
CHEMBL627585,13257,,14528,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,,U,0,Autocuration,Prostate gland,1,,2367.0,
CHEMBL627586,13257,,14529,,,In vivo,22224,,A,,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,,U,0,Autocuration,Muscle tissue,1,,2385.0,
CHEMBL627587,15413,,14530,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL627588,15413,,14531,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL628250,15413,,14532,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL628251,15413,,14533,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL628252,15413,,14534,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL628253,15413,,14535,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL628254,15413,,14536,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL877493,15413,,14537,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL628255,15413,,14538,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL628256,15413,,14539,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL628257,15413,,14540,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL628258,15413,,14541,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL628259,15413,,14542,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL628429,15413,,14543,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,,1,,,
CHEMBL626862,15413,,14544,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL626863,15413,,14545,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL625886,15413,,14546,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL625887,15413,,14547,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL625888,15413,,14548,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,,N,1,Intermediate,,1,,,
CHEMBL625889,15413,,14549,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,,N,1,Intermediate,,1,,,
CHEMBL625890,15413,,14550,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625891,15413,,14551,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL625892,15413,,14552,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL625893,15413,,14553,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL625894,15413,,14554,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,,N,1,Intermediate,Cerebellum,1,,2037.0,
CHEMBL625895,15413,,14555,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,,N,1,Intermediate,,1,,,
CHEMBL625896,12404,,14556,,,,22224,,A,,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,U,0,Autocuration,,1,,,
CHEMBL625897,568,,14557,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,U,0,Autocuration,,1,,,
CHEMBL625898,568,,14558,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,U,0,Autocuration,,1,,,
CHEMBL625899,568,,14559,,,,22224,,A,,BAO_0000019,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,U,0,Autocuration,,1,,,
CHEMBL626124,12404,,14560,,,,22224,,A,,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,U,0,Autocuration,,1,,,
CHEMBL628500,7624,,14561,,562.0,,50212,,A,Escherichia coli,BAO_0000218,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,,N,1,Intermediate,,1,,,
CHEMBL857856,7624,,14562,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,,N,1,Intermediate,,1,,,
CHEMBL628501,7624,,14563,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,,N,1,Intermediate,,1,,,
CHEMBL628502,4643,,14564,,,,22224,,A,,BAO_0000019,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,U,0,Autocuration,,1,,,
CHEMBL628503,11532,,14565,,,,22224,,A,,BAO_0000019,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,U,0,Autocuration,,1,,,
CHEMBL628504,11018,,14566,,,,22224,,A,,BAO_0000019,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL628505,2276,,14567,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL874452,2276,,14568,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,U,0,Autocuration,,1,,,
CHEMBL628506,2276,,14569,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL628507,2276,,14570,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL628508,2276,,14571,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,U,0,Autocuration,,1,,,
CHEMBL628509,8949,,14572,,,,22224,,A,,BAO_0000019,Michaelis constant (KM) was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL628510,12404,,14573,,,,22224,,A,,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,U,0,Autocuration,,1,,,
CHEMBL628511,7625,,14574,,,,22224,,B,,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,U,0,Autocuration,,1,,,
CHEMBL628512,7625,,14575,,,,22224,,B,,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,U,0,Autocuration,,1,,,
CHEMBL628513,7625,,14576,,,,22224,,B,,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,U,0,Autocuration,,1,,,
CHEMBL628514,7625,,14577,,,,22224,,B,,BAO_0000019,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,U,0,Autocuration,,1,,,
CHEMBL628515,12908,,14578,,,,22224,,A,,BAO_0000019,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,U,0,Autocuration,,1,,,
CHEMBL628516,10368,,14579,,,,22224,,A,,BAO_0000019,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,U,0,Autocuration,,1,,,
CHEMBL628517,13108,,14580,,,,22224,,A,,BAO_0000019,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,U,0,Autocuration,,1,,,
CHEMBL628518,13108,,14581,,,,22224,,A,,BAO_0000019,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,U,0,Autocuration,,1,,,
CHEMBL628519,15217,,14582,,,,22224,,A,,BAO_0000019,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,U,0,Autocuration,,1,,,
CHEMBL628520,15217,,14583,,,,22224,,A,,BAO_0000019,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,U,0,Autocuration,,1,,,
CHEMBL628521,10933,,14584,,,,22224,,A,,BAO_0000019,Binding constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL630443,2363,,14585,,,,22224,,A,,BAO_0000019,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL630444,2363,,14586,,,,22224,,A,,BAO_0000019,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,U,0,Autocuration,,1,,,
CHEMBL857732,2276,,14587,,,,22224,,A,,BAO_0000019,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,U,0,Autocuration,,1,,,
CHEMBL630445,14915,,14588,,,,22224,,P,,BAO_0000100,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,U,0,Autocuration,,1,,,
CHEMBL630446,8847,,14589,,,,22224,,A,,BAO_0000019,Catalytic rate constant of the compound,,,U,0,Autocuration,,1,,,
CHEMBL630447,15357,,14590,,,,22224,,B,,BAO_0000019,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,U,0,Autocuration,,1,,,
CHEMBL630448,2869,,14591,,,,22224,,A,,BAO_0000019,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,U,0,Autocuration,,1,,,
CHEMBL630449,3484,,14592,,,,22224,,A,,BAO_0000019,Catalytic rate constant against phospholipase A2 was determined,,,U,0,Autocuration,,1,,,
CHEMBL630450,1373,,14593,,,,22224,,A,,BAO_0000019,"Compound was evaluated for catalytic constant, Kcat",,,U,0,Autocuration,,1,,,
CHEMBL630451,8142,,14594,,,,22224,,A,,BAO_0000019,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL630452,14131,,14595,,,,22224,,A,,BAO_0000019,Kcat calculated from 0.693/T1/2,,,U,0,Autocuration,,1,,,
CHEMBL630453,17269,,14596,,,,22224,,A,,BAO_0000019,Kcat was determined,,,U,0,Autocuration,,1,,,
CHEMBL630454,3485,,14597,,,,22224,,A,,BAO_0000019,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,U,0,Autocuration,,1,,,
CHEMBL630455,3485,,14598,,,,22224,,A,,BAO_0000019,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,U,0,Autocuration,,1,,,
CHEMBL631487,3485,,14599,,,,22224,,A,,BAO_0000019,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,U,0,Autocuration,,1,,,
CHEMBL631488,5962,,14600,,,,22224,,A,,BAO_0000019,Kcat value was determined,,,U,0,Autocuration,,1,,,
CHEMBL876440,3133,,14601,,,,22224,,A,,BAO_0000019,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL631489,3133,,14602,,,,22224,,A,,BAO_0000019,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL857742,2276,,14603,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL631490,2276,,14604,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,U,0,Autocuration,,1,,,
CHEMBL631491,2276,,14605,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL631492,2276,,14606,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL631493,2276,,14607,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,U,0,Autocuration,,1,,,
CHEMBL631494,4892,,14608,,,,22224,,A,,BAO_0000019,Kinetic parameter for rate of conversion to PABA was determined,,,U,0,Autocuration,,1,,,
CHEMBL631495,3133,,14609,,,,22224,,A,,BAO_0000019,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL631496,11488,,14610,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL631497,11488,,14611,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631498,11488,,14612,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629776,11488,,14613,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629777,11488,,14614,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL629778,11488,,14615,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630456,11488,,14616,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630457,11488,,14617,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630458,11488,,14618,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630459,11488,,14619,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630460,11488,,14620,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL876550,11488,,14621,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630461,11488,,14622,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630462,11488,,14623,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630463,11488,,14624,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630464,11488,,14625,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630465,11488,,14626,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630466,11488,,14627,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630467,11488,,14628,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630633,11488,,14629,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630634,11488,,14630,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630635,11488,,14631,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630636,11488,,14632,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630637,11488,,14633,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,,N,1,Intermediate,,1,,,
CHEMBL630638,7132,,14634,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL630639,7132,,14635,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL630640,7132,,14636,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL876551,7132,,14637,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL630641,7132,,14638,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630642,7132,,14639,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630643,7132,,14640,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630644,7132,,14641,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL630645,7132,,14642,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625599,7132,,14643,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL625600,7132,,14644,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL625601,7132,,14645,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL625602,7132,,14646,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,N,1,Intermediate,Feces,1,,1988.0,
CHEMBL627470,7132,,14647,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627471,7132,,14648,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627472,7132,,14649,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627473,7132,,14650,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627474,7132,,14651,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627475,13925,,14652,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627476,13925,,14653,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL627477,12582,,14654,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627478,12582,,14655,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627479,12582,,14656,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627480,12582,,14657,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627481,12582,,14658,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627482,12582,,14659,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL627483,12582,,14660,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875636,12582,,14661,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625764,12582,,14662,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625765,12582,,14663,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625766,12582,,14664,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625767,12582,,14665,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625768,12582,,14666,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625769,12582,,14667,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625770,12582,,14668,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625771,12582,,14669,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625772,12582,,14670,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625773,12582,,14671,,9615.0,,50588,,A,Canis lupus familiaris,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625774,12582,,14672,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625775,12582,,14673,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625776,12582,,14674,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625777,12582,,14675,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625778,12582,,14676,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625779,12582,,14677,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625780,12582,,14678,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL625781,12582,,14679,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875637,12582,,14680,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626473,12582,,14681,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626474,12582,,14682,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626475,12582,,14683,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626476,12582,,14684,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL634397,12582,,14685,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL626477,12582,,14686,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631069,12582,,14687,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631070,12582,,14688,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631071,12582,,14689,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631072,12582,,14690,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631073,12582,,14691,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631074,12582,,14692,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631075,12582,,14693,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631725,12582,,14694,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631726,12582,,14695,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631727,12582,,14696,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631728,12582,,14697,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631729,12582,,14698,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631730,12582,,14699,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631731,12582,,14700,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631910,12582,,14701,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631911,15413,,14702,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,,N,1,Intermediate,Hippocampus,1,,10000000.0,
CHEMBL631912,15413,,14703,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL631913,15413,,14704,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,,N,1,Intermediate,Hypothalamus,1,,1898.0,
CHEMBL631914,12017,,14705,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631915,12017,,14706,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL875778,12017,,14707,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631916,12017,,14708,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631917,12017,,14709,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631918,12017,,14710,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631919,12017,,14711,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631920,12017,,14712,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631921,12017,,14713,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631922,12017,,14714,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631923,12017,,14715,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL631924,12017,,14716,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630234,12017,,14717,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630235,12017,,14718,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,,1,,,
CHEMBL630236,12017,,14719,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630237,12017,,14720,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630238,12017,,14721,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630239,12017,,14722,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630303,12017,,14723,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,,1,,,
CHEMBL630304,12017,,14724,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630305,12017,,14725,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,,1,,,
CHEMBL630306,12017,,14726,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630307,12017,,14727,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630308,12017,,14728,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630309,12017,,14729,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL629309,12017,,14730,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL629993,12017,,14731,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL629994,12017,,14732,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL629995,12017,,14733,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631993,12017,,14734,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631994,12017,,14735,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631995,12017,,14736,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL631996,12017,,14737,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631997,12017,,14738,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631998,12017,,14739,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631999,12017,,14740,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632000,12017,,14741,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632001,12017,,14742,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL874424,12017,,14743,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632002,12017,,14744,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632003,12017,,14745,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL632004,3133,,14746,,,,22224,,A,,BAO_0000019,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL632005,2742,,14747,,,,22224,,A,,BAO_0000019,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632006,2742,,14748,,,,22224,,A,,BAO_0000019,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632007,2742,,14749,,,,22224,,A,,BAO_0000019,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632008,2742,,14750,,,,22224,,A,,BAO_0000019,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632009,2742,,14751,,,,22224,,A,,BAO_0000019,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632010,2742,,14752,,,,22224,,A,,BAO_0000019,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,U,0,Autocuration,,1,,,
CHEMBL857750,2742,,14753,,,,22224,,A,,BAO_0000019,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632011,2742,,14754,,,,22224,,A,,BAO_0000019,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,U,0,Autocuration,,1,,,
CHEMBL632012,2276,,14755,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,U,0,Autocuration,,1,,,
CHEMBL632013,2276,,14756,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,U,0,Autocuration,,1,,,
CHEMBL632014,2276,,14757,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,U,0,Autocuration,,1,,,
CHEMBL629622,2276,,14758,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,U,0,Autocuration,,1,,,
CHEMBL629623,2276,,14759,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,U,0,Autocuration,,1,,,
CHEMBL629624,2276,,14760,,,,22224,,A,,BAO_0000019,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,U,0,Autocuration,,1,,,
CHEMBL629625,17269,,14761,,,,22224,,A,,BAO_0000019,Ratio of Kcat to that of Km was determined,,,U,0,Autocuration,,1,,,
CHEMBL629626,2276,,14762,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,U,0,Autocuration,,1,,,
CHEMBL629627,2276,,14763,,,,22224,,A,,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,U,0,Autocuration,,1,,,
CHEMBL629628,15917,,14764,,,,22224,,A,,BAO_0000019,"Compound was evaluated for constant, Kd",,,U,0,Autocuration,,1,,,
CHEMBL629629,10933,,14765,,,,22224,,A,,BAO_0000019,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,U,0,Autocuration,,1,,,
CHEMBL629630,10933,,14766,,,,22224,,A,,BAO_0000019,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,U,0,Autocuration,,1,,,
CHEMBL856030,14293,,14767,,,,22224,,A,,BAO_0000019,Dissociation Constant of compound determined,,,U,0,Autocuration,,1,,,
CHEMBL629631,6698,,14768,,,,22224,,B,,BAO_0000019,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,U,0,Autocuration,,1,,,
CHEMBL629632,6698,,14769,,,,22224,,B,,BAO_0000019,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,U,0,Autocuration,,1,,,
CHEMBL629633,4318,,14770,,,,22224,,P,,BAO_0000100,Dissociation constant of compound with Fructose was determined,,,U,0,Autocuration,,1,,,
CHEMBL629634,4318,,14771,,,,22224,,P,,BAO_0000100,Dissociation constant of compound with Fructose was determined; Not determined,,,U,0,Autocuration,,1,,,
CHEMBL629635,4318,,14772,,,,22224,,P,,BAO_0000100,Dissociation constant of compound with Lactulose was determined,,,U,0,Autocuration,,1,,,
CHEMBL629636,4318,,14773,,,,22224,,P,,BAO_0000100,Dissociation constant of compound with Lactulose was determined; Not determined,,,U,0,Autocuration,,1,,,
CHEMBL629637,14959,,14774,,,,22224,,P,,BAO_0000100,Dissociation constant of the Compound,,,U,0,Autocuration,,1,,,
CHEMBL629638,5913,,14775,,,,22224,,P,,BAO_0000100,Dissociation constant by non-linear regression analysis,,,U,0,Autocuration,,1,,,
CHEMBL629639,14218,,14776,,,,22224,,P,,BAO_0000100,Dissociation constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL629640,10689,,14777,,,,22224,,P,,BAO_0000100,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,U,0,Autocuration,,1,,,
CHEMBL629641,13925,,14778,,,,22224,,P,,BAO_0000100,Dissociation constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL631344,16359,,14779,,,,22224,,P,,BAO_0000100,Dissociation constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL631345,10944,,14780,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631346,11080,,14781,,,,22224,,A,,BAO_0000019,The dissociation constant determined by fluorescence displacement assay,,,U,0,Autocuration,,1,,,
CHEMBL631524,17805,,14782,,,,22224,,A,,BAO_0000019,kd value surface plasmon resonance (SPR) method,,,U,0,Autocuration,,1,,,
CHEMBL631525,10944,,14783,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631526,16645,,14784,,,,22224,,F,,BAO_0000019,First dissociation constant of the binding of compound to V30M TTR,,,U,0,Autocuration,,1,,,
CHEMBL631527,16645,,14785,,,,22224,,F,,BAO_0000019,Second dissociation constant of the binding of compound to V30M TTR,,,U,0,Autocuration,,1,,,
CHEMBL631528,7793,,14786,,,,22224,,A,,BAO_0000019,"Compound was evaluated for equilibrium constant, Ke",,,U,0,Autocuration,,1,,,
CHEMBL631529,12199,,14787,,,,22224,,A,,BAO_0000019,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,U,0,Autocuration,Hypothalamus,1,,1898.0,
CHEMBL631530,12199,,14788,,,,22224,,A,,BAO_0000019,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,U,0,Autocuration,Hypothalamus,1,,1898.0,
CHEMBL631531,9680,,14789,,,,22224,,A,,BAO_0000019,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL631532,9680,,14790,,,,22224,,A,,BAO_0000019,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL631533,9680,,14791,,,,22224,,A,,BAO_0000019,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL876552,13758,,14792,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631534,13758,,14793,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631535,13758,,14794,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631536,13758,,14795,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631537,13758,,14796,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631538,13758,,14797,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631539,13758,,14798,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,,N,1,Intermediate,,1,,,
CHEMBL631540,13758,,14799,,10090.0,,50594,,A,Mus musculus,BAO_0000218,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,N,1,Intermediate,,1,,,
CHEMBL625637,14393,,14800,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL625638,14393,,14801,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,N,1,Intermediate,,1,,,
CHEMBL625639,15078,,14802,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,N,1,Intermediate,,1,,,
CHEMBL625640,13925,,14803,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625641,13925,,14804,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625642,13925,,14805,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625643,13925,,14806,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625644,13925,,14807,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625645,13925,,14808,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL625646,13925,,14809,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625647,13925,,14810,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625648,13925,,14811,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625649,13925,,14812,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL625650,13925,,14813,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625651,13925,,14814,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL625652,13925,,14815,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL625653,13925,,14816,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Zone of skin,1,,14.0,
CHEMBL625654,13925,,14817,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625655,13925,,14818,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL625656,9712,,14819,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat blood after 15 minutes of administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625657,9712,,14820,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat blood after 2 minutes of administration,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL625658,9712,,14821,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat brain after 15 minutes of administration,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625659,9712,,14822,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat brain after 2 minutes of administration,,,N,1,Intermediate,Brain,1,,955.0,
CHEMBL625660,9712,,14823,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat heart after 15 minutes of administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625661,9712,,14824,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat heart after 2 minutes of administration,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL625662,9712,,14825,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat liver after 15 minutes of administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL625663,9712,,14826,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat liver after 2 minutes of administration,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL875621,9712,,14827,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat lung after 15 minutes of administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL628382,9712,,14828,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat lung after 2 minutes of administration,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL628383,9712,,14829,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat muscle after 15 minutes of administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL628384,9712,,14830,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution of Compound in rat muscle after 2 minutes of administration,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL628385,13925,,14831,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,,N,1,Intermediate,,1,,,
CHEMBL875753,13925,,14832,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,,N,1,Intermediate,,1,,,
CHEMBL628386,13925,,14833,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,,N,1,Intermediate,,1,,,
CHEMBL628387,6941,,14834,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat blood 2 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL628388,6941,,14835,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat blood 2 hr after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL628389,6941,,14836,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat blood 30 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL632756,6941,,14837,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat blood 30 min after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL628390,6941,,14838,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat brain 2 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631811,6941,,14839,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat brain 2 hr after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631812,6941,,14840,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat brain 30 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631813,6941,,14841,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat heart 2 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631814,6941,,14842,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat heart 2 hr after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631815,6941,,14843,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat heart 30 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631816,6941,,14844,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat kidney 2 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL875758,6941,,14845,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat kidney 2 hr after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631817,6941,,14846,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat kidney 30 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631818,6941,,14847,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat liver 2 minutes after intravenous injection,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631819,6941,,14848,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat liver 2 hr after intravenous injection,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631820,6941,,14849,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat liver 30 minutes after intravenous injection,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL631821,6941,,14850,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat lung 2 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631822,6941,,14851,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat lung 2 hr after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631823,6941,,14852,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat lung 30 minutes after intravenous injection,,,N,1,Intermediate,,1,,,
CHEMBL631824,6941,,14853,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat muscle 2 minutes after intravenous injection,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631825,6941,,14854,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat muscle 2 hr after intravenous injection,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631826,6941,,14855,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Organ distribution in rat muscle 30 minutes after intravenous injection,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631827,14439,,14856,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,,N,1,Intermediate,,1,,,
CHEMBL631828,14439,,14857,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,,N,1,Intermediate,,1,,,
CHEMBL631829,14439,,14858,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,,N,1,Intermediate,,1,,,
CHEMBL875759,12582,,14859,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631830,12582,,14860,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631831,12582,,14861,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631832,12582,,14862,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631833,12582,,14863,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631834,12582,,14864,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631835,12582,,14865,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631836,12582,,14866,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631837,12582,,14867,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631838,12582,,14868,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631839,12582,,14869,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631840,12582,,14870,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631841,12582,,14871,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631842,12582,,14872,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631843,12582,,14873,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631844,12582,,14874,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631845,12582,,14875,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631846,12582,,14876,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL875760,12582,,14877,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL632199,12582,,14878,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631847,12582,,14879,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL631848,12582,,14880,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628707,12582,,14881,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628708,12582,,14882,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628709,12582,,14883,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628710,12582,,14884,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628711,12582,,14885,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628712,12582,,14886,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628713,12582,,14887,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628714,12582,,14888,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,N,1,Intermediate,Urine,1,,1088.0,
CHEMBL628715,7415,,14889,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,,N,1,Intermediate,,1,,,
CHEMBL629179,7313,,14890,,,,22224,,A,,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,U,0,Autocuration,,1,,,
CHEMBL629180,7313,,14891,,,,22224,,A,,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,U,0,Autocuration,,1,,,
CHEMBL875108,7313,,14892,,,,22224,,A,,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,U,0,Autocuration,,1,,,
CHEMBL629181,7570,,14893,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,U,0,Autocuration,Adrenal cortex,1,,1235.0,
CHEMBL629182,7570,,14894,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,U,0,Autocuration,Adrenal cortex,1,,1235.0,
CHEMBL629183,7570,,14895,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629184,7570,,14896,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629185,7570,,14897,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,U,0,Autocuration,Adrenal cortex,1,,1235.0,
CHEMBL629186,7570,,14898,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,U,0,Autocuration,Adrenal cortex,1,,1235.0,
CHEMBL629187,7570,,14899,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629887,7570,,14900,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629888,7570,,14901,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629889,7570,,14902,,,,22224,,A,,BAO_0000019,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629890,7570,,14903,,,,22224,,A,,BAO_0000019,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,U,0,Autocuration,Adrenal cortex,1,,1235.0,
CHEMBL629891,7570,,14904,,,,22224,,A,,BAO_0000019,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629892,7570,,14905,,,,22224,,A,,BAO_0000019,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629893,7570,,14906,,,,22224,,A,,BAO_0000019,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,U,0,Autocuration,Adrenal cortex,1,,1235.0,
CHEMBL629894,7570,,14907,,,,22224,,A,,BAO_0000019,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL629895,7570,,14908,,,,22224,,A,,BAO_0000019,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,U,0,Autocuration,,1,,,
CHEMBL875109,14122,,14909,,9615.0,In vivo,22224,,A,Canis lupus familiaris,BAO_0000218,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,,U,0,Autocuration,,1,,,
CHEMBL629896,16449,,14910,,9541.0,In vivo,22224,,A,Macaca fascicularis,BAO_0000218,Absolute bioavailability in male cynomolgus monkeys,,,U,0,Autocuration,,1,,,
CHEMBL629897,16449,,14911,,10116.0,In vivo,22224,,A,Rattus norvegicus,BAO_0000218,Absolute bioavailability in maleSprague-Dawley rats,,,U,0,Autocuration,,1,,,
CHEMBL629898,12017,,14912,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630057,12017,,14913,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630058,12017,,14914,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630059,12017,,14915,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630060,12017,,14916,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630061,12017,,14917,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630062,12017,,14918,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630063,12017,,14919,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630064,12017,,14920,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630065,12017,,14921,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630066,12017,,14922,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630067,12017,,14923,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL630068,12017,,14924,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Lung,1,,2048.0,
CHEMBL631113,12017,,14925,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631114,12017,,14926,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631115,12017,,14927,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL631116,12017,,14928,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630528,12017,,14929,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630529,12017,,14930,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630530,12017,,14931,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630531,12017,,14932,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630532,12017,,14933,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630533,12017,,14934,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Muscle tissue,1,,2385.0,
CHEMBL630534,15045,,14935,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice blood after 120 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630535,15045,,14936,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice blood after 24 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630536,15045,,14937,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice blood after 4 hr,,,N,1,Intermediate,Blood,1,,178.0,
CHEMBL630537,15045,,14938,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice bone after 120 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL630538,15045,,14939,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice bone after 24 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL630539,15045,,14940,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice bone after 4 hr,,,N,1,Intermediate,Bone,1,,10000001.0,
CHEMBL630540,15045,,14941,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice heart after 120 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630541,15045,,14942,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice heart after 24 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630542,15045,,14943,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice heart after 4 hr,,,N,1,Intermediate,Heart,1,,948.0,
CHEMBL630543,15045,,14944,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice kidney after 120 hr,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630544,15045,,14945,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice kidney after 24 hr,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630545,15045,,14946,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice kidney after 4 hr,,,N,1,Intermediate,Kidney,1,,2113.0,
CHEMBL630546,15045,,14947,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice liver after 120 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630547,15045,,14948,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice liver after 24 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630548,15045,,14949,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice liver after 4 hr,,,N,1,Intermediate,Liver,1,,2107.0,
CHEMBL630549,15045,,14950,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice spleen after 120 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630550,15045,,14951,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice spleen after 24 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL876426,15045,,14952,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in normal mice spleen after 4 hr,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630551,12017,,14953,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630552,12017,,14954,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630553,12017,,14955,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630554,12017,,14956,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630555,12017,,14957,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630556,12017,,14958,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630557,12017,,14959,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630558,12017,,14960,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630559,12017,,14961,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL630560,12017,,14962,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Spleen,1,,2106.0,
CHEMBL876427,12017,,14963,,10116.0,In vivo,50597,,A,Rattus norvegicus,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,N,1,Intermediate,Thyroid gland,1,,2046.0,
CHEMBL630561,14941,,14964,,10116.0,,50597,,A,Rattus norvegicus,BAO_0000218,The Kel values in female wistar rats.,,,N,1,Intermediate,,1,,,
CHEMBL630562,4646,,14965,,,,22224,,A,,BAO_0000019,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL630563,8847,,14966,,,,22224,,A,,BAO_0000019,Hydrolysis rate constant of the compound,,,U,0,Autocuration,,1,,,
CHEMBL629673,11778,,14967,,,,22229,,P,,BAO_0000100,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,U,0,Autocuration,,1,,,
CHEMBL629674,2363,,14968,,,,22224,,A,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL629675,2363,,14969,,,,22224,,A,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,U,0,Autocuration,,1,,,
CHEMBL629676,2363,,14970,,,,22224,,A,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,U,0,Autocuration,,1,,,
CHEMBL629677,2363,,14971,,,,22224,,A,,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,U,0,Autocuration,,1,,,
CHEMBL629678,8371,,14972,,,,22224,,A,,BAO_0000019,Apparent inactivation rate constant was evaluated,,,U,0,Autocuration,,1,,,
CHEMBL629679,14883,,14973,,,,22224,,A,,BAO_0000019,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,U,0,Autocuration,,1,,,
CHEMBL629680,14883,,14974,,,,22224,,A,,BAO_0000019,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,U,0,Autocuration,,1,,,
CHEMBL629681,4643,,14975,,,,22224,,A,,BAO_0000019,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,U,0,Autocuration,,1,,,
CHEMBL629682,3519,,14976,,,,22224,,A,,BAO_0000019,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,U,0,Autocuration,,1,,,
CHEMBL629683,10600,,14977,,,,22224,,A,,BAO_0000019,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,U,0,Autocuration,,1,,,
CHEMBL629684,8501,,14978,,,,22224,,F,,BAO_0000019,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,U,0,Autocuration,,1,,,
CHEMBL629685,8505,,14979,,,,22224,,P,,BAO_0000100,Dissociation constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL629686,9778,,14980,,,,22224,,P,,BAO_0000100,Dissociation constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL872932,9778,,14981,,,,22224,,P,,BAO_0000100,Dissociation constant at pH 7.4,,,U,0,Autocuration,,1,,,
CHEMBL629687,9778,,14982,,,,22224,,P,,BAO_0000100,Dissociation constant in presence of 1 mM dithiothreitol,,,U,0,Autocuration,,1,,,
CHEMBL872931,13007,,14983,,,,22224,,A,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,U,0,Autocuration,,1,,,
CHEMBL628151,13007,,14984,,,,22224,,A,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,U,0,Autocuration,,1,,,
CHEMBL628152,13007,,14985,,,,22224,,A,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,U,0,Autocuration,,1,,,
CHEMBL628153,13007,,14986,,,,22224,,A,,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,U,0,Autocuration,,1,,,
CHEMBL628154,11482,,14987,,,,22224,,A,,BAO_0000019,Kinetic constant for aromatization of androstenedione,,,U,0,Autocuration,,1,,,
CHEMBL628155,11482,,14988,,,,22224,,A,,BAO_0000019,Kinetic constant for aromatization of testosterone,,,U,0,Autocuration,,1,,,
CHEMBL628156,2303,,14989,,,,22224,,A,,BAO_0000019,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,U,0,Autocuration,,1,,,
CHEMBL628157,11964,,14990,,,,22224,,A,,BAO_0000019,Local inhibition constant was determined,,,U,0,Autocuration,,1,,,
CHEMBL857533,3140,,14991,,4932.0,,50347,,A,Saccharomyces cerevisiae,BAO_0000218,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,,N,1,Intermediate,,1,,,
CHEMBL628158,10650,,14992,,,,22224,,P,,BAO_0000100,Dissociation constant value of the compound,,,U,0,Autocuration,,1,,,
CHEMBL628159,4667,,14993,,,,22224,,A,,BAO_0000019,In vitro permeability through cornea without epithelium,,,U,0,Autocuration,Cornea,1,,964.0,
CHEMBL875616,4667,,14994,,,,22224,,A,,BAO_0000019,In vitro permeability through intact cornea,,,U,0,Autocuration,Cornea,1,,964.0,
CHEMBL628160,9199,,14995,,9986.0,,50592,,A,Oryctolagus cuniculus,BAO_0000218,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,,N,1,Intermediate,Cornea,1,,964.0,
CHEMBL628161,11966,,14996,,,,22224,,A,,BAO_0000019,Rate of enzyme inactivation for the compound was determined,,,U,0,Autocuration,,1,,,
CHEMBL628162,4667,,14997,,,,22224,,A,,BAO_0000019,In vitro permeability through cornea without epithelium,,,U,0,Autocuration,Cornea,1,,964.0,
CHEMBL628163,4667,,14998,,,,22224,,A,,BAO_0000019,In vitro permeability through intact cornea,,,U,0,Autocuration,Cornea,1,,964.0,
CHEMBL628164,8354,,14999,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628165,8354,,15000,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628166,8354,,15001,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628167,8354,,15002,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628168,8354,,15003,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628169,8354,,15004,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628170,8354,,15005,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628171,8354,,15006,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL627434,8354,,15007,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL627435,8354,,15008,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628110,8354,,15009,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628111,8354,,15010,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628112,8354,,15011,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628260,8354,,15012,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628261,8354,,15013,,,,22224,,A,,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,U,0,Autocuration,,1,,,
CHEMBL628262,14439,,15014,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,,N,1,Intermediate,,1,,,
CHEMBL628263,14439,,15015,,9606.0,In vivo,50587,,A,Homo sapiens,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,,N,1,Intermediate,,1,,,
CHEMBL628264,14439,,15016,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,,N,1,Intermediate,,1,,,
CHEMBL628265,14439,,15017,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,,N,1,Intermediate,,1,,,
CHEMBL628266,14439,,15018,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,,N,1,Intermediate,,1,,,
CHEMBL628267,14439,,15019,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,,N,1,Intermediate,,1,,,
CHEMBL628268,14439,,15020,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,,N,1,Intermediate,,1,,,
CHEMBL628269,14439,,15021,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,,N,1,Intermediate,,1,,,
CHEMBL628270,14439,,15022,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,,N,1,Intermediate,,1,,,
CHEMBL628271,14439,,15023,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,,N,1,Intermediate,,1,,,
CHEMBL628272,14439,,15024,,10090.0,In vivo,50594,,A,Mus musculus,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,,N,1,Intermediate,,1,,,
